WorldWideScience

Sample records for trademark atherectomy system

  1. Treatment of the femoropopliteal arteries with a novel rotational atherectomy system: early single-center experience with the Pathway PV trademark Atherectomy System

    International Nuclear Information System (INIS)

    Wissgott, C.; Kamusella, P.; Richter, A.; Steinkamp, H.J.; Schink, T.; Klein-Weigel, P.

    2008-01-01

    Purpose: The main problem when treating the superficial femoral and popliteal artery with PTA or stent implantation is the relatively high restenosis rate. Several ablative systems are available as an alternative. The purpose of this prospective study was to evaluate the safety and performance of a novel rotational and aspirating atherectomy system. Materials and Methods: From June to December 2006, we treated 23 patients, median age 70.3 years (58 - 91), with the rotational atherectomy system. All patients had de-novo lesions of the SFA or PA with a minimum stenosis of 70%. According to the Rutherford classification, 39% of the patients were in category 2 and 61% in category 3. The median lesion length was 26.3 mm (5 - 100 mm). 26% of the patients had occlusions. Results: The technical success rate was 100%. In 14 cases (61%) additional balloon dilatation was applied, in two cases stent implantation were performed. The median treatment duration with the device was 187.7 ± 106.1 s (59 - 391 s). The aspirated volume was 116.5 ± 72.0 ml. The ankle brachial index improved from preinterventional 0.60 ± 0.16 to postinterventional 0.85 ± 0.13 and after 6 month 0.80 ± 0.13. During follow-up, two (8%) restenosis occurred. There were two complications, one dissection and one distal embolization. Follow-up could not be performed for two patients (8%). Conclusion: Atherectomy of femoropopliteal lesions with the Pathway PV trademark Atherectomy System is very safe and effective. The low restenosis rate of 8% is promising, but there is still a lack of long-term results

  2. Treatment of the femoropopliteal arteries with a novel rotational atherectomy system: early single-center experience with the Pathway PV trademark Atherectomy System; Behandlung von Laesionen der femoropoplitealen Arterien mittels eines neuartigen Rotationsatherektomiesystems: Erste single-center Erfahrungen mit dem Pathway PV trademark Atherectomy System

    Energy Technology Data Exchange (ETDEWEB)

    Wissgott, C.; Kamusella, P.; Richter, A.; Steinkamp, H.J. [Radiologie, DRK-Kliniken Berlin (Germany); Schink, T. [Institut fuer Biometrie, Charite Berlin (Germany); Klein-Weigel, P. [Angiologie, DRK-Kliniken Berlin (Germany)

    2008-09-15

    Purpose: The main problem when treating the superficial femoral and popliteal artery with PTA or stent implantation is the relatively high restenosis rate. Several ablative systems are available as an alternative. The purpose of this prospective study was to evaluate the safety and performance of a novel rotational and aspirating atherectomy system. Materials and Methods: From June to December 2006, we treated 23 patients, median age 70.3 years (58 - 91), with the rotational atherectomy system. All patients had de-novo lesions of the SFA or PA with a minimum stenosis of 70%. According to the Rutherford classification, 39% of the patients were in category 2 and 61% in category 3. The median lesion length was 26.3 mm (5 - 100 mm). 26% of the patients had occlusions. Results: The technical success rate was 100%. In 14 cases (61%) additional balloon dilatation was applied, in two cases stent implantation were performed. The median treatment duration with the device was 187.7 {+-} 106.1 s (59 - 391 s). The aspirated volume was 116.5 {+-} 72.0 ml. The ankle brachial index improved from preinterventional 0.60 {+-} 0.16 to postinterventional 0.85 {+-} 0.13 and after 6 month 0.80 {+-} 0.13. During follow-up, two (8%) restenosis occurred. There were two complications, one dissection and one distal embolization. Follow-up could not be performed for two patients (8%). Conclusion: Atherectomy of femoropopliteal lesions with the Pathway PV trademark Atherectomy System is very safe and effective. The low restenosis rate of 8% is promising, but there is still a lack of long-term results.

  3. Patient Selection and Procedural Considerations for Coronary Orbital Atherectomy System

    Science.gov (United States)

    Sotomi, Yohei; Shlofmitz, Richard A; Colombo, Antonio; Serruys, Patrick W

    2016-01-01

    Despite advances in technology, percutaneous coronary intervention (PCI) of severely calcified coronary lesions remains challenging. Rotational atherectomy is one of the current therapeutic options to manage calcified lesions, but has a limited role in facilitating the dilation or stenting of lesions that cannot be crossed or expanded with other PCI techniques due to unfavourable clinical outcome in long-term follow-up. However the results of orbital atherectomy presented in the ORBIT I and ORBIT II trials were encouraging. In addition to these encouraging data, necessity for sufficient lesion preparation before implantation of bioresorbable scaffolds lead to resurgence in the use of atherectomy. This article summarises currently available publications on orbital atherectomy (Cardiovascular Systems Inc.) and compares them with rotational atherectomy. PMID:29588702

  4. Outcomes in Diabetic Patients Undergoing Orbital Atherectomy System.

    Science.gov (United States)

    Lee, Michael S; Shlofmitz, Evan; Nguyen, Heajung; Shlofmitz, Richard A

    2016-10-01

    We evaluated the angiographic and clinical outcomes of orbital atherectomy to treat severely calcified coronary lesions in diabetic and non-diabetic patients. Diabetics have increased risk for death, myocardial infarction, and target vessel revascularization after percutaneous coronary intervention. Severely calcified coronary lesions are associated with increased cardiac events. Orbital atherectomy facilitates stent delivery and optimizes stent expansion by modifying severely calcified plaque. Outcomes in diabetic patients who undergo orbital atherectomy have not been reported. Our retrospective multicenter registry included 458 consecutive real-world patients with severely calcified coronary arteries who underwent orbital atherectomy. The primary safety endpoint was the rate of major adverse cardiac and cerebrovascular events at 30 days. Diabetics represented 42.1% (193/458) of the entire cohort. The primary endpoint was similar in diabetics and non-diabetics (1.0% vs. 3.0%%, P = 0.20), as were 30-day rates of death (0.5% vs. 1.9%, P = 0.41), myocardial infarction (0.5% vs. 1.5%, P = 0.40), target vessel revascularization (0% vs. 0%, P = 1), and stroke (0% vs. 0.4%, P > 0.9). Angiographic complications and stent thrombosis rate were low and did not differ between the 2 groups. Diabetics represented a sizeable portion of patients who underwent orbital atherectomy. Diabetics who had severely calcified coronary arteries and underwent orbital atherectomy had low event rates that were similar to non-diabetics. Orbital atherectomy appears to be a viable treatment strategy for diabetic patients. Randomized trials with longer-term follow-up are needed to determine the ideal treatment strategy for diabetics. © 2016, Wiley Periodicals, Inc.

  5. GammaCam trademark radiation imaging system

    International Nuclear Information System (INIS)

    1998-02-01

    GammaCam trademark, a gamma-ray imaging system manufactured by AIL System, Inc., would benefit a site that needs to locate radiation sources. It is capable of producing a two-dimensional image of a radiation field superimposed on a black and white visual image. Because the system can be positioned outside the radiologically controlled area, the radiation exposure to personnel is significantly reduced and extensive shielding is not required. This report covers the following topics: technology description; performance; technology applicability and alternatives; cost; regulatory and policy issues; and lessons learned. The demonstration of GammaCam trademark in December 1996 was part of the Large-Scale Demonstration Project (LSDP) whose objective is to select and demonstrate potentially beneficial technologies at the Argonne National Laboratory-East (ANL) Chicago Pile-5 Research Reactor (CP-5). The purpose of the LSDP is to demonstrate that by using innovative and improved decontamination and decommissioning (D and D) technologies from various sources, significant benefits can be achieved when compared to baseline D and D technologies

  6. Orbital atherectomy: device evolution and clinical data.

    Science.gov (United States)

    Staniloae, Cezar S; Korabathina, Ravikiran

    2014-05-01

    A number of atherectomy devices were developed in the last few years. Among them, the DiamondBack 360° Peripheral Orbital Atherectomy System (Cardiovascular Systems, Inc) was specifically designed to work in severely calcified plaque. This article reviews the history, mechanism of action, evolution, clinical data, and future applications of this particular atherectomy device.

  7. System 80+trademark Standard Design: CESSAR design certification

    International Nuclear Information System (INIS)

    1990-01-01

    This report, entitled Combustion Engineering Standard Safety Analysis Report -- Design Certification (CESSAR-DC), has been prepared in support of the industry effort to standardize nuclear plant designs. These volumes describe the Combustion Engineering, Inc. System 80 + trademark Standard Design. This volume 10 discusses the Steam and Power Conversion System and Radioactive Waste Management

  8. System 80+trademark Standard Design: CESSAR design certification

    International Nuclear Information System (INIS)

    1990-01-01

    This report, entitled Combustion Engineering Standard Safety Analysis Report -- Design Certification (CESSAR-DC), has been prepared in support of the industry effort to standardize nuclear plant designs. These volumes describe the Combustion Engineering, Inc. System 80 + trademark Standard Design. This volume 9 discusses Electric Power and Auxiliary Systems

  9. System 80+trademark Standard Design: CESSAR design certification

    International Nuclear Information System (INIS)

    1990-01-01

    This report, entitled Combustion Engineering Standard Safety Analysis Report - Design Certification (CESSAR-DC), has been prepared in support of the industry effort to standardize nuclear plant designs. These volumes describe the Combustion Engineering, Inc. System 80+trademark Standard Design. This Volume 16 details the application of Human Factors Engineering in the design process

  10. System 80+trademark Standard Design: CESSAR design certification

    International Nuclear Information System (INIS)

    1990-01-01

    This report, entitled Combustion Engineering Standard Safety Analysis Report -- Design Certification (CESSAR-DC), has been prepared in support of the industry effort to standardize nuclear plant designs. These volumes describe the Combustion Engineering, Inc. System 80 + trademark Standard Design. This volume 11 discusses Radiation Protection, Conduct of Operations, and the Initial Test Program

  11. System 80+trademark Standard Design: CESSAR design certification

    International Nuclear Information System (INIS)

    1990-01-01

    This report, entitled Combustion Engineering Standard Safety Analysis Report -- Design Certification (CESSAR-DC), has been prepared in support of the industry effort to standardize nuclear plant designs. These volumes describes the Combustion Engineering, Inc. System 80+trademark Standard Design. This Volume 17 provides Appendix A of this report, closure of unresolved and Genetic Safety Issues

  12. System 80+trademark Standard Design: CESSAR design certification

    International Nuclear Information System (INIS)

    1990-01-01

    This report, entitled Combustion Engineering Standard Safety Analysis Report -- Design Certification (CESSAR-DC), has been prepared in support of the industry effort to standardize nuclear plant designs. These volumes describe the Combustion Engineering, Inc. System 80 + trademark Standard Design. This volume 8 provides a description of instrumentation and controls

  13. System 80+trademark Standard Design: CESSAR design certification

    International Nuclear Information System (INIS)

    1990-01-01

    This report, entitled Combustion Engineering Standard Safety Analysis Report -- Design Certification (CESSAR-DC), has been prepared in support of the industry effort to standardize nuclear plant designs. These volumes describe the Combustion Engineering, Inc. System 80+trademark Standard Design. This Volume 18 provides Appendix B, Probabilistic Risk Assessment

  14. System 80+{trademark} standard design incorporates radiation protection lessons learned

    Energy Technology Data Exchange (ETDEWEB)

    Crom, T.D.; Naugle, C.L. [Duke Engineering & Services, Inc., Charlotte, NC (United States); Turk, R.S. [ABB Combustion Engineering Nuclear Power, Windsor, CT (United States)

    1995-03-01

    Many lessons have been learned from the current generation of nuclear plants in the area of radiation protection. The following paper will outline how the lessons learned have been incorporated into the design and operational philosophy of the System 80+{trademark} Standard Design currently under development by ABB Combustion Engineering (ABB-CE) with support from Duke Engineering and Services, Inc. and Stone and Webster Engineering Corporation in the Balance-of-Plant design. The System 80+{trademark} Standard Design is a complete nuclear power plant for national and international markets, designed in direct response to utility needs for the 1990`s, and scheduled for Nuclear Regulatory Commission (NRC) Design Certification under the new standardization rule (10 CFR Part 52). System 80+{trademark} is a natural extension of System 80{sup R} technology, an evolutionary change based on proven Nuclear Steam Supply System (NSSS) in operation at Palo Verde in Arizona and under construction at Yonggwang in the Republic of Korea. The System 80+{trademark} Containment and much of the Balance of Plant design is based upon Duke Power Company`s Cherokee Plant, which was partially constructed in the late 1970`s, but, was later canceled (due to rapid declined in electrical load growth). The System 80+{trademark} Standard Design meets the requirements given in the Electric Power Research Institute (EPRI) Advanced Light Water Reactor (ALWR) Requirements Document. One of these requirements is to limit the occupational exposure to 100 person-rem/yr. This paper illustrates how this goal can be achieved through the incorporation of lessons learned, innovative design, and the implementation of a common sense approach to operation and maintenances practices.

  15. Quantification by optical coherence tomography imaging of the ablation volume obtained with the Orbital Atherectomy System in calcified coronary lesions

    NARCIS (Netherlands)

    Sotomi, Yohei; Cavalcante, Rafael; Shlofmitz, Richard A.; Suwannasom, Pannipa; Tateishi, Hiroki; Tenekecioglu, Erhan; Zheng, Yaping; Abdelghani, Mohammad; de Winter, Robbert J.; Wykrzykowska, Joanna J.; Onuma, Yoshinobu; Serruys, Patrick W.

    2016-01-01

    Recently, favourable procedural 30-day and one-year outcomes with the Diamondback 360 Orbital Atherectomy System (OAS) in the treatment of severely calcified lesions have been reported. The purpose of this study was to assess the therapeutic mechanism and efficacy of the OAS with optical coherence

  16. System 80+trademark Standard Design: CESSAR design certification. Volume 16

    International Nuclear Information System (INIS)

    1997-01-01

    This report has been prepared in support of the industry effort to standardize nuclear plant designs. This document describes the Combustion Engineering, Inc. System 80+trademark Standard Design. This volume contain Chapter 18 -- Human Factors Engineering. Topics covered include: design team organization and responsibilities; design goals and design bases; design process and application to human factors engineering; functional task analysis; control room configuration; information presentation and panel layout evaluation; control and monitoring outside the main control room; and verification and validation

  17. Embolic Protection using the WIRION Embolic Protection System with JetStream Atherectomy in a Patient with Superficial Femoral Artery Chronic total Occlusion.

    Science.gov (United States)

    Shammas, Nicolas W

    2017-06-01

    Distal embolization is a common occurrence with peripheral arterial interventions and is more frequent with the use of atherectomy devices. We report the first case of JetStream atherectomy (Boston Scientific, Maple Grove, MN) with the use of the novel WIRION embolic protection system filter. The procedure was performed successfully with no distal embolizations beyond the filter and with no complications in the delivery or retrieval of the filter. The pros and cons of the off label use of this filter with JetStream atherectomy are discussed.

  18. Radiant{trademark} Liquid Radioisotope Intravascular Radiation Therapy System

    Energy Technology Data Exchange (ETDEWEB)

    Eigler, N.; Whiting, J.; Chernomorsky, A.; Jackson, J.; Knapp, F.F., Jr.; Litvack, F.

    1998-01-16

    RADIANT{trademark} is manufactured by United States Surgical Corporation, Vascular Therapies Division, (formerly Progressive Angioplasty Systems). The system comprises a liquid {beta}-radiation source, a shielded isolation/transfer device (ISAT), modified over-the-wire or rapid exchange delivery balloons, and accessory kits. The liquid {beta}-source is Rhenium-188 in the form of sodium perrhenate (NaReO{sub 4}), Rhenium-188 is primarily a {beta}-emitter with a physical half-life of 17.0 hours. The maximum energy of the {beta}-particles is 2.1 MeV. The source is produced daily in the nuclear pharmacy hot lab by eluting a Tungsten-188/Rhenium-188 generator manufactured by Oak Ridge National Laboratory (ORNL). Using anion exchange columns and Millipore filters the effluent is concentrated to approximately 100 mCi/ml, calibrated, and loaded into the (ISAT) which is subsequently transported to the cardiac catheterization laboratory. The delivery catheters are modified Champion{trademark} over-the-wire, and TNT{trademark} rapid exchange stent delivery balloons. These balloons have thickened polyethylene walls to augment puncture resistance; dual radio-opaque markers and specially configured connectors.

  19. Jetstream Atherectomy System treatment of femoropopliteal arteries: Results of the post-market JET Registry.

    Science.gov (United States)

    Gray, William A; Garcia, Lawrence A; Amin, Ali; Shammas, Nicolas W

    2017-12-27

    To report on procedural, safety, and effectiveness outcomes of real-world practice with the Jetstream rotational atherectomy system for treatment of femoropopliteal artery lesions. Safety and effectiveness of treatment with the Jetstream device has been demonstrated in clinical trials, but outcomes during real-world clinical practice have yet to be examined. 241 patients (66% male, mean age 67years, 41% diabetes; Rutherford 1-3) with de novo or restenotic (non-stent) femoropopliteal lesions ≥4cm in length were recruited. Major adverse events (MAE), defined as amputation, death, target lesion/vessel revascularization (TLR/TVR), myocardial infarction, or angiographic distal embolization that required a separate intervention; and binary restenosis were assessed at 30days and 12months. The mean (±SD) lesion length was 16.4±13.6cm; 35% of patients received adjunctive stents. Procedural success was achieved for 98.3% of lesions. The 30-day MAE rate was 2% (5/219; 2 TLR/TVR and 3 distal embolization); there were no deaths, index limb amputations, or myocardial infarctions. At 12months, the overall estimated freedom from TLR/TVR was 81.7% and 77.2% (44/57) of patients were free from duplex ultrasound-assessed restenosis. Efficacy and patency in a diabetic subset were similar to those of the overall cohort, while maintaining a similar safety profile. In a cohort reflecting real-world practice, the Jetstream Atherectomy System demonstrated a high procedural success rate with a low rate of complications and reinterventions, especially given the relatively long lesions studied. Copyright © 2017. Published by Elsevier Inc.

  20. Mechanism of lumen gain with a novel rotational aspiration atherectomy system for peripheral arterial disease: examination by intravascular ultrasound.

    Science.gov (United States)

    Hassan, Ali H M; Ako, Junya; Waseda, Katsuhisa; Honda, Yasuhiro; Zeller, Thomas; Leon, Martin B; Fitzgerald, Peter J

    2010-01-01

    The purpose of this study was to evaluate the mechanism of luminal gain with a novel atheroablation system (Pathway PV) for the treatment of peripheral artery disease using intravascular ultrasound (IVUS). The atherectomy system is a rotational atherectomy device, which employs expandable rotating blades with ports that allow flushing and aspiration of the plaque material or thrombus. In this first-in-man clinical study, IVUS analysis was available in 6 patients with lower limb ischemia treated with this device. The treatment results were assessed using IVUS at pre and post atherectomy. Lumen beyond burr size (LBB) was defined as lumen gain divided by the estimated burr area determined by the burr-size. IVUS analysis was available in six patients (superficial femoral artery n=3, popliteal artery n=2, posterior tibial artery n=1). Atheroablation achieved a significant increase in lumen area (LA) (preintervention 3.9+/-0.4, postatheroablation 8.0+/-1.7 mm(2), Patherectomy device achieved significant luminal gain by debulking in the absence of vessel stretching. The LA was greater than burr-sized lumen expectancy at cross-sections along the treated segments, suggesting a complimentary role of aspiration in luminal gain in atherosclerotic peripheral artery lesions.

  1. Atherectomy devices: technology update

    Science.gov (United States)

    Akkus, Nuri I; Abdulbaki, Abdulrahman; Jimenez, Enrique; Tandon, Neeraj

    2015-01-01

    Atherectomy is a procedure which is performed to remove atherosclerotic plaque from diseased arteries. Atherosclerotic plaques are localized in either coronary or peripheral arterial vasculature and may have different characteristics depending on the texture of the plaque. Atherectomy has been used effectively in treatment of both coronary and peripheral arterial disease. Atherectomy devices are designed differently to either cut, shave, sand, or vaporize these plaques and have different indications. In this article, current atherectomy devices are reviewed. PMID:25565904

  2. Fibradapt trademark: Adaptive Wind Turbine Control System; Fibradapt trademark: Adaptive Wind Turbine Control System

    Energy Technology Data Exchange (ETDEWEB)

    Wernicke, J.-Th. [Wind Force Engineering and Consulting GmbH, Bremerhaven (Germany)

    2004-07-01

    The technology of Time Division Multiplexing (TDM) is compared with conventional strain gauge technologies in practical operation in a wind power system. Load cycles in the rotor blade were measured during plant life, and the data were used in plant control. The system is a tool in technical project management and financial management of a wind park. (orig.)

  3. Pipe Explorer{trademark} surveying system. Innovative technology summary report

    Energy Technology Data Exchange (ETDEWEB)

    1999-06-01

    The US Department of Energy`s (DOE) Chicago Operations Office and the DOE`s Federal Energy Technology Center (FETC) developed a Large Scale Demonstration Project (LSDP) at the Chicago Pile-5 Research Reactor (CP-5) at Argonne National Laboratory-East (ANL). The objective of the LSDP is to demonstrate potentially beneficial decontamination and decommissioning (D and D) technologies in comparison with current baseline technologies. The Pipe Explorer{trademark} system was developed by Science and Engineering Associates, Inc. (SEA), Albuquerque, NM as a deployment method for transporting a variety of survey tools into pipes and ducts. Tools available for use with the system include alpha, beta and gamma radiation detectors; video cameras; and pipe locator beacons. Different versions of this technology have been demonstrated at three other sites; results of these demonstrations are provided in an earlier Innovative Technology Summary Report. As part of a D and D project, characterization radiological contamination inside piping systems is necessary before pipes can be recycled, remediated or disposed. This is usually done manually by surveying over the outside of the piping only, with limited effectiveness and risk of worker exposure. The pipe must be accessible to workers, and embedded pipes in concrete or in the ground would have to be excavated at high cost and risk of exposure to workers. The advantage of the Pipe Explorer is its ability to perform in-situ characterization of pipe internals.

  4. The feasibility of transradial laser atherectomy for chronic total occlusion using the 5 Fr sheath system

    Directory of Open Access Journals (Sweden)

    Khaled Sherif

    2016-05-01

    Full Text Available Objective. We present a case of chronic total occlusion (CTO approached with LASER endovascular intervention by radial artery approach using a 5 French sheath. Case report. A 57-year-old man presented to our hospital having had retrosternal chest pain for two days. Physical examination was normal at the time of presentation. The laboratory tests were within normal limits, including cardiac enzymes except the lipid panel which showed hypertriglyceridemia. The patient underwent a myocardial perfusion scintigraphy stress test that revealed inferior wall ischemia, with normal left ventricular ejection fraction. A 5-French vascular sheath was placed in the right radial artery. Selective coronary artery angiography was performed, which showed right coronary artery (RCA CTO. A 5-French JR4 guide catheter successfully engaged the RCA and Laser angioplasty was performed across the CTO into the RCA. A marked improvement of flow was evident thereafter. Conclusion. To best of our knowledge this is the first case report showing the feasibility of laser atherectomy using the 5 French sheath system in a coronary arterial CTO.

  5. The feasibility of transradial laser atherectomy for chronic total occlusion using the 5 Fr sheath system.

    Science.gov (United States)

    Sherif, Khaled; Yaqub, Yasir; Suarez, Jose A

    2016-05-01

    We present a case of chronic total occlusion (CTO) approached with LASER endovascular intervention by radial artery approach using a 5 French sheath. A 57-year-old man presented to our hospital having had retrosternal chest pain for two days. Physical examination was normal at the time of presentation. The laboratory tests were within normal limits, including cardiac enzymes except the lipid panel which showed hypertriglyceridemia. The patient underwent a myocardial perfusion scintigraphy stress test that revealed inferior wall ischemia, with normal left ventricular ejection fraction. A 5-French vascular sheath was placed in the right radial artery. Selective coronary artery angiography was performed, which showed right coronary artery (RCA) CTO. A 5-French JR4 guide catheter successfully engaged the RCA and Laser angioplasty was performed across the CTO into the RCA. A marked improvement of flow was evident thereafter. To best of our knowledge this is the first case report showing the feasibility of laser atherectomy using the 5 French sheath system in a coronary arterial CTO. Copyright © 2016 by Academy of Sciences and Arts of Bosnia and Herzegovina.

  6. BWR spent fuel transport and storage system for KKL: TN trademark 52L, TN trademark 97L, TN trademark 24 BHL

    International Nuclear Information System (INIS)

    Sicard, D.; Verdier, A.; Monsigny, P.A.

    2004-01-01

    The LEIBSTADT (KKL) nuclear power plant in Switzerland has opted to ship spent fuel to a central facility called ZWILAG for interim storage. In the mid-nineties, COGEMA LOGISTICS was contracted by KKL for the supply of the TN trademark a52L and TN trademark 97L transport and storage casks for BWR fuel types. In 2003, KKL also ordered from COGEMA LOGISTICS the supply of six TNae24 BHL transport and storage casks. This paper shows how all the three cask designs have responded to the KKL needs to ship and store BWR spent fuel. In addition, it highlights the already significant operational feedback of the TN trademark 52L and TN trademark 97L casks by the KKL and ZWILAG operators

  7. Atherectomy in Peripheral Artery Disease: A Review.

    Science.gov (United States)

    Bhat, Tariq M; Afari, Maxwell E; Garcia, Lawrence A

    2017-04-01

    Peripheral arterial disease (PAD) is a clinical manifestation of systemic atherosclerosis and is associated with significant morbidity and mortality. The physiological force and shear stress from angioplasty and stenting have made PAD treatment challenging. Atherectomy devices have continued to emerge as a major therapy in the management of peripheral vascular disease. This article presents a review of the current literature for the atherectomy devices used in PAD.

  8. Evolution of atherectomy devices.

    Science.gov (United States)

    Al Khoury, G; Chaer, R

    2011-08-01

    Percutaneous atherectomy provides an alternative approach to the endovascular treatment of peripheral atherosclerotic occlusive disease beyond angioplasty and stenting, and has the theoretical advantage of lesion debulking and minimizing barotrauma to the vessel wall. Atherectomy has evolved greatly during the last decade, with currently four FDA approved devices for the treatment of peripheral arterial disease. Several reports have focused on the initial technical success rates, and demonstrated the safety and short as well as mid-term efficacy of atherectomy devices. This article will review the evolution of current atherectomy devices and the associated literature.

  9. Archveyor{trademark} automated mining system - implementation at the Conant mine

    Energy Technology Data Exchange (ETDEWEB)

    Hofmann, W.J. [Arch of Illinois, Percy, IL (United States)

    1997-12-01

    Arch Mineral Corporation, through the Arch Technology Department, has developed an automated continuous haulage mining system called the `Archveyor{trademark}`. The original technology came from a Russian patent. Kloeckner-Becorit (K-B) further developed the system and called it the `Mobile Conveyor`. This system was utilized in both coal and trona mines in the United States and Canada. Consolidation Coal designed their version of this continuous haulage system, called the `Tramveyor`. The Tramveyor is presently operating in their Dilworth Mine, in Pennsylvania. This system has no computer guidance system related to the continuous miner or the Tramveyor. Arch Mineral Corporation has further developed this continuous haulage mining system. Their system is a programmable, logic-controlled (PLC) automated mining system. A highwall version of the Archveyor{trademark} is being operated at Arch of Wyoming near Hanna, Wyoming. This paper introduces the first underground version of Archveyor{trademark} to be implemented at Conant Mine in southern Illinois. During the development process, the Archveyor{trademark} mining system consists of a continuous miner, a bolter car, the Archveyor{trademark} (itself), a stageloader, and an operator`s cab. During the secondary mining process the bolter car is taken out of the system.

  10. Nexsys{trademark} real time risk management system and demonstration at Kushiro coal mine

    Energy Technology Data Exchange (ETDEWEB)

    Addinell, S.J.; Rowan, G.; Matsuyama, S. [CSIRO (Australia). Division of Exploration and Mining

    2005-03-01

    In March 2005, the CSIRO Nexsys{trademark} development team travelled to Kushiro Coal Mine (KCM) to install and evaluate the Nexsys{trademark} real time risk management system developed under joint collaboration with JCOAL and other industry partners. After successful installation and configuration the system was able to interface directly to the existing mine site MELSEC monitoring hardware and system database. Once fully commissioned, Nexsys{trademark} will provide mine operators with a real-time risk management system with the capability to initiate preemptive Trigger Action Response Plans (TARPS) should mine operating parameters change for the worse. A range of autonomous altering and alarming options are available, including the capability to email the nature and severity of the alarm to key personnel, on or off site. The system is also fully compatible with wireless network systems and can be accessed through WLAN devices such as Ethernet enabled PDAs. 2 refs., 3 figs.

  11. Cost effectiveness analysis of the SEAMIST trademark membrane system technology

    International Nuclear Information System (INIS)

    Henriksen, A.D.; Booth, S.R.

    1993-01-01

    This report describes the cost and performance characteristics of SEAMIST trademark, an innovative technology that facilitates measurements of contaminants in both vertical and horizontal vadose zone boreholes. This new technology consists of an airtight membrane linear that is pneumatically emplaced inside the borehole structure. Sampling ports with attached tubing, absorbent collectors, or various in situ measuring devices can be fabricated into the linear and used for monitoring volatile organic compounds (VOCs), semivolatile organic compounds (SVOCs), pesticides, herbicides, polynuclear aromatic hydrocarbons, polychlorinated biphenyls, or radioactive substances. In addition, small instruments can be guided through the lined borehole and measurements taken inside at specified intervals

  12. Task QA plan for Modified Prototypic Hydragard trademark Sampler Overflow System Demonstration at TNX

    International Nuclear Information System (INIS)

    Snyder, T.K.

    1993-01-01

    The primary objective of this task is to evaluate the proposed design modifications to the sample system, including the adequacy of the recommended eductor and the quality of samples obtained from the modified system. Presently, the sample streams are circulated from the originating tank, through a Hydragard trademark sampler system, and back to the originating tank. The overflow from the Hydragard trademark sampler flows to the Recycle Collection Tank (RCT). This report outlines the planned quality assurance controls for the design modification task, including organization and personnel, surveillances, and records package

  13. System 80+{trademark} Standard Design: CESSAR design certification. Volume 9: Amendment I

    Energy Technology Data Exchange (ETDEWEB)

    1990-12-21

    This report, entitled Combustion Engineering Standard Safety Analysis Report -- Design Certification (CESSAR-DC), has been prepared in support of the industry effort to standardize nuclear plant designs. These volumes describe the Combustion Engineering, Inc. System 80{sup +}{trademark} Standard Design. This volume 9 discusses Electric Power and Auxiliary Systems.

  14. Pheripheral Simpson atherectomy

    International Nuclear Information System (INIS)

    Kueffer, G.

    1990-01-01

    A report is given on the experience acquired to date with a new catheter method (Simpson atherectomy, S-AE) for reducing arteriosclerotic stenoses in the pelvic and leg arteries of 47 patients. If the correct instrument size is selected, one can regularly perform complete atherectomies in femoropopliteal vessels. The result of recanalization is not affected by the form of the stenosis, but eccentric, calcified or ulcerated lesions are ideal indications. Percutaneous transluminal angioplasty and atherectomy can be used as complementary methods to optimize, percutaneous peripheral vascular recanalization. The histological findings, methodological limitations, and clinical results are discussed. (orig.) [de

  15. ASRC Aerospace Corporation Selects Dynamically Reconfigurable Anadigm(Registered Trademark) FPAA For Advanced Data Acquisition System

    Science.gov (United States)

    Mata, Carlos T.

    2003-01-01

    Anadigm(registered trademark) today announced that ASRC Aerospace Corporation has designed Anadigm's dynamically reconfigurable Field Programmable Analog Array (FPAA) technology into an advanced data acquisition system developed under contract for NASA. ASRC Aerospace designed in the Anadigm(registered trademark) FPAA to provide complex analog signal conditioning in its intelligent, self-calibrating, and self-healing advanced data acquisition system (ADAS). The ADAS has potential applications in industrial, manufacturing, and aerospace markets. This system offers highly reliable operation while reducing the need for user interaction. Anadigm(registered trademark)'s dynamically reconfigurable FPAAs can be reconfigured in-system by the designer or on the fly by a microprocessor. A single device can thus be programmed to implement multiple analog functions and/or to adapt on-the-fly to maintain precision operation despite system degradation and aging. In the case of the ASRC advanced data acquisition system, the FPAA helps ensure that the system will continue to operating at 100% functionality despite changes in the environment, component degradation, and/or component failures.

  16. Characterization of radioactive contamination inside pipes with the Pipe Explorer{trademark} system. Final report

    Energy Technology Data Exchange (ETDEWEB)

    Cremer, C.D.; Kendrick, D.T.; Lowry, W.; Cramer, E.

    1997-09-30

    The Department of Energy (DOE) is currently in the process of decommissioning and dismantling many of its nuclear materials processing facilities that have been in use for several decades. Site managers throughout the DOE complex must employ the safest and most cost effective means to characterize, remediate and recycle or dispose of hundreds of miles of potentially contaminated piping and duct work. The DOE discovered that standard characterization methods were inadequate for its pipes, drains, and ducts because many of the systems are buried or encased. In response to the DOE`s need for a more specialized characterization technique, Science and Engineering Associates, Inc. (SEA) developed the Pipe Explorer{trademark} system through a DOE Office of Science and Technology (OST) contract administered through the Federal Energy Technology Center (FETC). The purpose of this report is to serve as a comprehensive overview of all phases of the Pipe Explorer{trademark} development project. The report is divided into 6 sections. Section 2 of the report provides an overview of the Pipe Explorer{trademark} system, including the operating principles of using an inverting membrane to tow sensors into pipes. The basic components of the characterization system are also described. Descriptions of the various deployment systems are given in Section 3 along with descriptions of the capabilities of the deployment systems. During the course of the development project 7 types of survey instruments were demonstrated with the Pipe Explorer{trademark} and are a part of the basic toolbox of instruments available for use with the system. These survey tools are described in Section 4 along with their typical performance specifications. The 4 demonstrations of the system are described chronologically in Section 5. The report concludes with a summary of the history, status, and future of the Pipe Explorer{trademark} system in Section 6.

  17. Characterization of radioactive contamination inside pipes with the Pipe Explorer trademark system. Final report

    International Nuclear Information System (INIS)

    Cremer, C.D.; Kendrick, D.T.; Lowry, W.; Cramer, E.

    1997-01-01

    The Department of Energy (DOE) is currently in the process of decommissioning and dismantling many of its nuclear materials processing facilities that have been in use for several decades. Site managers throughout the DOE complex must employ the safest and most cost effective means to characterize, remediate and recycle or dispose of hundreds of miles of potentially contaminated piping and duct work. The DOE discovered that standard characterization methods were inadequate for its pipes, drains, and ducts because many of the systems are buried or encased. In response to the DOE's need for a more specialized characterization technique, Science and Engineering Associates, Inc. (SEA) developed the Pipe Explorer trademark system through a DOE Office of Science and Technology (OST) contract administered through the Federal Energy Technology Center (FETC). The purpose of this report is to serve as a comprehensive overview of all phases of the Pipe Explorer trademark development project. The report is divided into 6 sections. Section 2 of the report provides an overview of the Pipe Explorer trademark system, including the operating principles of using an inverting membrane to tow sensors into pipes. The basic components of the characterization system are also described. Descriptions of the various deployment systems are given in Section 3 along with descriptions of the capabilities of the deployment systems. During the course of the development project 7 types of survey instruments were demonstrated with the Pipe Explorer trademark and are a part of the basic toolbox of instruments available for use with the system. These survey tools are described in Section 4 along with their typical performance specifications. The 4 demonstrations of the system are described chronologically in Section 5. The report concludes with a summary of the history, status, and future of the Pipe Explorer trademark system in Section 6

  18. System 80+{trademark} Standard Design: CESSAR design certification. Volume 8: Amendment I

    Energy Technology Data Exchange (ETDEWEB)

    1990-12-21

    This report, entitled Combustion Engineering Standard Safety Analysis Report -- Design Certification (CESSAR-DC), has been prepared in support of the industry effort to standardize nuclear plant designs. These volumes describe the Combustion Engineering, Inc. System 80{sup +}{trademark} Standard Design. This volume 8 provides a description of instrumentation and controls.

  19. System 80+{trademark} Standard Design: CESSAR design certification. Volume 11: Amendment I

    Energy Technology Data Exchange (ETDEWEB)

    1990-12-21

    This report, entitled Combustion Engineering Standard Safety Analysis Report -- Design Certification (CESSAR-DC), has been prepared in support of the industry effort to standardize nuclear plant designs. These volumes describe the Combustion Engineering, Inc. System 80{sup +}{trademark} Standard Design. This volume 11 discusses Radiation Protection, Conduct of Operations, and the Initial Test Program.

  20. Atherectomy devices: technology update

    Directory of Open Access Journals (Sweden)

    Akkus NI

    2014-12-01

    Full Text Available Nuri I Akkus,1 Abdulrahman Abdulbaki,1 Enrique Jimenez,2 Neeraj Tandon2 1Department of Cardiology, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA, USA; 2Department of Cardiology, Overton Brooks VA Medical Center, Shreveport, LA, USA Abstract: Atherectomy is a procedure which is performed to remove atherosclerotic plaque from diseased arteries. Atherosclerotic plaques are localized in either coronary or peripheral arterial vasculature and may have different characteristics depending on the texture of the plaque. Atherectomy has been used effectively in treatment of both coronary and peripheral arterial disease. Atherectomy devices are designed differently to either cut, shave, sand, or vaporize these plaques and have different indications. In this article, current atherectomy devices are reviewed. Keywords: coronary artery disease, peripheral arterial disease

  1. Safety and effectiveness of the Phoenix Atherectomy System in lower extremity arteries: Early and midterm outcomes from the prospective multicenter EASE study.

    Science.gov (United States)

    Davis, Thomas; Ramaiah, Venkatesh; Niazi, Khusrow; Martin Gissler, Hans; Crabtree, Tami

    2017-12-01

    Objectives To evaluate the novel Phoenix Atherectomy System as percutaneous treatment of de novo and restenotic infrainguinal arterial lesions. Methods This prospective, multicenter, nonrandomized investigational device exemption trial was conducted across 16 US and German centers between August 2010 and April 2013. Intention-to-treat enrollment was 128 patients (mean age: 71.8 years, 59% male) with 149 lesions (mean length: 34 mm, mean diameter stenosis: 89.5%), and the primary analysis per-protocol population consisted of 105 patients with 123 lesions. The primary efficacy endpoint, technical success, was the achievement of acute debulking with a post-atherectomy residual diameter stenosis ≤50% (before adjunctive therapy). The primary safety endpoint was the major adverse event (MAE) rate through 30 days. Results For the primary analysis per-protocol population, the rate of lesion technical success was 95.1% (117/123), with the lower limit of the 95% CI 90.6%, meeting the prospectively established target performance goal of ≥86%. After post-atherectomy adjunctive therapy, residual stenosis was ≤30% for 99.2% (122/123) of lesions (mean final diameter stenosis 10.5%). Improvement of ≥1 Rutherford class occurred for 74.5% of patients through 30 days and for 80% through six months. MAEs were experienced by 5.7% (6/105) of patients through 30 days (with the upper limit of the 95% CI 11.0%, meeting the target performance goal of Atherectomy System is safe and effective for the debulking of lower-extremity arterial lesions. ClinicalTrials.gov identifier NCT01541774.

  2. Peripheral artery atherectomy

    International Nuclear Information System (INIS)

    Quesnel, C.; Maquin, P.; Railhac, N.; Lefevre, G.; Bossavy, J.B.; Railhac, J.J.

    1988-01-01

    Twenty-one femoropopliteal percutaneous transluminal atherectomies were performed with the Simpson catheter. Evaluation included clinical examination, Doppler ultrasonography (ankle-arm index, before and immediately and 1,3 and 6 months after atherectomy), and angiography (6 months after or for clinical worsening). Twenty of 21 procedures achieved satisfactory vessel patency, with the addition of complementary angioplasty for residual stenosis over 30% (one of three cases). Early thrombosis occurred in only one of 21 cases (absence of platelet inhibitor pretherapy), and no distal embolization occurred. Six-month follow-up showed stable improvements in 11 of 12 patients and restenosis in only one (absence of platelet inhibitor pretherapy). Preliminary results indicate that atherectomy is the method of choice for restoring large lumens, with minimal arterial wall injury and fewer cases of restenosis than with angioplasty

  3. System 80+trademark standard design: CESSAR design certification

    International Nuclear Information System (INIS)

    1990-01-01

    This report has been prepared in support of the industry effort to standardize nuclear plant designs. The documents in this series describe the Combustion Engineering, Inc. System 80+ TM Standard Design

  4. Evaluation of a hemostatic device with percutaneous collagen application (VasoSeal trademark) compared to a mechanical compression system (Compressar trademark -) after transfemoral catheterization of patients suffering from arterial occlusive disease

    International Nuclear Information System (INIS)

    Neudecker, A.; Lenhart, M.; Zorger, N.; Paetzel, C.; Feuerbach, S.; Link, J.; Manke, C.

    2003-01-01

    Purpose: Comparison of the efficacy of VasoSeal trademark and a mechanical compression system (Compressar trademark ) for percutaneous hemostasis after femoral arterial catheterization of patients with arterial occlusive disease. Materials and Methods: 60 patients underwent either diagnostic angiography or interventional procedures. The level of anticoagulation, blood pressure, and activation clotting time were recorded, and the time to hemostasis after sheath removal was measured. VasoSeal trademark application was considered ''successful'' if the compression time was less than two minutes. On the subsequent day as well as 4 months later, color coded Doppler ultrasound was performed to register treatment success and potential (late) complications. Results: 57 patients qualified for inclusion in this study. In 21 of the 26 patients who underwent the procedure with the VasoSeal trademark , immediate hemostasis was achieved within 1.75 minutes. In all 31 patients who had the Compressar trademark applied, hemostasis was successful with a mean compression time of 17.4 minutes. Thus, VasoSeal trademark significantly reduced hemostasis time irrespective of anticoagulation status, but it had a much higher incidence of minor local complications (bleeding, hematoma) compared to the control group (34.6% vs. 5.8%). The technical success was lower with VasoSeal trademark than with Compressar trademark (81% vs. 100%). Both groups had no severe or late complications. Conclusion: According to our results, VasoSeal trademark does not provide a suitable alternative compared to the effective, safe and cheap application of Compressar trademark as a hemostatic device. (orig.) [de

  5. Characterization of radioactive contamination inside pipes with the Pipe Explorer trademark system

    International Nuclear Information System (INIS)

    Kendrick, D.T.; Cremer, C.D.; Lowry, W.; Cramer, E.

    1995-01-01

    The U.S. Department of Energy's nuclear facility decommissioning program needs to characterize radiological contamination inside piping systems before the pipe can be recycled, remediated, or disposed. Science and Engineering associates, Inc. under contract with the DOE Morgantown Energy Technology Center has developed and demonstrated the Pipe Explorer trademark system, which uses an inverting membrane to transport various characterization sensors into pipes. The basic process involves inverting (turning inside out) a tubular impermeable membrane under air pressure. A characterization sensor is towed down the interior of the pipe by the membrane. Advantages of this approach include the capability of deploying through constrictions in the pipe, around 90 degrees bends, vertically up and down, and in slippery conditions. Because the detector is transported inside the membrane (which is inexpensive and disposable), it is protected from contamination, which eliminates cross-contamination. Characterization sensors that have been demonstrated with the system thus far include: gamma detectors, beta detectors, video cameras, and pipe locators. Alpha measurement capability is currently under development. A remotely operable Pipe Explorer trademark system has been developed and demonstrated for use in DOE facilities in the decommissioning stage. The system is capable of deployment in pipes as small as 2-inch-diameter and up to 250 feet long. This paper describes the technology and presents measurement results of a field demonstration conducted with the Pipe Explorer trademark system at a DOE site. These measurements identify surface activity levels of U-238 contamination as a function of location in drain lines. Cost savings to the DOE of approximately $1.5 million dollars were realized from this one demonstration

  6. Percutaneous mechanical atherectomy for treatment of peripheral arterial occlusive disease

    International Nuclear Information System (INIS)

    Buecker, A.; Minko, P.; Massmann, A.; Katoh, M.

    2010-01-01

    Peripheral arterial occlusive disease (PAOD) is still an extremely important politico-economic disease. Diverse treatment procedures exist but the pillars of therapy are changes in lifestyle, such as nicotine abstinence and walking exercise as well as drug therapy. Further therapy options are considered after conventional procedures have been exhausted. These further options consist of improvement of the blood supply by surgical or minimally invasive procedures. The latter therapy options include balloon dilatation and stenting as the most widely used techniques. More recent techniques also used are cryoplasty, laser angioplasty, drug-coated stents or balloons as well as brachytherapy or atherectomy, whereby this list makes no claims to completeness. The multitude of different treatment methods emphatically underlines the fact that no resounding success can be achieved with one single method. The long-term results of both balloon dilatation and stenting techniques show a need for improvement, which elicited the search for additional methods for the treatment of PAOD. Atherectomy represents such an alternative method for treatment of PAOD. Basically, the term atherectomy means the removal of atheroma tissue. For percutaneous atherectomy, in contrast to surgical procedures, it is not necessary to create surgically access to the vessel but accomplishes the atherectomy by means of dedicated systems via a minimally invasive access. There are two basic forms of mechanical atherectomy: directional and rotational systems. (orig.) [de

  7. Regulatory issues resolved through design certification on the System 80+trademark standard plant design

    International Nuclear Information System (INIS)

    Ritterbusch, S.E.; Brinkman, C.B.

    1996-01-01

    The US Nuclear Regulatory Commission (NRC) has completed its review of the System 80+trademark Standard Plant Design, approving advanced design features and closing severe accident licensing issues. Final Design Approval was granted in July 1994. The NRC review was extensive, requiring written responses to over 4,950 questions and formal printing of over 50,000 Safety Analysis Report pages. New safety issues never before addressed in a regulatory atmosphere had to be resolved with detailed analysis and evaluation of design features. the System 80+ review demonstrated that regulatory issues can be firmly resolved only through presentation of a detailed design and completion of a comprehensive regulatory review

  8. ORBIT II sub-analysis: Impact of impaired renal function following treatment of severely calcified coronary lesions with the Orbital Atherectomy System.

    Science.gov (United States)

    Lee, Michael S; Lee, Arthur C; Shlofmitz, Richard A; Martinsen, Brad J; Hargus, Nick J; Elder, Mahir D; Généreux, Philippe; Chambers, Jeffrey W

    2017-04-01

    To investigate the safety and efficacy of the coronary Orbital Atherectomy System (OAS) to prepare severely calcified lesions for stent deployment in patients grouped by renal function. Percutaneous coronary intervention (PCI) of severely calcified lesions is associated with increased rates of major adverse cardiac events (MACE), including death, myocardial infarction (MI), and target vessel revascularization (TVR) compared with PCI of non-calcified vessels. Patients with chronic kidney disease (CKD) are at increased risk for MACE after PCI. The impact of CKD on coronary orbital atherectomy treatment has not been well characterized. ORBIT II was a prospective, multicenter trial in the U.S., which enrolled 443 patients with severely calcified coronary lesions. The MACE rate was defined as a composite of cardiac death, MI, and target vessel revascularization. Of the 441 patients enrolled with known estimated glomerular filtration rate (eGFR) values at baseline, 333 (75.5%) patients had eGFR renal impairment had a higher MACE rate through one year follow-up due to a higher rate of periprocedural MI. Interestingly, the rates of cardiac death and revascularization through 1-year were similar in patients with eGFR renal impairment and severely calcified coronary lesions. © 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

  9. Cost-effectiveness analysis of the SEAMIST trademark membrane system technology

    International Nuclear Information System (INIS)

    Henriksen, A.D.; Booth, S.R.

    1995-01-01

    SEAMIST trademark is a new technology that consists of an airtight membrane liner that is pneumatically emplaced inside the borehole. The positive air pressure inside the liner maintains the integrity of the borehole structure. Sampling ports with attached tubing, absorbent collectors, or various in situ measuring devices can be fabricated into the liner and used for monitoring volatile organic compounds (VOCs), semivolatile organic compounds (SVOCs), pesticides, herbicides, polynuclear aromatic hydrocarbons, polychlorinated biphenyls, or radioactive substances. In addition, small instruments can be guided through the lined borehole and measurements taken inside at specified intervals. The purpose of this study is to analyze the cost and performance effectiveness of this new technology. To do so, the authors constructed five hypothetical scenarios in which utilization of the SEAMIST trademark system can address various needs of the Department of Energy's environmental remediation program. Two of the scenarios involve vertical boreholes (or vertical instrument configurations) and two involve horizontal boreholes (or horizontal instrument configurations). The four scenarios jointly address contamination by VOCS, SVOCS, various water-soluble toxic substances, and low-level radioactive waste. One of the scenarios involves towing an instrument through a borehole and taking measurements of moisture levels in the surrounding soil

  10. Characterization of radioactive contamination inside pipes with the Pipe Explorer{sup trademark} system

    Energy Technology Data Exchange (ETDEWEB)

    Cremer, C.D.; Lowry, W.; Cramer, E. [Science and Engineering Associates, Inc., Albuquerque, NM (United States)] [and others

    1995-10-01

    The U.S. Department of Energy`s nuclear facility decommissioning program needs to characterize radiological contamination inside piping systems before the pipe can be recycled, remediated, or disposed. Historically, this has been attempted using hand held survey instrumentation, surveying only the accessible exterior portions of pipe systems. Difficulty, or inability of measuring threshold surface contamination values, worker exposure, and physical access constraints have limited the effectiveness of this approach. Science and Engineering associates, Inc. under contract with the DOE Morgantown Energy Technology Center has developed and demonstrated the Pipe Explorer{trademark} system, which uses an inverting membrane to transport various characterization sensors into pipes. The basic process involves inverting (turning inside out) a tubular impermeable membrane under air pressure. A characterization sensor is towed down the interior of the pipe by the membrane.

  11. Peripheral Atherectomy: Applications and Techniques.

    Science.gov (United States)

    Mittleider, Derek; Russell, Erich

    2016-06-01

    Peripheral atherectomy is a class of procedures that is rapidly increasing in volume. Multiple classes of devices exist, and newer variants are added to the market annually. The devices see wide application for de novo lesions, in-stent restenosis, and adjunctive therapy for drug-coated balloons. The body of evidence supporting atherectomy is less robust than for many other peripheral therapies. The frequency and severity of complications from atherectomy can be significant compared with angioplasty and stenting, and familiarity with preventative and bailout techniques is essential for the interventionalist. Copyright © 2016 Elsevier Inc. All rights reserved.

  12. SEAMIST trademark in-situ instrumentation and vapor sampling system applications in the Sandia Mixed Waste Landfill Integrated Demonstration Program

    International Nuclear Information System (INIS)

    Lowry, W.E.; Dunn, S.D.; Cremer, S.C.; Williams, C.

    1994-01-01

    The SEAMIST trademark inverting membrane deployment system has been used successfully at the Mixed Waste Landfill Integrated Demonstration (MWLID) for multipoint vapor sampling/pressure measurement/permeability measurement/sensor integration demonstrations and borehole lining. Several instruments were deployed inside the SEAMIST trademark lined boreholes to detect metals, radionuclides, moisture, and geologic variations. The liner protected the instruments from contamination, maintained support of the uncased borehole wall, and sealed the total borehole from air circulation. The current activities have included the installation of three multipoint vapor sampling systems and sensor integration systems in 100-foot-deep vertical boreholes. A long term pressure monitoring program has recorded barometric pressure effects at depth with relatively high spatial resolution. The SEAMIST trademark system has been integrated with a variety of hydrologic and chemical sensors for in-situ measurements, demonstrating its versatility as an instrument deployment system which allows easy emplacement and removal. Standard SEAMIST trademark vapor sampling systems were also integrated with state-of-the-art VOC analysis technologies (automated GC, UV laser fluorometer). The results and status of these demonstration tests are presented

  13. TRADEMARK IMAGE RETRIEVAL USING LOW LEVEL FEATURE EXTRACTION IN CBIR

    OpenAIRE

    Latika Pinjarkar*, Manisha Sharma, Smita Selot

    2016-01-01

    Trademarks work as significant responsibility in industry and commerce. Trademarks are important component of its industrial property, and violation can have severe penalty. Therefore designing an efficient trademark retrieval system and its assessment for uniqueness is thus becoming very important task now a days. Trademark image retrieval system where a new candidate trademark is compared with already registered trademarks to check that there is no possibility of resembl...

  14. Long-term safety and performance of the orbital atherectomy system for treating calcified coronary artery lesions: 5-Year follow-up in the ORBIT I trial

    International Nuclear Information System (INIS)

    Bhatt, Parloop; Parikh, Parth; Patel, Apurva; Chag, Milan; Chandarana, Anish; Parikh, Roosha; Parikh, Keyur

    2015-01-01

    Background/Purpose: The ORBIT I trial, a first-in-man study, was conducted to evaluate the safety and performance of the orbital atherectomy system (OAS) in treating de novo calcified coronary lesions. Methods/Materials: Fifty patients were enrolled between May and July 2008 based on several criteria, and were treated with the OAS followed by stent placement. The safety and performance of the OAS were evaluated by procedural success, device success, and overall major adverse cardiovascular event (MACE) rates, including cardiac death, myocardial infarction (MI) and need for target lesion revascularization (TLR). Our institution enrolled and treated 33 of the 50 patients and continued follow-up for 5 years. Results: Average age was 54 years and 91% were males. Mean lesion length was 15.9 mm. Device success was 100%, and average number of orbital atherectomy devices (OAD) used per patient was 1.3. Stents were placed directly after OAS in 31/32 patients (96.9%). All stents (average stent per lesion 1.1) were successfully deployed with 0.3% residual stenosis. The overall cumulative MACE rate was 6.1% in-hospital, 9.1% at 30 days, 12.1% at 6 months, 15.2% at 2 years, 18.2% at 3 years and 21.2% at 5 years (4 total cardiac deaths). None of the patients had Q-wave MIs. Angiographic complications were observed in 5 patients. No flow/slow flow due to distal embolization was observed. Conclusions: The ORBIT I trial suggests that OAS treatment continues to offer a safe and effective method to change compliance of calcified coronary lesions to facilitate optimal stent placement in these difficult-to-treat patients

  15. Long-term safety and performance of the orbital atherectomy system for treating calcified coronary artery lesions: 5-Year follow-up in the ORBIT I trial

    Energy Technology Data Exchange (ETDEWEB)

    Bhatt, Parloop; Parikh, Parth [Care Institute of Medical Sciences (CIMS), Ahmedabad 380060, Gujarat (India); Patel, Apurva [Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH (United States); Chag, Milan; Chandarana, Anish [Care Institute of Medical Sciences (CIMS), Ahmedabad 380060, Gujarat (India); Parikh, Roosha [Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH (United States); Parikh, Keyur, E-mail: keyur.parikh@cims.me [Care Institute of Medical Sciences (CIMS), Ahmedabad 380060, Gujarat (India)

    2015-06-15

    Background/Purpose: The ORBIT I trial, a first-in-man study, was conducted to evaluate the safety and performance of the orbital atherectomy system (OAS) in treating de novo calcified coronary lesions. Methods/Materials: Fifty patients were enrolled between May and July 2008 based on several criteria, and were treated with the OAS followed by stent placement. The safety and performance of the OAS were evaluated by procedural success, device success, and overall major adverse cardiovascular event (MACE) rates, including cardiac death, myocardial infarction (MI) and need for target lesion revascularization (TLR). Our institution enrolled and treated 33 of the 50 patients and continued follow-up for 5 years. Results: Average age was 54 years and 91% were males. Mean lesion length was 15.9 mm. Device success was 100%, and average number of orbital atherectomy devices (OAD) used per patient was 1.3. Stents were placed directly after OAS in 31/32 patients (96.9%). All stents (average stent per lesion 1.1) were successfully deployed with 0.3% residual stenosis. The overall cumulative MACE rate was 6.1% in-hospital, 9.1% at 30 days, 12.1% at 6 months, 15.2% at 2 years, 18.2% at 3 years and 21.2% at 5 years (4 total cardiac deaths). None of the patients had Q-wave MIs. Angiographic complications were observed in 5 patients. No flow/slow flow due to distal embolization was observed. Conclusions: The ORBIT I trial suggests that OAS treatment continues to offer a safe and effective method to change compliance of calcified coronary lesions to facilitate optimal stent placement in these difficult-to-treat patients.

  16. Long-term safety and performance of the orbital atherectomy system for treating calcified coronary artery lesions: 5-Year follow-up in the ORBIT I trial.

    Science.gov (United States)

    Bhatt, Parloop; Parikh, Parth; Patel, Apurva; Chag, Milan; Chandarana, Anish; Parikh, Roosha; Parikh, Keyur

    2015-06-01

    The ORBIT I trial, a first-in-man study, was conducted to evaluate the safety and performance of the orbital atherectomy system (OAS) in treating de novo calcified coronary lesions. Fifty patients were enrolled between May and July 2008 based on several criteria, and were treated with the OAS followed by stent placement. The safety and performance of the OAS were evaluated by procedural success, device success, and overall major adverse cardiovascular event (MACE) rates, including cardiac death, myocardial infarction (MI) and need for target lesion revascularization (TLR). Our institution enrolled and treated 33 of the 50 patients and continued follow-up for 5 years. Average age was 54 years and 91% were males. Mean lesion length was 15.9 mm. Device success was 100%, and average number of orbital atherectomy devices (OAD) used per patient was 1.3. Stents were placed directly after OAS in 31/32 patients (96.9%). All stents (average stent per lesion 1.1) were successfully deployed with 0.3% residual stenosis. The overall cumulative MACE rate was 6.1% in-hospital, 9.1% at 30 days, 12.1% at 6 months, 15.2% at 2 years, 18.2% at 3 years and 21.2% at 5 years (4 total cardiac deaths). None of the patients had Q-wave MIs. Angiographic complications were observed in 5 patients. No flow/slow flow due to distal embolization was observed. The ORBIT I trial suggests that OAS treatment continues to offer a safe and effective method to change compliance of calcified coronary lesions to facilitate optimal stent placement in these difficult-to-treat patients. Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

  17. Atherectomy for peripheral arterial disease.

    Science.gov (United States)

    Ambler, Graeme K; Radwan, Rami; Hayes, Paul D; Twine, Christopher P

    2014-03-17

    Symptomatic peripheral arterial disease may be treated by a number of options including exercise therapy, angioplasty, stenting and bypass surgery. Atherectomy is an alternative technique where atheroma is excised by a rotating cutting blade. The objective of this review was to analyse randomised controlled trials comparing atherectomy against any established treatment for peripheral arterial disease in order to evaluate the effectiveness of atherectomy. The Cochrane Peripheral Vascular Diseases Group Trials Search Co-ordinator searched the Specialised Register (last searched November 2013) and CENTRAL (2013, Issue 10). Trials databases were searched for details of ongoing or unpublished studies. Randomised controlled trials (RCTs) comparing atherectomy and other established treatments were selected for inclusion. All participants had symptomatic peripheral arterial disease with either claudication or critical limb ischaemia and evidence of lower limb arterial disease. Two review authors (GA and CT) screened studies for inclusion, extracted data and assessed the quality of the trials. Any disagreements were resolved through discussion. Four trials were included with a total of 220 participants (118 treated with atherectomy, 102 treated with balloon angioplasty) and 259 treated vessels (129 treated with atherectomy, 130 treated with balloon angioplasty). All studies compared atherectomy with angioplasty. No study was properly powered or assessors blinded to the procedures and there was a high risk of selection, attrition, detection and reporting biases.The estimated risk of success was similar between the treatment modalities although the confidence interval (CI) was compatible with small benefits of either treatment for the initial procedural success rate (Mantel-Haenszel risk ratio (RR) 0.92, 95% CI 0.44 to 1.91, P = 0.82), patency at six months (Mantel-Haenszel RR 0.92, 95% CI 0.51 to 1.66, P = 0.79) and patency at 12 months (Mantel-Haenszel RR 1.17, 95% CI 0

  18. The mechanism of directional coronary atherectomy

    NARCIS (Netherlands)

    V.A.W.M. Umans (Victor); E. Haine; J. Renkin; P.J. de Feyter (Pim); W. Wijns (William); P.W.J.C. Serruys (Patrick)

    1993-01-01

    textabstractAn attempt was made to assess the mechanism of directional coronary atherectomy using different methods of analysis. Quantitative coronary angiography was used as the gold standard to assess the immediate results of atherectomy, and a comparative quantitative analysis of atherectomy and

  19. Characterization of radioactive contamination inside pipes with the Pipe Explorer trademark system

    International Nuclear Information System (INIS)

    Lowry, W.

    1994-01-01

    The objective for the development of the Pipe Explorer trademark radiological characterization system is to achieve a cost effective, low risk means of characterizing gamma radioactivity on the inside surface of pipes. The unique feature of this inspection system is the use of a pneumatically inflated impermeable membrane which transports the detector into the pipe as it inverts. The membrane's internal air pressure tows the detector and tether through the pipe. This mechanism isolates the detector and its cabling from the contaminated surface, yet allows measurement of radioactive emissions which can readily penetrate the thin plastic membrane material (such as gamma and high energy beta emissions). In Phase 1, an initial survey of DOE facilities was conducted to determine the physical and radiological characteristics of piping systems. The inverting membrane deployment system was designed and extensively tested in the laboratory. A range of membrane materials was tested to evaluate their ruggedness and deployment characteristics. Two different sizes of gamma scintillation detectors were procured and tested with calibrated sources. Radiation transport modeling evaluated the measurement system's sensitivity to detector position relative to the contaminated surface, the distribution of the contamination, background gamma levels, and gamma source energy levels. In the culmination of Phase 1, a field demonstration was conducted at the Idaho National Engineering Laboratory's Idaho Chemical Processing Plant. The project is currently in transition from Phase 1 to Phase 2, where more extensive demonstrations will occur at several sites. Results to date are discussed

  20. Current status of rotational atherectomy.

    Science.gov (United States)

    Tomey, Matthew I; Kini, Annapoorna S; Sharma, Samin K

    2014-04-01

    Rotational atherectomy facilitates percutaneous coronary intervention for complex de novo lesions with severe calcification. A strategy of routine rotational atherectomy has not, however, conferred reduction in restenosis or major adverse cardiac events. As it is technically demanding, rotational atherectomy is also uncommon. At this 25-year anniversary since the introduction of rotational atherectomy, we sought to review the current state-of-the-art in rotational atherectomy technique, safety, and efficacy data in the modern era of drug-eluting stents, strategies to prevent and manage complications, including slow-flow/no-reflow and burr entrapment, and appropriate use in the context of the broader evolution in the management of stable ischemic heart disease. Fundamental elements of optimal technique include use of a single burr with burr-to-artery ratio of 0.5 to 0.6-rotational speed of 140,000 to 150,000 rpm, gradual burr advancement using a pecking motion, short ablation runs of 15 to 20 s, and avoidance of decelerations >5,000 rpm. Combined with meticulous technique, optimal antiplatelet therapy, vasodilators, flush solution, and provisional use of atropine, temporary pacing, vasopressors, and mechanical support may prevent slow-flow/no-reflow, which in contemporary series is reported in 0.0% to 2.6% of cases. On the basis of the results of recent large clinical trials, a subset of patients with complex coronary artery disease previously assigned to rotational atherectomy may be directed instead to medical therapy alone or bypass surgery. For patients with de novo severely calcified lesions for which rotational atherectomy remains appropriate, referral centers of excellence are required. Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

  1. Advanced Light Water Reactor Plants System 80+trademark Design Certification Program

    International Nuclear Information System (INIS)

    1993-01-01

    The purpose of this report is to provide a status of the progress that was made towards Design Certification of System 80+trademark during the US government's 1993 fiscal year. The System 80+ Advanced Light Water Reactor (ALWR) is a 3931 MW t (1350 MWe) Pressurized Water Reactor (PWR). The design consists of an essentially complete plant. It is based on evolutionary improvements to the Standardized System 80 nuclear steam supply system in operation at Palo Verde Units 1, 2, and 3, and the Duke Power Company P-81 balance-of-plant (BOP) that was designed and partially constructed at the Cherokee plant site. The System 80/P-81 original design has been substantially enhanced to increase conformance with the EPRI ALWR Utility Requirements Document (URD). Some design enhancements incorporated in the System 80+ design are included in the four units currently under construction in the Republic of Korea. These units form the basis of the Korean standardization program. The full System 80+ standard design has been offered to the Republic of China, in response to their recent bid specification. The ABB-CE Standard Safety Analysis Report (CESSAR-DC) was submitted to the NRC and a Draft Safety Evaluation Report was issued by the NRC in October 1992. CESSAR-DC contains the technical basis for compliance with the EPRI URD for simplified emergency planning. The Nuclear Steam Supply System (NSSS) is the standard ABB-Combustion Engineering two-loop arrangement with two steam generators, two hot legs and four cold legs each with a reactor coolant pump. The System 80+ standard plant includes a sperical steel containment vessel which is enclosed in a concrete shield building, thus providing the safety advantages of a dual containment

  2. Resolution of thermal-hydraulic safety and licensing issues for the system 80+trademark design

    International Nuclear Information System (INIS)

    Carpentino, S.E.; Ritterbusch, S.E.; Schneider, R.E.

    1995-01-01

    The System 80+ trademark Standard Design is an evolutionary Advanced Light Water Reactor (ALWR) with a generating capacity of 3931 MWt (1350 MWe). The Final Design Approval (FDA) for this design was issued by the Nuclear Regulatory Commission (NRC) in July 1994. The design certification by the NRC is anticipated by the end of 1995 or early 1996. NRC review of the System 80+ design has involved several new safety issues never before addressed in a regulatory atmosphere. In addition, conformance with the Electric Power Research Institute (EPRI) ALWR Utility Requirements Document (URD) required that the System 80+ plant address nuclear industry concerns with regard to design, construction, operation and maintenance of nuclear power plants. A large number of these issues/concerns deals with previously unresolved generic thermal-hydraulic safety issues and severe accident prevention and mitigation. This paper discusses the thermal-hydraulic analyses and evaluations performed for the System 80+ design to resolve safety and licensing issues relevant to both the Nuclear Stream Supply System (NSSS) and containment designs. For the NSSS design, the Safety Depressurization System mitigation capability and resolution of the boron dilution concern are described. Examples of containment design issues dealing with containment shell strength, robustness of the reactor cavity walls and hydrogen mixing under severe accident conditions are also provided. Finally, the overall approach used in the application of NRC's new (NUREG-1465) radiological source term for System 80+ evaluation is described. The robustness of the System 80+ containment design to withstand severe accident consequences was demonstrated through detailed thermal-hydraulic analyses and evaluations. This advanced design to shown to meet NRC severe accident policy goals and ALWR URD requirements without any special design features and unnecessary costs

  3. Resolution of thermal-hydraulic safety and licensing issues for the system 80+{sup {trademark}} design

    Energy Technology Data Exchange (ETDEWEB)

    Carpentino, S.E.; Ritterbusch, S.E.; Schneider, R.E. [ABB-Combustion Engineering, Windsor, CT (United States)] [and others

    1995-09-01

    The System 80+{sup {trademark}} Standard Design is an evolutionary Advanced Light Water Reactor (ALWR) with a generating capacity of 3931 MWt (1350 MWe). The Final Design Approval (FDA) for this design was issued by the Nuclear Regulatory Commission (NRC) in July 1994. The design certification by the NRC is anticipated by the end of 1995 or early 1996. NRC review of the System 80+ design has involved several new safety issues never before addressed in a regulatory atmosphere. In addition, conformance with the Electric Power Research Institute (EPRI) ALWR Utility Requirements Document (URD) required that the System 80+ plant address nuclear industry concerns with regard to design, construction, operation and maintenance of nuclear power plants. A large number of these issues/concerns deals with previously unresolved generic thermal-hydraulic safety issues and severe accident prevention and mitigation. This paper discusses the thermal-hydraulic analyses and evaluations performed for the System 80+ design to resolve safety and licensing issues relevant to both the Nuclear Stream Supply System (NSSS) and containment designs. For the NSSS design, the Safety Depressurization System mitigation capability and resolution of the boron dilution concern are described. Examples of containment design issues dealing with containment shell strength, robustness of the reactor cavity walls and hydrogen mixing under severe accident conditions are also provided. Finally, the overall approach used in the application of NRC`s new (NUREG-1465) radiological source term for System 80+ evaluation is described. The robustness of the System 80+ containment design to withstand severe accident consequences was demonstrated through detailed thermal-hydraulic analyses and evaluations. This advanced design to shown to meet NRC severe accident policy goals and ALWR URD requirements without any special design features and unnecessary costs.

  4. [Atherectomy for peripheral arterial disease].

    Science.gov (United States)

    Londero, Louise Skovgaard; Høgh, Annette Langager; Lindholt, Jes Sanddal

    2015-04-13

    Symptomatic peripheral arterial disease is managed according to national and international guidelines and the number of vascular reconstructions performed each year has increased over the past decade mainly due to an increasing frequency of endovascular procedures. Atherectomy as an alternative to the established treatment of symptomatic peripheral arterial disease has recently been analysed in a Cochrane review. In Denmark, atherectomy is not performed and so far the evidence is poor as the method is not an alternative to the established treatment in this country.

  5. Gamma Ray Imaging System (GRIS) GammaCam trademark. Final report, January 3, 1994 - May 31, 1996

    International Nuclear Information System (INIS)

    1996-01-01

    This report describes the activities undertaken during the development of the Gamma Ray Imaging System (GRIS) program now referred to as the GammaCam trademark. The purpose of this program is to develop a 2-dimensional imaging system for gamma-ray energy scenes that may be present in nuclear power plants. The report summarizes the overall accomplishments of the program and the most recent GammaCam measurements made at LANL and Estonia. The GammaCam is currently available for sale from AIL Systems as an off-the-shelf instrument

  6. Convolutional Neural Network on Embedded Linux(trademark) System-on-Chip: A Methodology and Performance Benchmark

    Science.gov (United States)

    2016-05-01

    Linux® is a registered trademark of Linus Torvalds. NVIDIA ® is a registered trademark of NVIDIA Corporation. Oracle® is a registered trademark of...two NVIDIA ® GTX580 GPUs [3]. Therefore, for this initial work, we decided to concentrate on small networks and small datasets until the methods are

  7. The disproportionate growth of office-based atherectomy.

    Science.gov (United States)

    Mukherjee, Dipankar; Hashemi, Homayoun; Contos, Brian

    2017-02-01

    The purpose of this study was to evaluate the trends in procedure volume, clinical sites of care, and Medicare expenditure for peripheral vascular interventions (PVIs) for lower extremity occlusive disease since the Centers for Medicare and Medicaid Services instituted reimbursement policy changes that broadened payment for procedures performed in physician-owned office-based laboratories (OBLs). We analyzed fee-for-service Medicare claims data from 2011 to 2014 to obtain the frequency of use of PVI by type, care setting, and physician specialty. We also assessed changes in the total Medicare cost for PVI by setting. There was a 60% increase in atherectomy cases among Medicare beneficiaries between 2011 and 2014. During the same period, OBLs experienced a 298% increase in atherectomy volume vs a 27% increase in hospital outpatient settings and an 11% decrease for inpatient hospital settings. In 2014, OBLs were the most common setting for atherectomy. Nonatherectomy PVIs grew more modestly at just 3% but also experienced site of care shifts. Vascular surgeons and cardiologists accounted for the majority of office-based PVIs in 2014. Total Medicare costs for PVIs increased 18% from 2011 to 2014. Hospital inpatient costs declined 1%, whereas costs for hospital outpatient PVIs increased by 41% and physician office costs increased by 258%. The migration of revascularization procedures for lower extremity peripheral arterial occlusive disease continues from the inpatient to the outpatient setting and especially to OBLs. Increased use of atherectomy in all segments of the lower extremity arterial system has been observed, particularly in OBLs, without substantial evidence in the literature of increased efficacy compared with standard angioplasty with or without stenting. Generous Medicare reimbursement for in-office atherectomy procedures is likely contributing to the volume shifts observed. Copyright © 2016 Society for Vascular Surgery. Published by Elsevier Inc. All

  8. An Interdisciplinary Inquiry into the Foundations of Trademark Law

    Directory of Open Access Journals (Sweden)

    Sh. Kasnavi

    2016-05-01

    Full Text Available The assessment of any legal system, such as trademark law, requires a comprehensive understanding of that system, and this can be made possible only through awareness of the objectives and foundations of that system. This awareness in trademark law helps us interpret better, especially where there are no statutes. Trademark law is highly influenced by both moral and legal issues and the basics of market economy because trademark has fully economic dimensions as well, and the existence of trademark depends on the economic efficiency of the market. This highlights the necessity of an interdisciplinary approach with the aim of understanding this supportive system. Natural law theory and contractual theory legally justify the protection of trademark. Beside these two theories, the search cost theory and incentive of producers, as two important economic factors, justify the protection of trademark even more powerfully. Nonetheless, trademark legal system relies on all these foundations and each of them is necessary to interpret trademark law.

  9. Quantitative angiography after directional coronary atherectomy

    NARCIS (Netherlands)

    P.W.J.C. Serruys (Patrick); V.A.W.M. Umans (Victor); B.H. Strauss (Bradley); R-J. van Suylen (Robert-Jan); M.J.B.M. van den Brand (Marcel); H. Suryapranata (Harry); P.J. de Feyter (Pim); J.R.T.C. Roelandt (Jos)

    1991-01-01

    textabstractOBJECTIVE: To assess by quantitative analysis the immediate angiographic results of directional coronary atherectomy. To compare the effects of successful atherectomy with those of successful balloon dilatation in a series of patients with matched lesions. DESIGN--Case series.

  10. Simpson's atherectomy in peripheral arteries

    International Nuclear Information System (INIS)

    Kueffer, G.; Spengel, F.A.; Hansen, R.; Pfluger, T.; Nathrath, W.; Muenchen Univ.; Muenchen Univ.

    1990-01-01

    Over a seventeen-month period, a percutaneous transluminal removal of stenosing plaque material from leg and pelvic arteries was performed successfully and without complication in 43 patients. A complete atherectomy in the femoropopliteal vessels succeeded in 99% of cases. In the pelvic region, the primary results were much lower (58%). After six months, the angiographically checked restenosis rate was 17% for femoropopliteal vessels and 11% for iliac arteries, and the corresponding Kaplan-Meier cumulative patency rates were 73.8 and 78.7% respectively. Simpson's atherectomy is the only method of its kind that is therapeutically effective and diagnostically significant, since the removed plaque can be used for further tests. (orig.) [de

  11. The potential cost-effectiveness of the Diamondback 360® Coronary Orbital Atherectomy System for treating de novo, severely calcified coronary lesions: an economic modeling approach.

    Science.gov (United States)

    Chambers, Jeffrey; Généreux, Philippe; Lee, Arthur; Lewin, Jack; Young, Christopher; Crittendon, Janna; Mann, Marita; Garrison, Louis P

    2016-04-01

    Patients who undergo percutaneous coronary intervention (PCI) for severely calcified coronary lesions have long been known to have worse clinical and economic outcomes than patients with no or mildly calcified lesions. We sought to assess the likely cost-effectiveness of using the Diamondback 360(®) Orbital Atherectomy System (OAS) in the treatment of de novo, severely calcified lesions from a health-system perspective. In the absence of a head-to-head trial and long-term follow up, cost-effectiveness was based on a modeled synthesis of clinical and economic data. A cost-effectiveness model was used to project the likely economic impact. To estimate the net cost impact, the cost of using the OAS technology in elderly (⩾ 65 years) Medicare patients with de novo severely calcified lesions was compared with cost offsets. Elderly OAS patients from the ORBIT II trial (Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions) [ClinicalTrials.gov identifier: NCT01092426] were indirectly compared with similar patients using observational data. For the index procedure, the comparison was with Medicare data, and for both revascularization and cardiac death in the following year, the comparison was with a pooled analysis of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI)/Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trials. After adjusting for differences in age, gender, and comorbidities, the ORBIT II mean index procedure costs were 17% (p economic modeling, the recently approved coronary OAS device is projected to be highly cost-effective for patients who undergo PCI for severely calcified lesions. © The Author(s), 2015.

  12. Atherectomy in complex infrainguinal lesions: a review.

    Science.gov (United States)

    Engelberger, S; van den Berg, J C

    2015-02-01

    In the femoropopliteal segment, endovascular revascularization techniques have gained the role as a first line treatment strategy. Nitinol stent placement has improved the short- and mid-term primary patency rates in most lesion types and is therefore widely applied. Stenting has several shortcomings as in-stent restenosis, stent fractures and foreign material being left behind in the vessel. The concept of atherectomy is plaque debulking. This results in a potential reduction of inflation pressure requirements in angioplasty. Stent placement and consecutive in-stent restenosis may be avoided. In this non systematic literature review, the performance of different atherectomy techniques, such as direct atherectomy, orbital atherectomy, laser debulking and rotational atherectomy in the treatment of complex femoropopliteal lesions, including long lesions, moderately to heavily calcified lesions as well as occlusions and in-stent restenosis, has been analyzed.

  13. Orbital atherectomy system in treating calcified coronary lesions: 3-Year follow-up in first human use study (ORBIT I trial)

    Energy Technology Data Exchange (ETDEWEB)

    Bhatt, Parloop, E-mail: parloop.bhatt@cims.me [Care Institute of Medical Sciences (CIMS), Ahmedabad 380060, Gujarat (India); Parikh, Parth, E-mail: parth.parikh@cimshospital.org [Care Institute of Medical Sciences (CIMS), Ahmedabad 380060, Gujarat (India); Patel, Apurva, E-mail: patela12@ccf.org [Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH (United States); Chag, Milan, E-mail: milan.chag@cims.me [Care Institute of Medical Sciences (CIMS), Ahmedabad 380060, Gujarat (India); Chandarana, Anish, E-mail: anish.chandarana@cims.me [Care Institute of Medical Sciences (CIMS), Ahmedabad 380060, Gujarat (India); Parikh, Roosha, E-mail: parikhr@ccf.org [Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH (United States); Parikh, Keyur, E-mail: keyur.parikh@cims.me [Care Institute of Medical Sciences (CIMS), Ahmedabad 380060, Gujarat (India)

    2014-06-15

    Background/Purpose: The ORBIT I trial evaluated the safety and performance of an orbital atherectomy system (OAS) in treating de novo calcified coronary lesions. Severely calcified coronary arteries pose ongoing treatment challenges. Stent placement in calcified lesions can result in stent under expansion, malapposition and procedural complications. OAS treatment may be recommended to facilitate coronary stent implantation in these difficult lesions. Materials/Methods: Fifty patients with de novo calcified coronary lesions were enrolled in the ORBIT I trial. Patients were treated with the OAS followed by stent placement. Our institution treated 33/50 patients and continued follow-up for 3 years. Results: Average age was 54.4 years and 90.9% were males. Mean lesion length was 15.9 mm. The average number of OAS devices used per patient was 1.3. Procedural success was achieved in 97% of patients. Angiographic complications were observed in five patients (two minor dissections, one major dissection and two perforations). The cumulative major adverse cardiac event (MACE) rate was 6.1% in-hospital, 9.1% at 30 days, 12.1% at 6 months, 15.2% at 2 years, and 18.2% at 3 years. The MACE rate included two in-hospital non Q-wave myocardial infarctions (MI), one additional non Q-wave MI at 30 days leading to target lesion revascularization (TLR), and three cardiac deaths. Conclusions: The ORBIT I trial suggests that OAS treatment may offer an effective method to modify calcified coronary lesion compliance to facilitate optimal stent placement in these difficult-to-treat patients with acceptable levels of safety up to 3 years post-index procedure.

  14. BMC{trademark}: Baseline report

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1997-07-31

    Barrier Membrane Containment (BMC){trademark} is a high-density polyethylene membrane (HOPE) groundwater barrier and pass-through system, with applications ranging from plume control and containment to groundwater manipulation coupled with in-site treatment. BMC{trademark} system can function as a permeable or impermeable reaction wall, a cut-off wall, interceptor trenches, a barrier with collection and/or monitoring system and a pass-through in a funnel and gate configuration. BMC{trademark} can be inspected with a down-hole video camera, producing a permanent VHS format tape, insuring the integrity of the wall and the interlocking joints. The joints are sealed with a ``U``-packing elastomeric gasket to prevent the flow of fluids or gases.

  15. The Aesthetics Of Trademarks

    Directory of Open Access Journals (Sweden)

    Peter H. Karlen

    2008-01-01

    Full Text Available Trademarks are not just property, they are aesthetic creations that pervade everyday experience. One estimate is that the average person encounters more than 1,000 trademarks per day, many of which influence purchases and product use. As pervasive aesthetic creations having literary, pictorial, graphic, sculptural, and musical content, trademarks deserve aesthetic analysis. The article discusses the origins, strength, appeal, and effectiveness of trademarks within the context of aesthetic considerations such as meaning, intention, authorship, and mode of creation. Also reviewed are morphemic and phonemic analysis of trademarks, semantic positioning, the dichotomy between creation and discovery of trademarks, and the differences between trademarks and titles. The discussion is confined to "word marks" consisting of alphanumeric characters, since discussing other kinds of marks (such as designs, configurations, sounds, colors, and scents would raise issues well beyond the scope of a single article.

  16. PTC-6 vacuum system: WallWaler trademark Blastrac reg-sign shot blast cleaning system

    International Nuclear Information System (INIS)

    1998-02-01

    The LTC Americas, Inc. wall decontamination technology consisted of two pneumatic hand-held tools: (1) a roto-peen scaler that used star cutters and (2) a 3-piston hammer with reciprocating bits. The hand-held tools were used in conjunction with the LTC PTC-6 vacuum system which captured dust and debris as the wall decontamination took place. Recommendations for improved worker safety and health during use of the PTC-6 vacuum system with hand-held tools include: (1) keeping all hoses and lines as orderly as possible in compliance with good housekeeping requirements; (2) ergonomic training to include techniques in lifting, bending, stooping, twisting, etc.; (3) use of a clamping system to hold hoses to the vacuum system; (4) a safety line on the air line connections; (5) use of a mechanical lifting system for waste drum removal; and (6) the use of ergonomically designed tools

  17. Lasagna trademark soil remediation

    International Nuclear Information System (INIS)

    1996-04-01

    Lasagna trademark is an integrated, in situ remediation technology being developed which remediates soils and soil pore water contaminated with soluble organic compounds. Lasagna trademark is especially suited to sites with low permeability soils where electroosmosis can move water faster and more uniformly than hydraulic methods, with very low power consumption. The process uses electrokinetics to move contaminants in soil pore water into treatment zones where the contaminants can be captured and decomposed. Initial focus is on trichloroethylene (TCE), a major contaminant at many DOE and industrial sites. Both vertical and horizontal configurations have been conceptualized, but fieldwork to date is more advanced for the vertical configuration. Major features of the technology are electrodes energized by direct current, which causes water and soluble contaminants to move into or through the treatment layers and also heats the soil; treatment zones containing reagents that decompose the soluble organic contaminants or adsorb contaminants for immobilization or subsequent removal and disposal; and a water management system that recycles the water that accumulates at the cathode (high pH) back to the anode (low pH) for acid-base neutralization. Alternatively, electrode polarity can be reversed periodically to reverse electroosmotic flow and neutralize pH

  18. The potential cost-effectiveness of the Diamondback 360® Coronary Orbital Atherectomy System for treating de novo, severely calcified coronary lesions: an economic modeling approach

    Science.gov (United States)

    Chambers, Jeffrey; Généreux, Philippe; Lee, Arthur; Lewin, Jack; Young, Christopher; Crittendon, Janna; Mann, Marita; Garrison, Louis P.

    2015-01-01

    Background: Patients who undergo percutaneous coronary intervention (PCI) for severely calcified coronary lesions have long been known to have worse clinical and economic outcomes than patients with no or mildly calcified lesions. We sought to assess the likely cost-effectiveness of using the Diamondback 360® Orbital Atherectomy System (OAS) in the treatment of de novo, severely calcified lesions from a health-system perspective. Methods and results: In the absence of a head-to-head trial and long-term follow up, cost-effectiveness was based on a modeled synthesis of clinical and economic data. A cost-effectiveness model was used to project the likely economic impact. To estimate the net cost impact, the cost of using the OAS technology in elderly (⩾ 65 years) Medicare patients with de novo severely calcified lesions was compared with cost offsets. Elderly OAS patients from the ORBIT II trial (Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions) [ClinicalTrials.gov identifier: NCT01092426] were indirectly compared with similar patients using observational data. For the index procedure, the comparison was with Medicare data, and for both revascularization and cardiac death in the following year, the comparison was with a pooled analysis of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI)/Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trials. After adjusting for differences in age, gender, and comorbidities, the ORBIT II mean index procedure costs were 17% (p < 0.001) lower, approximately US$2700. Estimated mean revascularization costs were lower by US$1240 in the base case. These cost offsets in the first year, on average, fully cover the cost of the device with an additional 1.2% cost savings. Even in the low-value scenario, the use of the OAS is cost-effective with a cost per life-year gained of US$11,895. Conclusions: Based on economic modeling

  19. Maximizing Lumen Gain With Directional Atherectomy.

    Science.gov (United States)

    Stanley, Gregory A; Winscott, John G

    2016-08-01

    To describe the use of a low-pressure balloon inflation (LPBI) technique to delineate intraluminal plaque and guide directional atherectomy in order to maximize lumen gain and achieve procedure success. The technique is illustrated in a 77-year-old man with claudication who underwent superficial femoral artery revascularization using a HawkOne directional atherectomy catheter. A standard angioplasty balloon was inflated to 1 to 2 atm during live fluoroscopy to create a 3-dimensional "lumenogram" of the target lesion. Directional atherectomy was performed only where plaque impinged on the balloon at a specific fluoroscopic orientation. The results of the LPBI technique were corroborated with multimodality diagnostic imaging, including digital subtraction angiography, intravascular ultrasound, and intra-arterial pressure measurements. With the LPBI technique, directional atherectomy can routinely achieve <10% residual stenosis, as illustrated in this case, thereby broadly supporting a no-stent approach to lower extremity endovascular revascularization. © The Author(s) 2016.

  20. Endovascular US: Adjunct to percutaneous atherectomy

    International Nuclear Information System (INIS)

    Schwarten, D.E.; Cutcliff, W.B.

    1987-01-01

    Percutaneous atherectomy with the Simpson atherectomy catheter has been performed at our institution since the third quarter of 1986. The first 45 patients underwent atherectomy with fluoroscopic guidance and multiplane documentary arteriography to assess the anatomic appearance of vessels after atherectomy and to assist in judging the completeness of the procedure. Each of the 45 patients underwent repeated cuts on each lesion until no further atheromatous specimens could be removed. Since late 1987, all lesions subjected to atherectomy have also been examined intraprocedure with an intraarterial US probe 0.040 inches in diameter fixed to a 0.040-inch guide wire and covered by a sonolucent radome. The US images were reviewed in real time and permitted much more accurate placement of the atherectomy catheter to effect more complete removal of the atheromatous material. It is anticipated that the use of the endovascular US device to accurately localize residual atheroma will result in more complete removal of atheroma, in turn decreasing the possibility of recurrence

  1. Advanced light water reactor plants System 80+trademark design certification program. Annual progress report, October 1, 1994 - September 30, 1995

    International Nuclear Information System (INIS)

    1998-01-01

    The purpose of this report is to provide the status of the progress that was made towards Design Certification of System 80+trademark during the US government's 1995 fiscal year. The System 80+ Advanced Light Water Reactor (ALWR) is a 3931 MW (1350 MWe) Pressurized Water Reactor (PWR). The design covers an essentially complete plant. It is based on EPRI ALWR Utility Requirements Document (URD) improvements to the Standardized System 80 Nuclear Steam Supply System (NSSS) in operation at Palo Verde Units 1, 2, and 3. The NSSS is a traditional two-loop arrangement with two steam generators, two hot legs and four cold legs, each with a reactor coolant pump. The System 80+ standard design houses the NSSS in a spherical steel containment vessel which is enclosed in a concrete shield building, thus providing the safety advantages of a dual barrier to radioactivity release. Other major features include an all-digital, human-factors-engineered control room, an alternate electrical AC power source, an In-Containment Refueling Water Storage Tank (IRWST), and plant arrangements providing complete separation of redundant trains in safety systems

  2. Advanced light water reactor plants System 80+{trademark} design certification program. Annual progress report, October 1, 1994--September 30, 1995

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1998-09-01

    The purpose of this report is to provide the status of the progress that was made towards Design Certification of System 80+{trademark} during the US government`s 1995 fiscal year. The System 80+ Advanced Light Water Reactor (ALWR) is a 3931 MW (1350 MWe) Pressurized Water Reactor (PWR). The design covers an essentially complete plant. It is based on EPRI ALWR Utility Requirements Document (URD) improvements to the Standardized System 80 Nuclear Steam Supply System (NSSS) in operation at Palo Verde Units 1, 2, and 3. The NSSS is a traditional two-loop arrangement with two steam generators, two hot legs and four cold legs, each with a reactor coolant pump. The System 80+ standard design houses the NSSS in a spherical steel containment vessel which is enclosed in a concrete shield building, thus providing the safety advantages of a dual barrier to radioactivity release. Other major features include an all-digital, human-factors-engineered control room, an alternate electrical AC power source, an In-Containment Refueling Water Storage Tank (IRWST), and plant arrangements providing complete separation of redundant trains in safety systems.

  3. Advanced light water reactor plants System 80+trademark design certification program. Annual progress report, October 1, 1995 - September 30, 1996

    International Nuclear Information System (INIS)

    1996-01-01

    The purpose of this report is to provide a status of the progress that was made towards Design Certification of System 80+trademark during the US government's 1996 fiscal year. The System 80+ Advanced Light Water Reactor (ALWR) is a 3931 MW (1350 MWe) Pressurized Water Reactor (PWR). The design covers an essentially complete plant. It is based on EPRI ALWR Utility Requirements Document (URD) improvements to the Standardized System 80 Nuclear Steam Supply System (NSSS) in operation at Palo Verde Units 1, 2 and 3. The NSSS is a traditional two-loop arrangement with two steam generators, two hot legs and four cold legs, each with a reactor coolant pump. The System 80+ standard design houses the NSSS in a spherical steel containment vessel which is enclosed in a concrete shield building, thus providing the safety advantages of a dual barrier to radioactivity release. Other major features include an all-digital, human-factors-engineered control room, an alternate electrical AC power source, an In-Containment Refueling Water Storage Tank (IRWST), and plant arrangements providing complete separation of redundant trains in safety systems

  4. Atherectomy for calcified coronary lesions: When and how?

    Science.gov (United States)

    Karatasakis, Aris; Brilakis, Emmanouil S

    2016-03-01

    Percutaneous coronary intervention of heavily calcified lesions can be challenging. Although the ROTAXUS trial did not demonstrate long-term clinical benefit with routine rotational atherectomy, atherectomy remains an indispensable tool to achieve acute procedural success. Until new data becomes available determining when and how to optimally use coronary atherectomy depends heavily on personal experience and clinical judgment. © 2016 Wiley Periodicals, Inc.

  5. The application of zonal trademark combustion monitoring and tuning system to coal boilers for efficiency improvement and emissions reduction

    Energy Technology Data Exchange (ETDEWEB)

    Xu, Guang; Zhou, Wei; Widmer, Neil C.; Moyeda, David K. [GE Energy, Irvine, CA (United States)

    2013-07-01

    Coal-fired boilers equipped with Low NO{sub x} Burner (LNB) and Overfire Air (OFA) are challenged with maintaining good combustion conditions. In many cases, the significant increases in carbon monoxide (CO) and unburned carbon levels can be attributed to local poor combustion conditions as a result of poorly controlled fuel-air distribution within the furnace. The Zonal trademark combustion monitoring and tuning system developed by GE is available to detect and correct the furnace air-fuel distribution imbalance. The system monitors the boiler excess oxygen (O{sub 2}) and combustible gases, primarily carbon monoxide (CO), by using spatially distributed multipoint sensors located in the boiler's high temperature upper convective backpass region. At these locations, the furnace flow is still significantly stratified allowing tracing of poor combustion zones to specific burners and OFA ports. Using a model-based tuning system, operators can rapidly respond to poor combustion conditions by redistributing airflows to select burners and OFA ports. By improving combustion at every point within the furnace, the boiler can operate at reduced excess O{sub 2} and reduced furnace exit gas temperature (FEGT) while also reducing localized hot spots, corrosive gas conditions, slag formation, and carbon-in-ash. Benefits include improving efficiency, reducing NO{sub X} emissions, increasing output and maximizing availability. This chapter presents the results from implementing the Zonal combustion monitoring and tuning system on a 460 MW tangential-fired coal boiler in the Western United States.

  6. Design as a trademark

    OpenAIRE

    Oma, Turid

    2016-01-01

    How to obtain the most favourable protection for the shape of a product or its packaging: Similarities and differences between an EU registered three-dimensional trademark and a community registered design

  7. Decon Green (trademark)

    National Research Council Canada - National Science Library

    Wagner, George W; Procell, Lawrence R; Henderson, Vikki D; Sorrick, David C; Hess, Zoe A; Gehring, David G; Brickhouse, Mark D

    2004-01-01

    ...; it affords the broad-spectrum decontamination of chemical and biological warfare agents. Composed entirely of ingredients commonly found in cosmetics, detergents, laundry boosters, and vitamins, Decon Green (trademark...

  8. Evaluation of a Gentex (registered trademark) ORO-NASAL Oxygen Mask for Integration with the Aqualung (registered trademark) Personal Helicopter Oxygen Delivery System (PHODS)

    National Research Council Canada - National Science Library

    Roller, Richard A; Curry, Ian P

    2008-01-01

    .... The United States Army Aeromedical Research Laboratory (USAARL) was tasked by the Product Manager Air Warrior to evaluate an oxygen mask for use with the Personal Helicopter Oxygen Delivery System (PHODS...

  9. IMCOM LonWorks (registered trademark) Building Automation Systems Implementation Strategy

    National Research Council Canada - National Science Library

    Schwenk, David M; Bush, Joseph; Hughes, Lucie M; Briggs, Stephen; White, Will

    2008-01-01

    Army Installations often expand their use of digital control systems for heating, ventilating, and air conditioning and other mechanical and electrical building systems on a building-by-building basis...

  10. System 80+{trademark} Standard Design: CESSAR design certification. Volume 3: Amendment I

    Energy Technology Data Exchange (ETDEWEB)

    1990-12-21

    This report, entitled Combustion Engineering Standard Safety Analysis Report - Design Certification (CESSAR-DC), has been prepared in support of the industry effort to standardize nuclear plant designs. These documents describe the Combustion Engineering, Inc. System 80+{sup TM} Standard Design. This report, Volume 3, in conjunction with Volume 2, provides the design of structures, components, equipment and systems.

  11. Femoropopliteal atherectomy with the Simpson catheter

    International Nuclear Information System (INIS)

    Maquin, P.; Fajadet, P.; Railhac, N.; Bossavy, J.P.; Brunet, M.; Railhac, J.J.

    1989-01-01

    Percutaneous atherectomy was performed in 32 patients with 38 symptomatic femoropopliteal stenoses. Treatment was successful in 30 patients, in whom claudication disappeared and the ankle-arm index increased (mean increase, 0.35). Two early thromboses occurred. Angiographic analysis revealed residual stenosis <30% in 30 lesions, no dissecton or embolization, effective treatment of eccentric and calcified lesions, and no significant dissection after additional angioplasty. At 1-year follow-up (19 patients, 21 lesions), there were stable improvement in 13 patients, four restenoses, and two new diseases. The authors conclude that atherectomy restores a large lumen with minimal wall trauma, thus perhaps decreasing the restenosis rate

  12. IMCOM LonWorks (registered trademark) Building Automation Systems Implementation Strategy

    National Research Council Canada - National Science Library

    Schwenk, David M; Bush, Joseph; Hughes, Lucie M; Briggs, Stephen; White, Will

    2008-01-01

    ...; however BASs can present their own technical and administrative (including contractual) challenges. This report defines a methodology for the development and execution of a basewide Open Building Automation System...

  13. Praktik Trademark Squatting dalam Proses Pendaftaran Merek di Indonesia

    Directory of Open Access Journals (Sweden)

    Widya Justitia

    2016-04-01

    Full Text Available Penelitian ini bertujuan untuk mengetahui dan menganalisis mengapa praktik trademark squatting dapat terjadi dalam proses pendaftaran merek beserta cara mengatasinya. Selanjutnya, penelitian ini juga membahas mengenai konsepsi ideal terkait proses pendaftaran merek di Indonesia guna menghindari dan meminimalisasi praktik trademark squatting. Penelitian ini merupakan penelitian kualitatif yang bersifat yuridis empiris dan data yang terkumpul dianalisa dengan metode deskriptif kualitatif. Hasil penelitian menunjukkan bahwa praktik trademark squatting merupakan suatu tindakan mendaftarkan merek milik orang lain yang belum terdaftar, sehingga membuat pemilik merek yang sebenarnya tidak dapat lagi mendaftarkan mereknya. Setelah itu, pelaku menjual sertifikat hak atas merek tersebut kepada pemilik aslinya dengan harga melebihi biaya permohonan pendaftaran merek pada umumnya. Kendala yang ditemui dalam proses pendaftaran merek di Indonesia adalah kurangnya sumber daya manusia dalam menangani jumlah permohonan pendaftaran merek yang mencapai ribuan setiap harinya. Hal ini berdampak pada tidak optimalnya proses pendaftaran merek di Indonesia yaitu dengan menggagas suatu sistem yang bernama first to file based on use guna mengoptimalisasikan perlindungan pemilik merek, pertimbangan untuk meratifikasi Madrid System juga merupakan salah satu opsi lain untuk mencegah praktik trademark squatting. Abstract The purpose of this research is to identify and analyze why the practice of trademark squatting could occur in Indonesia's trademark registration process along with the constraints found in the trademark registration process in Indonesia and how to overcome them. Furthermore, it will also discuss the ideal conception related to trademark registration process to avoid and minimize the practice of trademark squatting. This research is an empirical legal research and all data were analyzed with qualitative methods. The results showed that trademark squatting is

  14. Advanced Light Water Reactor Plants System 80+trademark Design Certification Program

    International Nuclear Information System (INIS)

    Davis, G.A.

    1992-01-01

    Since 1985, ABB Combustion Engineering Nuclear Power (CENP) and Duke Engineering ampersand Services, Inc. (DE ampersand S) have been developing the next generation of pressurized water reactor (PWR) plant for worldwide deployment. The goal is to make available a pre-licensed, standardized plant design that can satisfy the need for a reliable and economic supply of electricity for residential, commercial and industrial use. To ensure that such a design is available when needed, it must be based on proven technology and established licensing criteria. These requirements dictate development of nuclear technology that is advanced, yet evolutionary in nature. This has been achieved with the System 80+ Standard Plant Design

  15. Intravascular ultrasound evaluation of JETSTREAM atherectomy removal of superficial calcium in peripheral arteries.

    Science.gov (United States)

    Maehara, Akiko; Mintz, Gary S; Shimshak, Thomas M; Ricotta, Joseph J; Ramaiah, Venkatesh; Foster, Malcolm T; Davis, Thomas P; Gray, William A

    2015-05-01

    Endovascular treatment of calcified femoral-popliteal disease is challenging. We sought to evaluate the mechanism of lumen gain when using the JETSTREAM Atherectomy System to treat calcified peripheral artery lesions. The JETSTREAM Calcium Study was a prospective, single-arm, multicentre study to evaluate the JETSTREAM Atherectomy System for severely calcified femoral-popliteal artery lesions, i.e., patients with claudication and lesions with superficial calcium >90° and >5 mm in length as determined by intravascular ultrasound (IVUS). The 2.1 mm catheter was used in this study without distal protection. Fifty-five patients underwent angiographic screening: 26 (45%) met IVUS inclusion criteria. Angiographic calcium was moderate in eight cases and severe in 14, with no available data for four cases. Visual diameter stenosis was 86±9% pre-treatment, 37±13% post atherectomy, and 10±6% post adjunctive treatment (adjunctive PTA+stenting in eight and adjunct PTA alone in 16). IVUS showed lumen area increased from 6.6±3.7 mm2 to 10.0±3.6 mm2 (p=0.001): calcium reduction was responsible for 86±23% of the lumen increase. Although the superficial calcium arc did not change (151±70° to 146±71°, p=0.83), the arc of reverberation increased (23±20° to 65±40°, p=0.006), indicating device-related modification of calcium. Adjunctive balloon angioplasty was performed in 62% of the lesions, and stent implantation in 31%. In 11 cases with adjunctive balloon dilation, the MLA increased from 7.1 (6.4, 7.8) mm2 post atherectomy to 11.9 (10.3, 13.5) mm2 post balloon (pAtherectomy System increased lumen dimensions in moderately or severely calcified femoral-popliteal lesions by removing superficial calcium without major complications.

  16. European expert consensus on rotational atherectomy

    NARCIS (Netherlands)

    Barbato, Emanuele; Carrié, Didier; Dardas, Petros; Fajadet, Jean; Gaul, Georg; Haude, Michael; Khashaba, Ahmed; Koch, Karel; Meyer-Gessner, Markus; Palazuelos, Jorge; Reczuch, Krzysztof; Ribichini, Flavio L.; Sharma, Samin; Sipötz, Johann; Sjögren, Iwar; Suetsch, Gabor; Szabó, György; Valdés-Chávarri, Mariano; Vaquerizo, Beatriz; Wijns, William; Windecker, Stephan; de Belder, Adam; Valgimigli, Marco; Byrne, Robert A.; Colombo, Antonio; Di Mario, Carlo; Latib, Azeem; Hamm, Christian

    2015-01-01

    The interest in rotational atherectomy (RA) has increased over the past decade as a consequence of more complex and calcified coronary stenoses being attempted with percutaneous coronary interventions. Yet adoption of RA is hampered by several factors: amongst others, by the lack of a standardised

  17. OCT evaluation of directional atherectomy compared to balloon angioplasty.

    Science.gov (United States)

    Marmagkiolis, Konstantinos; Lendel, Vasili; Cilingiroglu, Mehmet

    2015-09-01

    Directional atherectomy (DA) is one of the most commonly used modalities for the treatment of obstructive femoropopliteal peripheral arterial disease (PAD), especially in patients with large and calcified atherosclerotic plaques. The effect of directional atherectomy to the vascular wall compared to balloon angioplasty by optical coherence tomography (OCT) has not been previously described. We present the first case of OCT after directional atherectomy with SilverHawk followed by angiosculpt balloon angioplasty. Copyright © 2015 Elsevier Inc. All rights reserved.

  18. Mast-sipping in EPR trademark plants

    International Nuclear Information System (INIS)

    Langenberger, Jan; Schienbein, Marcel; Geier, Roland

    2010-01-01

    For more than 20 years, AREVA applies and develops different sipping techniques to identify fuel assemblies with leaking fuel rods. For the EPR trademark reactors a Mast Sipping System with newest developments will be implemented considering radiation protection and latest standards requirements. The innovative EPR trademark Sipping System differs from previous systems in many ways. One of the main innovations is that all the necessary processes of the Sipping system have been fully digitized. Second, several ALARA design modifications have been implemented to meet the current radiation protection requirements. An additional implementable multilingual assistance program facilitates the handling of the system and helps to prevent incorrect operation. (orig.)

  19. Treating peripheral arterial disease percutaneously with atherectomy.

    Science.gov (United States)

    Schwartz, Bryan G; Kloner, Robert A; Burstein, Steven; Economides, Christina; Mayeda, Guy S

    2012-06-01

    To determine clinical outcomes of patients who underwent percutaneous revascularization (PR) with multiple devices. PR cases at a private, tertiary referral hospital were reviewed retrospectively. Limb salvage and patency rates were calculated by the Kaplan Meier method. Historical and procedural factors were analyzed by multivariate Cox proportional hazards models. We identified 66 patients and 87 limbs with 261 lesions, including 38 patients with critical limb ischemia (CLI) (51 limbs, 171 lesions). PR incorporated multiple devices (2.0 ± 1.2 devices/lesion, 2.4 ± 1.6 devices/procedure), including balloon angioplasty (57%), excisional atherectomy (54%), orbital atherectomy (44%), and stenting (13%). Last imaged patency was at 18 ± 13 months and last clinical follow-up was 22 ± 12 months. Thirty-five of 87 limbs had ≥1 repeat PR. In 51 limbs with CLI, limb salvage was 75% at 3 years. Independent predictors of amputation were higher creatinine (P=.01; hazard ratio [HR], 1.4), Rutherford category (P=.03; HR, 3.5), and history of coronary artery bypass graft (CABG) (P=.03; HR, 8.9). Overall patency remained 75% through 3 years. Loss of patency or primary patency (patency without repeat PR) was predicted by higher creatinine, Rutherford category, chronic total occlusion, history of CABG, female gender, current and past smoking. Use of excisional atherectomy maintained overall patency (P=.01; HR, 0.36). An aggressive approach to PR with frequent use of atherectomy resulted in high rates of limb salvage and patency. Smoking cessation and excisional atherectomy may improve patency rates.

  20. Numerical benchmarking of SPEEDUP trademark against point kinetics solutions

    International Nuclear Information System (INIS)

    Gregory, M.V.

    1993-02-01

    SPEEDUP trademark is a state-of-the-art, dynamic, chemical process modeling package offered by Aspen Technology. In anticipation of new customers' needs for new analytical tools to support the site's waste management activities, SRTC has secured a multiple-user license to SPEEDUP trademark. In order to verify both the installation and mathematical correctness of the algorithms in SPEEDUP trademark, we have performed several numerical benchmarking calculations. These calculations are the first steps in establishing an on-site quality assurance pedigree for SPEEDUP trademark. The benchmark calculations consisted of SPEEDUP trademark Version 5.3L representations of five neutron kinetics benchmarks (each a mathematically stiff system of seven coupled ordinary differential equations), whose exact solutions are documented in the open literature. In all cases, SPEEDUP trademark solutions to be in excellent agreement with the reference solutions. A minor peculiarity in dealing with a non-existent discontinuity in the OPERATION section of the model made itself evident

  1. Study to determine the clinical significance of HEmolysis During Orbital AtheRectomy (CLEAR study).

    Science.gov (United States)

    Staniloae, Cezar S; Korabathina, Ravikiran; Lane, Thomas A; Dattilo, Raymond; Church, Kevin J; Mody, Kanika P; Mayeda, Guy S

    2011-02-01

    To evaluate the incidence of clinically evident hemolysis associated with orbital atherectomy used to treat severe peripheral artery disease. The observational CLEAR study enrolled 31 subjects (16 men; mean age 71 ± 10 years, range 44-92) with claudication (58.1%) or critical limb ischemia (38.7%) who underwent orbital atherectomy with the Diamondback 360 system at 4 US centers. The 42 lesions in 31 limbs were located in the superficial femoral (n = 19, 45.2%), popliteal (n = 8, 19.0%), and tibial arteries (n = 15, 35.8%). The majority of lesions (34, 81.0%) were de novo; moderate or severe calcification was identified in 90.5% of cases. Lesion and procedural parameters were analyzed at a core laboratory. Blood samples were collected during and post procedure and analyzed for markers of hemolysis. The primary endpoint was the occurrence of clinically significant hemolysis. The secondary endpoints included the occurrence of any clinical symptoms/signs potentially related to hemolysis. Statistical analysis was performed to identify predictors for hemolysis. Laboratory evidence of hemolysis was seen in 11 (35.5%) subjects. No one met the clinical event criteria, and so the primary endpoint of the study was not reached. The secondary endpoints were hypertensive crisis (1, 3.2%) and transient hemoglobinuria (3, 9.7%). Lower glomerular filtration rates, calcified plaque, long atherectomy runs, and solid crown selection were independent predictors of hemolysis. There was no clinically significant hemolysis after orbital atherectomy. The results of this study will enable users to predict conditions that predispose to high levels of red cell hemolysis following orbital atherectomy and to take appropriate measures to limit its occurrence.

  2. Orbital atherectomy for severely calcified lesions: More dissections in women but similar 30-day outcomes to men.

    Science.gov (United States)

    Chandrasekhar, Jaya; Mehran, Roxana

    2016-03-01

    Calcified lesions are associated with lower rates of successful percutaneous coronary intervention (PCI), greater stent thrombosis, and increased target vessel revascularization. Women undergoing PCI are more often older than men and likely to present with severe lesion calcification. The ORBIT II study, for the first time compares the effect of the orbital atherectomy system (OAS) in men and women undergoing PCI for severely calcified lesions. Although the adjusted risk of severe dissections was higher in women, the incidence of in-hospital and 30-day outcomes was similar to men. Randomized comparisons of the OAS with rotational atherectomy and with stenting without atherectomy are needed to further elucidate sex-based differences in calcified lesion PCI. © 2016 Wiley Periodicals, Inc.

  3. Lower Extremity Revascularization Using Optical Coherence Tomography-Guided Directional Atherectomy: Final Results of the EValuatIon of the PantheriS OptIcal COherence Tomography ImagiNg Atherectomy System for Use in the Peripheral Vasculature (VISION) Study.

    Science.gov (United States)

    Schwindt, Arne G; Bennett, J Gray; Crowder, William H; Dohad, Suhail; Janzer, Sean F; George, Jon C; Tedder, Barry; Davis, Thomas P; Cawich, Ian M; Gammon, Roger S; Muck, Patrick E; Pigott, John P; Dishmon, Dwight A; Lopez, Lou A; Golzar, Jaafer A; Chamberlin, Jack R; Moulton, Michael J; Zakir, Ramzan M; Kaki, Amir K; Fishbein, Gary J; McDaniel, Huey B; Hezi-Yamit, Ayala; Simpson, John B; Desai, Arjun

    2017-06-01

    To evaluate the safety and efficacy of a novel optical coherence tomography (OCT)-guided atherectomy catheter in treating patients with symptomatic femoropopliteal disease. The VISION trial ( ClinicalTrials.gov identifier NCT01937351) was a single-arm, multicenter, global investigational device exemption study enrolling 158 subjects (mean age 67.2±10.5 years; 87 men) across 20 participating sites. In this cohort, 198 lesions were treated with an average length of 53±40 mm using the Pantheris catheter alone or Pantheris + adjunctive therapy. The primary safety endpoint was the composite of major adverse events (MAEs) through 6 months (objective performance goal 43.2%). Technical success (primary efficacy outcome) was defined as the percent of target lesions with a residual diameter stenosis ≤50% after treatment with the Pantheris device alone (objective performance goal 87.0%). Procedural success was defined as reduction in stenosis to ≤30% after Pantheris ± adjunctive therapy. Tissue specimens retrieved from each treated lesion were histologically analyzed to evaluate the accuracy and precision of OCT image guidance. The primary efficacy outcome was achieved in 192 (97.0%) of the 198 lesions treated with the Pantheris catheter. Across all lesions, mean diameter stenosis was reduced from 78.7%±15.1% at baseline to 30.3%±11.8% after Pantheris alone (patherectomy specimens confirmed atherectomy for femoropopliteal disease is safe and effective. Additionally, the precision afforded by OCT guidance leads to greater removal of plaque during atherectomy while sparing the adventitia.

  4. OCT evaluation of directional atherectomy compared to balloon angioplasty

    International Nuclear Information System (INIS)

    Marmagkiolis, Konstantinos; Lendel, Vasili; Cilingiroglu, Mehmet

    2015-01-01

    Directional atherectomy (DA) is one of the most commonly used modalities for the treatment of obstructive femoropopliteal peripheral arterial disease (PAD), especially in patients with large and calcified atherosclerotic plaques. The effect of directional atherectomy to the vascular wall compared to balloon angioplasty by optical coherence tomography (OCT) has not been previously described. We present the first case of OCT after directional atherectomy with SilverHawk followed by angiosculpt balloon angioplasty. - Highlights: • Directional atherectomy avoids the vascular mechanical damage caused by angioplasty balloons and the exposure of stent struts or the potential of stent fracture with stents. • OCT can accurately assess the effect of endovacular interventions to the vessel wall. • Although angiographic results after directional atherectomy are acceptable, OCT use demonstrated suboptimal improvement of the MLA requiring additional balloon angioplasty. • Longer studies are needed to define whether the improved OCT results with angioplasty compared to DA may offer better clinical outcomes.

  5. OCT evaluation of directional atherectomy compared to balloon angioplasty

    Energy Technology Data Exchange (ETDEWEB)

    Marmagkiolis, Konstantinos [Citizens Memorial Hospital Heart and Vascular Institute, Bolivar, MO (United States); Lendel, Vasili [Arkansas Heart Hospital, Peripheral Vascular Institute, Little Rock, AR (United States); Cilingiroglu, Mehmet, E-mail: mcilingiroglu@yahoo.com [Arkansas Heart Hospital, Peripheral Vascular Institute, Little Rock, AR (United States); Koc University, School of Medicine, Istanbul (Turkey)

    2015-09-15

    Directional atherectomy (DA) is one of the most commonly used modalities for the treatment of obstructive femoropopliteal peripheral arterial disease (PAD), especially in patients with large and calcified atherosclerotic plaques. The effect of directional atherectomy to the vascular wall compared to balloon angioplasty by optical coherence tomography (OCT) has not been previously described. We present the first case of OCT after directional atherectomy with SilverHawk followed by angiosculpt balloon angioplasty. - Highlights: • Directional atherectomy avoids the vascular mechanical damage caused by angioplasty balloons and the exposure of stent struts or the potential of stent fracture with stents. • OCT can accurately assess the effect of endovacular interventions to the vessel wall. • Although angiographic results after directional atherectomy are acceptable, OCT use demonstrated suboptimal improvement of the MLA requiring additional balloon angioplasty. • Longer studies are needed to define whether the improved OCT results with angioplasty compared to DA may offer better clinical outcomes.

  6. Skin dose measurement with MICROSPEC-2 trademark

    International Nuclear Information System (INIS)

    Hsu, H.H.

    1997-01-01

    For many years, the Eberline HP-260 trademark beta detectors were used for skin dose measurements at Los Alamos National Laboratory. This detector does not measure the beta spectrum and the skin dose can only be determined if the contaminating radioactive isotope is known. A new product MICROSPEC-2 trademark, has been developed which consists of a small portable computer with a multichannel analyzer and a beta probe consisting of a phoswich detector. The system measures the beta spectrum and automatically folds in the beta fluence-to-dose conversion function to yield the skin dose

  7. Intravascular ultrasound guided directional atherectomy versus directional atherectomy guided by angiography for the treatment of femoropopliteal in-stent restenosis

    Science.gov (United States)

    Krishnan, Prakash; Tarricone, Arthur; K-Raman, Purushothaman; Majeed, Farhan; Kapur, Vishal; Gujja, Karthik; Wiley, Jose; Vasquez, Miguel; Lascano, Rheoneil A.; Quiles, Katherine G.; Distin, Tashanne; Fontenelle, Ran; Atallah-Lajam, Farah; Kini, Annapoorna; Sharma, Samin

    2017-01-01

    Background: The aim of this study was to compare 1-year outcomes for patients with femoropopliteal in-stent restenosis using directional atherectomy guided by intravascular ultrasound (IVUS) versus directional atherectomy guided by angiography. Methods and results: This was a retrospective analysis for patients with femoropopliteal in-stent restenosis treated with IVUS-guided directional atherectomy versus directional atherectomy guided by angiography from a single center between March 2012 and February 2016. Clinically driven target lesion revascularization was the primary endpoint and was evaluated through medical chart review as well as phone call follow up. Conclusions: Directional atherectomy guided by IVUS reduces clinically driven target lesion revascularization for patients with femoropopliteal in-stent restenosis. PMID:29265002

  8. Rotational and aspiration atherectomy for infrainguinal in-stent restenosis.

    Science.gov (United States)

    Beschorner, Ulrich; Krankenberg, Hans; Scheinert, Dierk; Sievert, Horst; Tübler, Thilo; Sixt, Sebastian; Noory, Elias; Rastan, Aljoscha; Macharzina, Roland; Zeller, Thomas

    2013-03-01

    To report feasibility and safety of the Pathway PV™ Atherectomy System during percutaneous peripheral vascular interventions of in-stent restenosis. 33 patients (66.7 % men; mean age 68.7 years; 39.4 % diabetics) with symptomatic infrainguinal in-stent restenosis were enrolled at 5 study sites. Primary study endpoint was the 30-day serious adverse event (SAE) rate. At one study site a subgroup of 13 patients was scheduled for additional follow-up examinations with duplex. Forty lesions with a mean lesion length of 85.7 mm (range 6 - 370 mm) were treated including total occlusions (20 %) and infrapopliteal lesions (5 %). In sixteen target lesions (40 %) procedural success was reached with atherectomy alone, 23 lesions (57.5 %) received adjunctive percutaneous transluminal angioplasty to obtain a sufficient angiographic result. Freedom from device-related SAEs was 100 %. Overall there were 11 unexpected adverse events in 11 patients, two of which were serious (retroperitoneal bleeding and access site infection). The ankle-brachial index increased significantly from 0.65 ± 0.13 at baseline to 0.82 ± 0.15 at 30 days. Mean Rutherford category improved from 2.8 ± 0.7 at baseline to 1.0 ± 1.2. In the subgroup with longer follow- up primary patency was 33 % after 12 months and 25 % after 24 months. Secondary patency was 92 % after 12 and 24 months. The use of the Pathway PV™ System during percutaneous peripheral vascular interventions of in-stent restenosis appears to be feasible and safe but does not seem to offer a sustainable solution regarding long term patency. A combination with drug eluting balloon angioplasty could be an interesting option and should be evaluated in further clinical trials.

  9. Critical hand ischemia treatment via orbital atherectomy-A single center observational retrospective analysis.

    Science.gov (United States)

    Bahro, Abdul; Igyarto, Zsuzsanna; Martinsen, Brad

    2017-03-01

    Critical hand ischemia (CHI) can be devastating and may result in amputation. Distal vessel calcification has been shown to be a major factor in causing CHI. Atherectomy in the upper extremities is not typically considered due to the small anatomy; however, the Diamondback 360° Peripheral Orbital Atherectomy System (OAS) (Cardiovascular Systems, Inc.) can access treatment areas with a reference vessel diameter of 1.5mm. A retrospective, observational, single center (Merit Health Center, Jackson, MS) analysis of 11 CHI patients with calcific disease of the radial artery treated with orbital atherectomy (OAS) was completed. Demographics and procedural to 30-day outcomes were assessed. All patients had good blood flow to the hand after intervention and none experienced complications during or immediately post-procedure. At 30-days the freedom from revascularization and amputation was 100%, and all the wounds were healed. The following important principles were followed during the use of OAS for CHI: (1) ACT was therapeutic (~250s); (2) Gentle wire manipulation; (3) Utilization of a small OAS crown (1.25mm); (4) Aggressive vasodilator use-given through the exchange catheter; (5) Angioplasty balloon was matched to the size of the vessel and long and low pressure inflations were completed. Critical hand ischemia can be treated with endovascular techniques. Obtaining good outflow to the fingers is critical for wound healing and preventing amputation. Orbital atherectomy is a useful tool in preparing vessels for balloon angioplasty; particularly in cases where calcification is present. Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

  10. PTC-6 vacuum system: WallWalker{trademark} and Blastrac{reg_sign} shot blast cleaning system

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1998-02-01

    The LTC Americas, Inc. wall decontamination technology consisted of two pneumatic hand-held tools: (1) a roto-peen scaler that used star cutters and (2) a 3-piston hammer with reciprocating bits. The hand-held tools were used in conjunction with the LTC PTC-6 vacuum system which captured dust and debris as the wall decontamination took place. Recommendations for improved worker safety and health during use of the PTC-6 vacuum system with hand-held tools include: (1) keeping all hoses and lines as orderly as possible in compliance with good housekeeping requirements; (2) ergonomic training to include techniques in lifting, bending, stooping, twisting, etc.; (3) use of a clamping system to hold hoses to the vacuum system; (4) a safety line on the air line connections; (5) use of a mechanical lifting system for waste drum removal; and (6) the use of ergonomically designed tools.

  11. Orbital atherectomy as an adjunct to debulk difficult calcified lesions prior to mesenteric artery stenting.

    Science.gov (United States)

    Manunga, Jesse M; Oderich, Gustavo S

    2012-08-01

    To describe a technique in which percutaneous orbital atherectomy is used to debulk heavily calcified superior mesenteric artery (SMA) occlusions as an adjunct in patients undergoing angioplasty and stenting. The technique is demonstrated in a 62-year-old woman with a replaced right hepatic artery originating from an SMA occluded by densely calcified lesions. Via a left transbrachial approach, a 7-F MPA guide catheter was used to engage the ostium of the SMA, which was crossed using a catheter and guidewire. The calcified lesion was debulked using the 2-mm Diamondback 360° orbital atherectomy system. The wire was exchanged for a 0.014-inch filter wire and 0.018-inch guidewire. Using a 2-guidewire technique, the SMA was stented with a self-expanding stent for the distal lesion that crossed side branches and a balloon-expandable stent at the ostium. A 0.014-inch guidewire was placed into the replaced hepatic artery through a cell of the self-expanding stent, followed by deployment of a small balloon-expandable stent to address the residual lesion. The use of orbital atherectomy to debulk occluded and heavily calcified SMA lesions may optimize the technical results with angioplasty and stenting.

  12. Directional atherectomy for treatment of restenosis within coronary stents: clinical, angiographic and histologic results

    NARCIS (Netherlands)

    B.H. Strauss (Bradley); V.A.W.M. Umans (Victor); R-J. van Suylen (Robert-Jan); P.J. de Feyter (Pim); J. Marco (Jean); G. Robertson; J. Renkin; G.R. Heyndrickx (Guy); V.D. Vuzevski (Vojislav); F.T.B. Bosman (Fré); P.W.J.C. Serruys (Patrick)

    1992-01-01

    textabstractAbstract OBJECTIVES: The safety and long-term results of directional coronary atherectomy in stented coronary arteries were determined. In addition, tissue studies were performed to characterize the development of restenosis. METHODS: Directional coronary atherectomy was performed in

  13. Laser Atherectomy for Treatment of Femoropopliteal In-Stent Restenosis.

    Science.gov (United States)

    Armstrong, Ehrin J; Thiruvoipati, Thejasvi; Tanganyika, Kundai; Singh, Gagan D; Laird, John R

    2015-08-01

    To investigate if laser atherectomy with adjunctive balloon angioplasty can improve endovascular treatment outcomes for femoropopliteal in-stent restenosis (ISR). A dual center study included 135 symptomatic patients (mean age 71 years; 76 men) who underwent endovascular treatment of femoropopliteal ISR between 2006 and 2013. Of these, 54 (40%) were treated with laser atherectomy and the remaining 81 patients with balloon angioplasty alone. Angiographic images were reviewed for lesion morphology and characteristics, TransAtlantic InterSociety Consensus (TASC) II classification, and distal runoff. Class I ISR was defined as focal lesions ≤50 mm, class II ISR as lesions >50 mm, and class III ISR as stent total occlusion. Recurrent ISR was determined by a peak systolic velocity ratio >2.4 by duplex ultrasound. Patients treated with laser atherectomy had longer mean ISR lesion length (222 vs 114 mm, patherectomy and rates of recurrent restenosis or occlusion for patients with class I/II ISR, but there was a significantly lower rate of target lesion revascularization at 2 years among patients treated with laser atherectomy (14% vs 44%, p=0.05). In comparison, patients with class III ISR treated with laser atherectomy had lower rates of recurrent restenosis at 1 year (54% vs 91%, p=0.05) and 2 years (69% vs 100%, p=0.05). Patients with class III ISR treated with laser atherectomy also had lower rates of recurrent in-stent occlusion at 2-year follow-up (33% vs 71%, p=0.04). When used to treat complex ISR, including in-stent occlusions, laser atherectomy with adjunctive balloon angioplasty may be associated with improved patency. © The Author(s) 2015.

  14. Percutaneous mechanical atherectomy for treatment of peripheral arterial occlusive disease; Perkutane mechanische Atherektomie zur Behandlung der peripheren arteriellen Verschlusskrankheit

    Energy Technology Data Exchange (ETDEWEB)

    Buecker, A.; Minko, P.; Massmann, A.; Katoh, M. [Universitaetsklinikum des Saarlandes, Klinik fuer Diagnostische und Interventionelle Radiologie, Homburg (Germany)

    2010-01-15

    Peripheral arterial occlusive disease (PAOD) is still an extremely important politico-economic disease. Diverse treatment procedures exist but the pillars of therapy are changes in lifestyle, such as nicotine abstinence and walking exercise as well as drug therapy. Further therapy options are considered after conventional procedures have been exhausted. These further options consist of improvement of the blood supply by surgical or minimally invasive procedures. The latter therapy options include balloon dilatation and stenting as the most widely used techniques. More recent techniques also used are cryoplasty, laser angioplasty, drug-coated stents or balloons as well as brachytherapy or atherectomy, whereby this list makes no claims to completeness. The multitude of different treatment methods emphatically underlines the fact that no resounding success can be achieved with one single method. The long-term results of both balloon dilatation and stenting techniques show a need for improvement, which elicited the search for additional methods for the treatment of PAOD. Atherectomy represents such an alternative method for treatment of PAOD. Basically, the term atherectomy means the removal of atheroma tissue. For percutaneous atherectomy, in contrast to surgical procedures, it is not necessary to create surgically access to the vessel but accomplishes the atherectomy by means of dedicated systems via a minimally invasive access. There are two basic forms of mechanical atherectomy: directional and rotational systems. (orig.) [German] Die periphere arterielle Verschlusskrankheit (PAVK) stellt nach wie vor eine volkswirtschaftlich ueberaus bedeutsame Erkrankung dar. Diverse Behandlungsverfahren existieren; Lebensstilaenderungen wie Nikotinabstinenz und Gehtraining und auch medikamentoese Therapien machen einen Pfeiler der Therapie aus. Weitere Therapieansaetze kommen nach Ausreizen der konventionellen Verfahren zur Anwendung. Sie bestehen in der Verbesserung der

  15. The Creation and Use of an Analysis Capability Maturity Model (trademark) (ACMM)

    National Research Council Canada - National Science Library

    Covey, R. W; Hixon, D. J

    2005-01-01

    .... Capability Maturity Models (trademark) (CMMs) are being used in several intellectual endeavors, such as software engineering, software acquisition, and systems engineering. This Analysis CMM (ACMM...

  16. Intraluminal ultrasound guidance of transverse laser coronary atherectomy

    Science.gov (United States)

    Aretz, H. Thomas; Martinelli, Michael A.; LeDet, Earl G.; Sedlacek, Tomas; Hatch, G. F.; Gregg, Richard E.

    1990-07-01

    A coronary laser atherectomy system combining laser delivery and ultrasonic imaging capability is described. The system is being developed by Intra-Sonix, Inc. to treat severe stenoses. The imaging system provides the clinician with the guidance needed to remove substantial plaque without perforation. The ultrasound transducers and laser optics are mounted in a small (less than 4 F), flexible catheter, that is deliverable over a standard guidewire (0.016 inch). The laser and ultrasound beams are directed at the artery wall to permit debulking of lesions and ultrasonic depth profiling of the tissue structure throughout the thickness of the artery. This allows the physician to determine the level of therapy to be applied and to monitor the plaque removal as the therapy progresses. The precise location of the ultrasound and laser beams in the artery is determined by a navigation system. Navigation data are processed electronically in conjunction with ultrasound data to produce real-time cross-sectional and longitudinal images of the artery wall at selected locations, which are updated as the catheter progresses through the vessel lumen. Results of in vitro tests on human atherosclerotic arteries and early in vivo experiments in a canine-human xenograft model showing image construction and radial laser delivery are discussed.

  17. Clothing creator trademark : Business plan

    Energy Technology Data Exchange (ETDEWEB)

    Stern, B.

    1990-10-01

    SYMAGERY has developed a patented process to manufacture clothing without direct human labor. This CLOTHING CREATOR{trademark}, will have the ability to produce two (2) perfect garments every 45 seconds or one (1) every 30 seconds. The process will combine Computer Integrated Manufacturing (CIM) technology with heat molding and ultrasonic bonding/cutting techniques. This system for garment production, will have the capacity to produce garments of higher quality and at lower productions costs than convention cut and sew methods. ADVANTAGES of the process include: greatly reduced production costs; increased quality of garments; reduction in lead time; and capacity to make new class of garments. This technology will accommodate a variety of knit, woven and nonwoven materials containing a majority of synthetic fibers. Among the many style of garments that could be manufactured by this process are: work clothing, career apparel, athletic garments, medical disposables, health care products, activewear, haz/mat garments, military clothing, cleanroom clothing, outdoor wear, upholstery, and highly contoured stuffed toy shells. 3 refs.

  18. Orbital atherectomy for treating de novo, severely calcified coronary lesions: 3-year results of the pivotal ORBIT II trial.

    Science.gov (United States)

    Lee, Michael; Généreux, Philippe; Shlofmitz, Richard; Phillipson, Daniel; Anose, Bynthia M; Martinsen, Brad J; Himmelstein, Stevan I; Chambers, Jeff W

    2017-06-01

    The presence of heavy coronary artery calcification increases the complexity of percutaneous coronary intervention (PCI) and increases the incidence of major adverse cardiac events (MACE): death, myocardial infarction (MI), target vessel revascularization (TVR), and stent thrombosis. The ORBIT II (Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions) trial reported low rates of procedural, 30-day, 1-year, and 2-year ischemic complications after treatment of de novo, severely calcified lesions with the Diamondback 360° Coronary Orbital Atherectomy System (OAS) (Cardiovascular Systems, Inc.). ORBIT II was a single-arm trial that enrolled 443 patients at 49U.S. sites; in this study, de novo, severely calcified coronary lesions were treated with OAS prior to stenting. The primary safety endpoint was 30-day MACE: the composite of cardiac death, MI, and TVR (inclusive of target lesion revascularization (TLR)). The primary efficacy endpoint was procedural success: stent delivery with a residual stenosis of atherectomy. There were 360 (81.3%) subjects who completed the protocol-mandated 3-year visit.The overall cumulative rate of 3-year MACE was 23.5%, including cardiac death (6.7%), MI (11.2%), and TVR (10.2%). The 3-year target lesion revascularization rate was 7.8%. In the final 3-year analysis of the ORBIT II trial, orbital atherectomy of severely calcified coronary lesions followed by stenting resulted in a low rate of adverse ischemic events compared with historical controls.Orbital atherectomy represents a safe and effective revascularization strategy for patients with severely calcified coronary lesions. The ORBIT II trial enrolled 443 subjects to study orbital atherectomy followed by stenting for de novo severely calcified coronary lesions. The overall cumulative 3-year MACE rate was 23.5%, including cardiac death (6.7%), MI (11.2%), and TVR (10.2%); the 3-year target lesion revascularization rate was 7.8%. Orbital atherectomy

  19. Comparison of MultiHance {sup trademark} and Gadovist {sup trademark} for cerebral MR perfusion imaging in healthy volunteers; Vergleich von MultiHance {sup trademark} und Gadovist {sup trademark} zur zerebralen MR-Perfusionsmessung bei gesunden Probanden

    Energy Technology Data Exchange (ETDEWEB)

    Essig, M.; LeHuu, M.; Huebener, M.; Kaick, G. van [Deutsches Krebsforschungszentrum, Abt. Radiologische Diagnostik und Therapie, Heidelberg (Germany); Lodemann, K.P. [Bracco-Byk, Gulden (Germany); Schoenberg, S.O. [Institut fuer Klinische Radiologie, Ludwig-Maximilians-Universitaet Muenchen, Grosshadern (Germany)

    2002-11-01

    To evaluate the weakly protein interacting MR contrast agent MultiHance {sup trademark} and the one-molar agent Gadovist {sup trademark} for cerebral perfusion MR imaging, a randomized intraindividual study was conducted in 12 healthy male volunteers. Perfusion-MRI was performed with single and double dose of each contrast agent on a 1.5T MR system using a gradient-echo EPI sequence. The imaging parameters, slice positioning and contrast media application were standardized. For the quantitative assessment rCBV and rCBF measurements of gray and white matter were performed. Additionally, the percentage of signal drop and the full width half maximum (FWHM) of ROI signal time curves were quantified. In a qualitative analysis the image quality of the rCBV and rCBF maps were assessed.Single dosage of the used new contrast agents was sufficient to achieve high quality perfusion maps. The susceptibility effect, described by percentage of signal loss (Gadovist {sup trademark} : 29.4% vs. MultiHance {sup trademark} : 28.3%) and the FWHM (Gadovist {sup trademark} : 6.4 s vs. Multihance {sup trademark} : 7.0 s) were not different between the agents for single dose.The one molar MR contrast agent Gadovist {sup trademark} has no advantages over MultiHance {sup trademark}, a MR contrast agent with a higher relaxivity in perfusion MRI. Both agents allow the calculation of high quality perfusion maps at a dosage of 0.1 mmol/kg bw with physiologic absolute values for regional CBV and CBF. The susceptibility effect is comparable for both agents and stronger than with conventional MR contrast media. (orig.) [German] Zur Evaluierung des gering proteinbindenden MR-Kontrastmittels MultiHance {sup trademark} und des einmolaren MR-Kontrastmittels Gadovist {sup trademark} fuer die MR-Perfusionsmessung im Gehirn wurden in einer randomisierten, intraindividuellen Vergleichsstudie 12 gesunde maennliche Probanden untersucht. Die Perfusionsmessung wurde an einem 1,5-T-MRT mit einer T2

  20. Intraluminal laser atherectomy with ultrasound and electromagnetic guidance

    Science.gov (United States)

    Gregory, Kenton W.; Aretz, H. Thomas; Martinelli, Michael A.; LeDet, Earl G.; Hatch, G. F.; Gregg, Richard E.; Sedlacek, Tomas; Haase, Wayne C.

    1991-05-01

    The MagellanTM coronary laser atherectomy system is described. It uses high- resolution ultrasound imaging and electromagnetic sensing to provide real-time guidance and control of laser therapy in the coronary arteries. The system consists of a flexible catheter, an electromagnetic navigation antenna, a sensor signal processor and a computer for image processing and display. The small, flexible catheter combines an ultrasound transducer and laser delivery optics, aimed at the artery wall, and an electromagnetic receiving sensor. An extra-corporeal electromagnetic transmit antenna, in combination with catheter sensors, locates the position of the ultrasound and laser beams in the artery. Navigation and ultrasound data are processed electronically to produce real-time, transverse, and axial cross-section images of the artery wall at selected locations. By exploiting the ability of ultrasound to image beneath the surface of artery walls, it is possible to identify candidate treatment sites and perform safe radial laser debulking of atherosclerotic plaque with reduced danger of perforation. The utility of the system in plaque identification and ablation is demonstrated with imaging and experimental results.

  1. [Microscopic investigation of vessel wall after endovascular catheter atherectomy].

    Science.gov (United States)

    Tsygankov, V N; Khovalkin, R G; Chekmareva, I A; Kalinin, D V; Filippova, E M

    2014-01-01

    Endovascular target catheter atherectomy (ETCA) - method of artery patency allowing to obtain occlusion substrate. Given the high destructive effect of atherectome's elements on tissue the objective was determination possibility of histological and electron microscopic investigation of this substrate after atherectomy. The research included 8 patients who underwent ETCA of legs arteries. It was observed substrate removal from broken stent in 1 case. 2 of 8 patients had diabetes. Obtained substrate was available for histological and electron microscopic investigation. Atherosclerosis was confirmed in all cases. It was not observed substrate significant morphological changes in patients with presence or absence of diabetes. Microscopic investigation of substrate from broken stent shows pronounced development of granulation tissue that was regarded as special form of reparative regeneration. Finding internal elastic membrane during microscopic investigation in some cases proves radical intervention. The authors consider that microscopic investigation of substrate after ETCA may be used for diagnosis verification, thorough analysis of morphological changes in lesion area and radicalism of atherectomy.

  2. A polymer driveshaft for use in orbital and rotational atherectomy

    Science.gov (United States)

    Grothe, Preston Lee

    Driveshafts used in atherectomy medical devices are often comprised of coiled or braided metal wires. These constructions are designed to tolerate delivery through tortuous vessels and can endure high speed rotation used during activation of the atherectomy treatment. This research investigated polymer driveshaft designs, which were comprised of polymer inner and outer layers, and coiled or braided stainless steel wires. The polymer driveshaft materials included polyimide, nylon 12, and polytetrafluoroethylene (PTFE). Mechanical testing of polymer driveshafts was conducted to determine material response in bending, tension, compression, and torsion. The polymer driveshaft test results were then compared with current coiled metal wire driveshaft constructions. The investigation identified polymer driveshaft options that could feasibly work in an atherectomy application.

  3. Successful Expansion of an Underexpanded Stent by Rotational Atherectomy

    Science.gov (United States)

    Vales, Lori; Coppola, John; Kwan, Tak

    2013-01-01

    The current routine use of intracoronary stents in percutaneous coronary intervention (PCI) has significantly reduced rates of restenosis, compared with balloon angioplasty alone. On the contrary, small post-stenting luminal dimensions due to undilatable, heavily calcified plaques have repeatedly been shown to significantly increase the rates of in-stent restenosis. Rotational atherectomy of lesions is an alternative method to facilitate PCI and prevent underexpansion of stents, when balloon angioplasty fails to successfully dilate a lesion. Stentablation, using rotational atherectomy to expand underexpanded stents deployed in heavily calcified plaques, has also been reported. We report a case via the transradial approach of rotational-atherectomy–facilitated PCI of in-stent restenosis of a severely underexpanded stent due to a heavily calcified plaque. We review the literature and suggest rotational atherectomy may have a role in treating a refractory, severely underexpanded stent caused by a heavily calcified plaque through various proposed mechanisms. PMID:24436587

  4. High-speed rotary atherectomy under fluoroscopic and angioscopic guidance

    International Nuclear Information System (INIS)

    Deutsch, L.S.; Ahn, S.S.; Yeatman, L.A.; Marcus, D.R.; Auth, D.P.; Moore, W.S.

    1988-01-01

    This paper describes thirteen stenotic arteries treated by high-speed rotary abrasive burr atherectomy performed in the operating room under fluoroscopic-angioscopic control by a multidisciplinary team consisting of a vascular surgeon, an interventional radiologist, and an interventional cardiologist. Incrementally sized atherectomy burrs were used in each patient (1.75-4.0 mm in diameter). Rotary artherectomy was successful in 11 of 13 arteries ranging from 1 to 40 cm (median, 5 cm) with stenoses ranging from 50% to 99% (median, 90%), which improved to less than 30% in all 11 successfully atherectomized segments. Two early posttreatment failures (intimal dissection, burr shaft disruption), two posttreatment thromboses (unrelated to atherectomy), and two late failures (restenosis) occurred

  5. Morphological differences in coronary arteries following rotational atherectomy versus balloon angioplasty: ultrasound and angioscopic observations

    Science.gov (United States)

    Bass, Theodore A.; Gilmore, Paul S.; White, Christopher J.; Chami, Youssef G.; Kircher, Barbara J.; Conetta, Donald A.

    1993-09-01

    Percutaneous transluminal coronary rotational atherectomy (PTCRA) is an exciting new device to recannulate obstructed coronary arteries. This device works as a high speed `drill,' selectively cutting hard atherosclerotic plaque while preferentially sparing the softer, less diseased vascular luminal surface. At speeds as high as 200,000 rpm the plaque is pulverized into small particles easily handled by the circulatory system with no untoward clinical sequela. Balloon angioplasty does not remove atherosclerotic plaque. It dilates the vessel by mechanically stretching, compressing and splitting the plaque and vessel lining. We compare morphological and surface luminal characteristics of vessels post PTCRA to vessels post PTCA.

  6. Legal Protection of Well-known Trademark Rights in China : History, Current Situation and Challenge

    OpenAIRE

    Chen, Zhu

    2010-01-01

    The legal term of “Well-Known Trademark” first appeared in the 1883 Paris Convention for the Protection of Industrial Property, which sets forth the principles for granting special protection to well-known trademarks. In recent years, Sino-US disputes over intellectual property protection have the trend to upgrade, and among these disputes, well-known trademark protection is an important cornerstone. In recent years in China, the well-known trademark protection system is still relatively week...

  7. Clinical-pathological-angiographic correlations following transluminal atherectomy

    International Nuclear Information System (INIS)

    Althaus, S.J.; Maynar, M.; Reyes, R.; Pulido-Duque, J.M.; Casal, G.; Hunter, D.W.; Castaneda-Zuniga, W.R.; Amplatz, K.

    1989-01-01

    Following percutaneous atherectomy, arterial and catheter diameter relationships were correlated with angiographic and ankle-arm index results. There was a greater amount of tissue removed, improved luminal reconstitution, and ankle-arm index in lesions where the catheter and arterial diameters were equal or within 0.5 mm. Excluding lesions requiring angioplasty, 77% of our lesions had less than 30% residual stenosis; including lesions requiring concomitant angioplasty, the initial overall patency was 93%, with a 1-year patency rate of 92.5%. This study indicates that adequate matching of the atherectomy catheter diameter to the arterial diameter is necessary to optimize tissue removal and clinical results

  8. Optimal use of atherectomy in critical limb ischemia.

    Science.gov (United States)

    Rundback, John H; Herman, Kevin Chaim

    2014-09-01

    Critical limb ischemia (CLI) is the most severe and debilitating form of peripheral arterial disease and is associated with high rates of limb loss and cardiovascular mortality. The unique physical environment of tibial occlusive disease underlying most CLI cases limits treatment options and long-term durability, with resulting frequent rates of persistent obstruction, restenosis, and reintervention. Atherectomy represents a potential strategy to improve acute and late results when treating patients with CLI. Available atherectomy devices each have specific performance characteristics, evidentiary rationale, and limitations that mandate a clear understanding of the optimal albeit evolving use of this category of interventional tools. Copyright © 2014 Elsevier Inc. All rights reserved.

  9. Pegasus(Registered trademark) Wing-Glove Experiment to Document Hypersonic Crossflow Transition: Measurement System and Selected Flight Results

    Science.gov (United States)

    Bertelrud, Arild; delaTova, Geva; Hamory, Philip J.; Young, Ronald; Noffz, Gregory K.; Dodson, Michael; Graves, Sharon S.; Diamond, John K.; Bartlett, James E.; Noack, Robert; hide

    2000-01-01

    In a recent flight experiment to study hypersonic crossflow transition, boundary layer characteristics were documented. A smooth steel glove was mounted on the first stage delta wing of Orbital Sciences Corporation's Pegasus (R) launch vehicle and was flown at speeds of up to Mach 8 and altitudes of up to 250,000 ft. The wing-glove experiment was flown as a secondary payload off the coast of Florida in October 1998. This paper describes the measurement system developed. Samples of the results obtained for different parts of the trajectory are included to show the characteristics and quality of the data. Thermocouples and pressure sensors (including Preston tubes, Stanton tubes, and a "probeless" pressure rake showing boundary layer profiles) measured the time-averaged flow. Surface hot-films and high-frequency pressure transducers measured flow dynamics. Because the vehicle was not recoverable, it was necessary to design a system for real-time onboard processing and transmission. Onboard processing included spectral averaging. The quality and consistency of data obtained was good and met the experiment requirements.

  10. Optimal use of directional coronary atherectomy is required to ensure long-term angiographic benefit: a study with matched procedural outcome after atherectomy and angioplasty

    NARCIS (Netherlands)

    V.A.W.M. Umans (Victor); D.T.J. Keane (David); R. Melkert (Rein); P.W.J.C. Serruys (Patrick); D.P. Foley (David); H. Boersma (Eric)

    1994-01-01

    textabstractOBJECTIVES. This study was designed to examine whether restenosis is related to the extent or mechanism of lumen improvement and to explore angiographic determinants of optimal atherectomy. BACKGROUND. Directional atherectomy induces a greater extent of immediate gain and late loss but

  11. DuraChem trademark - challenges and solutions

    International Nuclear Information System (INIS)

    Howard, I.S.; Bowan, B.W.; Kirshe, M.H.

    1996-01-01

    Vitrification of low-level ion exchange resins represents numerous challenges never before successfully accomplished. These challenges include (1) Feed material preparation and transfer, (2) Melter temperature and volume control, (3) Glass composition, stabilization, and control, and (4) Off-gas treatment and particulate capture. The DuraChem trademark team of Chem-Nuclear Systems, Inc. and GTS Duratek, Inc. began its journey in 1994 and is in the process of starting-up the first centralized vitrification facility for commercial ion-exchange and filtration media. This paper addresses each of the challenges and provides an update of this unique volume-reduction and stabilization technology

  12. THE NOTORIOUS, REPUTED AND FAMOUS TRADEMARKS

    Directory of Open Access Journals (Sweden)

    Andreea LIVĂDARIU

    2015-07-01

    Full Text Available The owner of a trademark that has a reputation in Romania or in the European Union may request to court to forbid the infringer from using, without its consent, a sign identical or similar to its trademark, but for products or services different from those which are sold or provided under said trademark. According to Law no. 84/1998, the notorious (well-known trademark is the trademark which does not necessarily have to be registered under the Trademark law protection. The Romanian doctrine sustains that famous trademarks do exist. In this paper, we shall attempt to find (if it really does exist the difference between notorious (well-known, reputed and famous trademarks, the criteria by means of which these trademarks shall be distinguished and the evidence by means of which the notoriety, reputation or fame of a trademark may be argued. We shall also present the legal regime and our analysis will be based on the Trademark law, doctrine and case-law studies.

  13. A Comparison of Clinical Outcomes for Diabetic and Nondiabetic Patients Following Directional Atherectomy in the DEFINITIVE LE Claudicant Cohort.

    Science.gov (United States)

    Garcia, Lawrence A; Jaff, Michael R; Rocha-Singh, Krishna J; Zeller, Thomas; Bosarge, Christopher; Kamat, Suraj; McKinsey, James F

    2015-10-01

    To report a subset analysis that evaluated the hypothesis that directional atherectomy for peripheral artery disease in diabetic claudicants has noninferior primary patency at 12 months compared with nondiabetic claudicants. DEFINITIVE LE, a US/European multicenter study, assessed the effectiveness of directional atherectomy using SilverHawk/TurboHawk systems for treatment of peripheral artery disease in the superficial femoral, popliteal, and infrapopliteal arteries. Of the 800 patients enrolled in the study, only the 598 claudicant patients (mean age 69.5±10.4 years; 336 men) who were classified at baseline as Rutherford category 1-3 were eligible for this subset analysis. Of these, 46.8% (280/598) had diabetes. Follow-up to 12 months included duplex ultrasound examination, functional assessments, and adverse event evaluations. Independent angiographic and duplex ultrasound core laboratories assessed primary patency and secondary endpoints; a clinical events committee adjudicated adverse events. Although diabetics had significantly more baseline comorbidities, 12-month primary patency (77.0%) was no different than for nondiabetics (77.9%; superiority p=0.98; noninferiority patherectomy is an effective treatment in diabetic as well as nondiabetic claudicants. Directional atherectomy remains an attractive treatment option, improving luminal diameters without stents, which preserves future treatment options for both diabetic and nondiabetic patients with progressive, diffuse vascular disease. © The Author(s) 2015.

  14. How Should We Perform Rotational Atherectomy to an Angulated Calcified Lesion?

    Science.gov (United States)

    Sakakura, Kenichi; Taniguchi, Yousuke; Matsumoto, Mitsunari; Wada, Hiroshi; Momomura, Shin-Ichi; Fujita, Hideo

    2016-05-25

    Rotational atherectomy to an angulated calcified lesion is always challenging. The risk of catastrophic complications such as a burr becoming stuck or vessel perforation is greater when the calcified lesion is angulated. We describe the case of an 83-year-old female suffering from unstable angina. Diagnostic coronary angiography revealed an angulated calcified lesion in the proximal segment of the right coronary artery. We performed rotational atherectomy to the lesion, but intentionally did not advance the rotational atherectomy burr beyond the top of the angulation. We controlled the rotational atherectomy burr and stopped it just before the top of the angulation to avoid complications. Following rotational atherectomy, balloon dilatation with a non-compliant balloon was performed, and drug-eluting stents were successfully deployed. In this manuscript, we provide a review of the literature on this topic, and discuss how rotational atherectomy to an angulated calcified lesion should be performed.

  15. Promotion of artery occlusion in dogs by percutaneous rotational atherectomy.

    Science.gov (United States)

    Hou, Chuan-Ju; Zhang, Duan-Zhen; Wang, Qi-Guang; Cui, Chun-Sheng; Kuang, Li; Chen, Bing; Wang, Yang

    2014-07-01

    This study aims to offer experimental data and indirect evidences for the application of percutaneous rotational atherectomy to treat patent ductus arteriosus (PDA). Eleven dogs (6 male dogs and 5 female dogs; aged 14-20 months, with an average of 16.7±3.2 months; weight 20-25 kg, with an average of 22.7±2.5 kg) were enrolled in this study. The diameters of the left and right arteries ranged from 3.2 to 4.8 mm (average 3.9±0.6 mm) on percutaneous angiography. Percutaneous rotational atherectomy with proper rotablator (the size was 1-1.5 mm larger than the artery diameter) was performed in the arterial intima. After 4 weeks from percutaneous rotational atherectomy, arteriography was conducted to observe the changes in artery diameter. Then all dogs were sacrificed and the pathologic examination was conducted on the left and right axillary arteries. There were obvious changes with different degrees in 22 arteries, including 8 arteries with complete occlusion and 12 arteries with stenosis (≥2/3, 1/2, and 1/3 stenosis in 4, 4, and 4 arteries, respectively). The occlusion rate was 36.4% and the total effective rate was 90.9%. It was considered failure in other 2 arteries with atherectomy of arterial intima can promote the occlusion of arteries. This has provided a new choice for the treatment of PDA. Copyright © 2014 Elsevier Inc. All rights reserved.

  16. SINGLE-FACED GRAYQB{trademark} - A RADIATION MAPPING DEVICE

    Energy Technology Data Exchange (ETDEWEB)

    Mayer, J.; Farfan, E.; Immel, D.; Phillips, M.; Bobbitt, J.; Plummer, J.

    2013-12-12

    share the same fundamental detection system design (e.g., pinhole and PSPs). Therefore, performance tests completed on the single face GrayQB in this report is also applicable to the six- faced GrayQB (e.g., ambient light sensitivity and PSP response). This report details the characterization of the GrayQb{trademark} SF in both an uncontrolled environment; specifically, the Savannah River Site (SRS) Plutonium Fuel Form Facility in Building 235-F (Metallurgical Building) and controlled testing at SRS’s Health Physics Instrument Calibration Facility and SRS’s R&D Engineering Imaging and Radiation Systems Building. In this report, the resulting images from the Calibration Facility were obtained by overlaying the PSP and visual images manually using ImageJ. The resulting images from the Building 235-F tests presented in this report were produced using ImageJ and applying response trends developed from controlled testing results. The GrayQb{trademark} technology has been developed in two main stages at Savannah River National Laboratory (SRNL): 1) the GrayQb{trademark} development was supported by SRNL’s Laboratory Directed Research and Development Program and 2) the GrayQb{trademark} SF development and its testing in Building 235-F were supported by the Office of Deactivation and Decommissioning and Facility Engineering (EM-13), U.S. Department of Energy – Office of Environmental Management.

  17. Trademark Values in Corporate Restructuring

    OpenAIRE

    Torres, Fernando

    2007-01-01

    In corporate restructuring under Chapter 11, an asset valuation is a central task for both legal and financial reasons. In the area of intangible assets, however, generally accepted accounting principles (GAAP) do not reflect internally-generated assets such as brands, trademarks, and other intellectual property. In practice, arbitrary rules of thumb are used to fill this gap, and closure, liquidation, financing, and restructuring decisions are made on this basis. This paper reports the ...

  18. Percutaneous treatment of delayed post-atherectomy superficial femoral artery pseudoaneurysm.

    Science.gov (United States)

    Akkus, Nuri Ilker; Fay, Matt; Varma, Jai

    2012-10-01

    SilverHawk atherectomy is commonly used in lower extremity percutaneous interventions. Minor perforations during SilverHawk atherectomy procedures are reported at a range of 0.8%. There are few reported cases in the literature about very late pseuodoaneursym formation after SilverHawk atherectomy. Herein we report a very unusual, late, concealed, acute rupture of superficial femoral artery with a large, painful pseuodoaneursym formation, 1 week after Silver- Hawk atherectomy and its treatment with Viabahn stent graft (W.L. Gore & Associates).

  19. Fermi UNIX trademark environment

    International Nuclear Information System (INIS)

    Nicholls, J.

    1991-03-01

    The introduction of UNIX at Fermilab involves multiple platforms and multiple vendors. Additionally, a single user may have to use more than one platform. This heterogeneity and multiplicity makes it necessary to define a Fermilab environment for UNIX so that as much as possible the systems ''look and feel'' the same. We describe our environment, including both the commercial products and the local tools used to support it. Other products designed for the UNIX environment are also described. 19 refs

  20. Can Rotational Atherectomy Cause Thermal Tissue Damage? A Study of the Potential Heating and Thermal Tissue Effects of a Rotational Atherectomy Device

    International Nuclear Information System (INIS)

    Gehani, Abdurrazzak A.; Rees, Michael R.

    1998-01-01

    Purpose: Thermal tissue damage (TTD) is customarily associated with some lasers. The thermal potential of rotational atherectomy (RA) devices is unknown. We investigated the temperature profile and potential TTD as well as the value of fluid flushing of an RA device. Methods: We used a high-resolution infrared imaging system that can detect changes as small as 0.1 deg. C to measure the temperature changes at the tip of a fast RA device with and without fluid flushing. To assess TTD, segments of porcine aorta were subjected to the rotating tip under controlled conditions, stained by a special histochemical stain (picrisirius red) and examined under normal and polarized light microscopy. Results: There was significant heating of the rotating cam. The mean 'peak' temperature rise was 52.8 ± 16.9 deg. C. This was related to rotational speed; thus the 'peak' temperature rise was 88.3 ± 12.6 deg. C at 80,000 rpm and 17.3 ± 3.8 deg. C at 20,000 rpm (p < 0.001, t-test). Fluid flushing at 18 ml/min reduced, but did not abolish, heating of the device (11.8 ± 2.9 deg. C). A crater was observed in all segments exposed to the rotating tip. The following features were most notable: (i) A zone of 'thermal' tissue damage extended radially from the crater reaching adventitia in some sections, especially at high speeds. This zone showed markedly reduced or absent birefringence. (ii) Fluid flushing of the catheter reduced the above changes but increased the incidence and extent of dissections in the media, especially when combined with high atherectomy speeds. (iii) These changes were observed in five of six specimens exposed to RA without flushing, but in only one of six with flushing (p < 0.05). (iv) None of the above changes was seen in control segments. Conclusion: RA is capable of generating significant heat and potential TTD. Fluid flushing reduced heating and TTD. These findings warrant further studies in vivo, and may influence the design of atherectomy devices

  1. WIPO Publishes Guide to Trademarks for Business

    Institute of Scientific and Technical Information of China (English)

    2003-01-01

    Entrepreneurs and managers of small andmedium-sized enterprises(SMEs)can nowconsult a World Intellectual PropertyOrganization(WIPO)publication thatexplains the basics of trademarks from abusiness perspective.The guide,entitled"Making a Mark:An Introduction toTrademarks for Small and Medium-sizedEnterprises",is intended to enhance thereader's understanding of the strategic valueof trademarks in business planning.It is the

  2. Aspects of National and Community Trademarks

    Directory of Open Access Journals (Sweden)

    Constantin Anechitoae

    2012-05-01

    Full Text Available When Romania joined the EU on January 1, 2007, all Community trademarks (CTM, with thefiling date before that date, were automatically extended and have effects in Romania. National brands do notextend across the EU. In order to obtain a Community trade mark, a single application is filled in at OHIM. Itcan convert a Community trade mark application into national trade mark. The registered community trademark has effect in all EU Member States, including Romania. The national trademarks registered nationally -at the State Office for Inventions and Trademarks (OSIM - are effective only in Romania and have no effectin the European Community.

  3. Percutaneous common femoral artery interventions using angioplasty, atherectomy, and stenting.

    Science.gov (United States)

    Mehta, Manish; Zhou, Yi; Paty, Philip S K; Teymouri, Medhi; Jafree, Kamran; Bakhtawar, Humayun; Hnath, Jeffrey; Feustel, Paul

    2016-08-01

    This study evaluated the feasibility, safety, and effectiveness of endovascular interventions for common femoral artery (CFA) occlusive disease. Using a prospectively maintained multicenter database, we analyzed outcomes in 167 consecutive patients who underwent percutaneous CFA interventions for Rutherford class 3 to class 6 (R3-R6) disease. The standardized treatment approach included primary percutaneous transluminal angioplasty (PTA) only, atherectomy + PTA, and provisional stenting. Outcomes included technical failure rate, recurrence, complications, and major or minor amputation rate. Data were analyzed using multivariate regression analysis. During a 7-year period, 167 patients with R3 (n = 91 [54.5%]) and R4 to R6 (n = 76 [45.5%]) disease underwent CFA interventions that included PTA only (n = 114 [68.2%]), atherectomy ± PTA (n = 38 [22.8%]), and provisional stenting (n = 15 [9.0%]) for failed atherectomy ± PTA. Procedure-related complications included pseudoaneurysm (n = 1 [0.6%]), thrombosis (n = 1 [0.6%]), distal embolization (n = 1 [0.6%]), and death (R6, n = 1 [0.06%]). CFA restenosis was observed in 34 (20.4%) patents; these underwent further percutaneous (n = 18 [10.8%]) or surgical (n = 17 [10.2%]) revascularization that included CFA endarterectomy ± femoral distal bypass. Major or minor amputations were observed in none of the R3 patients and in only three (3.9%) and five (6.5%) of the R4 to R6 patients, respectively. Compared with the atherectomy + PTA group, patients in the PTA-only group had a significantly lower patency. Furthermore, during long-term mean follow-up of 42.5 months, the CFA provisional stent group had a 100% primary patency, which was significantly better than the primary patency in the CFA nonstent groups combined (77.0%; P = .0424). Data from this study to date would suggest that percutaneous CFA interventions in select patients are relatively safe and effective. In the long term, CFA stenting has

  4. Trademarks enhance customers' trust; Die Marke schafft Vertrauen

    Energy Technology Data Exchange (ETDEWEB)

    Forst, M.

    2007-07-01

    While users still rely primarily on the product features of solar systems, the importance of trademarks is increasing, and it is to be expected that sales in future will be determined not only by availability but also by image. The solar industry is fighting for the image of its products. (orig.)

  5. Treatment of an ostial and a bifurcation lesion with a new directional atherectomy device

    Science.gov (United States)

    Favero, L; Simpson, J B; Reimers, B

    2004-01-01

    Two cases of directional coronary atherectomy performed with a new 8 French monorail device for selective plaque excision are illustrated. This report underlines the technical characteristics of this new device, which allows the negotiation of complex coronary anatomy and emphasises the potential utility of directional coronary atherectomy in bifurcation and ostial lesions. PMID:15253988

  6. Theta-Cream trademark versus Bepanthol trademark lotion in breast cancer patients under radiotherapy. A new prophylactic agent in skin care?

    International Nuclear Information System (INIS)

    Roeper, B.; Kaisig, D.; Auer, F.; Mergen, E.; Molls, M.

    2004-01-01

    Background and purpose: in radiotherapy of the breast following breast-conserving surgery, the adverse reaction predominatly found is confined to the skin. After phase II studies, Theta-Cream trademark , containing CM glucan, hydroxyprolisilan C und matrixyl as active substances, was said to have prophylactic properties of preventing acute radiation side effects in skin tissue. In a prospective randomized study, Theta-Cream trademark was compared with standard skin care using Bepanthol trademark lotion. Patients and methods: 20 breast cancer patients were randomly assigned to use Theta-Cream trademark or Bepanthol trademark lotion during radiotherapy. At 0, 30, and 50 Gy, acute skin toxicity was scored with a modified RTOG scoring system. The patients' content with the skin care and the technical assistants' content with the skin marks were recorded. Results: for single aspects of toxicity and their sums in defined skin areas, no differences in median and range between study groups were found. The maximal toxicity anywhere in the breast averaged in a moderate erythema, mild elevation of skin temperature, no desquamation in both groups. Mild itchiness and sporadic efflorescences more frequently seen with Theta-Cream trademark . According to a ranking of anonymized breast photos at 50 Gy by independent investigators, side effects were equal. Patients' content was high with both skin care regimens (1.25 on a scale from 0 to 10). With Theta-Cream trademark a trend toward worse skin marks was noted. Adverse events exclusively occurred in Theta-Cream trademark users: suspected allergic reaction once, and the necessity for resimulation twice. Conclusion: in direct comparison with dexpanthenol-containing lotion, no advantage for Theta-Cream trademark was found. Higher costs and problems with skin marks prevent a general recommendation. (orig.)

  7. Outcomes in Elderly Patients With Severely Calcified Coronary Lesions Undergoing Orbital Atherectomy.

    Science.gov (United States)

    Lee, Michael S; Shlofmitz, Evan; Lluri, Gentian; Shlofmitz, Richard A

    2017-04-01

    We evaluated the clinical outcomes of elderly patients who underwent orbital atherectomy for the treatment of severe coronary artery calcification (CAC) prior to stenting. Percutaneous coronary intervention (PCI) of severe CAC is associated with worse clinical outcomes including death, myocardial infarction (MI), and target vessel revascularization (TVR). The elderly represents a high-risk group of patients, often have more comorbid conditions, and have worse outcomes after PCI compared to younger patients. Clinical trials and a large multicenter registry have demonstrated the safety and efficacy of orbital atherectomy for the treatment of severe CAC. Clinical outcomes of elderly patients who undergo orbital atherectomy are unknown. Of the 458 patients, 229 were ≥75 years old (elderly) and 229 were atherectomy. It is a safe and effective treatment strategy for elderly patients with severe CAC as the clinical outcomes were similar to their younger counterparts. A randomized trial should further clarify the role of orbital atherectomy in these patients. © 2017, Wiley Periodicals, Inc.

  8. 76 FR 72000 - Patent, Trademark & Copyright Acts

    Science.gov (United States)

    2011-11-21

    ... DEPARTMENT OF THE INTERIOR Geological Survey Patent, Trademark & Copyright Acts AGENCY: U.S... Consultants, 1255 Roberts Boulevard NW., Suite 200, Kennesaw, GA 30144, on U.S. Patent Application Serial No. 12/133,666, and a divisional patent application to be filed shortly at the Patent and Trademark...

  9. Endovascular Management of the Popliteal Artery: Comparison of Atherectomy and Angioplasty

    Science.gov (United States)

    Semaan, Elie; Hamburg, Naomi; Nasr, Wael; Shaw, Palma; Eberhardt, Robert; Woodson, Jonathan; Doros, Gheorghe; Rybin, Denis; Farber, Alik

    2013-01-01

    Purpose Symptomatic atherosclerotic disease of the popliteal artery presents challenges for endovascular therapy. We evaluated the technical success, complications and midterm outcomes of atherectomy and angioplasty involving the popliteal segment. Methods We conducted a retrospective review of outcomes of popliteal artery intervention using atherectomy or angioplasty performed between 2003 and 2008. Results A total of 56 patients (36% women, age 72.8±12.2 years, 77% critical limb ischemia) underwent popliteal atherectomy (n=18) or angioplasty (n=38). These patients had similar clinical characteristics, TASC/TASC II classification, mean lesion length, and run-off scores. We observed a trend toward higher rates of technical success defined as atherectomy compared to angioplasty (94% vs. 71%, p=0.08). While angioplasty was associated with a higher frequency of arterial dissection (23% vs. 0%, p=0.003), atherectomy was associated with a higher rate of thromboembolic events (22% vs 0%, p=0.01). Adjunctive stenting was used more frequently following angioplasty compared to atherectomy (45% vs. 6%, p=0.005). Thrombolysis was used to treat embolization in 4 patients in the atherectomy group. The improvement in the ankle-brachial index was similar between the two treatment groups. Primary patency of the popliteal artery at 3, 6, and 12 months was 94%, 88%, and 75% in the atherectomy group and 89%, 82%, and 73% in the angioplasty group (p=NS). There were no significant differences in limb salvage and freedom from reintervention at 1 year between the atherectomy and angioplasty groups. Conclusions Our experience with popliteal artery endovascular therapy indicates a distinct pattern of procedural complications with atherectomy compared to angioplasty but similar midterm patency, limb salvage and freedom from intervention. PMID:19942598

  10. Waste treatment by the CCP/EuRec {sup trademark} process; Abfallbehandlung nach dem CCP/EuRec {sup trademark} -Restabfallbehandlungsverfahren

    Energy Technology Data Exchange (ETDEWEB)

    Lippmann, A. [CCP GmbH, Waste Management, Merkers (Germany)

    2002-07-01

    The CCP/EuRec {sup trademark} process involves either an aerobic (composting) or an anaerobic (fermentation) biological treatment stage, or a combination of both. [German] Bei dem CCP/EuRec {sup trademark} -Restabfallbehandlungsverfahren handelt es sich um ein leistungsfaehiges System zur biologischen Behandlung von Restabfaellen. Die biologische Behandlungsstufe kann wahlweise aerob (Rotte) oder anaerob (Vergaerung) erfolgen. Eine Kombination zwischen beiden Varianten ist ebenfalls moeglich. (orig.)

  11. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the CALCIUM 360 randomized pilot trial.

    Science.gov (United States)

    Shammas, Nicolas W; Lam, Russell; Mustapha, Jihad; Ellichman, Jonathan; Aggarwala, Gaurav; Rivera, Ernesto; Niazi, Khusrow; Balar, Nilesh

    2012-08-01

    To evaluate the role of orbital atherectomy in calcified infrapopliteal arteries in patients with critical limb ischemia compared to balloon angioplasty (BA) alone. A randomized multicenter study was undertaken to evaluate short and 1-year outcomes in 50 patients (32 men; mean age 71 years, range 40-90) with confirmed calcified lesions using 1∶1 randomization to the Diamondback 360° Orbital Atherectomy System followed by BA vs. BA alone. All patients had severe (≥50% stenosis) peripheral artery disease (Rutherford classification 4-6) in the popliteal, tibial, and/or peroneal arteries. The primary endpoint was defined as restoration of a normal lumen (residual stenosis ≤30%) with no bailout stenting or dissection types C through F. Scheduled follow-up visits were conducted according to a common protocol at 1, 6, and 12 months. Procedural success was 93.1% (27/29 lesions) for atherectomy + BA patients and 82.4% (28/34 lesions) for BA alone (p = 0.27). Bailout stenting was needed in 2 (6.9%) of the 29 atherectomy + BA lesions and in 5 (14.3%) of the 35 BA-treated lesions (p = 0.44). At 1 year, there were no amputations in either group related to the index procedure. Estimates for freedom from target vessel revascularization and all-cause mortality were 93.3% and 100% in the atherectomy + BA group vs. 80.0% (p = 0.14) and 68.4% (p = 0.01) in the BA group, respectively. Proportional hazard models evaluating survival time vs. status of residual stenosis determined a hazard ratio for major adverse events of 5.6 for patients with an acute post-procedure residual stenosis >30% (p = 0.01). Debulking with orbital atherectomy appeared to increase the chance of reaching a desirable angioplasty result, with less acute need for bailout stenting and a higher procedure success. A negative association between procedure success and risk of serious adverse outcomes should encourage larger confirmatory studies.

  12. Novel Use of an Orbital Atherectomy Device for In-Stent Restenosis: Lessons Learned

    Directory of Open Access Journals (Sweden)

    K. Shaikh

    2016-01-01

    Full Text Available We present a case of a 67-year-old man with stage III chronic kidney disease, uncontrolled diabetes mellitus, coronary artery disease, and high surgical risk who presented with two episodes of acute coronary syndrome attributed to in-stent restenosis (ISR associated with heavily calcified lesions. In this case, we were able to improve luminal patency with orbital atherectomy system (OAS; however, withdrawal of the device resulted in a device/stent interaction, causing failure of the device. Given limitations in current evidence and therapies, managing ISR can be a technical and cognitive challenge. Balloon expansion of the affected region often provides unsatisfactory results, possibly related to significant calcium burden. OAS could be an efficacious way of reestablishing luminal patency in ISR lesions, as these lesions are often heavily calcified.

  13. Debulking Atherectomy in the Peripheral Arteries: Is There a Role and What is the Evidence?

    Science.gov (United States)

    Katsanos, Konstantinos; Spiliopoulos, Stavros; Reppas, Lazaros; Karnabatidis, Dimitris

    2017-07-01

    Traditional percutaneous balloon angioplasty and stent placement is based on mechanical plaque disruption and displacement within the arterial wall. On the contrary, transcatheter atherectomy achieves atherosclerotic plaque clearance by means of directional plaque excision or rotational plaque removal or laser plaque ablation. Debulking atherectomy may allow for a more uniform angioplasty result at lower pressures with consequently less vessel barotrauma and improved luminal gain, thereby decreasing the risk of plaque recoil and dissection that may require permanent metal stenting. It has been also argued that atherectomy may disrupt the calcium barrier and optimize drug transfer and delivery in case of drug-coated balloon applications. The authors discuss the various types of atherectomy devices available in clinical practice to date and critically appraise their mode of action as well as relevant published data in each case. Overall, amassed randomized and observational evidence indicates that percutaneous atherectomy of the femoropopliteal and infrapopliteal arteries may achieve high technical success rates and seems to lessen the frequency of bailout stenting, however, at the expense of increased risk of peri-procedural distal embolization. Long-term clinical outcomes reported to date do not support the superiority of percutaneous atherectomy over traditional balloon angioplasty and stent placement in terms of vessel patency or limb salvage. The combination of debulking atherectomy and drug-coated balloons has shown promise in early studies, especially in the treatment of more complex lesions. Unanswered questions and future perspectives of this continuously evolving endovascular technology as part of a broader treatment algorithm are discussed.

  14. In-Hospital Outcomes of Atherectomy During Endovascular Lower Extremity Revascularization.

    Science.gov (United States)

    Panaich, Sidakpal S; Arora, Shilpkumar; Patel, Nilay; Patel, Nileshkumar J; Patel, Samir V; Savani, Chirag; Singh, Vikas; Jhamnani, Sunny; Sonani, Rajesh; Lahewala, Sopan; Thakkar, Badal; Patel, Achint; Dave, Abhishek; Shah, Harshil; Bhatt, Parth; Jaiswal, Radhika; Ghatak, Abhijit; Gupta, Vishal; Deshmukh, Abhishek; Kondur, Ashok; Schreiber, Theodore; Grines, Cindy; Badheka, Apurva O

    2016-02-15

    Contemporary data on clinical outcomes after utilization of atherectomy in lower extremity endovascular revascularization are sparse. The study cohort was derived from Healthcare Cost and Utilization Project nationwide inpatient sample database from the year 2012. Peripheral endovascular interventions including atherectomy were identified using appropriate International Classification of Diseases, Ninth Revision, Clinical Modification diagnostic and procedural codes. The subjects were divided and compared in 2 groups: atherectomy versus no atherectomy. Two-level hierarchical multivariate mixed models were created. The coprimary outcomes were in-hospital mortality and amputation; secondary outcome was a composite of in-hospital mortality and periprocedural complications. Hospitalization costs were also assessed. Atherectomy utilization (odds ratio, 95% CI, p value) was independently predictive of lower in-hospital mortality (0.46, 0.28 to 0.75, 0.002) and lower amputation rates (0.83, 0.71 to 0.97, 0.020). Atherectomy use was also predictive of significantly lower secondary composite outcome of in-hospital mortality and complications (0.79, 0.69 to 0.90, 0.001). In the propensity-matched cohort, atherectomy utilization was again associated with a lower rate of amputation (11.18% vs 12.92%, p = 0.029), in-hospital mortality (0.71% vs 1.53%, p 0.001), and any complication (13.24% vs 16.09%, p 0.001). However, atherectomy use was also associated with higher costs ($24,790 ± 397 vs $22635 ± 251, p Atherectomy use in conjunction with angioplasty (with or without stenting) was associated with improved in-hospital outcomes in terms of lower amputation rates, mortality, and postprocedural complications. Copyright © 2016 Elsevier Inc. All rights reserved.

  15. Industrial ecology Prosperity Game{trademark}

    Energy Technology Data Exchange (ETDEWEB)

    Beck, D.; Boyack, K.; Berman, M.

    1998-03-01

    Industrial ecology (IE) is an emerging scientific field that views industrial activities and the environment as an interactive whole. The IE approach simultaneously optimizes activities with respect to cost, performance, and environmental impact. Industrial Ecology provides a dynamic systems-based framework that enables management of human activity on a sustainable basis by: minimizing energy and materials usage; insuring acceptable quality of life for people; minimizing the ecological impact of human activity to levels that natural systems can sustain; and maintaining the economic viability of systems for industry, trade and commerce. Industrial ecology applies systems science to industrial systems, defining the system boundary to incorporate the natural world. Its overall goal is to optimize industrial activities within the constraints imposed by ecological viability, globally and locally. In this context, Industrial systems applies not just to private sector manufacturing and services but also to government operations, including provision of infrastructure. Sandia conducted its seventeenth Prosperity Game{trademark} on May 23--25, 1997, at the Hyatt Dulles Hotel in Herndon, Virginia. The primary sponsors of the event were Sandia National Laboratories and Los Alamos National Laboratory, who were interested in using the format of a Prosperity Game to address some of the issues surrounding Industrial Ecology. Honorary game sponsors were: The National Science Foundation; the Committee on Environmental Improvement, American Chemical Society; the Industrial and Engineering Chemistry Division, American Chemical Society; the US EPA--The Smart Growth Network, Office of Policy Development; and the US DOE-Center of Excellence for Sustainable Development.

  16. 19 CFR 133.21 - Articles bearing counterfeit trademarks.

    Science.gov (United States)

    2010-04-01

    ... 19 Customs Duties 1 2010-04-01 2010-04-01 false Articles bearing counterfeit trademarks. 133.21... Recorded Trademarks or Recorded Trade Names § 133.21 Articles bearing counterfeit trademarks. (a... substantially indistinguishable from, a registered trademark. (b) Seizure. Any article of domestic or foreign...

  17. Atherectomy offers no benefits over balloon angioplasty in tibial interventions for critical limb ischemia.

    Science.gov (United States)

    Todd, Kevin E; Ahanchi, Sadaf S; Maurer, Christian A; Kim, Jung H; Chipman, Candice R; Panneton, Jean M

    2013-10-01

    Endovascular adjuncts, like atherectomy, were developed to improve outcomes of endovascular arterial interventions. The true impact of atherectomy on endovascular outcomes remains to be determined, and little data exist on the influence of atherectomy on tibial interventions. Our study compares early and late outcomes of tibial intervention with angioplasty vs atherectomy-assisted interventions. We completed a retrospective review of all tibial interventions between 2008 and 2010. Outcomes were analyzed using single and multivariate analysis, Cox regression, and Kaplan-Meier curves. Primary outcomes were primary, primary assisted, and secondary patency rates, as well as limb salvage and survival rates. Over a 2-year period, 480 tibial interventions were completed for 421 patients. Eighty-seven percent (n = 418) of interventions were performed for critical limb ischemia (CLI) and 13% (n = 62) for claudication. The CLI cohort of 418 interventions was analyzed. These patients had a mean age of 71 years with a mean follow-up time of 16 ± 15 months (range, 0-59 months). Of the 418 interventions, 339 underwent percutaneous transluminal angioplasty (PTA): 333 PTA alone, six PTA + stent. The remaining 79 interventions received atherectomy: 33 laser, 13 directional, and 33 orbital either alone or in conjunction with PTA (11 atherectomy only, 68 atherectomy + PTA). The groups did not differ significantly in terms of demographics, risk factors, or technical success. The atherectomy group had more TASC B lesions (54% vs 38%; P = .013), while the PTA-alone group had more TASC D lesions (25% vs 13%; P = .004). TASC A and C lesions did not differ significantly between the groups. No significant differences existed with respect to the early (30-day) outcomes of loss of patency (11% vs 13%; P = .699), complications (8% vs 13%; P = .292), or major amputation (17% vs 13%; P = .344) in the PTA-alone group vs the atherectomy-assisted group. Kaplan-Meier analysis revealed no difference

  18. ALARA trademark 1146 strippable coating

    International Nuclear Information System (INIS)

    Fricke, V.

    1999-01-01

    Strippable or temporary coatings are innovative technologies for decontamination that effectively reduce loose contamination at low cost. These coatings have become a viable option during the deactivation and decommissioning of both US Department of Energy (DOE) and commercial nuclear facilities to remove or fix loose contamination on both vertical and horizontal surfaces. The ALARA trademark 1146 strippable coating was demonstrated as part of the Savannah River Site LSDDP and successfully removed transferable (surface) contamination from multiple surfaces (metal and concrete) with an average decontamination factor for alpha contamination of 6.68 and an average percentage of alpha contamination removed of 85.0%. Beta contamination removed was an average DF of 5.55 and an average percentage removed of 82.0%. This paper is an Innovative Technology Summary Report designed to provide potential users with the information they need to quickly determine if a technology would apply to a particular environmental management problem. They also are designed for readers who may recommend that a technology be considered by prospective users. This Innovative Technology offers a 35% cost savings over the Baseline Technology

  19. Sub-criticality monitoring for ADTR trademark control

    International Nuclear Information System (INIS)

    Ashworth, Roger

    2014-01-01

    Following the debut of the Accelerator Driven Thorium Reactor (ADTR trademark) Power Station at ENC 2010 in Barcelona, thorium as a reactor fuel has gained increasing support. The ADTR trademark concept reactor introduced the combination of an accelerator driven system (ADS) with traditional control rod technology, to provide a very high gain novel sub-critical ADS reactor design. The high gain of the system, while significantly reducing the demands on the accelerator design, pushes up operational sub-criticality (k eff ) closer to unity. In this paper we review this design and the progress made since ENC 2010. We compare 2 different methods of measuring the sub-critical neutron multiplication factor as the fuel cycle develops. The paper discusses the most recent work on k eff measurement and the interesting relationship between neutron flux, accelerator current and fuel temperature when using beam pulse methods to determine operational sub-criticality, of which a European patent is being granted. (orig.)

  20. Subanalysis of the CONFIRM Registries: Acute Procedural Outcomes in Claudicant and Critical Limb Ischemia Patients With Varying Levels of Calcification Treated for Peripheral Arterial Disease With Orbital Atherectomy.

    Science.gov (United States)

    Adams, George L; Das, Tony; Lee, Michael S; Beasley, Robert; Mustapha, Jihad

    2015-11-01

    Patients with peripheral arterial disease (PAD) can be classified into groups based upon the severity of the disease using the Rutherford classification system. This analysis compares the procedural outcomes of PAD patients treated with orbital atherectomy stratified by Rutherford class (1-3 = intermittent claudication; 4-6 = critical limb ischemia [CLI]), and acute angiographic outcomes of these patients stratified by degree of lesion calcification. The CONFIRM registry series was analyzed and included 1697 patients with intermittent claudication (Rutherford class 1-3) and 1320 patients with CLI (Rutherford class 4-6) treated with orbital atherectomy. The composite rate of dissection, perforation, slow-flow, vessel closure, spasm, embolism, and thrombus formation was compared between claudicants and CLI patients with varying degrees of lesion calcification. Patients with CLI were older and had a higher prevalence of diabetes, coronary artery disease, and renal disease (Patherectomy resulted in similar low procedural complication rates in the CLI group compared with the claudicant group. These results suggest that orbital atherectomy is safe and effective for treating calcified lesions in high-risk patients with varying severity of PAD symptoms.

  1. Is Atherectomy the Best First-Line Therapy for Limb Salvage in Patients With Critical Limb Ischemia?

    Science.gov (United States)

    Loor, Gabriel; Skelly, Christopher L.; Wahlgren, Carl-Magnus; Bassiouny, Hisham S.; Piano, Giancarlo; Shaalan, Wael

    2010-01-01

    Objective To determine the efficacy of atherectomy for limb salvage compared with open bypass in patients with critical limb ischemia. Methods Ninety-nine consecutive bypass and atherectomy procedures performed for critical limb ischemia between January 2003 and October 2006 were reviewed. Results A total of 99 cases involving TASC C (n = 43, 44%) and D (n = 56, 56%) lesions were treated with surgical bypass in 59 patients and atherectomy in 33 patients. Bypass and atherectomy achieved similar 1-year primary patency (64% vs 63%; P = .2). However, the 1-year limb salvage rate was greater in the bypass group (87% vs 69%; P = .004). In the tissue loss subgroup, there was a greater limb salvage rate for bypass patients versus atherectomy (79% vs 60%; P = .04). Conclusions Patients with critical limb ischemia may do better with open bypass compared with atherectomy as first-line therapy for limb salvage. PMID:19640919

  2. Connecting icons, logos and slogans in graphic trademarks

    OpenAIRE

    Ambrožič, Maja

    2016-01-01

    In the public eye the organization is always considered or fully represented by its corporate identity that includes the size of the organization, annual payments, organizational structure, organizational culture, systems owned by the organization, premises, organizational culture, organizational strategy, mission, vision, number of employees etc. Graphic designer when designing graphic trademark by connecting graphic elements (logo, slogan and icon) must take in to consideration all abovemen...

  3. One hundred and thirteen attempts at directional coronary atherectomy: the early and combined experience of two European centres using quantitative angiography to assess their results

    NARCIS (Netherlands)

    V.A.W.M. Umans (Victor); E. Haine; J. Renkin; P.J. de Feyter (Pim); W. Wijns (William); P.W.J.C. Serruys (Patrick)

    1992-01-01

    textabstractDirectional coronary atherectomy has been introduced as an alternative to conventional balloon angioplasty when treating coronary artery stenoses with complex lesion morphology. To determine the immediate efficacy of coronary atherectomy in patients with such lesions, the first 113

  4. A critical view of the peripheral atherectomy data in the treatment of infrainguinal arterial disease.

    Science.gov (United States)

    Quevedo, Henry C; Arain, Salman A; Ali, Gholam; Abi Rafeh, Nidal

    2014-01-01

    Revascularization of the peripheral arteries remains technically challenging. By decreasing the volume of the atherosclerotic plaque, debulking procedures may confer superior primary patency after revascularization. To assess the impact of atherectomy on primary patency rates at 12 months compared to balloon angioplasty and/or stent placement alone in patients with infrainguinal arterial disease. A database search for "directional," "orbital," "rotational," and "laser atherectomy" in peripheral arterial disease (PAD) was performed. Studies were screened according to the STROBE (Strengthening the Reporting of Observational studies in Epidemiology) critical appraisal tool and summarized by population, methodology, and outcomes (primary patency and major adverse events). Only two randomized studies were found. Most of the data were obtained from single-arm studies and registries. The primary patency with directional atherectomy approaches 60% at 12 months as a stand-alone technique, whereas orbital atherectomy in conjunction with balloon angioplasty and stenting achieved primary patency rates of 90%. Laser atherectomy is universally employed with balloon angioplasty and stenting for in-stent restenosis lesions with a primary patency rate of 64%. Although there are data for the safe use of rotational atherectomy, robust data to support its effectiveness are lacking. The combination of drug-coated balloons and atherectomy for the treatment of heavily calcified lesions in patients with critical limb ischemia is under evaluation. Despite the successful procedural outcomes reported in clinical registries, the available data do not support the use of atherectomy alone in PAD. Larger randomized controlled studies are warranted to define its role in contemporary endovascular practice.

  5. Experimental investigation of the abrasive crown dynamics in orbital atherectomy.

    Science.gov (United States)

    Zheng, Yihao; Belmont, Barry; Shih, Albert J

    2016-07-01

    Orbital atherectomy is a catheter-based minimally invasive procedure to modify the plaque within atherosclerotic arteries using a diamond abrasive crown. This study was designed to investigate the crown motion and its corresponding contact force with the vessel. To this end, a transparent arterial tissue-mimicking phantom made of polyvinyl chloride was developed, a high-speed camera and image processing technique were utilized to visualize and quantitatively analyze the crown motion in the vessel phantom, and a piezoelectric dynamometer measured the forces on the phantom during the procedure. Observed under typical orbital atherectomy rotational speeds of 60,000, 90,000, and 120,000rpm in a 4.8mm caliber vessel phantom, the crown motion was a combination of high-frequency rotation at 1000, 1500, and 1660.4-1866.1Hz and low-frequency orbiting at 18, 38, and 40Hz, respectively. The measured forces were also composed of these high and low frequencies, matching well with the rotation of the eccentric crown and the associated orbital motion. The average peak force ranged from 0.1 to 0.4N at different rotational speeds. Copyright © 2016 IPEM. Published by Elsevier Ltd. All rights reserved.

  6. TRADEMARK VS BRAND: A CONCEPTUAL APPROACH

    Directory of Open Access Journals (Sweden)

    Tudor NISTORESCU

    2013-06-01

    Full Text Available In this paper we realized a study regarding the concepts of trademark and brand. There are numerous confusions between the two concepts, among theorists and practitioners. We deepened the debate related to these terms, studying a series of articles and papers in the field. Our research showed that there are differences of substance between the two concepts. If the trademark identifies a property right over an enterprise or a product, the brand is the sum of meanings and significations of a product, beyond the utility of that product or the service.

  7. Short-term outcomes of excisional atherectomy in lower limb arterial disease.

    Science.gov (United States)

    Werner-Gibbings, Keagan; Dubenec, Steven

    2017-06-01

    Endovascular interventions are increasingly utilized in managing occlusive peripheral vascular disease. Angioplasty and stenting remain the mainstay of endovascular management; however, newer treatment modalities such as excisional atherectomy provide the clinician with additional treatment options. While demonstrating promising results in available trials, a paucity of data exist regarding peripheral atherectomy. The purpose of this retrospective clinical study was to assess the efficacy and safety of excisional atherectomy with the TurboHawk atherectomy device (Covidien/ev3, Plymouth, MN, USA) in the treatment of lower limb peripheral vascular disease and to evaluate the learning curve involved in the institution of a new treatment modality. A retrospective analysis was performed on all patients undergoing atherectomy for symptomatic lower limb peripheral vascular disease by a single clinician between November 2011 and June 2013. Forty-seven vessels on 28 legs in 24 patients were treated during the period. Atherectomy was possible in 98% of cases. The 6- and 12-month primary patency was 72.6 and 58.9%, respectively. The primary-assisted patency was 93.2% at 6 months and 74.6% at 12 months. There were significantly greater patency rates in the TransAtlantic Inter-Society Consensus A + B lesions and a non-significant trend towards improved patency rates in claudicants versus critical limb ischaemia. There were four instances of embolization and four cases of dissection. Excisional atherectomy provides a further option for the minimally invasive management of peripheral vascular disease. It has similar patency rates to established endovascular therapies and should be considered among the treatment options in patients with favourable pathology. © 2014 Royal Australasian College of Surgeons.

  8. Undilatable Stent Neoatherosclerosis Treated with Ad Hoc Rotational Atherectomy

    Directory of Open Access Journals (Sweden)

    Michael Koutouzis

    2017-01-01

    Full Text Available A middle age woman with known ischemic heart disease and old stents in proximal left anterior descending coronary artery (LAD was admitted to Coronary Care Unit with acute coronary syndrome. The coronary angiography showed one vessel disease with significant restenosis within the previously implanted stents. The lesion was tough and remained undilatable despite high pressure balloon inflation. Eventually, the balloon ruptured creating a massive dissection of the LAD beginning immediately after the distal part of the undilatable lesion. We proceeded with a challenging ad hoc rotational atherectomy of the lesion and finally stenting of the lesion. In-stent restenosis many years after stent implantation is considered to be mainly due to neoatheromatosis compared to intimal hyperplasia, making lesion treatment more difficult and unpredictable.

  9. 76 FR 53885 - Patent and Trademark Resource Centers Metrics

    Science.gov (United States)

    2011-08-30

    ... DEPARTMENT OF COMMERCE United States Patent and Trademark Office Patent and Trademark Resource Centers Metrics ACTION: Proposed collection; comment request. SUMMARY: The United States Patent and... ``Patent and Trademark Resource Centers Metrics comment'' in the subject line of the message. Mail: Susan K...

  10. Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial.

    Science.gov (United States)

    Shammas, Nicolas W; Coiner, Denise; Shammas, Gail A; Dippel, Eric J; Christensen, Lori; Jerin, Michael

    2011-09-01

    Target lesion revascularization (TLR) with primary percutaneous transluminal angioplasty (PTA) versus SilverHawk atherectomy and adjunctive PTA of de novo infrainguinal disease has not been well defined. This study was conducted to compare the two approaches. In this prospective, two-center randomized trial of PTA versus atherectomy of infrainguinal vessels, the primary endpoint of TLR was evaluated at 1 year. Secondary endpoints included the rate of "bailout" stent placement for suboptimal acute angiographic results and the rate of target vessel revascularization (TVR). Fifty-eight patients were included in the study. Of these, 29 (36 vessels) were randomized to the atherectomy arm and 29 (48 vessels) to the PTA arm. Final acute angiographic success rates were 100% in the PTA arm and 97.2% in the atherectomy arm (P value not significant). There was no statistical difference in TLR (16.7% vs 11.1%) or TVR (21.4% vs 11.1%) between the PTA and atherectomy groups, respectively. Bailout stent placement was performed in 18 of 29 patients (62.1%) in the PTA arm and eight of 29 patients (27.6%) in the atherectomy arm (P = .017). Major adverse events were similar between the PTA and atherectomy arms. Finally, when embolic filter protection was used, distal macroembolization occurred in 11 of 17 patients (64.7%) treated with atherectomy versus none of 10 in the PTA group (P atherectomy and primary PTA. Atherectomy reduced the need for bailout stent placement compared with primary PTA. Copyright © 2011 SIR. Published by Elsevier Inc. All rights reserved.

  11. Directional Atherectomy in Iliac Stent Failure: Clinical Technique and Histopathologic Correlation

    International Nuclear Information System (INIS)

    Ettles, Duncan F.; MacDonald, Alastair W.; Burgess, Paul A.; Nicholson, Anthony A.; Dyet, John F.

    1998-01-01

    Purpose: To assess the feasibility and efficacy of directional atherectomy in the treatment of iliac stent stenosis or occlusion and to evaluate the histologic composition of excised atherectomy specimens. Methods: Directional atherectomy of six occluded and 10 severely stenosed iliac stents was undertaken in 12 patients at a mean interval of 28 months (range 3-69 months) after stent insertion for occlusive aortoiliac disease. In cases of stent occlusion, atherectomy was preceded by low-dose thrombolysis. In all patients stent clearance with return of femoral pulses was achieved within 24 hr and there were no significant complications. All excised specimens were sent for histologic examination. Results: Eleven patients (92%) remain symptom free with unlimited walking distance at a mean follow-up interval of 11.5 months (range 3-31 months) after treatment. Histologic examination revealed typical myointimal hyperplasia at three excision sites, intimal fibrosis at three sites, atheroma at four sites and organized thrombus at six sites. Conclusion: Atherectomy offers an effective treatment in iliac stent occlusion and restenosis with no significant adverse effects. Debulking of these lesions seems to offer a more logical approach than simple balloon angioplasty. Clinical and duplex follow-up confirms satisfactory outcome within the first year but longer-term results are not yet known. The histologic data obtained demonstrate that stent restenosis and occlusion are likely to be multifactorial, and challenge the assumption that myointimal hyperplasia is the sole cause of iliac stent occlusion

  12. Orbital Atherectomy in the Renal Artery: A New Frontier for an Emerging Technology?

    Science.gov (United States)

    Valle, Javier A; Armstrong, Ehrin J; Waldo, Stephen W

    2017-01-01

    Orbital atherectomy has been developed as a method to modify calcified plaque in the peripheral vasculature, with extensive experience and data supporting its use in infrainguinal peripheral arterial disease. However, calcific atherosclerotic disease occurs in other vascular beds and may benefit from the application of this technology. In this case report, we describe the first reported use of orbital atherectomy in a renal artery. A 55-year-old male with severe drug-refractory hypertension was found to have renal artery stenosis, with severe calcification of the right renal artery. Orbital atherectomy was utilized for initial plaque modification, and he underwent stenting of the renal artery lesion with an excellent angiographic and clinical result at follow-up. In conclusion, orbital atherectomy is a safe and effective means of plaque modification for severely calcified lesions. The safe and effective use of orbital atherectomy in the renal vasculature suggests an opportunity for ongoing evaluation into expanded roles for this technology beyond the coronary and lower-extremity arterial beds.

  13. Coronary Atherectomy in the United States (from a Nationwide Inpatient Sample).

    Science.gov (United States)

    Arora, Shilpkumar; Panaich, Sidakpal S; Patel, Nilay; Patel, Nileshkumar J; Savani, Chirag; Patel, Samir V; Thakkar, Badal; Sonani, Rajesh; Jhamnani, Sunny; Singh, Vikas; Lahewala, Sopan; Patel, Achint; Bhatt, Parth; Shah, Harshil; Jaiswal, Radhika; Gupta, Vishal; Deshmukh, Abhishek; Kondur, Ashok; Schreiber, Theodore; Badheka, Apurva O; Grines, Cindy

    2016-02-15

    Contemporary real-world data on clinical outcomes after utilization of coronary atherectomy are sparse. The study cohort was derived from Healthcare Cost and Utilization Project Nationwide Inpatient Sample database from year 2012. Percutaneous coronary interventions including atherectomy were identified using appropriate International Classification of Diseases, 9th Revision diagnostic and procedural codes. Two-level hierarchical multivariate mixed models were created. The primary outcome was a composite of in-hospital mortality and periprocedural complications; the secondary outcome was in-hospital mortality. Hospitalization costs were also assessed. A total of 107,131 procedures were identified in 2012. Multivariate analysis revealed that atherectomy utilization was independently predictive of greater primary composite outcome of in-hospital mortality and complications (odds ratio 1.34, 95% confidence interval 1.22 to 1.47, p atherectomy utilization was again associated with a higher rate of complications (12.88% vs 10.99%, p = 0.001), in-hospital mortality +a ny complication (13.69% vs 11.91%, p = 0.003) with a nonsignificant difference in terms of in-hospital mortality alone (3.45% vs 2.88%, p = 0.063) and higher hospitalization costs ($25,341 ± 353 vs $21,984 ± 87, p Atherectomy utilization during percutaneous coronary intervention is associated with a higher rate of postprocedural complications without any significant impact on in-hospital mortality. Copyright © 2016 Elsevier Inc. All rights reserved.

  14. Are trademarks a valid indicator of innovation? : results of an in-depth study of new Benelux trademarks filed by SMEs

    NARCIS (Netherlands)

    Flikkema, M.; De Man, A.P.; Castaldi, C.

    2014-01-01

    This paper extends the emerging literature on the value of trademarks for innovation studies and policy-making with the first empirical study at the trademark level. It gives a view on how companies use trademarks and interpret trademark activities. A sample of 660 new Benelux trademarks registered

  15. Are Trademark Counts a Valid Indicator of Innovation? Results of an In-Depth Study of New Benelux Trademarks Filed by SMEs.

    NARCIS (Netherlands)

    Flikkema, M.J.; de Man, A.P.; Castaldi, C.

    2014-01-01

    This paper extends the emerging literature on the value of trademarks for innovation studies and policy-making with the first empirical study at the trademark level. It gives a view on how companies use trademarks and interpret trademark activities. A sample of 660 new Benelux trademarks registered

  16. Houdini{trademark}: Reconfigurable in-tank mobile robot. Final report, June 1995--January 1997

    Energy Technology Data Exchange (ETDEWEB)

    Thompson, B.; Slifko, A.

    1998-12-31

    This report details the development of a reconfigurable in-tank robotic cleanup system called Houdini{trademark}. Driven by the general need to develop equipment for the removal of radioactive waste from hundreds of DOE waste storage tanks and the specific needs of DOE sites such as Oak Ridge National Laboratory and Fernald, Houdini{trademark} represents one of the possible tools that can be used to mobilize and retrieve this waste material for complete remediation. Houdini{trademark} is a hydraulically powered, track driven, mobile work vehicle with a collapsible frame designed to enter underground or above ground waste tanks through existing 24 inch riser openings. After the vehicle has entered the waste tank, it unfolds and lands on the waste surface or tank floor to become a remotely operated mini-bulldozer. Houdini{trademark} utilizes a vehicle mounted plow blade and 6-DOF manipulator to mobilize waste and carry other tooling such as sluicing pumps, excavation buckets, and hydraulic shears. The complete Houdini{trademark} system consists of the tracked vehicle and other support equipment (e.g., control console, deployment system, hydraulic power supply, and controller) necessary to deploy and remotely operate this system at any DOE site. Inside the storage tanks, the system is capable of performing heel removal, waste mobilization, waste size reduction, and other tank waste retrieval and decommissioning tasks. The first Houdini{trademark} system was delivered on September 24, 1996 to Oak Ridge National Laboratory (ORNL). The system acceptance test was successfully performed at a cold test facility at ORNL. After completion of the cold test program and the training of site personnel, ORNL will deploy the system for clean-up and remediation of the Gunite storage tanks.

  17. Houdini trademark: Reconfigurable in-tank mobile robot. Final report, June 1995 - January 1997

    International Nuclear Information System (INIS)

    Thompson, B.; Slifko, A.

    1998-01-01

    This report details the development of a reconfigurable in-tank robotic cleanup system called Houdini trademark. Driven by the general need to develop equipment for the removal of radioactive waste from hundreds of DOE waste storage tanks and the specific needs of DOE sites such as Oak Ridge National Laboratory and Fernald, Houdini trademark represents one of the possible tools that can be used to mobilize and retrieve this waste material for complete remediation. Houdini trademark is a hydraulically powered, track driven, mobile work vehicle with a collapsible frame designed to enter underground or above ground waste tanks through existing 24 inch riser openings. After the vehicle has entered the waste tank, it unfolds and lands on the waste surface or tank floor to become a remotely operated mini-bulldozer. Houdini trademark utilizes a vehicle mounted plow blade and 6-DOF manipulator to mobilize waste and carry other tooling such as sluicing pumps, excavation buckets, and hydraulic shears. The complete Houdini trademark system consists of the tracked vehicle and other support equipment (e.g., control console, deployment system, hydraulic power supply, and controller) necessary to deploy and remotely operate this system at any DOE site. Inside the storage tanks, the system is capable of performing heel removal, waste mobilization, waste size reduction, and other tank waste retrieval and decommissioning tasks. The first Houdini trademark system was delivered on September 24, 1996 to Oak Ridge National Laboratory (ORNL). The system acceptance test was successfully performed at a cold test facility at ORNL. After completion of the cold test program and the training of site personnel, ORNL will deploy the system for clean-up and remediation of the Gunite storage tanks

  18. Cost-effectiveness analysis of orbital atherectomy plus balloon angioplasty vs balloon angioplasty alone in subjects with calcified femoropopliteal lesions

    Directory of Open Access Journals (Sweden)

    Weinstock B

    2014-03-01

    Full Text Available Barry Weinstock,1 Raymond Dattilo,2 Tiffini Diage3 1Orlando Health Heart Institute, Mid-Florida Cardiology Specialists, Orlando, FL, USA; 2Department of Cardiology, St Francis Health Center, Topeka, KS, USA; 3North American Science Association (NAMSA, Sunnyvale, CA, USA Introduction: As cost considerations become increasingly critical when selecting optimal endovascular treatment strategies, a cost-benefit analysis was conducted comparing the Diamondback 360°® Orbital Atherectomy System (OAS (Cardiovascular Systems, Inc., St Paul, MN, USA and balloon angioplasty (BA vs BA alone for treatment of calcified femoropopliteal lesions. Patients and methods: The clinical outcomes from COMPLIANCE 360°, a prospective, multicenter, randomized study comparing OAS+BA vs BA alone for treatment of calcified femoropopliteal lesions, were correlated with cost data and previously published quality of life data. Site of service, hospital charges, and associated medical resource utilization were obtained from Uniform Billing statements for index treatments and associated revascularizations out to 1 year. Hospital costs were estimated using hospital-specific, procedure-specific cost-to-charge ratios. Length of stay and procedural data were collected from participating study sites. Results: Twenty-five subjects with 38 lesions and 25 subjects with 27 lesions were randomized to the OAS+BA and BA-alone groups, respectively. Mean hospital charges (US$51,755 vs US$39,922 and estimated hospital costs (US$15,100 vs US$11,016 were higher for OAS+BA compared with BA alone (not statistically significant. Stent utilization was statistically significantly higher with BA-alone treatment for all subjects (1.1 vs 0.1, P=0.001 and in the subset of subjects with one lesion (1.0 vs 0.1, P<0.00001. There was a significant difference in cost for single-lesion versus multiple-lesion treatment. Using costs and quality-adjusted life years (QALYs for the single-lesion cohort, the 1-year

  19. ULTOR(Registered TradeMark) Passive Pose and Position Engine For Spacecraft Relative Navigation

    Science.gov (United States)

    Hannah, S. Joel

    2008-01-01

    The ULTOR(Registered TradeMark) Passive Pose and Position Engine (P3E) technology, developed by Advanced Optical Systems, Inc (AOS), uses real-time image correlation to provide relative position and pose data for spacecraft guidance, navigation, and control. Potential data sources include a wide variety of sensors, including visible and infrared cameras. ULTOR(Registered TradeMark) P3E has been demonstrated on a number of host processing platforms. NASA is integrating ULTOR(Registerd TradeMark) P3E into its Relative Navigation System (RNS), which is being developed for the upcoming Hubble Space Telescope (HST) Servicing Mission 4 (SM4). During SM4 ULTOR(Registered TradeMark) P3E will perform realtime pose and position measurements during both the approach and departure phases of the mission. This paper describes the RNS implementation of ULTOR(Registered TradeMark) P3E, and presents results from NASA's hardware-in-the-loop simulation testing against the HST mockup.

  20. SEAMIST trademark soil sampling for tritiated water: First year's results

    International Nuclear Information System (INIS)

    Mallon, B.; Martins, S.A.; Houpis, J.L.; Lowry, W.; Cremer, C.D.

    1992-01-01

    SEAMIST trademark is a recently developed sampling system that enables one to measure various soil parameters by means of an inverted, removable, impermeable membrane tube inserted in a borehole. This membrane tube can have various measuring devices installed on it, such as gas ports, adsorbent pads, and electrical sensors. These membrane tubes are made of a laminated polymer. The Lawrence Livermore National Laboratory in Livermore, California, has installed two of these systems to monitor tritium in soil resulting from a leak in an underground storage tank. One tube is equipped with gas ports to sample soil vapor and the other with adsorbent pads to sample soil moisture. Borehole stability was maintained using either sand-filled or air-inflated tubes. Both system implementations yielded concentrations or activities that compared well with the measured concentrations of tritium in the soil taken during borehole construction. In addition, an analysis of the data suggest that both systems prevented the vertical migration of tritium in the boreholes. Also, a neutron probe was successfully used in a blank membrane inserted in one of the boreholes to monitor the moisture in the soil without exposing the probe to the tritium. The neutron log showed excellent agreement with the soil moisture content measured in soil samples taken during borehole construction. This paper describes the two SEAMIST trademark systems used and presents sampling results and comparisons

  1. Znaki towarowe w sporcie = Trademarks in sports

    Directory of Open Access Journals (Sweden)

    Krzysztof M. Westfal

    2015-12-01

    Abstract                     By getting the right protection for national trade mark, it is understood use of the mark for profit or for professional purposes throughout the territory of Poland. In contrast, a similar right conferred by a Community trade mark, concerns the application of the mark throughout the Community. Use of the mark is in particular the placement of the sign to the goods covered by the right of protection or their packaging, delivering and placing the goods on the market, import or export, as well as offering or providing services under that mark and the use of such a sign for advertising purposes. In the era of big money that undoubtedly govern the sport today, the law of trademarks, beside the rights to broadcast sporting events, gaining for all sporting significance of key organizational units. Clubs, associations and sports federations benefit from trademark rights, principally through the granting of licenses to entrepreneurs to use them. This process is most easily seen by the way the organization of major sporting events.                     As the aim of the research undersigned has chosen an indication of the legal rules governing trademarks in sports, in the face of ever increasing significance. The publication will include a presentation method and rules for the use of sports characters already registered by sports entities, as well as the benefits flowing from here. The implementation of the research will be carried out primarily by the method dogmatic. The analysis will be subject to national laws and EU. Taken the issue arises, however, need to take into account the achievements of other sciences, especially marketing, business and economics. Among the materials analyzed, in addition to the acts of commonly mention should also be stored in the data registers trademarks UP RP and OHIM. Behind the main conclusion flowing from this report should be regarded assertion that quality in modern

  2. Longitudinal outcomes after tibioperoneal angioplasty alone compared to tibial stenting and atherectomy for critical limb ischemia.

    Science.gov (United States)

    Reynolds, Shaun; Galiñanes, Edgar Luis; Dombrovskiy, Viktor Y; Vogel, Todd R

    2013-10-01

    There are limited data available evaluating longitudinal outcomes after tibioperoneal angioplasty (TA) alone compared to adjunctive tibial procedures including stenting and atherectomy. Using the Centers for Medicare & Medicaid Services inpatient claims (2005-2007), patients evaluated TA only, TA plus stent placement (TA + S), and TA plus atherectomy (TA + A). A total of 2080 patients with critical limb ischemia underwent percutaneous tibioperoneal intervention for the indication of ulceration. Procedures included TA (56.3%), TA + S (16.2%), and TA + A (27.5%). Rates of amputation were not statistically different between the groups at 30, 90, and 365 days after the intervention. Mean total hospital charges were TA ($35,867), TA + A ($41,698; P = .0004), and TA + S ($51,040; P atherectomy for ulceration demonstrated no improvement in limb salvage. Future analysis of adjunctive tibioperoneal interventions is essential to temper cost, as they fail to improve long-term limb salvage.

  3. Successful Use of Orbital Atherectomy as an Adjunct in Treating Extensively Calcified Mesenteric Artery Lesions.

    Science.gov (United States)

    Richard, Michele; Krol, Emilia; Dietzek, Alan

    2016-10-01

    To describe the use of orbital technique of atherectomy as an adjunct to successful angioplasty and stent placement of the superior mesenteric artery (SMA). The technique is demonstrated in a 68-year-old man with critical SMA stenosis. The SMA was cannulated with 0.014-in wire, but the lesion was highly stenotic and densely calcified and prevented the passage of even the smallest 1.5-mm balloon. Orbital atherectomy was thus performed with a 1.25-mm CSI crown. Balloon angioplasty was then possible with a 4 mm × 2 cm balloon followed by placement of a 7 mm × 22 mm balloon-mounted stent. The use of atherectomy as an adjunct to angioplasty and stenting in extensive, calcified SMA lesions supports the value of this technique to avoid a much larger and morbid open procedure. Published by Elsevier Inc.

  4. CAMAC Driver Support for Windows NT trademark and Lunux trademark

    International Nuclear Information System (INIS)

    Slimmer, D.A.; Streets, J.M.

    1999-01-01

    CAMAC is a Modular Instrumentation and Digital Interface System defined as a standardized instrumentation system for Computer Automated Measurement and Control. CAMAC hardware and software has been defined by the NIM Committee (National Instrumentation Methods Committee) of the US Department of Energy and the ESONE Committee (European Standards on Nuclear Electronics Committee) of European Laboratories. Fermi National Accelerator Laboratory has for many years produced software packages that follow the ANSI/IEEE standard 758-1979 for a variety of computers, CAMAC controller interfaces, and operating systems. In order to enable the re-use of existing hardware and software, Fermilab now supports standard routine libraries and drivers for Windows NT 4.0 and the Linux operating systems for the Jorway 411s SCSI Bus CAMAC Driver[l] and the Jorway73A SCSI Bus CAMAC Crate Controller. A number of test stands and small experiments both on-site and off-site are using this software for their CAMAC data acquisition needs

  5. Endovascular Revascularization of Symptomatic Infrapopliteal Arteriosclerotic Occlusive Disease: Comparison of Atherectomy and Angioplasty

    Science.gov (United States)

    Tan, Tze-Woei; Semaan, Elie; Nasr, Wael; Eberhardt, Robert T.; Hamburg, Naomi; Doros, Gheorghe; Rybin, Denis; Shaw, Palma M.; Farber, Alik

    2011-01-01

    The preferred method for revascularization of symptomatic infrapopliteal arterial occlusive disease (IPAD) has traditionally been open vascular bypass. Endovascular techniques have been increasingly applied to treat tibial disease with mixed results. We evaluated the short-term outcome of percutaneous infrapopliteal intervention and compared the different techniques used. A retrospective analysis of consecutive patients undergoing endovascular treatment for infrapopliteal arterial occlusive lesions between 2003 and 2007 in a tertiary teaching hospital was performed. Patient demographic data, indication for intervention, and periprocedural complications were recorded. Periprocedural and short-term outcomes were measured and compared. Forty-nine infrapopliteal arteries in 35 patients were treated. Twenty vessels (15 patients) underwent angioplasty and 29 vessels (20 patients) were treated with atherectomy. Demographic and angiographic characteristics were similar between the groups. Twenty-six patients had concurrent femoral and/or popliteal artery interventions. Overall, technical success was 90% and similar between angioplasty and atherectomy groups (85% versus 93%, p = NS). The vessel-specific complication rate was 10% and was similar between both groups (angioplasty 5% versus atherectomy 14%, p = NS). One dissection occurred in the angioplasty group; one perforation and three thromboembolic events occurred in the atherectomy group. Limb salvage and freedom from reintervention at 6 months were 81% and 68%, respectively, and were not significantly different between the angioplasty and atherectomy groups. Endovascular intervention for IPAD had acceptable periprocedural and short-term success rates in our high-risk patient population. Both atherectomy and angioplasty can be used successfully to treat symptomatic IPAD. PMID:22532766

  6. Atherectomy of the femoropopliteal artery: a systematic review and meta-analysis of randomized controlled trials.

    Science.gov (United States)

    Diamantopoulos, A; Katsanos, K

    2014-10-01

    A systematic review was performed to provide a qualitative analysis and quantitative data synthesis of randomized controlled trials (RCTs) assessing debulking atherectomy versus balloon angioplasty for treatment of femoropopliteal artery occlusive disease. PubMed (MEDLINE), EMBASE, AMED, Scopus, online content and meeting abstracts were searched in May 2014 for eligible RCTs following the PRISMA selection process. Risk of bias was assessed using the Cochrane Collaboration's tool. Pooled risks were calculated with a random effects model to account for clinical and conceptual heterogeneity. Sensitivity analysis was employed to test the robustness of the results. Six RCTs comprising 287 patients (328 lesions) treated with either debulking atherectomy or balloon angioplasty for femoropopliteal artery disease were analyzed and synthesized. Technical success was similar between the atherectomy and the angioplasty group (93.6% vs. 96.2%, RR: 0.99. 95%CI: 0.95-1.03, P=0.57, I(2)=0%). Need for bail-out stenting and distal arterial embolization were largely similar between atherectomy and balloon angioplasty alone. After a median follow-up of 9 months the 2 groups showed similar primary patency (RR: 0.90, 95%CI: 0.56-1.46, P=0.68, I(2)=69%). Only 2 low-quality studies reported amputation and mortality rates, both of which were found significantly less in the atherectomy arms. Analysis of a limited body of low quality evidence with high risk of bias showed that debulking atherectomy of the femoropopliteal artery does not seem to confer any procedural advantage or improvement of clinical outcomes over balloon angioplasty alone.

  7. Biomedical technology prosperity game{trademark}

    Energy Technology Data Exchange (ETDEWEB)

    Berman, M.; Boyack, K.W.; Wesenberg, D.L.

    1996-07-01

    Prosperity Games{trademark} are an outgrowth and adaptation of move/countermove and seminar War Games. Prosperity Games{trademark} are simulations that explore complex issues in a variety of areas including economics, politics, sociology, environment, education and research. These issues can be examined from a variety of perspectives ranging from a global, macroeconomic and geopolitical viewpoint down to the details of customer/supplier/market interactions in specific industries. All Prosperity Games{trademark} are unique in that both the game format and the player contributions vary from game to game. This report documents the Biomedical Technology Prosperity Game{trademark} conducted under the sponsorship of Sandia National Laboratories, the Defense Advanced Research Projects Agency, and the Koop Foundation, Inc. Players were drawn from all stakeholders involved in biomedical technologies including patients, hospitals, doctors, insurance companies, legislators, suppliers/manufacturers, regulators, funding organizations, universities/laboratories, and the legal profession. The primary objectives of this game were to: (1) Identify advanced/critical technology issues that affect the cost and quality of health care. (2) Explore the development, patenting, manufacturing and licensing of needed technologies that would decrease costs while maintaining or improving quality. (3) Identify policy and regulatory changes that would reduce costs and improve quality and timeliness of health care delivery. (4) Identify and apply existing resources and facilities to develop and implement improved technologies and policies. (5) Begin to develop Biomedical Technology Roadmaps for industry and government cooperation. The deliberations and recommendations of these players provided valuable insights as to the views of this diverse group of decision makers concerning biomedical issues. Significant progress was made in the roadmapping of key areas in the biomedical technology field.

  8. Orbital Atherectomy Plaque Modification Assessment of the Femoropopliteal Artery Via Intravascular Ultrasound (TRUTH Study).

    Science.gov (United States)

    Babaev, Anvar; Zavlunova, Susanna; Attubato, Michael J; Martinsen, Brad J; Mintz, Gary S; Maehara, Akiko

    2015-10-01

    The Tissue Removal Assessment with Ultrasound of the SFA and Popliteal (TRUTH) study assessed the performance of the orbital atherectomy system (OAS) to treat femoropopliteal arteries, including determining its effect on plaque removal. Patients with symptomatic femoropopliteal peripheral arterial disease were treated with the OAS followed by adjunctive balloon angioplasty (BA). Intravascular ultrasound (IVUS) images were collected pre- and post-OAS and post-OAS BA. Patients were followed through 12 months post-procedure. Twenty-nine lesions were treated with OAS-BA in 25 patients. The mean maximum balloon inflation pressure was 5.2 ± 1.2 atm. Virtual histology IVUS (VH-IVUS) analysis revealed at the maximum calcium ablation site that calcium reduction was responsible for 86% of the lumen area increase. The minimum lumen area increased from 4.0 mm(2) to 9.1 mm(2) (<.0001), and the percentage of area stenosis decreased from 76.9% to 43.0% (<.0001) after OAS-BA. At 12 months, the target lesion revascularization rate was 8.2%, and ankle-brachial index and Rutherford classification improved significantly from baseline through follow-up. The VH-IVUS analysis reveals that OAS modifies the calcified component of the plaque burden. It is hypothesized that calcium modification by OAS changes the lesion compliance, allowing for low pressure adjunctive BA. The clinical outcomes were favorable through 12-month follow-up. © The Author(s) 2015.

  9. The added benefits and efficacy of atherectomy in the lower limb.

    Science.gov (United States)

    VAN DEN Berg, Jos C

    2016-08-01

    Atherectomy has been used as an adjunct therapy for balloon angioplasty and/or stent placement in the superficial femoral artery for many years, but has never gained global popularity in the treatment of peripheral arterial disease, most probably related to the conflicting results as published in the literature. Novel techniques that have been developed over the past years are yielding promising results in the infrainguinal region. This paper will describe the added benefits of atherectomy as compared to plain old balloon angioplasty and bail-out bare-metal stenting, both in the treatment of primary lesions of the superficial femoral artery as well as in cases of in-stent restenosis.

  10. JETSTREAM Atherectomy: A Review of Technique, Tips, and Tricks in Treating the Femoropopliteal Lesions

    Science.gov (United States)

    Shammas, Nicolas W.

    2014-01-01

    JETSTREAM (Bayer, Whippany, NJ) atherectomy is a highly effective rotational atherectomy device with active aspiration capacity approved in the United States to treat infrainguinal obstructive peripheral arterial disease. The technique in using the JETSTREAM is critical and relies on appropriate wire use, appropriate sizing, and speed in advancing the cutter as well as the use of fluoroscopic imaging and tactile and auditory senses. Using the right technique, the device appears to have a low rate of distal embolization and complications and results in high procedural success. We describe our own experience with the JETSTREAM device and the techniques used in our endovascular laboratory. PMID:26060377

  11. Peripheral atherectomy practice patterns in the United States from the Vascular Quality Initiative.

    Science.gov (United States)

    Mohan, Sathish; Flahive, Julie M; Arous, Edward J; Judelson, Dejah R; Aiello, Francesco A; Schanzer, Andres; Simons, Jessica P

    2018-06-21

    Peripheral atherectomy has been shown to have technical success in single-arm studies, but clinical advantages over angioplasty and stenting have not been demonstrated, leaving its role unclear. We sought to describe patterns of atherectomy use in a real-world U.S. cohort to understand how it is currently being applied. The Vascular Quality Initiative was queried to identify all patients who underwent peripheral vascular intervention from January 2010 to September 2016. Descriptive statistics were performed to analyze demographics of the patients, comorbidities, indication, treatment modalities, and lesion characteristics. The intermittent claudication (IC) and critical limb ischemia (CLI) cohorts were analyzed separately. Of 85,605 limbs treated, treatment indication was IC in 51% (n = 43,506) and CLI in 49% (n = 42,099). Atherectomy was used in 15% (n = 13,092) of cases, equivalently for IC (15%; n = 6674) and CLI (15%; n = 6418). There was regional variation in use of atherectomy, ranging from a low of 0% in one region to a high of 32% in another region. During the study period, there was a significant increase in the proportion of cases that used atherectomy (11% in 2010 vs 18% in 2016; P < .0001). Compared with nonatherectomy cases, those with atherectomy use had higher incidence of prior peripheral vascular intervention (IC, 55% vs 43% [P < .0001]; CLI, 47% vs 41% [P < .0001]), greater mean number of arteries treated (IC, 1.8 vs 1.6 [P < .0001]; CLI, 2.1 vs 1.7 [P < .0001]), and lower proportion of prior leg bypass (IC, 10% vs 14% [P < .0001]; CLI, 11% vs 17% [P < .0001]). There was lower incidence of failure to cross the lesion (IC, 1% vs 4% [P < .0001]; CLI, 4% vs 7% [P < .0001]) but higher incidence of distal embolization (IC, 1.9% vs 0.8% [P < .0001]; CLI, 3.0% vs 1.4% [P < .0001]) and, in the CLI cohort, arterial perforation (1.4% vs 1.0%; P = .01). Despite a lack of evidence for atherectomy over angioplasty and stenting, its use has

  12. Recent developments in MCNPX trademark

    International Nuclear Information System (INIS)

    Hughes, H.G.; Adams, K.J.; Chadwick, M.B.

    1998-01-01

    The MCNPX Monte Carlo particle transport code is rapidly developing into a significant computational tool for high-energy transport applications. In this paper, the authors will discuss three recent enhancements to MCNPX: a new charged-particle collisional energy-loss model, a geometry-independent mesh-based tally system, and a radiography simulation capability

  13. Combined Directional Atherectomy and Drug-Eluting Balloon Angioplasty for Isolated Popliteal Artery Lesions in Patients With Peripheral Artery Disease.

    Science.gov (United States)

    Stavroulakis, Konstantinos; Bisdas, Theodosios; Torsello, Giovanni; Stachmann, Arne; Schwindt, Arne

    2015-12-01

    To evaluate the midterm results of combined directional atherectomy (DA) and drug-eluting balloon (DEB) angioplasty for atherosclerotic lesions of the popliteal artery. In a single-arm, prospective study, 21 patients (mean age 63±16 years; 16 men) with isolated popliteal artery lesions were enrolled and underwent treatment with combined DA and DEB angioplasty under filter protection between October 2009 and February 2014. The majority (18, 86%) presented with lifestyle-limiting intermittent claudication and 3 with critical limb ischemia. Fifteen (71%) target sites were de novo lesions; 4 were occlusions. The main outcome was primary patency; secondary outcomes were technical success, secondary patency, and early and midterm morbidity and mortality. The TurboHawk atherectomy device was used in 15 (71%) patients and the SilverHawk peripheral plaque excision system in the remaining 6 patients. The In.Pact Admiral/Pacific DEB was used in the majority of cases (15, 71%). The technical success rate was 90% (n=19). One flow-limiting dissection was treated with bailout stenting. Complications included a perforation of the popliteal artery and 2 puncture site hematomas; there was no distal embolic event. The mean follow-up was 18±12 months. Two restenoses were retreated successfully. Kaplan-Meier estimates of primary patency at 12 and 18 months were 95% and 90%, respectively; the secondary patency was 100%. One (5%) patient died in follow-up. None of the patients had an amputation. In this prospective single-arm study, the combined therapy of DA and DEB angioplasty for popliteal artery lesions showed promising midterm performance. The combination of DA and DEB may, in highly selected patients, overcome the challenges presented by the mobility of the knee joint. © The Author(s) 2015.

  14. Verification and validation of decision support software: Expert Choice{trademark} and PCM{trademark}

    Energy Technology Data Exchange (ETDEWEB)

    Nguyen, Q.H.; Martin, J.D.

    1994-11-04

    This report documents the verification and validation of two decision support programs: EXPERT CHOICE{trademark} and PCM{trademark}. Both programs use the Analytic Hierarchy Process (AHP) -- or pairwise comparison technique -- developed by Dr. Thomas L. Saaty. In order to provide an independent method for the validating the two programs, the pairwise comparison algorithm was developed for a standard mathematical program. A standard data set -- selecting a car to purchase -- was used with each of the three programs for validation. The results show that both commercial programs performed correctly.

  15. Reduced rectal toxicity with ultrasound-based image guided radiotherapy using BAT trademark (B-mode acquisition and targeting system) for prostate cancer

    International Nuclear Information System (INIS)

    Bohrer, Markus; Schroeder, Peter; Welzel, Grit; Wertz, Hansjoerg; Lohr, Frank; Wenz, Frederik; Mai, Sabine Kathrin

    2008-01-01

    To evaluate the effect of image guided radiotherapy with stereotactic ultrasound BAT (B-mode acquisition and targeting system) on rectal toxicity in conformal radiotherapy of prostate cancer. Patients and Methods 42 sequential patients with prostate cancer undergoing radiotherapy before and after the introduction of BAT were included. Planning computed tomography (CT) was performed with empty rectum and moderately filled bladder. The planning target volume (PTV) included the prostate and seminal vesicles with a safety margin of 1.5 cm in anterior and lateral direction. In posterior direction the anterior 1/3 of the rectum circumference were included. Total dose was 66 Gy and a boost of 4 Gy excluding the seminal vesicles. 22 patients (BAT group) were treated with daily stereotactic ultrasound positioning, for the other 20 patients (NoBAT group) an EPID (electronic portal imaging device) was performed once a week. Acute and late genito-urinary (GU) and rectal toxicity and PSA values were evaluated after 1.5, 3, 6, 9 and 12 months. The total median follow up of toxicity was 3 years in the BAT group and 4 years in the NoBAT group. Results In the NoBAT group significant more rectal toxicity occurred, while in GU toxicity no difference was seen. Two patients in the NoBAT group showed late rectal toxicity grade 3, no toxicity > grade 2 occurred in the BAT group. There was no significant difference in PSA reduction between the groups. Conclusion Without BAT significant more acute and a trend to more late rectal toxicity was found. With regard to dose escalation this aspect is currently evaluated with a larger number of patients using intensity-modulated radiotherapy (IMRT). (orig.)

  16. SOx-NOx-Rox Box{trademark} flue gas clean-up demonstration. Final report

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1995-09-01

    The SNRB{trademark} Flue Gas Cleanup Demonstration Project was cooperatively funded by the U.S. Department of Energy (DOE), the Ohio Coal Development Office (OCDO), B&W, the Electric Power Research Institute (EPRI), Ohio Edison, Norton Chemical Process Products Company and the 3M Company. The SNRB{trademark} technology evolved from the bench and laboratory pilot scale to be successfully demonstrated at the 5-MWe field scale. Development of the SNRB{trademark} process at B&W began with pilot testing of high-temperature dry sorbent injection for SO{sub 2} removal in the 1960`s. Integration of NO{sub x} reduction was evaluated in the 1970`s. Pilot work in the 1980`s focused on evaluation of various NO{sub x} reduction catalysts, SO{sub 2} sorbents and integration of the catalyst with the baghouse. This early development work led to the issuance of two US process patents to B&W - No. 4,309,386 and No. 4,793,981. An additional patent application for improvements to the process is pending. The OCDO was instrumental in working with B&W to develop the process to the point where a larger scale demonstration of the technology was feasible. This report represents the completion of Milestone M14 as specified in the Work Plan. B&W tested the SNRB{trademark} pollution control system at a 5-MWe demonstration facility at Ohio Edison`s R. E. Burger Plant located near Shadyside, Ohio. The design and operation were influenced by the results from laboratory pilot testing at B&W`s Alliance Research Center. The intent was to demonstrate the commercial feasibility of the SNRB{trademark} process. The SNRB{trademark} facility treated a 30,000 ACFM flue gas slipstream from Boiler No. 8. Operation of the facility began in May 1992 and was completed in May 1993.

  17. ReflectoActive(trademark) Seals for Materials Control and Accountability

    International Nuclear Information System (INIS)

    Richardson, G.D.; Younkin, J.R.; Bell, Z.W.

    2002-01-01

    The ReflectoActive(trademark) Seals system, a continuously monitored fiber optic, active seal technology, provides real-time tamper indication for large arrays of storage containers. The system includes a PC running the RFAS software, an Immediate Detection Unit (IDU), an Optical Time Domain Reflectometer (OTDR), links of fiber optic cable, and the methods and devices used to attach the fiber optic cable to the containers. When a breach on any of the attached fiber optic cable loops occurs, the IDU immediately signals the connected computer to control the operations of an OTDR to seek the breach location. The ReflectoActive(trademark) Seals System can be adapted for various types of container closure designs and implemented in almost any container configuration. This automatic protection of valued assets can significantly decrease the time and money required for surveillance. The RFAS software is the multi-threaded, client-server application that monitors and controls the components of the system. The software administers the security measures such as a two-person rule as well as continuous event logging. Additionally the software's architecture provides a secure method by which local or remote clients monitor the system and perform administrative tasks. These features provide the user with a robust system to meet today's material control and accountability needs. A brief overview of the hardware, and different hardware configurations will be given. The architecture of the system software, and its benefits will then be discussed. Finally, the features to be implemented in future versions of the system will be presented

  18. Incidence of Bradycardia and Outcomes of Patients Who Underwent Orbital Atherectomy Without a Temporary Pacemaker.

    Science.gov (United States)

    Lee, Michael S; Nguyen, Heajung; Shlofmitz, Richard

    2017-02-01

    We analyzed the incidence of bradycardia and the safety of patients with severely calcified coronary lesions who underwent orbital atherectomy without the insertion of a temporary pacemaker. The presence of severely calcified coronary lesions can increase the complexity of percutaneous coronary intervention due to the difficulty in advancing and optimally expanding the stent. High-pressure inflations to predilate calcified lesions may cause angiographic complications like perforation and dissection. Suboptimal stent expansion is associated with stent thrombosis and restenosis. Orbital atherectomy safely and effectively modifies calcified plaque to facilitate optimal stent expansion. The incidence of bradycardia in orbital atherectomy is unknown. Fifty consecutive patients underwent orbital atherectomy from February 2014 to September 2016 at our institution, none of whom underwent insertion of a temporary pacemaker. The final analysis included 47 patients in this retrospective study as 3 patients were excluded because of permanent pacemaker implantation. The primary endpoint was significant bradycardia, defined as bradycardia requiring emergent pacemaker placement or a heart rate pacemaker appears to be safe.

  19. Comparative quantitative angiographic analysis of directional coronary atherectomy and balloon coronary angioplasty

    NARCIS (Netherlands)

    V.A.W.M. Umans (Victor); K.J. Beatt (Kevin); B.J.W.M. Rensing (Benno); W.R.M. Hermans (Walter); P.J. de Feyter (Pim); P.W.J.C. Serruys (Patrick)

    1991-01-01

    markdownabstract__Abstract__ An attempt to assess the “utility” of directional atherectomy was made using a new quantitative angiographic index. This index can be subdivided into an initial gain component and a restenosis component. The initial gain index is the ratio between the gain in diameter

  20. Excimer laser coronary atherectomy in septal collaterals during retrograde recanalization of a chronic total occlusion

    Directory of Open Access Journals (Sweden)

    Bernward Lauer

    2011-09-01

    Full Text Available Management of chronic total occlusions has been refined through the development of a retrograde approach via collateral pathways. We describe the use of Excimer Laser Coronary Atherectomy in the septal collaterals. This appraoch was not yet described in the literature.

  1. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease

    NARCIS (Netherlands)

    E.J. Topol (Eric); F. Leya; C.A. Pinkerton; P.L. Whitlow (Patrick); B. Hofling; C.A. Simonton; R.R. Masden; P.W.J.C. Serruys (Patrick); M.B. Leon (Martin); D.O. Williams (David); S.B. King 3rd (Spencer); B. Daniel; D.B. Mark (Daniel); J.M. Isner; D.R. Holmes Jr (David); S.G. Ellis (Stephen); K.L. Lee (Kerry); G.P. Keeler; L.G. Berdan (Lisa); T. Hinohara; R.M. Califf (Robert)

    1993-01-01

    textabstractBACKGROUND. Directional coronary atherectomy is a new technique of coronary revascularization by which atherosclerotic plaque is excised and retrieved from target lesions. With respect to the rate of restenosis and clinical outcomes, it is not known how this procedure compares with

  2. Atherectomy-Associated Complications in the Southern California Vascular Outcomes Improvement Collaborative.

    Science.gov (United States)

    Azar, Yara; DeRubertis, Brian; Baril, Donald; Woo, Karen

    2018-05-01

    Atherectomy has become an increasingly utilized modality for the endovascular treatment of peripheral arterial occlusive disease. The objective of this study was to determine the incidence and risk factors for atherectomy-associated complications. A retrospective review was performed for all atherectomy procedures performed between January 2011 and December 2015 in the Southern California Vascular Outcomes Improvement Collaborative. Atherectomy was defined as laser, orbital, or excisional atherectomy. Complications were dissection, perforation, and distal embolization. Seven hundred twenty-nine atherectomy procedures were performed at 7 institutions by 27 practitioners. The mean age was 73 years with 415 (57%) males. Four hundred nineteen (57%) were diabetic, 673 (92%) hypertensive, 457 (63%) smokers, and 244 (34%) had coronary artery disease. Dissection occurred in 51 (7%) procedures, embolization in 23 (3.1%), and perforation in 12 (1.6%). The mean number of lesions treated per artery was the same at 1.6 in patients with any complication and no complication (P = 0.77). The total occluded length was 7.4 cm for complications versus 7.2 cm for no complication (P = 0.73). The total treated length was 12.9 cm for complications versus 11.3 cm for no complication (P = 0.03). The incidence of complications for Trans-Atlantic Inter-Society Consensus (TASC) C/D lesions were 13% compared to 10% for TASC A/B lesions (P = 0.05). The incidence of complications in superficial femoral/popliteal lesions was 12.9% vs. 10.4% in tibial lesions (P = 0.13). In multivariable analysis, treatment length was associated with a small increased risk of complication (odds ratio = 1.02, 95% confidence interval = 1.0-1.04). Increased treatment length is associated with an increased risk of atherectomy-associated complications. Demographic factors and comorbidities were not predictors of complications. Copyright © 2017 Elsevier Inc. All rights reserved.

  3. Subacute narrowing of the left main coronary artery following directional atherectomy for proximal obstructive coronary artery disease

    NARCIS (Netherlands)

    Piek, J. J.; Koch, K. T.; van der Wal, A. C.; Becker, A. E.

    1997-01-01

    Directional atherectomy is an alternative device for treatment of highly eccentric or proximal coronary lesions considered less suitable for balloon angioplasty. We report a patient with exuberant neointimal proliferation, extending into the left main coronary artery, following directional

  4. Late presenting, contained rupture of the superficial femoral artery following atherectomy and stenting: case report and literature review.

    Science.gov (United States)

    Clegg, Stacey; Aghel, Arash; Rogers, R Kevin

    2014-08-01

    Excisional atherectomy alone or followed by stenting is considered an appropriate treatment strategy for patients with lifestyle-limiting claudication due to obstructive infra-inguinal peripheral arterial disease (Ramaiah et al., J Endovasc Ther 2006;13:592-6021). We present a case of a 69-year-old man with eccentric severely calcified disease of the superficial femoral artery (SFA) treated with excisional atherectomy followed by stenting with an interwoven nitinol stent. The procedure was complicated by extravascular stent migration associated with a contained rupture presenting 30 days after the intervention. The complication was successfully treated with a stent graft. Although rare, pseudoaneurysms have been reported at the site of prior atherectomy; however, this case is the first description of a contained rupture post atherectomy associated with erosion of a nitinol stent into an extra-luminal position. The mechanism and management of this complication are discussed. © 2014 Wiley Periodicals, Inc.

  5. Real-World Multicenter Registry of Patients with Severe Coronary Artery Calcification Undergoing Orbital Atherectomy.

    Science.gov (United States)

    Lee, Michael S; Shlofmitz, Evan; Kaplan, Barry; Alexandru, Dragos; Meraj, Perwaiz; Shlofmitz, Richard

    2016-08-01

    We evaluated the safety and efficacy of orbital atherectomy in real-world patients with severe coronary artery calcification (CAC). The presence of severe CAC increases the complexity of percutaneous coronary intervention as it may impede stent delivery and optimal stent expansion. Atherectomy may be an indispensable tool for uncrossable or undilatable lesions by modifying severe CAC. Although the ORBIT I and II trials report that orbital atherectomy was safe and effective for the treatment of severe CAC, patients with kidney disease, recent myocardial infarction, long diffuse disease, severe left ventricular dysfunction, and unprotected left main disease were excluded. This retrospective study included 458 consecutive patients with severe CAC who underwent orbital atherectomy followed by stenting from October 2013 to December 2015 at 3 centers. The primary endpoint of major adverse cardiac and cerebrovascular events at 30 days was 1.7%. Low rates of 30-day all-cause mortality (1.3%), myocardial infarction (1.1%), target vessel revascularization (0%), stroke (0.2%), and stent thrombosis (0.9%) were observed. Angiographic complications were low: perforation was 0.7%, dissection 0.9%, and no-reflow 0.7%. Emergency coronary artery bypass graft surgery was performed in 0.2% of patients. In the largest real-world study of patients who underwent orbital atherectomy, including high-risk patients who were not surgical candidates as well as those with very complex coronary anatomy, acute and short-term adverse clinical event rates were low. A randomized clinical trial is needed to identify the ideal treatment strategy for patients with severe CAC. © 2016 The Authors. Journal of Interventional Cardiology Published by Wiley Periodicals, Inc.

  6. Real‐World Multicenter Registry of Patients with Severe Coronary Artery Calcification Undergoing Orbital Atherectomy

    Science.gov (United States)

    Shlofmitz, Evan; Kaplan, Barry; Alexandru, Dragos; Meraj, Perwaiz; Shlofmitz, Richard

    2016-01-01

    Objectives We evaluated the safety and efficacy of orbital atherectomy in real‐world patients with severe coronary artery calcification (CAC). Background The presence of severe CAC increases the complexity of percutaneous coronary intervention as it may impede stent delivery and optimal stent expansion. Atherectomy may be an indispensable tool for uncrossable or undilatable lesions by modifying severe CAC. Although the ORBIT I and II trials report that orbital atherectomy was safe and effective for the treatment of severe CAC, patients with kidney disease, recent myocardial infarction, long diffuse disease, severe left ventricular dysfunction, and unprotected left main disease were excluded. Methods This retrospective study included 458 consecutive patients with severe CAC who underwent orbital atherectomy followed by stenting from October 2013 to December 2015 at 3 centers. Results The primary endpoint of major adverse cardiac and cerebrovascular events at 30 days was 1.7%. Low rates of 30‐day all‐cause mortality (1.3%), myocardial infarction (1.1%), target vessel revascularization (0%), stroke (0.2%), and stent thrombosis (0.9%) were observed. Angiographic complications were low: perforation was 0.7%, dissection 0.9%, and no‐reflow 0.7%. Emergency coronary artery bypass graft surgery was performed in 0.2% of patients. Conclusion In the largest real‐world study of patients who underwent orbital atherectomy, including high‐risk patients who were not surgical candidates as well as those with very complex coronary anatomy, acute and short‐term adverse clinical event rates were low. A randomized clinical trial is needed to identify the ideal treatment strategy for patients with severe CAC. PMID:27358246

  7. Outcomes After Orbital Atherectomy of Severely Calcified Left Main Lesions: Analysis of the ORBIT II Study.

    Science.gov (United States)

    Lee, Michael S; Shlofmitz, Evan; Shlofmitz, Richard; Sahni, Sheila; Martinsen, Brad; Chambers, Jeffrey

    2016-09-01

    The ORBIT II trial reported excellent outcomes in patients with severely calcified coronary lesions treated with orbital atherectomy. Severe calcification of the left main (LM) artery represents a complex coronary lesion subset. This study evaluated the safety and efficacy of coronary orbital atherectomy to prepare severely calcified protected LM artery lesions for stent placement. The ORBIT II trial was a prospective, multicenter clinical trial that enrolled 443 patients with severely calcified coronary lesions in the United States. The major adverse cardiac event (MACE) rate through 2 years post procedure, defined by cardiac death, myocardial infarction (CK-MB >3x upper limit of normal with or without a new pathologic Q-wave) and target-vessel revascularization, was compared in the LM and non-left main (NLM) groups. Among the 443 patients, a total of 10 underwent orbital atherectomy of protected LM artery lesions. At 2 years, there was no significant difference in the 2-year MACE rate in the LM and NLM groups (30.0% vs 19.1%, respectively; P=.36). Cardiac death was low in both groups (0% vs 4.4%, respectively; P=.99). Myocardial infarction occurred within 30 days in both groups (10.0% vs 9.7%, respectively; P=.99). Severe dissection, perforation, persistent slow flow, and persistent no reflow did not occur in the LM group. Abrupt closure occurred in 1 patient in the LM group. Orbital atherectomy for patients with heavily calcified LM coronary artery lesions is safe and feasible. Further studies are needed to assess the safety and efficacy of orbital atherectomy in patients with severely calcified LM artery lesions.

  8. Alterations of Blood Flow Through Arteries Following Atherectomy and the Impact on Pressure Variation and Velocity.

    Science.gov (United States)

    Plourde, Brian D; Vallez, Lauren J; Sun, Biyuan; Nelson-Cheeseman, Brittany B; Abraham, John P; Staniloae, Cezar S

    2016-09-01

    Simulations were made of the pressure and velocity fields throughout an artery before and after removal of plaque using orbital atherectomy plus adjunctive balloon angioplasty or stenting. The calculations were carried out with an unsteady computational fluid dynamic solver that allows the fluid to naturally transition to turbulence. The results of the atherectomy procedure leads to an increased flow through the stenotic zone with a coincident decrease in pressure drop across the stenosis. The measured effect of atherectomy and adjunctive treatment showed decrease the systolic pressure drop by a factor of 2.3. Waveforms obtained from a measurements were input into a numerical simulation of blood flow through geometry obtained from medical imaging. From the numerical simulations, a detailed investigation of the sources of pressure loss was obtained. It is found that the major sources of pressure drop are related to the acceleration of blood through heavily occluded cross sections and the imperfect flow recovery downstream. This finding suggests that targeting only the most occluded parts of a stenosis would benefit the hemodynamics. The calculated change in systolic pressure drop through the lesion was a factor of 2.4, in excellent agreement with the measured improvement. The systolic and cardiac-cycle-average pressure results were compared with measurements made in a multi-patient study treated with orbital atherectomy and adjunctive treatment. The agreements between the measured and calculated systolic pressure drop before and after the treatment were within 3%. This excellent agreement adds further confidence to the results. This research demonstrates the use of orbital atherectomy to facilitate balloon expansion to restore blood flow and how pressure measurements can be utilized to optimize revascularization of occluded peripheral vessels.

  9. Linking international trademark databases to inform IP research and policy

    Energy Technology Data Exchange (ETDEWEB)

    Petrie, P.

    2016-07-01

    Researchers and policy makers are concerned with many international issues regarding trademarks, such as trademark squatting, cluttering, and dilution. Trademark application data can provide an evidence base to inform government policy regarding these issues, and can also produce quantitative insights into economic trends and brand dynamics. Currently, national trademark databases can provide insight into economic and brand dynamics at the national level, but gaining such insight at an international level is more difficult due to a lack of internationally linked trademark data. We are in the process of building a harmonised international trademark database (the “Patstat of trademarks”), in which equivalent trademarks have been identified across national offices. We have developed a pilot database that incorporates 6.4 million U.S., 1.3 million Australian, and 0.5 million New Zealand trademark applications, spanning over 100 years. The database will be extended to incorporate trademark data from other participating intellectual property (IP) offices as they join the project. Confirmed partners include the United Kingdom, WIPO, and OHIM. We will continue to expand the scope of the project, and intend to include many more IP offices from around the world. In addition to building the pilot database, we have developed a linking algorithm that identifies equivalent trademarks (TMs) across the three jurisdictions. The algorithm can currently be applied to all applications that contain TM text; i.e. around 96% of all applications. In its current state, the algorithm successfully identifies ~ 97% of equivalent TMs that are known to be linked a priori, as they have shared international registration number through the Madrid protocol. When complete, the internationally linked trademark database will be a valuable resource for researchers and policy-makers in fields such as econometrics, intellectual property rights, and brand policy. (Author)

  10. External Data and Attribute Hyperlink Programs for Promis*e(Registered Trademark)

    Science.gov (United States)

    Derengowski, Rich; Gruel, Andrew

    2001-01-01

    External Data and Attribute Hyperlink are computer programs that can be added to Promis*e(trademark) which is a commercial software system that automates routine tasks in the design (including drawing schematic diagrams) of electrical control systems. The programs were developed under the Stennis Space Center's (SSC) Dual Use Technology Development Program to provide capabilities for SSC's BMCS configuration management system which uses Promis*e(trademark). The External Data program enables the storage and management of information in an external database linked to a drawing. Changes can be made either in the database or on the drawing. Information that originates outside Promis*e(trademark) can be stored in custom fields that can be added to the database. Although this information is not available in Promis*e(trademark) printed drawings, it can be associated with symbols in the drawings, and can be retrieved through the drawings when the software is running. The Attribute Hyperlink program enables the addition of hyperlink information as attributes of symbols. This program enables the formation of a direct hyperlink between a schematic diagram and an Internet site or a file on a compact disk, on the user's hard drive, or on another computer on a network to which the user's computer is connected. The user can then obtain information directly related to the part (e.g., maintenance, or troubleshooting information) associated with the hyperlink.

  11. Development of the SEA Corporation Powergrid{trademark} photovoltaic concentrator

    Energy Technology Data Exchange (ETDEWEB)

    Kaminar, N.; Curchod, D.; Daroczi, S.; Walpert, M.; Sahagian, J.; Pepper, J. [Photovoltaics International, LLC, Sunnyvale, CA (United States)

    1998-03-01

    This report covers the three phase effort to bring the SEA Corporation`s Powergrid{trademark} from the concept stage to pilot production. The three phases of this contract covered component development, prototype module development, and pilot line production. The Powergrid is a photovoltaic concentrator that generates direct current electricity directly from sunlight using a linear Fresnel lens. Analysis has shown that the Powergrid has the potential to be very low cost in volume production. Before the start of the project, only proof of concept demonstrations of the components had been completed. During the project, SEA Corporation developed a low cost extruded Fresnel lens, a low cost receiver assembly using one sun type cells, a low cost plastic module housing, a single axis tracking system and frame structure, and pilot production equipment and techniques. In addition, an 800 kW/yr pilot production rate was demonstrated and two 40 kW systems were manufactured and installed.

  12. Trademark Trends and Brand Activity in Higher Education

    Science.gov (United States)

    Rooksby, Jacob H.; Collins, Christopher S.

    2016-01-01

    Trademarks figure prominently in college and university brand formation efforts. Trademarks are intangible rights that allow institutions to define and protect aspects of their identities important to them as they engage in markets. This multiple-method study, grounded in legal and policy research, provides a first look at how institutions are…

  13. Praktik Trademark Squatting dalam Proses Pendaftaran Merek di Indonesia

    OpenAIRE

    Widya Justitia

    2016-01-01

    Penelitian ini bertujuan untuk mengetahui dan menganalisis mengapa praktik trademark squatting dapat terjadi dalam proses pendaftaran merek beserta cara mengatasinya. Selanjutnya, penelitian ini juga membahas mengenai konsepsi ideal terkait proses pendaftaran merek di Indonesia guna menghindari dan meminimalisasi praktik trademark squatting. Penelitian ini merupakan penelitian kualitatif yang bersifat yuridis empiris dan data yang terkumpul dianalisa dengan metode deskriptif kualitatif. Hasil...

  14. 2-gram-based Phonetic Feature Generation for Convolutional Neural Network in Assessment of Trademark Similarity

    OpenAIRE

    Ko, Kyung Pyo; Lee, Kwang Hee; Jang, Mi So; Park, Gun Hong

    2018-01-01

    A trademark is a mark used to identify various commodities. If same or similar trademark is registered for the same or similar commodity, the purchaser of the goods may be confused. Therefore, in the process of trademark registration examination, the examiner judges whether the trademark is the same or similar to the other applied or registered trademarks. The confusion in trademarks is based on the visual, phonetic or conceptual similarity of the marks. In this paper, we focus specifically o...

  15. BWR-spent fuel transport and storage with the TN trademark 9/4 and TN trademark 24BH casks

    International Nuclear Information System (INIS)

    Wattez, L.; Marguerat, Y.; Hoesli, C.

    2004-01-01

    The Swiss Nuclear Utilities have started in 2001 to store spent fuel in dry metallic dual-purpose casks in ZWILAG, the Swiss interim storage facility. BKW FMB Energy Ltd., as Muehleberg Nuclear Power Plant owner, is involved in this process and has selected to store its spent fuel, a new high capacity dual-purpose cask, the TN trademark 24BH. For the transport in a medium size cask, COGEMA LOGISTICS has developed a new cask, the TN trademark 9/4, to replace the NTL9 cask, which performed numerous transports of BWR spent fuel in the past decades. Licensed IAEA 1996, the TN trademark 9/4 is a 40 ton transport cask, for 7 BWR high burn-up spent fuel assemblies. The spent fuel assemblies can be transferred in the ZWILAG hot cell in the TN trademark 24BH cask. The first use of these casks took place in 2003. Ten TN trademark 9/4 transports were performed, and one TN trademark 24BH was loaded. After a brief presentation of the operational aspects, the paper will focus on the TN trademark 24BH high capacity dual purpose cask, the TN trademark 9/4 transport cask and describe in detail their characteristics and possibilities

  16. TRADEMARK APPLICATIONS IN A SECTORAL APPROACH

    Directory of Open Access Journals (Sweden)

    MATE Domician

    2015-07-01

    Full Text Available The economic roles of the Intellectual Property Rights (IPRs are one of the key mysteries of the economic theories. At the beginning of the 1760s a sustained and rapid growth in per capita income occurred all over the word and since then the broad history of economic institutions has still quite important. This research paper relies on the conceptual framework of IPRs. However, the academic literature has claimed that the presences of these institutions are essential elements of a well-functioning economy, but intellectual property has come to mean not only the right to own and sell, but also the right to regulate its use. Moreover several unexploited dilemmas have still remained in practice. In order to support the theoretical insights we inspect to overview the trademarks growth tendencies in various OECD countries. In this perspective we followed a specific taxonomy of the traditional Nice Classes (NCL to identify the distribution and the growth changes of these property right applications in a specific sectoral approach. Besides determining the differences with some comparative statistics in the branches, we could also demonstrate the economic importance of trademark applicants that place on the protection of brands in the service-oriented industries. However, there was falls in due to the last economic crisis; it seemed to follow a persistent and substantial growth path again. In this sense, we could also suggest the better valorization of IPRs that must be considered in a context to facilitate SMEs’ access to the benefits of globalised markets in these industries.

  17. RangerMaster trademark: Real-time pattern recognition software for in-field analysis of radiation sources

    International Nuclear Information System (INIS)

    Murray, W.S.; Ziemba, F.; Szluk, N.

    1998-01-01

    RangerMaster trademark is the embedded firmware for Quantrad Sensor's integrated nuclear instrument package, the Ranger trademark. The Ranger trademark, which is both a gamma-ray and neutron detection system, was originally developed at Los Alamos National Laboratory for in situ surveys at the Plutonium Facility to confirm the presence of nuclear materials. The new RangerMaster trademark software expands the library of isotopes and simplifies the operation of the instrument by providing an easy mode suitable for untrained operators. The expanded library of the Ranger trademark now includes medical isotopes 99 Tc, 201 Tl, 111 In, 67 Ga, 133 Xe, 103 Pa, and 131 I; industrial isotopes 241 Am, 57 Co, 133 Ba, 137 Cs, 40 K, 60 Co, 232 Th, 226 Ra, and 207 Bi; and nuclear materials 235 U, 238 U, 233 U, and 239 Pu. To accomplish isotopic identification, a simulated spectrum for each of the isotopes was generated using SYNTH. The SYNTH spectra formed the basis for the knowledge-based expert system and selection of the regions of interest that are used in the pattern recognition system. The knowledge-based pattern recognition system was tested against actual spectra under field conditions

  18. Directional atherectomy of a heavy calcified axillary artery stenosis inducing critical hand ischemia.

    Science.gov (United States)

    Anzuini, Angelo; Palloshi, Altin; Aprigliano, Gianfranco; Ielasi, Alfonso

    2013-07-01

    The presence of a severe calcified peripheral artery lesion is responsible for a poor response to balloon dilation, due to significant acute vessel recoil and frequent flow-limiting dissections requiring stent implantation. This possibility could be associated with very high compression and/or fracture rates particularly in cases of lesion located at the mobile joints. In this setting directional atherectomy offers the theoretical advantages of eliminating stretch injury on arterial walls and reducing the restenosis rate by direct plaque excision. In this report, we present a case of critical hand ischemia due to a heavily calcified axillary artery lesion managed by directional atherectomy and balloon angioplasty followed by immediate angiographic success and sustained clinical benefit up to 3 years of follow-up.

  19. Complete Healing of the Diabetic Ulcerative Osteomyelitis with Atherectomy and Flexible Stent

    Directory of Open Access Journals (Sweden)

    Veysel Temizkan

    2014-06-01

    Full Text Available Diabetes mellitus is a chronic disease that causes arterial and neurological disorders. Extremities threatening a diabetic foot ulcer might occur in the long term, especially in irregular glycemia levels. A multidisciplinary approach including infection treatment, pressure relief in the wound and arterial revascularization is important for limb salvage and to prevent such life-threatening complications as septicemia. Compared to the surgery, endovascular procedures can be performed with low complication rates in diabetic foot ulcers complicated with infection. Atherectomy is an alternative to the classical percutaneous angioplasty techniques, especially in totally occluded lesions. We are reporting complete healing of osteomyelitis associated with critical limb ischemia, resistant to classical treatment with debridement, antibacterial therapy and hyperbaric oxygen therapy, by atherectomy following long-segment flexible stent implantation. [Arch Clin Exp Surg 2014; 3(3.000: 193-196

  20. Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries.

    Science.gov (United States)

    Sixt, Sebastian; Carpio Cancino, Oscar Gerardo; Treszl, András; Beschorner, Ulrich; Macharzina, Roland; Rastan, Aljoscha; Krankenberg, Hans; Neumann, Franz-Josef; Zeller, Thomas

    2013-09-01

    Restenosis remains an unresolved problem despite different treatment modalities and new stent technology in femoropopliteal arteries. No standard therapy has proven to provide acceptable outcome data for this entity. Directional atherectomy alone did not result in satisfactory long-term patency rates. The outcome might be improved in conjunction with drug-coated balloon angioplasty. In this retrospective study, restenotic lesions of the femoropopliteal arteries were treated with directed atherectomy in 89 lesions of consecutive patients (58% male; mean age, 69 ± 11 years). All patients received adjunctive treatment with conventional balloon percutaneous angioplasty (PTA; n = 60) or drug-coated balloon angioplasty (DCB; n = 29). Lesion location was in the stent (DCB [n = 27] vs PTA [n = 36]) and in native restenotic vessels (DCB [n = 2] vs PTA [n = 25]). The 1-year Kaplan-Meier freedom from restenosis estimates (95% confidence intervals) in the DCB and PTA groups were 84.7% (70.9%-98.5%) and 43.8% (30.5%-57.1%), respectively. In a multivariable Cox model for restenosis, DCB treatment had a hazard ratio (95% confidence interval) of 0.28 (0.12-0.66; P = .0036) compared with the PTA group. In the multivariable model for procedural success, the effect of treatment did not differ between PTA and DCB (P = .134). The combination of directed atherectomy with adjunctive DCB is associated with a better event-free survival at 12 months of follow-up compared with PTA after directed atherectomy. Copyright © 2013 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

  1. Cost-effectiveness analysis of orbital atherectomy plus balloon angioplasty vs balloon angioplasty alone in subjects with calcified femoropopliteal lesions.

    Science.gov (United States)

    Weinstock, Barry; Dattilo, Raymond; Diage, Tiffini

    2014-01-01

    As cost considerations become increasingly critical when selecting optimal endovascular treatment strategies, a cost-benefit analysis was conducted comparing the Diamondback 360°® Orbital Atherectomy System (OAS) (Cardiovascular Systems, Inc., St Paul, MN, USA) and balloon angioplasty (BA) vs BA alone for treatment of calcified femoropopliteal lesions. The clinical outcomes from COMPLIANCE 360°, a prospective, multicenter, randomized study comparing OAS+BA vs BA alone for treatment of calcified femoropopliteal lesions, were correlated with cost data and previously published quality of life data. Site of service, hospital charges, and associated medical resource utilization were obtained from Uniform Billing statements for index treatments and associated revascularizations out to 1 year. Hospital costs were estimated using hospital-specific, procedure-specific cost-to-charge ratios. Length of stay and procedural data were collected from participating study sites. Twenty-five subjects with 38 lesions and 25 subjects with 27 lesions were randomized to the OAS+BA and BA-alone groups, respectively. Mean hospital charges (US$51,755 vs US$39,922) and estimated hospital costs (US$15,100 vs US$11,016) were higher for OAS+BA compared with BA alone (not statistically significant). Stent utilization was statistically significantly higher with BA-alone treatment for all subjects (1.1 vs 0.1, P=0.001) and in the subset of subjects with one lesion (1.0 vs 0.1, Pcost for single-lesion versus multiple-lesion treatment. Using costs and quality-adjusted life years (QALYs) for the single-lesion cohort, the 1-year incremental cost of OAS+BA vs BA alone was US$549, and incremental QALY was 0.16. This results in an incremental cost-effectiveness ratio of US$3,441, well below the US$50,000 threshold. One-year index procedure cost and cost-effectiveness were comparable for OAS+BA vs BA alone. This study provides compelling cost-effectiveness data for using atherectomy for treatment of

  2. Three-year results after directional atherectomy of calcified stenotic lesions of the superficial femoral artery.

    Science.gov (United States)

    Minko, P; Buecker, A; Jaeger, S; Katoh, M

    2014-10-01

    To investigate the 3-year outcome of patients with peripheral arterial disease (PAD) and heavily calcified stenotic lesions of the superficial femoral artery after directional atherectomy. Fifty-three patients (mean age 67 ± 10 years; 18 females, 35 males, TASC B and C, mean lesion length 7.9 ± 3.5 cm) with PAD (Rutherford 2-6) were enrolled into this prospective monocentric study. In total, 59 calcified lesions of the superficial femoral artery were treated with the Silverhawk atherectomy device (Covidien, Plymouth, MN, USA). Patients were followed-up for 36 months with a 6-month interval to perform clinical re-evaluation, including measurement of maximum walking distance and ankle-brachial index (ABI) as well as duplex-sonography. The primary success rate of the procedure was 92 %. In five cases (8 %), additional balloon-PTA and/or stent-PTA was necessary. Procedure-related embolization occurred in seven cases (12 %), which were all successfully treated by aspiration. The primary patency rate after 3 years was 55 %. Median Rutherford score decreased significantly from 5 to 0 after 36 months (p atherectomy was successfully applied to decrease the plaque burden. Results after 3 years showed a significant decrease of Rutherford score with persistent improvement of ABI and reasonable patency rate.

  3. Mechanical Recanalization of Subacute Vessel Occlusion in Peripheral Arterial Disease with a Directional Atherectomy Catheter

    International Nuclear Information System (INIS)

    Massmann, Alexander; Katoh, Marcus; Shayesteh-Kheslat, Roushanak; Buecker, Arno

    2012-01-01

    Purpose: To retrospectively examine the technical feasibility and safety of directional atherectomy for treatment of subacute infrainguinal arterial vessel occlusions. Methods: Five patients (one woman, four men, age range 51–81 years) with peripheral arterial disease who experienced sudden worsening of their peripheral arterial disease–related symptoms during the last 2–6 weeks underwent digital subtraction angiography, which revealed vessel occlusion in native popliteal artery (n = 4) and in-stent occlusion of the superficial femoral artery (n = 1). Subsequently, all patients were treated by atherectomy with the SilverHawk (ev3 Endovascular, USA) device. Results: The mean diameter of treated vessels was 5.1 ± 1.0 mm. The length of the occlusion ranged 2–14 cm. The primary technical success rate was 100%. One patient experienced a reocclusion during hospitalization due to heparin-induced thrombocytopenia. There were no further periprocedural complications, in particular no peripheral embolizations, until hospital discharge or during the follow-up period of 1 year. Conclusion: The recanalization of infrainguinal arterial vessel occlusions by atherectomy with the SilverHawk device is technically feasible and safe. In our limited retrospective study, it was associated with a high technical success rate and a low procedure-related complication rate.

  4. Complex coronary lesions and rotational atherectomy: one hospital’s experience*

    Science.gov (United States)

    Jiang, Jun; Sun, Yong; Xiang, Mei-xiang; Dong, Liang; Liu, Xian-bao; Hu, Xin-yang; Feng, Yan; Wang, Jian-an

    2012-01-01

    Objective: To evaluate the safety and effectiveness of rotational atherectomy followed by drug eluting stent (DES) implantation in patients with complex coronary lesions. Methods: From August 2006 to August 2012, 253 consecutive patients with 289 lesions and who underwent rotational atherectomy in our center were enrolled in this study. Results: The overall procedure success rate was 98% with the cost of two (0.8%) coronary perforations, three (1.2%) dissections, five (2.0%) slow flows or no flows, three (1.2%) peri-procedure myocardial infarctions, and two (0.8%) in hospital deaths. During follow-up (mean three years), one (0.4%) patient died, two (0.8%) patients had acute myocardial infarction, 14 (5.5%) had restenosis, and target lesion revascularization occurred in eight patients (3.2%). Conclusions: Rotational atherectomy followed by DES implantation is a safe and effective technique for patients with complex coronary lesions, especially calcified and non-dilatable lesions. PMID:22843185

  5. Preliminary clinical application of SilverHawk directional atherectomy device in arteriosclerosis obliterans of lower extremity

    International Nuclear Information System (INIS)

    Qian Jun; Jiang Hong; Xu Gang; Yang Xiaohong

    2011-01-01

    Objective: To evaluate the clinical efficiency and security of SilverHawk directional atherectomy device in treating arteriosclerosis obliterans of lower extremity. Methods: Seven patients with lower extremity ischemia were treated with SilverHawk directional atherectomy. The lesions length varied from 1.8 to 14.5 cm. Clinical symptoms (Fontaine classification) included 4 cases of grade Ⅱ b, I case of grade Ⅲ, 2 cases of grade Ⅳ. The ABI varied from 0.28 to 0.65. Patency was evaluated with color duplex sonography or CTA besides clinical examination during follow-up. Results: Seven occlusive lesions were recanalizated successfully. The technical success (residual stenosis < 30%) rate was 100%. Clinical symptoms were obviously improved or disappeared. The ABI varied from 0.82 to 1.18 (P=0.002), and Fontaine classification included 6 cases of Ⅰ; 1 case of Ⅱ a. Patency rate was 100% and the ABI varied from 0.75 to 1.14 (P=0.938). Fontaine classifications keep consistent 1-6 months after operation. Conclusion: SilverHawk directional atherectomy was a safe and effective way for treatment of lower arteriosclerosis obliteran. (authors)

  6. Removal of focal atheromatous lesions by angioscopically guided high-speed rotary atherectomy. Preliminary experimental observations

    International Nuclear Information System (INIS)

    Ahn, S.S.; Auth, D.; Marcus, D.R.; Moore, W.S.

    1988-01-01

    A new high-speed rotary atherectomy device, inserted over a guide wire and directed with an angioscope, offers the potential of restoring patency of outflow vessels by boring out the atheromatous lesion of the orifices of runoff vessels. The device was tested on 68 cadaver arteries with atheromatous lesions involving the superficial femoral, popliteal, and tibial arteries. This was performed with either free segments or in situ with the device placed through a popliteal arteriotomy. The gross results of rotary atherectomy were assessed by angioscopy, angiography, or both. The luminal surfaces were studied with scanning electron microscopy and transverse sections of vessels were studied with light microscopy. The pulverized atheroma, in colloidal suspension, was analyzed for particle size by Coulter counter. The effect of a colloidal suspension of atheromatous particles on distal capillary circulation was measured in animal experiments. Obstructive lesions were successfully removed in 36 of 37 stenotic arteries (97%) and 18 of 31 completely occluded arteries (58%), an overall efficacy of 54 of 68 (79%). In successfully atherectomized arteries, angioscopy and angiography demonstrated a widely patent, smooth, polished surface. Light microscopy demonstrated removal of the diseased intima with maintenance of the outer media and adventitia. The pulverized atheroma particles were generally smaller than red blood cells and injection of the colloidal atheroma into canine femoral arteries failed to produce local tissue injury. We conclude that in the human cadaver this atherectomy device effectively enlarges and recanalizes obstructed superficial femoral, popliteal, and tibial arteries

  7. Mechanical Recanalization of Subacute Vessel Occlusion in Peripheral Arterial Disease with a Directional Atherectomy Catheter

    Energy Technology Data Exchange (ETDEWEB)

    Massmann, Alexander, E-mail: Alexander.Massmann@uks.eu; Katoh, Marcus [Saarland University Hospital, Department of Diagnostic and Interventional Radiology (Germany); Shayesteh-Kheslat, Roushanak [Saarland University Hospital, Department of General Surgery, Visceral, Vascular, and Pediatric Surgery (Germany); Buecker, Arno [Saarland University Hospital, Department of Diagnostic and Interventional Radiology (Germany)

    2012-10-15

    Purpose: To retrospectively examine the technical feasibility and safety of directional atherectomy for treatment of subacute infrainguinal arterial vessel occlusions. Methods: Five patients (one woman, four men, age range 51-81 years) with peripheral arterial disease who experienced sudden worsening of their peripheral arterial disease-related symptoms during the last 2-6 weeks underwent digital subtraction angiography, which revealed vessel occlusion in native popliteal artery (n = 4) and in-stent occlusion of the superficial femoral artery (n = 1). Subsequently, all patients were treated by atherectomy with the SilverHawk (ev3 Endovascular, USA) device. Results: The mean diameter of treated vessels was 5.1 {+-} 1.0 mm. The length of the occlusion ranged 2-14 cm. The primary technical success rate was 100%. One patient experienced a reocclusion during hospitalization due to heparin-induced thrombocytopenia. There were no further periprocedural complications, in particular no peripheral embolizations, until hospital discharge or during the follow-up period of 1 year. Conclusion: The recanalization of infrainguinal arterial vessel occlusions by atherectomy with the SilverHawk device is technically feasible and safe. In our limited retrospective study, it was associated with a high technical success rate and a low procedure-related complication rate.

  8. The relevance of introducing opposition proceedings into the Serbian trademark legislation

    Directory of Open Access Journals (Sweden)

    Vasić Aleksandra

    2014-01-01

    Full Text Available This paper analyzes the quality of certain legal procedures applied in domestic trademark legislation in the light of harmonizing our legislation with those of the EU. Trademark Law in the Republic of Serbia (2009 does not rely on opposition proceedings as a phase in the process of trademark registration and a tool that would ensure that only those trademarks that fulfill the necessary conditions are granted legal protection. Intellectual Property Office examines the so-called relative grounds for trademark registration refusal but does so ex officio, thus preventing the holders of trademark rights from benefiting from a relatively inexpensive and effective opposition procedure regarding the registration of a second trademark which violates their previously established rights. In contrast to our trademark laws, EU Council Regulation 207/2009 on Community Trademarks of February 26, 2009 (CTMR -Community trademark regulation enforces opposition proceedings as the most important phase in the process of trademark registration. European experience shows that opposition proceedings carry significant benefits for the process of trademark application. First of all, they allow the holders of previously established trademark rights to avoid long and costly court proceedings whose purpose is to dispute trademarks that violate the owner's rights. Also, state agencies authorizing in trademark approval no longer need to monitor registered trademarks.

  9. Development of Collective Trademark for Batik Industry in Kampung Batik Laweyan (Laweyan Batik’s Village, Solo

    Directory of Open Access Journals (Sweden)

    Agus Sardjono

    2015-04-01

    Full Text Available In the previous research, it was found that the individual trademark system has not been effectively utilized to support the business of batik SMEs, particularly in several Batik industry centers in Java, namely Bantul in Yogyakarta province, Kauman in Pekalongan, and Laweyan in Solo. However, the fact that those SMEs gather in a community, organization, or kinships bring potentials for development of collective trademarks, which can address the problems that individual trademark cannot anticipate. This can also be a strategy to anticipate the free-trade ‘attack,’ i.e. imported textiles with batik patterns/motifs; yet not the original Indonesian Batik. Therefore, Indonesian batik SMEs need to be nurtured and encouraged to register their own collective trademarks, and to build their branding infrastructure, through local batik community’s standardization, and collective batik labeling. This present research focuses on the development of collective trademark utilization by one long-known Batik community in Solo province, Kampung Batik Laweyan.

  10. Orbital Atherectomy for Treating De Novo Severely Calcified Coronary Narrowing (1-Year Results from the Pivotal ORBIT II Trial).

    Science.gov (United States)

    Généreux, Philippe; Lee, Arthur C; Kim, Christopher Y; Lee, Michael; Shlofmitz, Richard; Moses, Jeffrey W; Stone, Gregg W; Chambers, Jeff W

    2015-06-15

    Percutaneous coronary intervention of severely calcified lesions has historically been associated with major adverse cardiac event (MACE) rates as high as 30%. In the ORBIT II (Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions) trial, treatment of de novo severely calcified lesions with the Diamondback 360° Coronary Orbital Atherectomy System (OAS) resulted in low rates of procedural and 30-day adverse ischemic events. The long-term results from this trial have not been reported. We sought to determine the 1-year outcomes after orbital atherectomy of severely calcified coronary lesions. ORBIT II was a single-arm trial enrolling 443 subjects at 49 US sites with severely calcified lesions usually excluded from randomized trials. OAS utilizes a centrifugal differential sanding mechanism of action for plaque modification prior to stent implantation. After OAS drug-eluting stents were implanted in 88.2% of the patients. The primary safety end point was 30-day MACE, the composite of cardiac death, myocardial infarction, or target vessel revascularization [TVR]. The present analysis reports the 1-year follow-up results from ORBIT II. One-year data were available in 433 of 443 patients (97.7%), with median follow-up time of 16.7 months. The 1-year MACE rate was 16.4%, including cardiac death (3.0%), myocardial infarction (9.7%), and target vessel revascularization (5.9%). The 1-year target lesion revascularization rate was 4.7%, and stent thrombosis occurred in 1 patient (0.2%). Independent predictors of 1-year MACE and target vessel revascularization were diameter stenosis at baseline and the use of bare-metal stents. In patients with severely calcified lesions who underwent percutaneous coronary intervention, the use of OAS was associated with low rates of 1-year adverse ischemic events compared with historical controls. This finding has important clinical implications for the selection of optimum treatment strategies for patients

  11. An assessment of Microtox trademark as a biomonitoring tool for whole effluent testing for Los Alamos National Laboratory

    International Nuclear Information System (INIS)

    Zachritz, W.H. II; Morrow, J.

    1994-01-01

    Los Alamos National Laboratory (LANL) has special discharge problems relating to potential radioactive content of the effluent discharge waters. Because of this all testing must be performed on-site and results must be rapidly determined. There is a need to examine the development of a real-time procedure for effluent biomonitoring to met these site limitations. The Microtox trademark unit for toxicity testing is a microbially-based test system that shows great promise to be used for WET testing. The overall goal of this study is to develop an acceptable protocol for operational biomonitoring using the Microtox trademark toxicity test for LANL. The specific objectives include: development of an appropriate toxicity testing protocol using the Microtox trademark toxicity test for whole effluent toxicity testing and evaluation of the protocol based on factors such as sensitivity, response time, cost of analysis, and simplicity of operation

  12. Percutaneous Coronary Intervention in Severely Calcified Unprotected Left Main Coronary Artery Disease: Initial Experience With Orbital Atherectomy.

    Science.gov (United States)

    Lee, Michael S; Shlofmitz, Evan; Kaplan, Barry; Shlofmitz, Richard

    2016-04-01

    We report the clinical outcomes of patients who underwent percutaneous coronary intervention (PCI) with orbital atherectomy for severely calcified unprotected left main coronary artery (ULMCA) disease. Although surgical revascularization is the gold standard for patients with ULMCA disease, not all patients are candidates for this. PCI is increasingly used to treat complex coronary artery disease, including ULMCA disease. The presence of severely calcified lesions increases the complexity of PCI. Orbital atherectomy can be used to facilitate stent delivery and expansion in severely calcified lesions. The clinical outcomes of patients treated with orbital atherectomy for severely calcified ULMCA disease have not been reported. From May 2014 to July 2015, a total of 14 patients who underwent PCI with orbital atherectomy for ULMCA disease were retrospectively evaluated. The primary endpoint was major cardiac and cerebrovascular event (cardiac death, myocardial infarction, stroke, and target-lesion revascularization) at 30 days. The mean age was 78.2 ± 5.8 years. The mean ejection fraction was 41.8 ± 19.8%. Distal bifurcation disease was present in 9 of 14 patients. Procedural success was achieved in all 14 patients. The 30-day major adverse cardiac and cerebrovascular event rate was 0%. One patient had coronary dissection that was successfully treated with stenting. No patient had perforation, slow flow, or thrombosis. Orbital atherectomy in patients with severely calcified ULMCA disease is feasible, even in high-risk patients who were considered poor surgical candidates. Randomized trials are needed to determine the role of orbital atherectomy in ULMCA disease.

  13. Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study.

    Science.gov (United States)

    McKinsey, James F; Zeller, Thomas; Rocha-Singh, Krishna J; Jaff, Michael R; Garcia, Lawrence A

    2014-08-01

    The aim of this study was to assess the safety and effectiveness of directional atherectomy (DA) for endovascular treatment of peripheral arterial disease (PAD) in infrainguinal arteries in patients with claudication or critical limb ischemia. To date, no prospective, multicenter, independently-adjudicated study has evaluated the effectiveness and durability of DA in the treatment of PAD. Previous DA studies have not been prospectively powered to evaluate any differences in outcomes in patients with and without diabetes. DEFINITIVE LE (Determination of EFfectiveness of the SilverHawk(®) PerIpheral Plaque ExcisioN System (SIlverHawk Device) for the Treatment of Infrainguinal VEssels / Lower Extremities) prospectively enrolled subjects at 47 multinational centers with an infrainguinal lesion length up to 20 cm. Primary endpoints were defined as primary patency at 12 months for claudicants and freedom from major unplanned amputation for critical limb ischemia (CLI) subjects. A pre-specified statistical hypothesis evaluated noninferiority of primary patency in diabetic versus nondiabetic claudicants. Independent angiographic and sonographic core laboratories assessed outcomes, and events were adjudicated by a clinical events committee. A total of 800 subjects were enrolled. The 12-month primary patency was 78% (95% confidence interval: 74.0% to 80.6%) in claudicants, with a 77% rate in the diabetic subgroup versus 78% in the nondiabetic subgroup (noninferior, p < 0.001). The rate of freedom from major unplanned amputation of the target limb at 12 months in CLI subjects was 95% (95% confidence interval: 90.7% to 97.4%). Periprocedural adverse events included embolization (3.8%), perforation (5.3%), and abrupt closure (2.0%). The bail-out stent rate was 3.2%. The DEFINITIVE LE study demonstrated that DA is a safe and effective treatment modality at 12 months for a diverse patient population with either claudication or CLI. Furthermore, DA was shown to be noninferior for

  14. Pipe explorer trademark: Overview, applications, and recent developments

    International Nuclear Information System (INIS)

    Kendrick, D.T.; Cremer, C.D.

    1996-01-01

    As the Department of Energy (DOE) continues to dismantle its nuclear process facilities, site managers throughout the complex must employ the safest and most cost effective means of disposing or remediating hundreds of miles of potentially contaminated piping and duct work. Much of this is buried or encased, making quantification of contamination levels inside the pipes extremely difficult. Without adequate characterization, it is usually necessary to assume the piping is contaminated and to extract and dispose of it accordingly. For buried drain lines this approach can cost on the order of $1,200/ft and is often unnecessary as residual contamination levels are below free release criteria. The Science ampersand Engineering Associates, Inc. (SEA) Pipe Explorer trademark technology offers a simple and effective approach of transporting characterization tools into pipes and ducts so that these costs can be avoided. The system uses a pneumatically operated tubular membrane to tow radiation detectors and video cameras into pipes while simultaneously providing a clean conduit for the sensors to travel through. This paper describes the operation of the system, the DOE sites where it has been used, and the cost savings that have resulted from its use. In addition, recently added features to the technology, such as the ability to perform alpha and video surveys, are discussed

  15. SENTINEL trademark technical basis report for Limerick. Final report

    International Nuclear Information System (INIS)

    Burns, E.T.; Lee, L.K.; Mitman, J.T.; Vanover, D.E.; Wilson, D.K.

    1997-12-01

    PECO Energy in cooperation with the Electric Power Research Institute (EPRI) installed the SENTINEL trademark software at its Limerick Generating Station. This software incorporates models of the safety and support systems which are used to display the defense in depth present in the plant and a quantitative assessment of the plant risks during proposed on-line maintenance. During the past year, PECO Energy personnel have used this display to evaluate the safety of proposed on-line maintenance schedules. The report describes the motivation for and the development of the SENTINEL software. It describes the generation of Safety Function Assessment Trees and Plant Transient Assessment Trees and their use in evaluating the level of defense-in-depth of key plant safety functions and the susceptibility of the plant to critical transient events. Their results are displayed by color indicators ranging from green, through yellow and orange to red to show increasingly hazardous conditions. The report describes the use of the Limerick Probabilistic Safety Assessment within the SENTINEL code to calculate an instantaneous core damage frequency and the criteria by which this frequency is translated to a color indicator. Finally, the report describes the Performance Criteria Assessment which tracks and trends system/train unavailability to document conformance to the requirements of the Maintenance Rule

  16. SENTINEL trademark technical basis report for Peach Bottom. Final report

    International Nuclear Information System (INIS)

    1998-04-01

    PECO Energy in cooperation with the Electric Power Research Institute (EPRI) installed the SENTINEL trademark software at its Peach Bottom Atomic Power Station (PBAPS). This software incorporates models of the safety and support systems which are used to display the defense in depth present in the plant and a quantitative assessment of the plant risks during proposed on-line maintenance. During the past nine months, PECO Energy personnel have used this display to evaluate the safety of proposed on-line maintenance schedules. The report describes the motivation for and the development of the SENTINEL software. It describes the generation of Safety Function Assessment Trees and Plant Transient Assessment Trees and their use in evaluating the level of defense-in-depth of key plant safety functions and the susceptibility of the plant to critical transient events. Their results are displayed by color indicators ranging from green, through yellow and orange, to red to show increasingly hazardous conditions. The report describes the use of the PBAPS Probabilistic Safety Assessment within the SENTINEL code to calculate an instantaneous core damage frequency and the criteria by which this frequency is translated to a color indicator

  17. Accelerated hydrocarbon removal with the NoVOCs trademark process

    International Nuclear Information System (INIS)

    Dawson, G.W.; McKeon, T.J.

    1996-01-01

    It has been estimated that by 1990, there were over 240,000 leaking underground storage tanks in the US and that the majority of those tanks had contained some type of petroleum fuel. The resulting hydrocarbon contamination from those leaking tanks became the focus of a significant amount of environmental restoration effort. Free product was collected and removed from the water table. Contaminated soils were excavated for thermal desorption or land farming, or aerated in place to promote bioremediation. Affected ground water was withdrawn by means of extraction wells and routed to air stripping towers or, more recently, stripped in place with in situ air sparging. NoVOCs trademark is a patented design for the application of in-well stripping as an alternative to pump and treat systems over which it offers two unique advantages: (1) Development of a circulation pattern within the saturated zone that optimizes dissolution and transport of contaminants to the well; and (2) Separation of the volatile contaminants for the ground water in the well so that only vapor is transported above ground and there are no water discharges to be managed

  18. Strip-coat decontamination of ducting interiors with SEAMIST trademark -safe and fast

    International Nuclear Information System (INIS)

    Keller, C.

    1994-01-01

    The SEAMIST trademark system was invented for sampling and instrumentation of boreholes. However, the SEAMIST trademark pneumatically driven everting membrane has the ability to install absorbent liner materials for wicking and recovery of hazardous fluids (e.g., PCB'S) from ducting. The most useful vent cleaning technique is the installation of a stripcoat saturated duct liner which is then peeled from the liner retrieving contaminated particles (e. g., uranium, plutonium,...), much like the stripcoat which is used to clean glove boxes. Because of the everting SEAMIST trademark hole liner's ability to traverse ducting of many combinations of diameters, slope, turns, and obstructions, the stripcoat application method is exceptionally fast, (>10 ft/min.). This paper describes the method of installation, the prototype tests, the science, and the first results of a full scale test. This unusual method of cleaning ducting results in major advantages in safety, cost, and speed of the cleaning process. Comparisons are made with the traditional methods of sand blasting and washing. Additional benefits of the method are the ability to assess the distribution of the contamination of the ducting and to also use the everting membrane for a video camera examination of the cleaned duct coupled with contamination sensors, such as radiation logging tools. The technique can be extended to clean all manner of contamination in ducting such as microbial residues in hospitals. Very large ducts (12--120 inch dia.), are especially easily cleaned while still in place in the building

  19. Application of rotational atherectomy in the drug-eluting stent era

    Science.gov (United States)

    Chen, Chun-Chi; Hsieh, I-Chang

    2013-01-01

    Rotational atherectomy (RA) was introduced in the interventional arena in 1988 as a dedicated device for calcified lesions. Due to the complexity of the technique, the development of alternative methods such as the cutting balloon procedure, and the high restenosis rate of subsequent bare metal stenting in long lesions, its use had later declined. However, with the increasing use of drug-eluting stents (DES) and the aggressive treatment of longer lesions, the number of procedure performed with RA has increased significantly again in recent years. In this article, we reviewed the application of RA in DES era. PMID:24133506

  20. Optical coherence tomography following percutaneous coronary intervention with Excimer laser coronary atherectomy

    Energy Technology Data Exchange (ETDEWEB)

    Rawlins, John, E-mail: john.rawlins@doctors.net.uk; Talwar, Suneel; Green, Mark; O’Kane, Peter

    2014-01-15

    The indications for Excimer laser coronary atherectomy (ELCA) have been refined in modern interventional practice. With the expanding role for optical coherence tomography (OCT) providing high-resolution intra-coronary imaging, this article examines the appearance of the coronary lumen after ELCA. Each indication for ELCA is discussed and illustrated with a clinical case, followed by detailed analysis of the OCT imaging pre and post ELCA. The aim of the article is to provide information to interventional cardiologists to facilitate decision making during PCI, when ELCA has been used as part of the interventional strategy.

  1. Novel Use of the GuideLiner Catheter to Deliver Rotational Atherectomy Burrs in Tortuous Vessels

    Directory of Open Access Journals (Sweden)

    Minh Vo

    2014-01-01

    Full Text Available Rotational atherectomy (RA for heavily calcified lesions is essential for improved stent delivery and stent expansion. In tortuous vessels it is often difficult to advance the burr without rotation and possible injury to the endothelium of healthy vessel. The GuideLiner catheter, a child in mother catheter, has recently been used to allow for increased support for delivery of stents through tortuous vessels. We report a novel use of the GuideLiner for the delivery of an RA burr in tortuous vessels requiring increased guide support.

  2. Impact of Angioscopic Evaluation for Femoropopliteal In-Stent Restenosis Before and After Excimer Laser Atherectomy.

    Science.gov (United States)

    Idemoto, Akiko; Okamoto, Naotaka; Tanaka, Akihiro; Mori, Naoki; Nakamura, Daisuke; Yano, Masamichi; Makino, Nobuhiko; Egami, Yasuyuki; Shutta, Ryu; Tanouchi, Jun; Nishino, Masami

    2017-07-01

    In-stent restenosis (ISR) is a prevalent problem following stenting of femoropopliteal lesions. A potential novel treatment modality for ISR including excimer laser atherectomy (ELA) has become available. We performed ELA for in-stent chronic total occlusion (CTO) of femoropopliteal lesions and evaluated lesion morphology before and after ELA by angioscopy in 2 patients. The angioscopic findings clearly showed removal of in-stent thrombi after ELA. Thus, ELA may be effective for in-stent CTO of femoropopliteal lesions. This is the first report describing the direct visualization of ELA effect for vaporization of thrombi in femoropopliteal in-stent lesions by angioscopy.

  3. Expanding TAVI options: elective rotational atherectomy during trans-catheter aortic valve implantation

    International Nuclear Information System (INIS)

    Piccoli, Anna; Lunardi, Mattia; Ariotti, Sara; Ferrero, Valeria; Vassanelli, Corrado; Ribichini, Flavio

    2015-01-01

    Summary: Aortic valve stenosis (AVS) in the elderly is frequently associated to coronary artery disease (CAD). In patients with significant coronary stenosis surgical valve replacement is associated to coronary bypass grafting, but whether coronary angioplasty is needed in patients receiving trans-catheter aortic valve implantation (TAVI) is unknown. Given the frequent complexity of CAD in the elderly with calcific AVS, rotational atherectomy (RA) may be needed in some cases. No data are available about feasibility and safety of RA during TAVI. The need for myocardial revascularization in TAVI candidates is discussed, and a series of RA cases performed during TAVI is described

  4. Expanding TAVI options: elective rotational atherectomy during trans-catheter aortic valve implantation

    Energy Technology Data Exchange (ETDEWEB)

    Piccoli, Anna; Lunardi, Mattia; Ariotti, Sara; Ferrero, Valeria; Vassanelli, Corrado; Ribichini, Flavio, E-mail: flavio.ribichini@univr.it

    2015-01-15

    Summary: Aortic valve stenosis (AVS) in the elderly is frequently associated to coronary artery disease (CAD). In patients with significant coronary stenosis surgical valve replacement is associated to coronary bypass grafting, but whether coronary angioplasty is needed in patients receiving trans-catheter aortic valve implantation (TAVI) is unknown. Given the frequent complexity of CAD in the elderly with calcific AVS, rotational atherectomy (RA) may be needed in some cases. No data are available about feasibility and safety of RA during TAVI. The need for myocardial revascularization in TAVI candidates is discussed, and a series of RA cases performed during TAVI is described.

  5. EPR trademark project delivery. The value of experience

    International Nuclear Information System (INIS)

    Leverenz, Ruediger

    2013-01-01

    We are building the EPR trademark reactor fleet. Together. With four EPR trademark projects under construction in the world, AREVA has unrivalled experience in the delivery of large-scale nuclear projects, including more than a thousand lessons learned captured from Olkiluoto 3 and Flamanville 3 projects. This book of knowledge as well as the return of experience of AREVA's and EDF's teams are now being fully leveraged on ongoing projects, especially on Flamanville 3 and Taishan, and will be incorporated in all future EPR TM projects.

  6. The inner containment of an EPR trademark pressurized water reactor

    Energy Technology Data Exchange (ETDEWEB)

    Ostermann, Dirk; Krumb, Christian; Wienand, Burkhard [AREVA GmbH, Offenbach (Germany)

    2014-08-15

    On February 12, 2014 the containment pressure and subsequent leak tightness tests on the containment of the Finnish Olkiluoto 3 EPR trademark reactor building were completed successfully. The containment of an EPR trademark pressurized water reactor consists of an outer containment to protect the reactor building against external hazards (such as airplane crash) and of an inner containment that is subjected to internal overpressure and high temperature in case of internal accidents. The current paper gives an overview of the containment structure, the design criteria, the validation by analyses and experiments and the containment pressure test.

  7. Initial clinical experience with a new percutaneous peripheral atherectomy device for the treatment of femoro-popliteal stenoses

    International Nuclear Information System (INIS)

    Zeller, T.; Frank, U.; Buergelin, K.; Schwarzwaelder, U.; Neumann, F.J.; Reimers, B.

    2004-01-01

    Background: Evaluation of the efficacy and safety of a new 7F-atherectomy device (30-day endpoint) for the treatment of short and mid-length arterial lesions with a reference diameter of 2.5-7 mm. Material and Methods: Fifty-eight femoto-popliteal stenoses in 46 patients (67% male, mean age 66± 9 years) with chronic peripheral occlusive disease of the lower limbs [Rutherford stage 2: n = 13 (28%); stage 3: n = 29 (63%); stage 4: 2 (4%), stage 5: n = 2 (4%]), were treated with directional atherectomy. Target lesion characteristics: Common femoral artery: n = 1 (2%), superficial femoral artery: n = 47 (81%); popliteal artery, n = 10 (17%); instent n = 3 (5%). Thirty (65%) of the interventions were performed using an antegrade approach, 16 (35%) interventions in cross-over technique. Mean degree of stenosis was 83 ± 11 mm, mean length of lesion was 37 ± 37 mm. Results: 6.5 ± 2 (4-10) passes of the lesion were performed with the catheter. Three lesions were treated after predilatation, 55 (95%) interventions as primary atherectomy. In 31/58 lesions (53%) additional balloon angioplasty was performed, in 1 lesion (2%) additional stent placement was needed. The mean degree of stenosis after atherectomy was reduced to 29 ± 20% (0-60%) after additional balloon angioplasty, it was 11 ± 10% (0-30%). A residual stenosis of [de

  8. Treatment of Angio-Seal-Related Femoral Artery Occlusion Using Directional Atherectomy-Primary Results and Midterm Follow-Up.

    Science.gov (United States)

    Babaev, Anvar; Gokhale, Rohit; Zavlunova, Susanna; Attubato, Michael

    2016-11-01

    We describe a novel approach for the endovascular treatment of femoral artery occlusion as a result of Angio-Seal closure device deployment. Angio-Seal is the most commonly used vascular closure device following percutaneous coronary and peripheral catheterizations worldwide. A rare complication of Angio-Seal deployment is an occlusion of the femoral artery leading to limb ischemia requiring revascularization. Given its unique ability to cut both atherosclerotic plaque and the Angio-Seal anchor with a collagen plug at operator-directed planes, TurboHawk/HawkOne atherectomy device can be a fast and effective approach to treat Angio-Seal-associated femoral artery occlusions. We studied 13 consecutive patients who developed Angio-Seal-associated femoral artery occlusions that occurred from 3 hours to several weeks after catheterization. These patients were successfully treated with TurboHawk/HawkOne directional atherectomy followed by balloon angioplasty with no complications. During a mean follow-up period of 20.4 ± 17.3 months, 12 patients remained claudication free with no evidence of obstructive arterial disease of the treated segment on imaging studies. One patient developed restenosis that was treated with repeat atherectomy and balloon angioplasty following which he was asymptomatic at follow-up. The use of directional atherectomy followed by balloon angioplasty is a quick, safe, and effective endovascular approach to treating Angio-Seal-associated femoral artery occlusions. It is associated with an excellent success rate, no complications, and good midterm outcomes.

  9. Local lysis with Alteplase for the treatment of acute embolic leg ischemia following the use of the Duett {sup trademark} closure device: preliminary results; Lokale Alteplase-Lyse zur Therapie der akuten embolischen Beinischaemie nach Einsatz des Duett {sup trademark} -Verschluss-Systems: vorlaeufige Ergebnisse

    Energy Technology Data Exchange (ETDEWEB)

    Schuermann, K.; Buecker, A.; Wingen, M.; Tacke, J.; Wein, B.; Guenther, R.W. [Klinik fuer Radiologische Diagnostik des Universitaetsklinikums der RWTH Aachen (Germany); Janssens, U. [Medizinische Klinik I (Kardiologie) des Universitaetsklinikums der RWTH Aachen (Germany)

    2004-04-01

    Purpose: To analyze retrospectively the result of the alteplase lysis therapy of embolic complications following the use of the Duett closure device. Methods and Materials: For 3.5 years, the Duett closure device was used in 1,398 angiographies to close the femoral puncture site. The Duett device consists of a balloon and a liquid procoagulant containing collagen and thrombin, which is injected into the puncture tract under endovascular balloon protection of the arterial puncture site. In 9 patients (0.64%), the procoagulant was incidentally injected into the femoral artery causing acute leg ischemia. Eight patients received local lysis therapy with alteplase via a contralateral femoral access. One patient underwent surgery. On average, 21 mg alteplase (4-35 mg) were administered within 14 h (4-21 h). The course of the lysis was followed angiographyically and clinically. All patients were inteerviewed by telephone 23 months (4-35 months) later.Results: In 3 patients, lysis was complete. In 5 patients, only little thrombotic material remained. In all patients, symptoms of ischemia resolved completely within the first hours after initiation of lysis. In 5 cases, bleeding occurred at the puncture site closed with the Duett device during lysis, including development of a false aneurysm in 2 cases. Complications led to premature termination (n=2) or interruption of the lysis (n=3). All complications were treated conservatively. Clinically, long-term sequelae were paresthesia and hypoesthesia in the lower leg and foot in 2 patients treated with lysis, and in the patient who underwent surgery. (orig.) [German] Ziel: Das Ergebnis der Alteplase-Lysetherapie von Embolien nach Einsatz des Duett-Verschluss-Systems wurde retrospektiv untersucht. Methoden: Innerhalb von 3,5 Jahren wurde nach 1398 Angiographien das Duett-System zum Verschluss der femoralen Punktionsstelle eingesetzt. Das System besteht aus einem Ballon und einem fluessigen Prokoagulans (Kollagen, Thrombin), das

  10. 商標名稱通用化之理論與實務 The Theories and Practices of Trademark

    Directory of Open Access Journals (Sweden)

    鄧振球 Cheng-Chiou Teng

    2008-06-01

    Full Text Available 商標具有表彰商品來源之功能,商標之設計為順應其功能,必須具有識別性,不具識別性之商標設計,不僅無法註冊,更無法主張商標專用之權利。商標名稱通用化,則是指原本具有識別性之商標,通常為著名商標,因為社會大眾消費習慣以及認知的改變,變成商品的通用名稱,落入公共財領域,無法受到法律之保護。商標名稱通用化,在國外並非新概念,惟在我國商標法領域中因屬新規定,未見我國學者進行專門之闡述。本文乃參考美國法制,就商標名稱通用化之意義、形成原因、判斷標準、法律效果,以及我國法制之檢討等議題,分別加以闡釋,期有助於解決商標名稱通用化所衍生 之各項行政救濟,以及法院訴訟上面臨之新議題。 A basic function of trademarks is to identify the source of a product. In order to carry out this function, it is necessary to design a trademark with distinctiveness. A trademark without distinctiveness can not be registered with the Patent and Trademark Office or serve as a basis for claiming trademark rights because it lacks the function of source identification. Trademark genericism, also known as genericide, genericness and generalization, is the rule which governs the loss of trademark protection of a registered trademark that was once distinctive and often well known, but fell into the public domain and became a generic name owing to the change in the perception of the consuming public. Genericism in U.S. court practices is not a new concept but is just beginning to appear in Taiwanese Trademark Law when the latest amendment went in effect on 28/11/2003. Considering the fact that this topic is rarely addressed among Taiwan academics or practitioners, this article examines the American legal system and courts practices and attempts to interpret the current Taiwan Trademark Law in order to find the meaning

  11. From the Stadium Parking Lot to the Information Superhighway: How To Protect Your Trademarks from Infringement.

    Science.gov (United States)

    Bearby, Scott; Siegal, Bruce

    2002-01-01

    Provides an overview of collegiate trademark cases; discusses several forms of infringement, including traditional infringement on commercial products, ambush marketing, and Internet infringement; addresses available remedies; and offers practical tips for dealing effectively with trademark protection. (EV)

  12. 77 FR 49426 - Notice of Inquiry Regarding Adjustment of Fees for Trademark Applications

    Science.gov (United States)

    2012-08-16

    ... Trademark Assistance Center, Concourse Level, James Madison Building-East Wing, 600 Dulany Street... , and will also be available at the Office of the Commissioner for Trademarks, Madison East, Tenth Floor...

  13. [Meta-analysis of percutaneous transluminal atherectomy in the treatment for in-stent restenosis of lower extremity peripheral artery disease].

    Science.gov (United States)

    Li, Weihao; Zhang, Tao; Liu, Yunfeng; Zhang, Yongbao; Li, Qingle; Zhang, Xiaoming; Shen, Chenyang

    2015-11-24

    To evaluate the clinical safety and efficacy of percutaneous transluminal atherectomy for in-stent restenosis (ISR) in patients with low extremity peripheral arterial diseases (PAD). PubMed, Elsevier, EBSCO, Spring databases and Cochrane Library were searched for relevant articles. Based on the different mechanisms of atherectomy, the patients were divided into mechanic atherectomy group and laser atherectomy group. The safety end points included the rate of distal embolism and severe arterial wall injuries. And the efficacy end points included primary patency rate and freedom from target vessel revascularization (TVR-free) 6 months and 12 months after surgery. A total of 9 studies and 620 patients (published between 2006 and 2014) were accepted. The rate of distal embolism was 4.2% (95% confidence interval (CI): 1.7%-6.7%), while that of severe arterial wall injuries was 1.9% (95%CI: 0.9%-3.0%), respectively. Laser atherectomy was responsible for more distal embolism (6.8%) compared to mechanic atherectomy (2.0%), which was significantly different (Q=21.66, P=0.010). At 6-month follow-up, primary patency rate and rate of TVR-free were 63.0% (95% CI: 55.5%-70.6%) and 80.4% (95% CI: 70.5%-90.3%), while at 12-month follow-up were 43.5% (95%CI: 32.2%-54.9%) and 58.0% (95% CI: 52.1%-63.9%), respectively. The free-TVR rate at 6 months follow-up in mechanical atherectomy group was 77.9%, and was inferior to that in laser atherectomy group (80.8%, Q=13.49, P=0.009). Published bias was discovered at the analysis of 12-month TVR-free rate by means of Begg Test (P=0.039). Meta analysis concerned about the 3 randomized controlled trials demonstrated that there was no significant improvement using atherectomy for ISR comparing to standard balloon at 6-month TVR-free rate (OR=1.34, 95% CI: 0.86-2.07, P=0.196). To treat ISR lesion in lower extremities, laser atherectomy has a lower free-TVR rate in the middle term follow-up.A higher rate of distal embolism is noted though. On

  14. An Algorithm for the Use of Embolic Protection During Atherectomy for Femoral Popliteal Lesions.

    Science.gov (United States)

    Krishnan, Prakash; Tarricone, Arthur; Purushothaman, K Raman; Purushothaman, Meerarani; Vasquez, Miguel; Kovacic, Jason; Baber, Usman; Kapur, Vishal; Gujja, Karthik; Kini, Annapoorna; Sharma, Samin

    2017-02-27

    This study sought to identify an algorithm for the use of distal embolic protection on the basis of angiographic lesion morphology and vascular anatomy for patients undergoing atherectomy for femoropopliteal lesions. Atherectomy has been shown to create more embolic debris than angioplasty alone. Distal embolic protection has been shown to be efficacious in capturing macroemboli; however, no consensus exists for the appropriate lesions to use distal embolic protection during atherectomy. Patients with symptomatic lower extremity peripheral artery disease treated with atherectomy and distal embolic protection were evaluated to identify potential predictors of DE. Plaque collected from the SilverHawk nose cone subset was sent to pathology for analysis to evaluate the accuracy of angiography in assessing plaque morphology. Significant differences were found in lesion length (142.1 ± 62.98 vs. 56.91 ± 41.04; p = 0.0001), low-density lipoprotein (82.3 ± 40.3 vs. 70.9 ± 23.2; p = 0.0006), vessel runoff (1.18 ± 0.9 vs. 1.8 ± 0.9; p = 0.0001), chronic total occlusion (131 vs. 10; p = 0.001), in-stent restenosis (33 vs. 6; p = 0.0081), and calcified lesions (136 vs. 65; p 40 mm, and atherosclerotic lesions >140 mm identified by peripheral angiography necessitate concomitant filter use during atherectomy to prevent embolic complications. Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

  15. Gender-Based Differences in Outcomes After Orbital Atherectomy for the Treatment of De Novo Severely Calcified Coronary Lesions.

    Science.gov (United States)

    Lee, Michael S; Shlofmitz, Evan; Mansourian, Pejman; Sethi, Sanjum; Shlofmitz, Richard A

    2016-11-01

    We evaluated the relationship between gender and angiographic and clinical outcomes in patients with severely calcified lesions who underwent orbital atherectomy. Female gender is associated with increased risk of adverse clinical events after percutaneous coronary intervention (PCI). Severe coronary artery calcification increases the complexity of PCI and increases the risk of adverse cardiac events. Orbital atherectomy is effective in plaque modification, which facilitates stent delivery and expansion. Whether gender differences exist after orbital atherectomy is unclear. Our analysis retrospectively analyzed 458 consecutive real-world patients (314 males and 144 females) from three centers who underwent orbital atherectomy. The primary endpoint was the major adverse cardiac and cerebrovascular event (MACCE) rate, defined as the composite of death, myocardial infarction (MI), target-vessel revascularization (TVR), and stroke, at 30 days. The primary endpoint of MACCE was low and similar in females and males (0.7% vs 2.9%; P=.14). The individual endpoints of death (0.7% vs 1.6%; P=.43), MI (0.7% vs 1.3%; P=.58), TVR (0% vs 0%; P>.99), and stroke (0% vs 0.3%; P=.50) were low in both groups and did not differ. Angiographic complications were low: perforation (0.8% vs 0.7%; P>.90), dissection (0.8% vs 1.1%; P=.80), and no-reflow (0.8% vs 0.7%; P>.90). Plaque modification with orbital atherectomy was safe and provided similar angiographic and clinical outcomes between females and males. Randomized trials with longer-term follow-up are needed to support our results.

  16. Ubiquitous Nature of Distal Athero/Thromboembolic Events during Lower Extremity Atherectomy Procedures Involving the Superficial Femoral Artery

    Science.gov (United States)

    Wasty, Najam; Khakwani, M. Z.; Kotev, Spas; Boiangiu, Catalin; Hasan, Omar; Anna, Manjusha; Tayal, Rajiv; Kaid, Khalil; Baker, Gail; Cohen, Marc

    2016-01-01

    This study aims to evaluate occurrence, size, composition, and clinical significance of embolized debris during superficial femoral artery atherectomy using all commercially available atherectomy devices. Distal athero/thromboembolic events (DATE) are a universal phenomenon in lower extremity atherectomy procedures (LEAPs) due to the sheer volume of atheroma and the thrombus burden in peripheral arterial disease. Some of these events can be clinically significant. We prospectively gathered clinical and histopathological data on all commercially available atherectomy devices by using embolic protection devices (EPD) in every case. After intervention, the contents of EPD were examined both microscopically and macroscopically. Data from 59 consecutive patients undergoing LEAP were analyzed. DATE occurred 100% of the time. The composition of particulate debris varied with the device used. Grossly visible agglomerated debris was captured by the filter in the majority of patients 54/59 (91.5%). Clinically significant debris, defined by the Preventing Lower Extremity Distal Embolization Using Embolic Filter Protection registry as particle diameter > 0.2 cm, was found in 33/59 (56%) patients. The size of captured debris particles ranged from 0.1 to 2.4 mm. While DATE occurred in all patients, clinically significant DATE occurred in 56% patients undergoing LEAP regardless of the atherectomy device. In spite of a large fraction of the clinically significant debris occurring on our routine dual antiplatelet regimen, no patient suffered an amputation. Although DATE was prevented by the use of EPD in all 59 cases, more data are needed to determine whether the use of EPD translates into a long-term clinical benefit. Use of EPD and optimal thromboprophylaxis should be considered in patients, especially in the setting of compromised distal runoff. PMID:27867291

  17. 76 FR 59114 - Request for Comments on Establishment of a One-Year Retention Period for Trademark-Related Papers...

    Science.gov (United States)

    2011-09-23

    ... Cynthia C. Lynch; by hand delivery to the Trademark Assistance Center, Concourse Level, James Madison... Commissioner for Trademarks, Madison East, Tenth Floor, 600 Dulany Street, Alexandria, Virginia. Because...

  18. The relevance of introducing opposition proceedings into the Serbian trademark legislation

    OpenAIRE

    Vasić Aleksandra

    2014-01-01

    This paper analyzes the quality of certain legal procedures applied in domestic trademark legislation in the light of harmonizing our legislation with those of the EU. Trademark Law in the Republic of Serbia (2009) does not rely on opposition proceedings as a phase in the process of trademark registration and a tool that would ensure that only those trademarks that fulfill the necessary conditions are granted legal protection. Intellectual Property Office examines the so-called relative groun...

  19. Orbital atherectomy for the treatment of severely calcified coronary lesions: evidence, technique, and best practices.

    Science.gov (United States)

    Shlofmitz, Evan; Martinsen, Brad J; Lee, Michael; Rao, Sunil V; Généreux, Philippe; Higgins, Joe; Chambers, Jeffrey W; Kirtane, Ajay J; Brilakis, Emmanouil S; Kandzari, David E; Sharma, Samin K; Shlofmitz, Richard

    2017-11-01

    The presence of severe coronary artery calcification is associated with higher rates of angiographic complications during percutaneous coronary intervention (PCI), as well as higher major adverse cardiac events compared with non-calcified lesions. Incorporating orbital atherectomy (OAS) for effective preparation of severely calcified lesions can help maximize the benefits of PCI by attaining maximal luminal gain (or stent expansion) and improve long-term outcomes (by reducing need for revascularization). Areas covered: In this manuscript, the prevalence, risk factors, and impact of coronary artery calcification on PCI are reviewed. Based on current data and experience, the authors review orbital atherectomy technique and best practices to optimize lesion preparation. Expert Commentary: The coronary OAS is the only device approved for use in the U.S. as a treatment for de novo, severely calcified coronary lesions to facilitate stent delivery. Advantages of the device include its ease of use and a mechanism of action that treats bi-directionally, allowing for continuous blood flow during treatment, minimizing heat damage, slow flow, and subsequent need for revascularization. The OAS technique tips reviewed in this article will help inform interventional cardiologists treating patients with severely calcified lesions.

  20. Intravascular Ultrasound Imaging of Peripheral Arteries as an Adjunct to Balloon Angioplasty and Atherectomy

    International Nuclear Information System (INIS)

    Korogi, Yukunori; Hirai, Toshinori; Takahashi, Mutsumasa

    1996-01-01

    This article reviews many of the applications of intravascular ultrasound (US) imaging for peripheral arterial diseases. In vitro studies demonstrate an excellent correlation between ultrasound measurements of lumen and plaque crossectional area compared with histologic sections. In vivo clinical studies reveal the enhanced diagnostic capabilities of this technology compared with angiography. Intravascular US imaging can provide valuable information on the degree, eccentricity, and histologic type of stenosis before intervention, and on the morphological changes in the arterial wall and the extent of excision after intervention. Intravascular US may also serve as a superior index for gauging the diameter of balloon, stent, laser probe, and/or atherectomy catheter appropriate for a proposed intervention. Significant new insights into the mechanisms of balloon angioplasty and atherectomy have been established by intravascular US findings. Intravascular US imaging has been shown to be a more accurate method than angiography for determining the cross-sectional area of the arterial lumen, and for assessing severity of stenosis. Quantitative assessment of the luminal cross-sectional area after the balloon dilatation should be more accurate than angiography as intimal tears or dissections produced by the dilatation may not be accurately evaluated with angiography. At the present time, intravascular US is still a controversial imaging technique. Outcome studies are currently being organized to assess the clinical value and cost effectiveness of intravascular ultrasound in the context of these interventional procedures

  1. Full scaled tests of the KERENA trademark containment cooling condenser at the INKA test facility

    International Nuclear Information System (INIS)

    Leyer, Stephan; Maisberger, Fabian; Lineva, Natalia; Wagner, Thomas; Doll, Mathias; Herbst, Vasilli; Wich, Michael

    2010-01-01

    KERENA trademark is a medium-capacity boiling water reactor. It combines passive safety systems with active safety equipment of service-proven design. The passive systems utilize basic laws of physics, such as gravity and natural convection, enabling them to function without any power supply or actuation by instrumentation and control (I and C) equipment. They are designed to bring the plant to a safe and stable condition without the aid of active systems. Furthermore, the passive safety features partially replace the active systems, which reduces costs significantly and provides a safe, reliable and economically competitive plant design. At the new test facility at Karlstein called INKA (Integral Test Stand Karlstein), the key components of the KERENA trademark passive safety concept - the Emergency Condenser (EC), the Containment Cooling Condenser (CCC) and the passive core flooding system (PCFS) - are presently under full-scale testing,. Integral system tests will also be performed to show how the passive safety systems interact under various anticipated accident conditions and to demonstrate the ability of the passive systems to bring the plant to a safe and stable condition without the aid of active systems or actuation by I and C signals. The passive pressure pulse transmitter (PPPT) will be included in these integral tests. In this report the experimental setup and the first test results with the full scaled Containment Cooling Condenser will be described. (orig.)

  2. Future{at}Labs.Prosperity Game{trademark}

    Energy Technology Data Exchange (ETDEWEB)

    Beck, D.F.; Boyack, K.W.; Berman, M. [Sandia National Labs., Albuquerque, NM (United States). Innovative Alliances Dept.

    1996-10-01

    Prosperity Games{trademark} are an outgrowth and adaptation of move/countermove and seminar War Games, Prosperity Games{trademark} are simulations that explore complex issues in a variety of areas including economics, politics, sociology, environment, education, and research. These issues can be examined from a variety of perspectives ranging from global, macroeconomic and geopolitical viewpoint down to the details of customer/supplier/market interactions specific industries. All Prosperity Games{trademark} are unique in that both the game format and the player contributions vary from game to game. This report documents the Future{at}Labs.Prosperity Game{trademark} conducted under the sponsorship of the Industry Advisory Boards of the national labs, the national labs, Lockheed Martin Corporation, and the University of California. Players were drawn from all stakeholders involved including government, industry, labs, and academia. The primary objectives of this game were to: (1) explore ways to optimize the role of the multidisciplinary labs in serving national missions and needs; (2) explore ways to increase collaboration and partnerships among government, laboratories, universities, and industry; and (3) create a network of partnership champions to promote findings and policy options. The deliberations and recommendations of these players provided valuable insights as to the views of this diverse group of decision makers concerning the future of the labs.

  3. 75 FR 69921 - Trademark Manual of Examining Procedure, Seventh Edition

    Science.gov (United States)

    2010-11-16

    ... applications. The seventh edition incorporates USPTO trademark practice and relevant case law reported prior to September 1, 2010. The policies stated in this revision supersede any previous policies stated in prior editions, examination guides, or any other statement of USPTO policy, to the extent that there is any...

  4. 78 FR 61185 - Patent and Trademark Office Acquisition Guidelines (PTAG)

    Science.gov (United States)

    2013-10-03

    ..., Analysis and Liaison Division, United States Patent and Trademark Office, Madison East Building, Room MDE... Federal eRulemaking Portal Web site will be made available for public inspection. Therefore, any... all comments received. To view the PTAG, please visit the USPTO's Web site at http://www.uspto.gov and...

  5. 76 FR 34062 - Patent and Trademark Financial Transactions

    Science.gov (United States)

    2011-06-10

    ... processing and other services related to patents, trademarks, and information products. Customers may submit... EFT to make online fee payments to the USPTO. Customers must first establish a user profile with their... financial activity records online, customers may create a Financial Profile through the USPTO Web site...

  6. 75 FR 38543 - Patent, Trademark and Copyright Acts

    Science.gov (United States)

    2010-07-02

    ... DEPARTMENT OF THE INTERIOR Geological Survey Patent, Trademark and Copyright Acts AGENCY: Geological Survey, Interior. ACTION: Notice of prospective intent to award exclusive license. SUMMARY: The... Technologies Group, Inc., 253 Portman Lane, Suite 107, Bridgeville, PA 15017 on U.S. Patent No. 6,485,696 B1...

  7. 76 FR 11208 - Proposed Collection; Substantive Submissions Made During Prosecution of the Trademark Application

    Science.gov (United States)

    2011-03-01

    ... Petition to Revive Deficiency Letter, Petition to the Director Under Trademark Rule 2.146, Due Diligence...) Due Diligence Petition Under Trademark Rule 2.66 (Paper).. 20 7 2 Due Diligence Petition Under... 0.44 2.00 Petition to the Director Under Trademark Rule 2.146....... 16 0.44 7.00 Due Diligence...

  8. 19 CFR 148.55 - Exemption for articles bearing American trademark.

    Science.gov (United States)

    2010-04-01

    ... registered with the U.S. Patent and Trademark Office and recorded with Customs. The exemption may be applied... 19 Customs Duties 2 2010-04-01 2010-04-01 false Exemption for articles bearing American trademark... § 148.55 Exemption for articles bearing American trademark. (a) Application of exemption. An exemption...

  9. 19 CFR 134.47 - Souvenirs and articles marked with trademarks or trade names.

    Science.gov (United States)

    2010-04-01

    ... 19 Customs Duties 1 2010-04-01 2010-04-01 false Souvenirs and articles marked with trademarks or... Imported Articles § 134.47 Souvenirs and articles marked with trademarks or trade names. When as part of a trademark or trade name or as part of a souvenir marking, the name of a location in the United States or...

  10. 37 CFR 2.27 - Pending trademark application index; access to applications.

    Science.gov (United States)

    2010-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2010-07-01 2010-07-01 false Pending trademark application... Registration § 2.27 Pending trademark application index; access to applications. (a) An index of pending... particular pending application will be permitted prior to publication under § 2.80 upon written request. (c...

  11. Cost-effectiveness analysis of orbital atherectomy plus balloon angioplasty vs balloon angioplasty alone in subjects with calcified femoropopliteal lesions

    Science.gov (United States)

    Weinstock, Barry; Dattilo, Raymond; Diage, Tiffini

    2014-01-01

    Introduction As cost considerations become increasingly critical when selecting optimal endovascular treatment strategies, a cost-benefit analysis was conducted comparing the Diamondback 360°® Orbital Atherectomy System (OAS) (Cardiovascular Systems, Inc., St Paul, MN, USA) and balloon angioplasty (BA) vs BA alone for treatment of calcified femoropopliteal lesions. Patients and methods The clinical outcomes from COMPLIANCE 360°, a prospective, multicenter, randomized study comparing OAS+BA vs BA alone for treatment of calcified femoropopliteal lesions, were correlated with cost data and previously published quality of life data. Site of service, hospital charges, and associated medical resource utilization were obtained from Uniform Billing statements for index treatments and associated revascularizations out to 1 year. Hospital costs were estimated using hospital-specific, procedure-specific cost-to-charge ratios. Length of stay and procedural data were collected from participating study sites. Results Twenty-five subjects with 38 lesions and 25 subjects with 27 lesions were randomized to the OAS+BA and BA-alone groups, respectively. Mean hospital charges (US$51,755 vs US$39,922) and estimated hospital costs (US$15,100 vs US$11,016) were higher for OAS+BA compared with BA alone (not statistically significant). Stent utilization was statistically significantly higher with BA-alone treatment for all subjects (1.1 vs 0.1, P=0.001) and in the subset of subjects with one lesion (1.0 vs 0.1, Patherectomy for treatment of calcified femoropopliteal lesions, a longstanding challenge for peripheral artery disease interventionalists. PMID:24672251

  12. 37 CFR 2.190 - Addresses for trademark correspondence with the United States Patent and Trademark Office.

    Science.gov (United States)

    2010-07-01

    ... filed through the Office's web site, at http://www.uspto.gov. Paper documents and cover sheets to be... trademark documents can be ordered through the Office's web site at www.uspto.gov. Paper requests for...: Madrid Processing Unit, 600 Dulany Street, MDE-7B87, Alexandria, VA 22314-5793. [68 FR 48289, Aug. 13...

  13. SmartShelf trademark: Report of activities for fiscal year 1996

    International Nuclear Information System (INIS)

    Bell, Z.W.; Lawson, R.L.; Long, C.D.

    1996-01-01

    The SmartShelf trademark system is designated to maintain an up-to-the-minute inventory of containers or other assets. Through the use of Dallas Semiconductor touch memory devices affixed to containers and entrusted to authorized operators, the system can determine which operator added or removed which container and when the transaction occurred. Through the use of a PC-based data base system, reports of the current status of all containers and nodes can be generated in minutes. This report covers activities on the SmartShelf trademark project for the period 1 October 1995 through 30 September 1996. During this year, project team members have advanced the state of the hardware and software from rough prototypes to a working system ready for field trials.The project team has developed an intimate working knowledge of the hardware and software, and has become expert at implementations of Dallas Semiconductor touch memory devices. System hardware includes a desktop PC running LabView and Microsoft Access, and an STD-bus 8086 computer to monitor container storage locations (nodes). The STD-bus computer monitors up to 128 nodes, and responds to operator actions (adding or removing containers) within 10 seconds. The PC uses LabView software to query the STD-bus machine to obtain records of transactions, and to download configuration information. Microsoft Access is used to store the transactions and configuration data in a user-accessible form

  14. A comparative study of percutaneous atherectomy for femoropopliteal arterial occlusive disease.

    Science.gov (United States)

    Gu, Yongquan; Malas, Mahmoud B; Qi, Lixing; Guo, Lianrui; Guo, Jianming; Yu, Hengxi; Tong, Zhu; Gao, Xixiang; Zhang, Jian; Wang, Zhonggao

    2017-08-01

    SilverHawk™ directional atherectomy has been used to treat more than 300 thousand cases of lower extremity atherosclerotic occlusive disease in the world since it was approved by FDA in 2003. This study aimed to analyze the safety and effectiveness of symptomatic femoral popliteal atherosclerotic disease treated by directional atherectomy (DA). Clinical data of all consecutive patients treated with percutaneous atherectomy utilizing the SilverHawk™ plaque excision was retrospectively analyzed. The anatomic criteria of the atherosclerotic lesions were divided into four types: type I stenosis; type II occlusion; type III in-stent restenosis; type IV stent occlusion. There were 160 patients treated during the study period. Intermittent claudication in 75 patients (47%), rest pain in 55 patients (34.5%) and tissue loss in 30 patients (18.5%). The number of patients was 72, 15, 49 and 24 in type I, II, III and IV lesions, respectively. Technical success rate was 98.6%, 93.3%, 97.9% and 91.7% in type I, II, III and IV lesions, respectively. Debris of intimal plaque was captured by protection device in 92 patients (71.3%). The mean follow-up period was 23.5±10.4 months. Restenosis rate of type I to IV lesions was 21%, 36%, 36% and 40% respectively. Restenosis rate in type I lesion was significantly lower than that in type III and IV lesions (P<0.05). Patients with tissue loss responded to revascularization as follow: type I, 11/13 healed or reduced (84.6%), type II, 3/3 patients improved (100%), type III, 5/6 patients improved (83.3%) and type IV 4/4 healed (100%). In type IV group, four patients had in-stent thrombosis found by postoperative Duplex ultrasonography. They all underwent DA after catheter-directed thrombolysis with good angiographic results. Percutaneous DA is safe and effective for both de-novo atherosclerotic and in-stent stenotic or occlusive lesions. Thrombolysis before plaque excision is recommended in case of in-stenting thrombosis.

  15. 37 CFR 1.414 - The United States Patent and Trademark Office as a Designated Office or Elected Office.

    Science.gov (United States)

    2010-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2010-07-01 2010-07-01 false The United States Patent and Trademark Office as a Designated Office or Elected Office. 1.414 Section 1.414 Patents, Trademarks, and Copyrights UNITED STATES PATENT AND TRADEMARK OFFICE, DEPARTMENT OF COMMERCE GENERAL RULES OF PRACTICE IN PATENT CASES International Processing...

  16. APPLICATION OF THE LASAGNA(trademark) SOIL REMEDIATION TECHNOLOGY AT THE DOE PADUCAH GASEOUS DIFFUSION PLANT

    International Nuclear Information System (INIS)

    Swift, Barry D.; Tarantino, Joseph J. P. E.

    2003-01-01

    depth of 45 feet. TCE in the test sites. Based on the successful field tests (Phases I and IIa), the ROD was prepared and the Lasagna(trademark) alternative was selected for remediation of TCE contaminated soils at the cylinder testing site Solid Waste Management Unit 91(SWMU 91). Bechtel Jacobs Company LLC contracted CDM to construct and operate a full-scale Lasagna(trademark) remediation system at the site (Phase IIb). Construction began in August 1999 and the operational phase was initiated in December 1999. The Lasagna(trademark) system was operated for two years and reduced the average concentration of TCE in SWMU 91 soil from 84 ppm to less than 5.6 ppm. Verification sampling was conducted during May, 2002. Results of the verification sampling indicated the average concentration of TCE in SWMU 91 soil was 0.38 ppm with a high concentration of 4.5 ppm

  17. The AMTEX Partnership{trademark}. Fourth quarter FY95 report

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1995-09-01

    The AMTEX Partnership{trademark} is a collaborative research and development program among the US Integrated Textile Industry, the Department of Energy (DOE), the national laboratories, other federal agencies and laboratories, and universities. The goal of AMTEX is to strengthen the competitiveness of this vital industry, thereby preserving and creating US jobs. The operations and program management of the AMTEX Partnership{trademark} is provided by the Program Office. This report is produced by the Program Office on a quarterly basis and provides information on the progress, operations, and project management of the partnership. Progress is reported on the following projects: computer-aided fabric evaluation; cotton biotechnology; demand activated manufacturing architecture; electronic embedded fingerprints; on-line process control for flexible fiber manufacturing; rapid cutting; sensors for agile manufacturing; and textile resource conservation.

  18. A Multimodal Approach to Meaning-Making in Trademarks

    DEFF Research Database (Denmark)

    Johannessen, Christian Mosbæk

    2008-01-01

    When enterprises go to court to settle disputes over confusable graphic trademarks and intellectual property, they usually present evidence to the nature of the design of the involved marks, which is based on subjective judgment – usually on the part of an appraiser with a professional background...... of the human body, whereas the PR marks is the result of an abstract formalized and stylized use of the same resources known from typography....

  19. Trademarks, consumer protection and domain names on the Internet

    Directory of Open Access Journals (Sweden)

    Hana Kelblová

    2007-01-01

    Full Text Available The article deals with current problems of the conflict of domain names on the Internet with trade marks in relation to the consumer protection. The aim of the article is to refer to ways and means of protection against of the speculative registration of a domain name. In the Czech legal order these means represent legal regulation of the unfair competition in Commercial Code, regulation of liability for damage together with the Trademarks Act.

  20. The role of atherectomy in the treatment of lower extremity peripheral artery disease

    Science.gov (United States)

    2012-01-01

    Background The incidence of lower extremity peripheral artery disease (LE-PAD) continues to increase and associated morbidity remains high. Despite the significant development of percutaneous revascularization strategies, over the past decade, LE-PAD still represents a unique challenge for interventional cardiologists and vascular surgeons. Method Typical features of atherosclerosis that affects peripheral vascular bed (diffuse nature, poor distal runoff, critical limb ischemia, chronic total occlusion) contribute to the disappointing results of traditional percutaneous transluminal angioplasty (PTA). New technologies have been developed in attempt to improve the safety and effectiveness of percutaneous revascularization. Among these, atherectomy, debulking and removing atherosclerotic plaque, offers the potential advantage of eliminating stretch on arterial walls and reducing rates of restenosis. Conclusions This review summarizes the features and the current applications of new debulking devices. PMID:23173800

  1. Use of orbital atherectomy in acute myocardial infarction via the transradial approach

    Science.gov (United States)

    Mowakeaa, Samer; Snyder, Branden; Kakouros, Nikolaos

    2016-01-01

    Severe coronary artery calcifications pose an ongoing challenge when performing percutaneous coronary interventions, resulting in an increased likelihood of procedural complications. Orbital atherectomy (OA) has emerged as a promising technology that helps improve outcomes in this complex patient population. Its safety and efficacy are yet to be demonstrated in the setting of acute myocardial infarction. We present a case of a patient with acute ST-elevation myocardial infarction (STEMI) evaluated with emergent transradial coronary angiography. The culprit lesion was a severely stenotic, heavily calcified, segment of the right coronary artery. The use of OA facilitated lesion expansion and implantation of a drug-eluting stent. Although OA should be considered as contraindicated for the management of soft-ruptured plaque, which accounts for the majority of STEMI presentations, it may be well applied to the small subset of patients with calcified nodule pathology, even in the acute setting. PMID:28180008

  2. Rotational atherectomy ablation for an unexpandable stent under the guide of IVUS

    Science.gov (United States)

    Si, Daoyuan; Liu, Guohui; Tong, Yaliang; He, Yuquan

    2018-01-01

    Abstract Rationale: Inadequate stent expansion due to rigid calcified may result in restenosis lesions, but the available options are limited. Patient concerns: We report a case via the trans-radial approach of the severely underexpanded freshly deployed stent due to heavily calcified plaques Diagnoses: Coronary angiography revealed that there was no adequate expansion of the freshly deployed stent. Interventions: Under the guide of intravascular ultrasound (IVUS), rotational atherectomy (RA) successfully ablated the stent layers and the protruding calcified plaque. Followed by balloon angioplasty, the ablated segment was scaffolded with another stent, well expanded and documented by IVUS. Outcomes: The patient was uneventful during the procedure and remained angina free at the point of one year of clinical follow-up. Lessons: This case indicated that RA via the trans-radial approach could be a useful remedy in the situation of under-expansion of implanted stents, and the debulking should be performed under IVUS-guidance. PMID:29443790

  3. SHORT CONSIDERATIONS ON THE USE OF TRADE INDICATORS AS TRADEMARKS

    Directory of Open Access Journals (Sweden)

    PAUL-GEORGE BUTA

    2012-05-01

    Full Text Available In today's global marketplace products and services are exchanged internationally not only by large companies wielding a large portfolio of internationally protected trademarks but also by small enterprises and even individuals who have neither the resources nor an interest in the building of such a portfolio. Since they are nonetheless economic agents using either their own or others' trade indicators to indicate the origin and quality of the products and services they provide or simply to advertise them, the present paper addresses some of the issues arising out of that use which is akin to trademark use in what regards said products and services. Special attention is paid to the change in purpose of the trade indicators when used as trademarks and the effects said change causes in the legal protection conferred to those trade indicators. Moreover the possible conflicts between such rights are shortly analyzed and the means for resolution of such conflicts briefly reviewed. Far from being an exhaustive study of the issues raised the present paper aims at identifying these issues and pointing to contentious points to be addressed by future research.

  4. Pooled analysis of the CONFIRM registries: safety outcomes in diabetic patients treated with orbital atherectomy for peripheral artery disease.

    Science.gov (United States)

    Lee, Michael S; Yang, Tae; Adams, George

    2014-04-01

    To compare the acute outcomes of orbital atherectomy treatment in diabetic vs. non-diabetic patients with peripheral artery disease (PAD). The CONFIRM registry series contained 1842 diabetic patients (1111 men; mean age 70.6±10.2 years) with 2819 lesions and 1247 non-diabetic patients (732 men; mean age 72.9±10.7 years) with 1885 lesions. The composite rate of procedure-related complications, including dissection, perforation, slow flow, vessel closure, spasm, embolism, and thrombus formation, was analyzed for the diabetic and non-diabetic groups. Diabetics were younger but had a higher prevalence of coronary artery disease (patherectomy resulted in similar low procedure-related complication rates in both the diabetic and non-diabetic groups, despite diabetics having more unfavorable baseline clinical and lesion characteristics. This study suggests that orbital atherectomy is a safe and effective treatment modality in both the diabetic and the non-diabetic populations.

  5. Development of the SEAMIST trademark concept for site characterization and monitoring

    International Nuclear Information System (INIS)

    Lowry, W.; Keller, C.

    1992-11-01

    SEAMIST trademark (Science and Engineering Associates Membrane Instrumentation and Sampling Technique) is a borehole liner and instrument emplacement technique with applications in contaminant monitoring and site characterization. The system incorporates an impermeable tubular membrane which is deployed in a borehole by inversion under pneumatic pressure. Once in place the membrane remains under internal pressure to support the borehole wall and seal the hole against air circulation. Instruments and sampling devices mounted on the surface of the membrane are pressed against the borehole wall to maintain intimate contact with the geologic media. The membrane is left pressurized with air for short term applications (less than a month, for example) or filled with sand for longer term semi-permanent installations. This effort developed the SEAMIST trademark system explicitly for vadose zone gas and pore fluid sampling in monitoring circumstances of particular interest to the DOE. The emplacement hardware, membrane materials, sampling components, and ancillary equipment were fabricated and field tested. Absorbent collector materials were shown in laboratory tests to wick water samples at metric potentials as high as 15 bars. Soil vapor sampling tubing and fittings were tested with the deployment system to assess their integrity during the emplacement process and achievable sampling rates. A technique for measuring effective gas permeability at multiple elevations in the borehole was analyzed and tested in the field

  6. Expression of tumour necrosis factor alpha and accumulation of fibronectin in coronary artery restenotic lesions retrieved by atherectomy.

    Science.gov (United States)

    Clausell, N.; de Lima, V. C.; Molossi, S.; Liu, P.; Turley, E.; Gotlieb, A. I.; Adelman, A. G.; Rabinovitch, M.

    1995-01-01

    BACKGROUND--The formation of coronary artery neointima experimentally induced in piglets after cardiac transplantation is related to an immune-inflammatory reaction associated with increased expression of T cells and inflammatory mediators (tumour necrosis factor alpha and interleukin 1 beta) and upregulation of fibronectin. In vivo blockade of tumour necrosis factor alpha in rabbits after cardiac transplantation results in reduced neointimal formation. The objective of this study was to investigate the hypothesis that coronary restenosis after atherectomy or percutaneous balloon angioplasty is associated with a similar inflammatory cascade initiated by mechanical injury. METHODS--Specimens taken at coronary atherectomy were analysed from 16 patients. Nine had had the procedure performed twice, firstly, to remove a primary lesion, and secondly, to remove a restenotic lesion. Seven had percutaneous balloon angioplasty after removal of restenotic tissue. Coronary atherectomy specimens were analysed by immunohistochemistry for the presence of T cells, macrophages, major histocompatibility complex II, interleukin 1 beta, tumour necrosis factor alpha, fibronectin, and the receptor for hyaluronan mediated motility. RESULTS--The groups were clinically and angiographically similar with equivalent lumens before and after atherectomy. Restenotic lesions had increased expression of tumour necrosis factor alpha and fibronectin compared with the primary lesions (P < 0.05 for both). There was also a trend towards a greater number of T cells and increased expression of interleukin 1 beta. CONCLUSIONS--Restenosis is associated with increased expression of tumour necrosis factor alpha and fibronectin, suggesting that an immune-inflammatory reaction probably contributes to neointimal formation and may represent a form of wound healing and repair secondary to mechanical injury. Images PMID:7626352

  7. Optical coherence tomography assessment of the mechanistic effects of rotational and orbital atherectomy in severely calcified coronary lesions.

    Science.gov (United States)

    Kini, Annapoorna S; Vengrenyuk, Yuliya; Pena, Jacobo; Motoyama, Sadako; Feig, Jonathan E; Meelu, Omar A; Rajamanickam, Anitha; Bhat, Arjun M; Panwar, Sadik; Baber, Usman; Sharma, Samin K

    2015-11-15

    This study sought to assess the mechanistic effect of rotational atherectomy (RA) and orbital atherectomy (OA) on heavily calcified coronary lesions and subsequent stent placement using optical coherence tomography (OCT). RA and OA are two main approaches to ablate coronary calcium. While small case reports have described the mechanistic effect of RA in calcified coronary lesions, there has been no imaging study to assess the effect of OA on coronary artery architecture and/or compare the effects of two atherectomy devices. This study analyzed 20 consecutive patients with OCT imaging performed after atherectomy and after stent implantation, RA (n = 10) and OA (n = 10). Postatherectomy OCT analysis identified tissue modification with deep dissections in around a third of lesions after RA and OA; however, post OA dissections ("lacunae") were significantly deeper (1.14 vs. 0.82 mm, P = 0.048). Post OA/RA lesions with dissections had significantly higher percentage of lipid rich plaques and smaller calcification arcs as compared to plaques without dissections. Stents after OA were associated with a significantly lower percent of stent strut malapposition than post RA stents (4.36 vs. 8.02%, P = 0.038). Although the incidence of dissections was comparable between RA and OA cases, OA resulted in deeper tissue modifications (lacunae) as shown by OCT imaging. The finding might provide an explanation for a better stent apposition after OA as compared to RA. Their impact on long-term outcome needs to be determined. © 2015 Wiley Periodicals, Inc.

  8. Neointimal Hyperplasia after Silverhawk Atherectomy versus Percutaneous Transluminal Angioplasty (PTA) in Femoropopliteal Stent Reobstructions: A Controlled, Randomized Pilot Trial

    International Nuclear Information System (INIS)

    Brodmann, Marianne; Rief, Peter; Froehlich, Harald; Dorr, Andreas; Gary, Thomas; Eller, Philipp; Hafner, Franz; Deutschmann, Hannes; Seinost, Gerald; Pilger, Ernst

    2013-01-01

    Due to intimal hyperplasia instent reobstruction in the femoropopliteal arterial segment is still an unsolved problem. Different techniques have been discussed in case of reintervention to guarantee longlasting patency rate. We conducted a randomized, controlled, pilot trial comparing Silverhawk atherectomy with percutaneous transluminal angioplasty (PTA) in patients with a first instent reobstruction in the femoropopliteal arterial segment, to evaluate intima media thickness (IMT) within the treated segment, as a parameter of recurrence of intimal hyperplasia. In a total 19 patients were included: 9 patients in the atherectomy device and 10 patients in the PTA arm. IMT within the treated segment was statistically significantly elevated in all patients treated with the Silverhawk device versus the patients treated with PTA. The obvious differentiation in elevation of IMT in nonfavor for patients treated with the Silverhawk device started at month 2 (max IMT SH 0.178 mm vs. IMT PTA 0.1 mm, p = 0.001) with a spike at month 5 (max IMT SH 0.206 mm vs. IMT PTA 0.145 mm, p = 0.003) and a decline once again at month 6 (max IMT SH 0.177 mm vs. IMT PTA 0.121 mm, p = 0.02). The values for mean IMT performed the same way. Although Silverhawk atherectomy provides good results at first sight, in the midterm follow-up of treatment of first instent restenosis it did not perform better than PTA as it showed elevated reoccurrence of intimal media hyperplasia.

  9. Safety and efficacy of rotational atherectomy for the treatment of undilatable underexpanded stents implanted in calcific lesions.

    Science.gov (United States)

    Ferri, Luca A; Jabbour, Richard J; Giannini, Francesco; Benincasa, Susanna; Ancona, Marco; Regazzoli, Damiano; Mangieri, Antonio; Montorfano, Matteo; Colombo, Antonio; Latib, Azeem

    2017-08-01

    Coronary stent underexpansion is a known risk factor for in-stent restenosis and stent thrombosis. There are limited options once noncompliant balloons have failed to achieve optimal stent expansion. Excimer Laser Coronary Angioplasty with contrast medium injection is one possibility, but not readily available. Rotational atherectomy is an alternative, and has been described in case reports, but concerns exist regarding safety. All consecutive patients undergoing rotational atherectomy for symptomatic in-stent restenosis due to stent underexpansion resistant to noncompliant balloon postdilatation between January 2005 and December 2015 were analysed. A total of 16 patients underwent treatment during the study period and the procedure was successful in 14 cases (87.5%). The mean postprocedural minimal lumen diameter increased by 2.3 ± 0.8 mm and percentage diameter stenosis decreased from 82.17% ± 17.2% to 11.9% ± 9.1%. Intraprocedural complications occurred in two patients (burr entrapment successfully managed percutaneously and periprocedural myocardial infarction). At 1-year follow-up, the incidence of target lesion revascularisation was 13.3% (2 out of 15 patients), and one patient died from noncardiac death. In this small series of underexpanded stents, rotational atherectomy was an effective treatment for resistant stent underexpansion with acceptable outcomes. © 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

  10. One-Year Outcomes Following Directional Atherectomy of Popliteal Artery Lesions: Subgroup Analysis of the Prospective, Multicenter DEFINITIVE LE Trial

    Science.gov (United States)

    Rastan, Aljoscha; McKinsey, James F.; Garcia, Lawrence A.; Rocha-Singh, Krishna J.; Jaff, Michael R.; Harlin, Stuart; Kamat, Suraj; Janzer, Sean; Zeller, Thomas

    2017-01-01

    Purpose: To report the effectiveness of directional atherectomy for the treatment of popliteal artery occlusive disease. Methods: This subset of the prospective, multicenter, single-arm DEFINITIVE LE trial included 158 patients (mean age 72.0±10.9 years; 82 men) who underwent directional atherectomy in 162 popliteal artery lesions between 2009 and 2011. Forty-eight (30.4%) patients were suffering from critical limb ischemia (CLI). The mean lesion length was 5.8±3.9 cm; 38 (23.5%) arteries were occluded. The primary outcome measure for patients with intermittent claudication (IC) was duplex ultrasound–defined primary patency at 1 year; the outcome for subjects with CLI was freedom from major amputation of the target limb at 1 year. Outcomes and adverse events were independently assessed. Results: Procedure success (≤30% residual stenosis) was achieved in 84.4% of treated lesions; adjunctive stenting was required in 6 (3.7%) of the 162 lesions. The 1-year primary patency rate was 75.0% (IC patients 78.2% and CLI patients 67.5%, p=0.118). The freedom from major amputation in both cohorts was 100%. In both IC and CLI patients, significant improvements were demonstrated at 1 year in the Rutherford category, walking distance, and quality of life in comparison to baseline. Conclusion: This study indicates that directional atherectomy in popliteal arteries leads to favorable technical and clinical results at 1 year for claudicant as well as CLI patients. PMID:29117818

  11. Histopathological Evidence of Adventitial or Medial Injury Is a Strong Predictor of Restenosis During Directional Atherectomy for Peripheral Artery Disease.

    Science.gov (United States)

    Tarricone, Arthur; Ali, Ziad; Rajamanickam, Anitha; Gujja, Karthik; Kapur, Vishal; Purushothaman, K-Raman; Purushothaman, Meerarani; Vasquez, Miguel; Zalewski, Adrian; Parides, Micheal; Overbey, Jessica; Wiley, Jose; Krishnan, Prakash

    2015-10-01

    To investigate the impact on restenosis rates of deep injury to the adventitial layer during directional atherectomy. Between 2007 and 2010, 116 consecutive patients (mean age 69.6 years; 56 men) with symptomatic femoropopliteal stenoses were treated with directional atherectomy at a single center. All patients had claudication and TASC A/B lesions in the superficial femoral or popliteal arteries. Histopathology analysis of atherectomy specimens was performed to identify adventitial injury. Clinical follow-up included physical examination and duplex ultrasound scans at 3, 6, and 12 months in all patients. The primary endpoint was the duplex-documented 1-year rate of restenosis, which was determined by a peak systolic velocity ratio 0.05), lesion length (58.7±12.8 vs 56.2±13.6 mm, p=0.40), or vessel runoff (1.9±0.6 vs 2.0±0.6, p=0.37) between patients with and without adventitial injury, respectively. The overall 1-year incidence of restenosis was 57%, but the rate was significantly higher (patherectomy for femoropopliteal stenosis is strongly related to patency at 1 year. © The Author(s) 2015.

  12. Neointimal Hyperplasia after Silverhawk Atherectomy versus Percutaneous Transluminal Angioplasty (PTA) in Femoropopliteal Stent Reobstructions: A Controlled, Randomized Pilot Trial

    Energy Technology Data Exchange (ETDEWEB)

    Brodmann, Marianne, E-mail: marianne.brodmann@medunigraz.at; Rief, Peter; Froehlich, Harald; Dorr, Andreas; Gary, Thomas; Eller, Philipp; Hafner, Franz [Medical University of Graz, Division of Angiology (Austria); Deutschmann, Hannes [Medical University Graz, Division of Interventional Radiology (Austria); Seinost, Gerald; Pilger, Ernst [Medical University of Graz, Division of Angiology (Austria)

    2013-02-15

    Due to intimal hyperplasia instent reobstruction in the femoropopliteal arterial segment is still an unsolved problem. Different techniques have been discussed in case of reintervention to guarantee longlasting patency rate. We conducted a randomized, controlled, pilot trial comparing Silverhawk atherectomy with percutaneous transluminal angioplasty (PTA) in patients with a first instent reobstruction in the femoropopliteal arterial segment, to evaluate intima media thickness (IMT) within the treated segment, as a parameter of recurrence of intimal hyperplasia. In a total 19 patients were included: 9 patients in the atherectomy device and 10 patients in the PTA arm. IMT within the treated segment was statistically significantly elevated in all patients treated with the Silverhawk device versus the patients treated with PTA. The obvious differentiation in elevation of IMT in nonfavor for patients treated with the Silverhawk device started at month 2 (max IMT SH 0.178 mm vs. IMT PTA 0.1 mm, p = 0.001) with a spike at month 5 (max IMT SH 0.206 mm vs. IMT PTA 0.145 mm, p = 0.003) and a decline once again at month 6 (max IMT SH 0.177 mm vs. IMT PTA 0.121 mm, p = 0.02). The values for mean IMT performed the same way. Although Silverhawk atherectomy provides good results at first sight, in the midterm follow-up of treatment of first instent restenosis it did not perform better than PTA as it showed elevated reoccurrence of intimal media hyperplasia.

  13. SoilSaw trademark demonstration. Final report, September 1992--January 1995

    International Nuclear Information System (INIS)

    Saugier, K.; Isaac, R.E.

    1996-02-01

    The US Department of Energy (DOE) has identified leaking underground storage tanks and buried mixed waste at numerous sites within the DOE complex. Preventing these wastes from entering the environment is a challenging task. One method of preventing waste migration is to isolate the contaminants using subsurface containment barriers. Isolation and containment can be accomplished by both in situ and ex situ methods. This report describes a novel in situ construction method of forming vertical containment barriers (slurry walls) using the SoilSaw trademark Barrier System. The SoilSaw trademark Barrier System is shown to be a feasible process for constructing subsurface vertical containment barriers to depths of fifty feet. The process is most efficient in sandy soil (including free flowing sand) with barrier construction rates of over 130 square feet per minute. Productivity diminishes to approximately 30 square feet per minute as soils become harder and more cohesive. The present hardware is designed to form a barrier of approximately 12 inch in width. Additional barrier widths can be constructed with this technology by application of wider jet heads. The requirement for a varied arrangement of barrier widths is an increase in hydraulic horse power and additional jet heads

  14. SoilSaw{trademark} demonstration. Final report, September 1992--January 1995

    Energy Technology Data Exchange (ETDEWEB)

    Saugier, K.; Isaac, R.E.

    1996-02-01

    The US Department of Energy (DOE) has identified leaking underground storage tanks and buried mixed waste at numerous sites within the DOE complex. Preventing these wastes from entering the environment is a challenging task. One method of preventing waste migration is to isolate the contaminants using subsurface containment barriers. Isolation and containment can be accomplished by both in situ and ex situ methods. This report describes a novel in situ construction method of forming vertical containment barriers (slurry walls) using the SoilSaw{trademark} Barrier System. The SoilSaw{trademark} Barrier System is shown to be a feasible process for constructing subsurface vertical containment barriers to depths of fifty feet. The process is most efficient in sandy soil (including free flowing sand) with barrier construction rates of over 130 square feet per minute. Productivity diminishes to approximately 30 square feet per minute as soils become harder and more cohesive. The present hardware is designed to form a barrier of approximately 12 inch in width. Additional barrier widths can be constructed with this technology by application of wider jet heads. The requirement for a varied arrangement of barrier widths is an increase in hydraulic horse power and additional jet heads.

  15. Bluetooth(Registered Trademark) Heart Rate Monitors for Spaceflight

    Science.gov (United States)

    Buxton, Roxanne E.; West, Michael R.; Kalogera, Kent L.; Hanson, Andrea M.

    2016-01-01

    Heart rate monitoring is required during exercise for crewmembers aboard the International Space Station (ISS) and will be for future exploration missions. The cardiovascular system must be sufficiently stressed throughout a mission to maintain the ability to perform nominal and contingency/emergency tasks. High quality heart rate data is required to accurately determine the intensity of exercise performed by the crewmembers and show maintenance of VO2max. The quality of the data collected on ISS is subject to multiple limitations and is insufficient to meet current requirements. PURPOSE: To evaluate the performance of commercially available Bluetooth® heart rate monitors (BT_HRM) and their ability to provide high quality heart rate data to monitor crew health on board ISS and during future exploration missions. METHODS: Nineteen subjects completed 30 data collection sessions of various intensities on the treadmill and/or cycle. Subjects wore several BT_HRM technologies for each testing session. One electrode-based chest strap (CS) was worn, while one or more optical sensors (OS) was worn. Subjects were instrumented with a 12-lead ECG to compare the heart rate data from the Bluetooth sensors. Each BT_RHM data set was time matched to the ECG data and a +/-5bpm threshold was applied to the difference between the two data sets. Percent error was calculated based on the number of data points outside the threshold and the total number of data points. REULTS: The electrode-based chest straps performed better than the optical sensors. The best performing CS was CS1 (1.6%error), followed by CS4 (3.3%error), CS3 (6.4%error), and CS2 (9.2%error). The OS resulted in 10.4% error for OS1 and 14.9% error for OS2. CONCLUSIONS: The highest quality data came from CS1, unfortunately it has been discontinued by the manufacturer. The optical sensors have not been ruled out for use, but more investigation is needed to determine how to get the best quality data. CS2 will be used in an

  16. Risk Metrics for Android (trademark) Devices

    Science.gov (United States)

    2017-02-01

    reasons: • Some malware families do not engage in behavior that the system was designed to detect. For instance, malware that utilizes social engineering... Procedia Computer Science 78:587–594. 4. Victor Chebyshev and Roman Unuchek. 2014. “Mobile Malware Evolution: 2013.” Kaspersky Lab ZAOs...Android Platforms: Evolution and Characterization,” Procedia Computer Science 94:465–472. 7. Amin Kharraz, William Robertson, Davide Balzarotti, Leyla

  17. Recent experience with the CQE{trademark}

    Energy Technology Data Exchange (ETDEWEB)

    Harrison, C.D.; Kehoe, D.B.; O`Connor, D.C.; Stallard, G.S.

    1997-12-31

    CQE (the Coal Quality Expert) is a software tool that brings a new level of sophistication to fuel decisions by seamlessly integrating the system-wide effects of fuel purchase decisions on power plant performance, emissions, and power generation costs. The CQE technology, which addresses fuel quality from the coal mine to the busbar and the stack, is an integration and improvement of predecessor software tools including: EPRI`s Coal Quality Information System, EPRI`s Coal Cleaning Cost Model, EPRI`s Coal Quality Impact Model, and EPRI and DOE models to predict slagging and fouling. CQE can be used as a stand-alone workstation or as a network application for utilities, coal producers, and equipment manufacturers to perform detailed analyses of the impacts of coal quality, capital improvements, operational changes, and/or environmental compliance alternatives on power plant emissions, performance and production costs. It can be used as a comprehensive, precise and organized methodology for systematically evaluating all such impacts or it may be used in pieces with some default data to perform more strategic or comparative studies.

  18. Calyx trademark EA implementation at AECB

    International Nuclear Information System (INIS)

    1997-01-01

    This report describes a project to examine the applicability of a knowledge-based decision support software for environmental assessment (Calyx) to assist the Atomic Energy Control Board in environmental screenings, assessment, management, and database searches. The report begins with background on the Calyx software and then reviews activities with regard to modification of the Calyx knowledge base for application to the nuclear sector. This is followed by lists of standard activities handled by the software and activities specific to the Board; the hierarchy of environmental components developed for the Board; details of impact rules that describe the conditions under which environmental impacts will occur (the bulk of the report); information on mitigation and monitoring rules and on instance data; and considerations for future work on implementing Calyx at the Board. Appendices include an introduction to expert systems and an overview of the Calyx knowledge base structure

  19. Applying Strategic Visualization(Registered Trademark) to Lunar and Planetary Mission Design

    Science.gov (United States)

    Frassanito, John R.; Cooke, D. R.

    2002-01-01

    NASA teams, such as the NASA Exploration Team (NEXT), utilize advanced computational visualization processes to develop mission designs and architectures for lunar and planetary missions. One such process, Strategic Visualization (trademark), is a tool used extensively to help mission designers visualize various design alternatives and present them to other participants of their team. The participants, which may include NASA, industry, and the academic community, are distributed within a virtual network. Consequently, computer animation and other digital techniques provide an efficient means to communicate top-level technical information among team members. Today,Strategic Visualization(trademark) is used extensively both in the mission design process within the technical community, and to communicate the value of space exploration to the general public. Movies and digital images have been generated and shown on nationally broadcast television and the Internet, as well as in magazines and digital media. In our presentation will show excerpts of a computer-generated animation depicting the reference Earth/Moon L1 Libration Point Gateway architecture. The Gateway serves as a staging corridor for human expeditions to the lunar poles and other surface locations. Also shown are crew transfer systems and current reference lunar excursion vehicles as well as the Human and robotic construction of an inflatable telescope array for deployment to the Sun/Earth Libration Point.

  20. Unsupervised symmetrical trademark image retrieval in soccer telecast using wavelet energy and quadtree decomposition

    Science.gov (United States)

    Ong, Swee Khai; Lim, Wee Keong; Soo, Wooi King

    2013-04-01

    Trademark, a distinctive symbol, is used to distinguish products or services provided by a particular person, group or organization from other similar entries. As trademark represents the reputation and credit standing of the owner, it is important to differentiate one trademark from another. Many methods have been proposed to identify, classify and retrieve trademarks. However, most methods required features database and sample sets for training prior to recognition and retrieval process. In this paper, a new feature on wavelet coefficients, the localized wavelet energy, is introduced to extract features of trademarks. With this, unsupervised content-based symmetrical trademark image retrieval is proposed without the database and prior training set. The feature analysis is done by an integration of the proposed localized wavelet energy and quadtree decomposed regional symmetrical vector. The proposed framework eradicates the dependence on query database and human participation during the retrieval process. In this paper, trademarks for soccer games sponsors are the intended trademark category. Video frames from soccer telecast are extracted and processed for this study. Reasonably good localization and retrieval results on certain categories of trademarks are achieved. A distinctive symbol is used to distinguish products or services provided by a particular person, group or organization from other similar entries.

  1. Impact of Advanced Age on Procedural and Acute Angiographic Outcomes in Patients Treated for Peripheral Artery Disease With Orbital Atherectomy: A CONFIRM Registries Subanalysis.

    Science.gov (United States)

    Lee, Michael S; Beasley, Robert; Adams, George L

    2015-08-01

    Data on the outcomes of elderly patients with peripheral arterial disease (PAD) who undergo orbital atherectomy are limited. This analysis compares the procedural and acute angiographic outcomes of PAD patients treated with orbital atherectomy stratified by age (≥ 75 years of age [elderly] vs atherectomy. The composite rate of adverse events including dissection, perforation, slow flow, vessel closure, spasm, embolism, and thrombus formation was compared between groups. Elderly patients had a higher proportion of females (47.5% vs 35.3%; Patherectomy resulted in similar composite rates of adverse events despite the elderly having unfavorable baseline Rutherford classification and lesion characteristics. The higher rate of perforation may be explained by longer and more below-the-knee lesions.

  2. Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease.

    Science.gov (United States)

    Foley, T Raymond; Cotter, Ryan P; Kokkinidis, Damianos G; Nguyen, Daniel D; Waldo, Stephen W; Armstrong, Ehrin J

    2017-05-01

    To assess the intraprocedural and mid-term outcomes of orbital atherectomy (OA) combined with drug-coated balloon (DCB) angioplasty for the treatment of calcified femoropopliteal disease. In this single-center cohort, 89 patients (139 lesions) were treated with DCB angioplasty for claudication or critical limb ischemia (CLI). Angiographic characteristics and procedural outcomes were reviewed for patients treated with or without adjunctive OA. Lesion calcification was graded using two previously published scoring systems, the angiographic calcium score (ACS) and the peripheral artery calcification scoring system (PACSS). Among 139 lesions, 40 (29%) were treated with OA + DCB. Mean lesion length was 135 ± 100 mm for lesions treated with OA + DCB and 139 ± 100 mm for DCB alone (P = 0.9). Moderate to severe calcification was present in 83% of patients treated with OA, compared to 42% of patients treated with DCB alone (P < 0.001). Lesions treated with OA + DCB were less likely to require bailout stenting (18% vs. 39%, P =0.01). Rates of embolization (0% in OA + DCB vs. 2% in DCB only, P = 0.4), dissection (13% vs. 14%, P = 0.8), and perforation (0%) did not differ significantly between groups. The freedom from TLR at 1 year was 82% in both groups (P = 0.6) while primary patency was 81% in-patients treated with DCB alone and 77% in-patients treated with DCB with concomitant OA (P = 0.8). In this single-center analysis of patients undergoing DCB angioplasty for claudication or CLI, OA was most often used for the treatment of severely calcified lesions. These lesions were more likely to be treated with scoring balloons and less likely to require bailout stenting. At 1 year, target lesion revascularization and primary patency was similar in patients treated with and without adjunctive OA, despite the higher lesion complexity among those receiving the combination procedure. © 2017 Wiley Periodicals, Inc. © 2017 Wiley

  3. The AMTEX Partnership{trademark}. Fourth quarter report, September 1994

    Energy Technology Data Exchange (ETDEWEB)

    Lemon, D.K.; Quisenberry, R.K.

    1994-06-01

    The AMTEX Partnership{trademark} is a collaborative research and development program among the US Integrated Textile Industry, the Department of Energy (DOE), the DOE laboratories, other federal agencies and laboratories, and universities. The goal of AMTEX is to strengthen the competitiveness of this vital industry, thereby preserving and creating US jobs. The operational and program management of the AMTEX Partnership is provided by the Program Office. This report is produced by the Program Office on a quarterly basis and provides information on the progress, operations, and project management of the partnership.

  4. MCNP trademark Monte Carlo: A precis of MCNP

    International Nuclear Information System (INIS)

    Adams, K.J.

    1996-01-01

    MCNP trademark is a general purpose three-dimensional time-dependent neutron, photon, and electron transport code. It is highly portable and user-oriented, and backed by stringent software quality assurance practices and extensive experimental benchmarks. The cross section database is based upon the best evaluations available. MCNP incorporates state-of-the-art analog and adaptive Monte Carlo techniques. The code is documented in a 600 page manual which is augmented by numerous Los Alamos technical reports which detail various aspects of the code. MCNP represents over a megahour of development and refinement over the past 50 years and an ongoing commitment to excellence

  5. Expression of IGF-I, IGF-I receptor and IGF binding proteins-1, -2, -3, -4 and -5 in human atherectomy specimens.

    Science.gov (United States)

    Grant, M B; Wargovich, T J; Ellis, E A; Tarnuzzer, R; Caballero, S; Estes, K; Rossing, M; Spoerri, P E; Pepine, C

    1996-12-17

    The molecular and cellular processes that induce rapid atherosclerotic plaque progression in patients with unstable angina and initiate restenosis following coronary interventional procedures are uncertain. We examined primary (de novo) and restenotic lesions retrieved at the time of directional coronary atherectomy for expression of insulin-like-growth factor-I (IGF-I). IGF-I receptor, and five IGF binding proteins (IGFBPs), IGFBP-1, IGFBP-2, IGFBP-3, IGFBP-4, and IGFBP-5 in smooth muscle cells (SMCs) using colloidal gold immunocytochemistry. IGF-1, its receptor and binding proteins were not detected in SMCs of normal coronary arteries. IGF-I localized primarily in synthetic smooth muscle cells (sSMCs) in both de novo and restenotic plaques. IGF-I receptor localized on sSMCs and their processes and colocalized with IGF-I. Although morphometric analysis of IGF-I and IGF-I receptor immunoreactivity in sSMCs of de novo and restenotic lesions showed comparable levels of IGF-I (3.2 +/- 1.0 and 2.9 +/- 0.9, respectively). IGF-I receptor was significantly higher in de novo lesions as compared to restenotic lesions (10.7 +/- 2.5 and 4.2 +/- 1.3, P system.

  6. Development and Positioning of the Collective Product of Slovenian Craft Trademark

    Directory of Open Access Journals (Sweden)

    Adrijana Poljanšek

    2017-09-01

    Full Text Available The new collective trademark Izdelek slovenske obrti (hereinafter: PSC; English: Product of Slovenian Craft was launched on the market in 2014. The initiative for the trademark was provided by the Textile Section at the Chamber of Craft and Small Business of Slovenia (hereinafter: the OZS, which also registered the trademark. Members of the OZS have the right to obtain and use the trademark, and to use it to promote their products or services. After two years, only a small number of section members use the trademark. Because the section would like to see an increased number of members use the trademark, research regarding the latter was carried out. The results are presented in this article. The descriptive course of development and registration of the collective trademark PSC is presented in the first part of our research. In the second part, questionnaires were drafted for collective trademark PSC users, potential users and consumers. The results obtained using three questionnaires were analysed using a SWOT analysis. Based on the results, it was determined that the trademark has not yet been properly positioned on the Slovenian market. Advantages include the familiarity of Textile Section members with the trademark, and their eagerness to use it. One disadvantage is the trademark’s current lack of recognition among consumers. For this reason, section members who are also potential users of the trademark do not give it priority and therefore do not opt to use it. The following will impact the trademark’s recognition among consumers: innovative marketing campaigns, the inclusion of the media and social networks, the improved recognition and visibility of the logotype, and an effective and pervasive slogan, as was determined in our research.

  7. Development of the SEAtrace{trademark} barrier verification and validation technology. Final report

    Energy Technology Data Exchange (ETDEWEB)

    Dunn, S.D.; Lowry, W.; Walsh, R.; Rao, D.V. [Science and Engineering Associates, Santa Fe, NM (United States); Williams, C. [Sandia National Labs., Albuquerque, NM (United States). Underground Storage Technology Dept.

    1998-08-01

    In-situ barrier emplacement techniques and materials for the containment of high-risk contaminants in soils are currently being developed by the Department of Energy (DOE). Because of their relatively high cost, the barriers are intended to be used in cases where the risk is too great to remove the contaminants, the contaminants are too difficult to remove with current technologies, or the potential movement of the contaminants to the water table is so high that immediate action needs to be taken to reduce health risks. Assessing the integrity of the barrier once it is emplaced, and during its anticipated life, is a very difficult but necessary requirement. Science and Engineering Associates, Inc., (SEA) and Sandia National Laboratories (SNL) have developed a quantitative subsurface barrier assessment system using gaseous tracers in support of the Subsurface Contaminants Focus Area barrier technology program. Called SEAtrace{trademark}, this system integrates an autonomous, multi-point soil vapor sampling and analysis system with a global optimization modeling methodology to locate and size barrier breaches in real time. The methodology for the global optimization code was completed and a prototype code written using simplifying assumptions. Preliminary modeling work to validate the code assumptions were performed using the T2VOC numerical code. A multi-point field sampling system was built to take soil gas samples and analyze for tracer gas concentration. The tracer concentration histories were used in the global optimization code to locate and size barrier breaches. SEAtrace{trademark} was consistently able to detect and locate leaks, even under very adverse conditions. The system was able to locate the leak to within 0.75 m of the actual value, and was able to determine the size of the leak to within 0.15 m.

  8. Development of the SEAtrace trademark barrier verification and validation technology. Final report

    International Nuclear Information System (INIS)

    Dunn, S.D.; Lowry, W.; Walsh, R.; Rao, D.V.; Williams, C.

    1998-08-01

    In-situ barrier emplacement techniques and materials for the containment of high-risk contaminants in soils are currently being developed by the Department of Energy (DOE). Because of their relatively high cost, the barriers are intended to be used in cases where the risk is too great to remove the contaminants, the contaminants are too difficult to remove with current technologies, or the potential movement of the contaminants to the water table is so high that immediate action needs to be taken to reduce health risks. Assessing the integrity of the barrier once it is emplaced, and during its anticipated life, is a very difficult but necessary requirement. Science and Engineering Associates, Inc., (SEA) and Sandia National Laboratories (SNL) have developed a quantitative subsurface barrier assessment system using gaseous tracers in support of the Subsurface Contaminants Focus Area barrier technology program. Called SEAtrace trademark, this system integrates an autonomous, multi-point soil vapor sampling and analysis system with a global optimization modeling methodology to locate and size barrier breaches in real time. The methodology for the global optimization code was completed and a prototype code written using simplifying assumptions. Preliminary modeling work to validate the code assumptions were performed using the T2VOC numerical code. A multi-point field sampling system was built to take soil gas samples and analyze for tracer gas concentration. The tracer concentration histories were used in the global optimization code to locate and size barrier breaches. SEAtrace trademark was consistently able to detect and locate leaks, even under very adverse conditions. The system was able to locate the leak to within 0.75 m of the actual value, and was able to determine the size of the leak to within 0.15 m

  9. Aggressive plaque modification with rotational atherectomy and cutting balloon for optimal stent expansion in calcified lesions

    Science.gov (United States)

    Tang, Zhe; Bai, Jing; Su, Shao-Ping; Lee, Pui-Wai; Peng, Liang; Zhang, Tao; Sun, Ting; Nong, Jing-Guo; Li, Tian-De; Wang, Yu

    2016-01-01

    Objective To evaluate the factors affecting optimal stent expansion in calcified lesions treated by aggressive plaque modification with rotational atherectomy (RA) and a cutting balloon (CB). Methods From January 2014 to May 2015, 92 patients with moderate to severe coronary calcified lesions underwent rotational atherectomy and intravascular ultrasound imaging at Chinese PLA General Hospital (Beijing, China) were included in this study. They were divided into a rotational artherectomy combined with cutting balloon (RACB) group (46 patients treated with RA followed by CB angioplasty) and an RA group (46 patients treated with RA followed by plain balloon angioplasty). Another 40 patients with similar severity of their calcified lesions treated with plain old balloon angioplasty (POBA) were demographically matched to the other groups and defined as the POBA group. All patients received a drug-eluting stent after plaque preparation. Lumen diameter and lumen diameter stenosis (LDS) were measured by quantitative coronary angiography at baseline, after RA, after dilatation, and after stenting. Optimal stent expansion was defined as the final LDS < 10%. Results The initial and post-RA LDS values were similar among the three groups. However, after dilatation, the LDS significantly decreased in the RACB group (from 54.5% ± 8.9% to 36.1% ± 7.1%) but only moderately decreased (from 55.7% ± 7.8% to 46.9% ± 9.4%) in the RA group (time × group, P < 0.001). After stenting, there was a higher rate of optimal stent expansion in the RACB group (71.7% in the RACB group, 54.5% in the RA group, and 15% in the POBA group, P < 0.001), and the final LDS was significantly diminished in the RACB group compared to the other two groups (6.0% ± 2.3%, 10.8% ± 3.3%, 12.7% ± 2.1%, P < 0.001). Moreover, an LDS ≤ 40% after plaque preparation (OR = 2.994, 95% CI: 1.297–6.911) was associated with optimal stent expansion, which also had a positive correlation with the appearance of a

  10. Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency

    Science.gov (United States)

    Langhoff, Ralf; Rocha-Singh, Krishna J.; Jaff, Michael R.; Blessing, Erwin; Amann-Vesti, Beatrice; Krzanowski, Marek; Peeters, Patrick; Scheinert, Dierk; Torsello, Giovanni; Sixt, Sebastian; Tepe, Gunnar

    2017-01-01

    Background— Studies assessing drug-coated balloons (DCB) for the treatment of femoropopliteal artery disease are encouraging. However, challenging lesions, such as severely calcified, remain difficult to treat with DCB alone. Vessel preparation with directional atherectomy (DA) potentially improves outcomes of DCB. Methods and Results— DEFINITIVE AR study (Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency—A Pilot Study of Anti-Restenosis Treatment) was a multicenter randomized trial designed to estimate the effect of DA before DCB to facilitate the development of future end point-driven randomized studies. One hundred two patients with claudication or rest pain were randomly assigned 1:1 to DA+DCB (n=48) or DCB alone (n=54), and 19 additional patients with severely calcified lesions were treated with DA+DCB. Mean lesion length was 11.2±4.0 cm for DA+DCB and 9.7±4.1 cm for DCB (P=0.05). Predilation rate was 16.7% for DA+DCB versus 74.1% for DCB; postdilation rate was 6.3% for DA+DCB versus 33.3% for DCB. Technical success was superior for DA+DCB (89.6% versus 64.2%; P=0.004). Overall bail-out stenting rate was 3.7%, and rate of flow-limiting dissections was 19% for DCB and 2% for DA+DCB (P=0.01). One-year primary outcome of angiographic percent diameter stenosis was 33.6±17.7% for DA+DCB versus 36.4±17.6% for DCB (P=0.48), and clinically driven target lesion revascularization was 7.3% for DA+DCB and 8.0% for DCB (P=0.90). Duplex ultrasound patency was 84.6% for DA+DCB, 81.3% for DCB (P=0.78), and 68.8% for calcified lesions. Freedom from major adverse events at 1 year was 89.3% for DA+DCB and 90.0% for DCB (P=0.86). Conclusions— DA+DCB treatment was effective and safe, but the study was not powered to show significant differences between the 2 methods of revascularization in 1-year follow-up. An adequately powered randomized trial is warranted. Clinical Trial Registration— http

  11. 16 CFR 303.41 - Use of fiber trademarks and generic names in advertising.

    Science.gov (United States)

    2010-01-01

    ... use of a fiber trademark shall require a full disclosure of the fiber content information required by... or generic name is used in non-required information in advertising, such fiber trademark or generic... advertising. 303.41 Section 303.41 Commercial Practices FEDERAL TRADE COMMISSION REGULATIONS UNDER SPECIFIC...

  12. 19 CFR 133.22 - Restrictions on importation of articles bearing copying or simulating trademarks.

    Science.gov (United States)

    2010-04-01

    ... shall be detained for 30 days from the date on which the goods are presented for Customs examination, to... counterfeit trademarks. The provisions of paragraph (c)(1) of this section are not applicable to articles bearing counterfeit trademarks at the time of importation (see § 133.26). (e) Release of detained articles...

  13. 77 FR 58097 - Extension of Comment Period for Notice of Inquiry Regarding Adjustment of Fees for Trademark...

    Science.gov (United States)

    2012-09-19

    ... Trademark Assistance Center, Concourse Level, James Madison Building-East Wing, 600 Dulany Street... , and will also be available at the Office of the Commissioner for Trademarks, Madison East, Tenth Floor...

  14. Evaluation of the Pullback Atherectomy Catheter in the Treatment of Lower Limb Vascular Disease

    International Nuclear Information System (INIS)

    Grubnic, Sisa; Heenan, Susan D.; Buckenham, Timothy M.; Belli, Anna-Maria

    1996-01-01

    Purpose: To evaluate prospectively the Pullback Atherectomy Catheter (PAC) in terms of its technical success and 1-year patency in the treatment of lower limb vascular disease. Methods: Thirty-nine PAC procedures were performed in 34 patients to treat atherosclerotic disease (occlusive in 51%) of the femoropopliteal arteries, including four cases of graft neointimal hyperplasia and three dissection flaps. Follow-up was by ankle - brachial indices at 24 hr and 1 month, and arteriography at 6 and 12 months. Results: Technical success was achieved in 38 of 39 procedures (97.4%). There was a reduction in mean stenosis from 89.4% to 12.1%, but 69.2% of procedures required additional balloon dilatation to achieve an adequate arterial lumen. Complications followed 15.4% of procedures, a third of which required surgery. Conclusion: The PAC is an easy and relatively safe catheter to use, but does not provide a satisfactory arterial lumen without additional percutaneous transluminal angioplasty (PTA). It proved to be effective, however, in the treatment of graft neointimal hyperplasia and in the resection of obstructive intimal flaps following PTA

  15. Peeled Guidewire Coating with Debulked Plaque Obtained by Directional Coronary Atherectomy

    Directory of Open Access Journals (Sweden)

    Rikuta Hamaya

    2017-01-01

    Full Text Available Percutaneous directional coronary atherectomy (DCA is a plaque debulking method performed in Japan, and recently a renewed DCA device has been launched. We present a case with a tight left anterior descending lesion undergoing percutaneous coronary intervention with application of DCA. After several sessions of DCA, white plaques accompanied by green, stringed materials were obtained from the device; some materials were considerably long (approximately 15 mm in length. A drug-eluting stent was subsequently implanted, and the procedure was completed successfully without any complications. The extracted plaques and artificial materials were pathologically examined, and no inflammatory changes were detected on plaques adjacent to the material. Assessing pathological findings and structure of the DCA catheter, the obtained artificial materials were considered as peeled guidewire, possibly resulting from the friction between the guidewire and metallic bearing in the housing of DCA catheter. Of note, this phenomenon has been recognized even in other DCA cases in which guidewires of the other kind are used. We report this phenomenon for the first time, warning of theoretically possible distal embolization of artificial materials caused by any debulking devices.

  16. Neointimal hyperplasia after silverhawk atherectomy versus percutaneous transluminal angioplasty (PTA) in femoropopliteal stent reobstructions: a controlled, randomized pilot trial.

    Science.gov (United States)

    Brodmann, Marianne; Rief, Peter; Froehlich, Harald; Dorr, Andreas; Gary, Thomas; Eller, Philipp; Hafner, Franz; Deutschmann, Hannes; Seinost, Gerald; Pilger, Ernst

    2013-02-01

    Due to intimal hyperplasia instent reobstruction in the femoropopliteal arterial segment is still an unsolved problem. Different techniques have been discussed in case of reintervention to guarantee longlasting patency rate. We conducted a randomized, controlled, pilot trial comparing Silverhawk atherectomy with percutaneous transluminal angioplasty (PTA) in patients with a first instent reobstruction in the femoropopliteal arterial segment, to evaluate intima media thickness (IMT) within the treated segment, as a parameter of recurrence of intimal hyperplasia. In a total 19 patients were included: 9 patients in the atherectomy device and 10 patients in the PTA arm. IMT within the treated segment was statistically significantly elevated in all patients treated with the Silverhawk device versus the patients treated with PTA. The obvious differentiation in elevation of IMT in nonfavor for patients treated with the Silverhawk device started at month 2 (max IMT SH 0.178 mm vs. IMT PTA 0.1 mm, p = 0.001) with a spike at month 5 (max IMT SH 0.206 mm vs. IMT PTA 0.145 mm, p = 0.003) and a decline once again at month 6 (max IMT SH 0.177 mm vs. IMT PTA 0.121 mm, p = 0.02). The values for mean IMT performed the same way. Although Silverhawk atherectomy provides good results at first sight, in the midterm follow-up of treatment of first instent restenosis it did not perform better than PTA as it showed elevated reoccurrence of intimal media hyperplasia.

  17. Restenosis after hot-tip laser-balloon angioplasty: histologic evaluation of the samples removed by Simpson atherectomy

    Science.gov (United States)

    Barbieri, Enrico; Tanganelli, Pietro; Taddei, Giuseppe; Perbellini, Antonio; Attino, Vito; Destro, Gianni; Zardini, Piero

    1991-05-01

    Laser balloon angioplasty has been used in recent years to treat peripheral artery disease. Despite a primary success the technique is plagued by a high restenosis rate. Directional atherectomy was performed in a small group of patients affected by primitive stenosis or restenosis after an invasive procedure. Light microscopy, immunohistochemistry, and transmission electron microscopy have identified the cellular component of intimal hyperplasia as smooth muscle cells in an active synthetic phenotype. The arterial healing process after invasive procedures seems to develop similarly independently of the device employed.

  18. 77 FR 3745 - Establishment of a One-Year Retention Period for Trademark-Related Papers That Have Been Scanned...

    Science.gov (United States)

    2012-01-25

    ... to the USPTO's past practice of indefinitely retaining papers that have been scanned into TICRS stems... One-Year Retention Period for Trademark- Related Papers That Have Been Scanned Into the Trademark... retention period that began on September 26, 2011, for papers scanned into the Trademark Initial Capture...

  19. The Flight Control System of the Hovereye (Trademark) VTOL UAV

    National Research Council Canada - National Science Library

    Binetti, Paolo; Trouchet, Daniel; Pollini, Lorenzo; Innocenti, Mario; Hamel, Tarek; Le Bras, Florent

    2007-01-01

    .... Hovereye is a demonstrator of a short range reconnaissance platform in support of army units engaged in urban combat, such as in peace-keeping missions, with an electro-optic day or night camera payload...

  20. The Flight Control System of the Hovereye (Trademark) VTOL UAV

    Science.gov (United States)

    2007-05-01

    10 RTO-MP-AVT-146 UNCLASSIFIED/UNLIMITED UNCLASSIFIED/UNLIMITED Envelope protection -+ SISO linear Controllers α_dotc Cinematic decoupler ωc αest...T. Ward, “Reentry Vehicle Flight Controls Design Guidelines: Dynamic Inversion”, NASA/TP-2002–210771, March 2002 [14] Pollini, L., Innocenti, M

  1. Pooled analysis of the CONFIRM registries: impact of gender on procedure and angiographic outcomes in patients undergoing orbital atherectomy for peripheral artery disease.

    Science.gov (United States)

    Lee, Michael S; Canan, Timothy; Rha, Seung-Woon; Mustapha, Jihad; Adams, George L

    2015-02-01

    To compare the acute procedure and angiographic outcomes of peripheral artery disease (PAD) patients treated with orbital atherectomy stratified by gender. The CONFIRM I, II, and III registries are US multicenter, nonrandomized, all-comers registries of PAD patients who were treated with orbital atherectomy. All patients with gender specified in the registry database were included in the current analysis, which compared the final residual stenosis achieved after atherectomy and the rate of acute complications in female and male patients. The 3 registries included 3131 patients with 4761 lesions: 1261 women (mean age 73.2 ± 10.7 years) with 1874 lesions and 1870 men (mean age 70.4 ± 10.2) with 2887 lesions. The women were older (p atherectomy in both men and women; however, women had a higher rate of dissection (all types). This difference is likely because of the older age and higher percentage of critical limb ischemia in women in this cohort. These results, however, suggest that additional studies should be completed to further understand the increased risks for women vs. men during endovascular procedures. © The Author(s) 2015.

  2. Fat-Suppressed Gadolinium-Enhanced Three-Dimensional Magnetic Resonance Angiography Adequately Depicts the Status of Iliac Arteries Following Atherectomy and Stent Placement

    International Nuclear Information System (INIS)

    Amano, Yasuo; Gemma, Kazuhito; Kawamata, Hiroshi; Kumazaki, Tatsuo

    1998-01-01

    Fat-suppressed, three-dimensional magnetic resonance angiography (3D MRA) was performed on nine patients with 11 iliac artery stenoses following atherectomy or stent placement. The MRA accurately depicted continued patency, restenosis, or aneurysm formation when compared with immediate posttreatment conventional arteriography. Therefore MRA is accurate and can be used independently for clinical decision making

  3. Percutaneous transluminal rotational atherectomy in the treatment of peripheral vascular disease using a transluminal endatherectomy catheter (TEC): Initial results and angiographic follow-up

    International Nuclear Information System (INIS)

    Rilinger, Norbert; Goerich, Johannes; Scharrer-Pamler, Reinhard; Vogel, Jochen; Tomczak, Reinhard; Merkle, Elmar; Sokiranski, Roman; Brambs, Hans-Juergen

    1997-01-01

    Purpose. To evaluate the clinical results of percutaneous transluminal rotational atherectomy in the treatment of peripheral vascular disease. Methods. Rotational atherectomy was performed in 39 patients aged 39-87 years (mean 66.6 years). A total of 71 lesions (43 stenoses and 28 occlusions) were treated in 40 limbs. Additional balloon angioplasty was required in 54% of lesions. Fifteen patients (37.5%) presented in Fontaine stage II, 10 patients (25%) in Fontaine stage III and 15 patients (37.5%) in Fontaine stage IV. Rotational atherectomy at 750 rpm was carried out over a 0.014-inch guidewire with continuous aspiration into a vacuum, bottle. Follow-up angiography and color flow Doppler examinations were performed in 22 patients (23 limbs) after a mean period of 6 months (range 2-14 months). Results. There was one primary technical failure. In 36 of 40 lesions there was a good angiographic result with residual stenoses in less than 30%. In 70 lesions treated by rotational atherectomy, however, 54% showed residual stenoses of 30%-50% and these cases required additional balloon angioplasty. The mean ankle-brachial index improved significantly (p<0.001), from 0.49 before the procedure to 1.01 after the procedure. A single distal embolus, related to primary recanalization, occurred and there were two large inguinal hematomas. Cumulative clinical patency after 6 months was 83.8% and cumulative angiographic patency after 6 months was 79.1%. Conclusion. Percutaneous rotational atherectomy is a promising approach for the treatment of chronic peripheral vascular disease. Further prospective, randomized studies are necessary to compare percutaneous transluminal angioplasty with this new technical approach

  4. Competition in prescription drug markets: the roles of trademarks, advertising, and generic names.

    Science.gov (United States)

    Feldman, Roger; Lobo, Félix

    2013-08-01

    We take on two subjects of controversy among economists-advertising and trademarks-in the context of the market for generic drugs. We outline a model in which trademarks for drug names reduce search costs but increase product differentiation. In this particular framework, trademarks may not benefit consumers. In contrast, the generic names of drugs or "International Nonproprietary Names" (INN) have unquestionable benefits in both economic theory and empirical studies. We offer a second model where advertising of a brand-name drug creates recognition for the generic name. The monopoly patent-holder advertises less than in the absence of a competitive spillover.

  5. Operational experience for the latest generation of ATRIUM trademark 10 fuel assemblies

    International Nuclear Information System (INIS)

    Schoss, Volker; Hoffmann, Petra Britt; Schaefer, Jens

    2011-01-01

    AREVA NP's ATRIUM trademark 10 product family was first introduced to the BWR market in 1992. Lead test campaigns confirmed the outstanding product performance and justified introduction of reload quantities. Further development of particular product features was demonstrated and implemented in the fuel design to meet highest expectations for reliability and fuel economics. The latest generation called ATRIUM trademark 10XP and subsequently ATRIUM trademark 10XM was introduced in 2002 and 2005, respectively. The first lead test assemblies completed their operation successfully after seven cycles. (orig.)

  6. Advanced power conversion based on the Aerocapacitor{trademark}. Final report

    Energy Technology Data Exchange (ETDEWEB)

    Roark, D.

    1997-03-05

    This report summarizes work performed under contract No. DE-FC07-94ID13283, {open_quotes}Advanced Power Conversion Based on the Aerocapacitors{trademark}.{close_quotes} Under this contract high power density, high energy density, organic electrolyte Aerocapacitors{trademark} were developed and characterized for power conversion applications. Pilot facilities for manufacturing prototype AA-size Aerocapacitors{trademark} were put in place. The low ESR and good frequency response of these devices show that they are ideal components for high discharge rate and low to moderate frequency (< 10 kHz) applications such as power conversion.

  7. Trademark protection for store designs. One trademark a day keeps apple’s competitors away

    Directory of Open Access Journals (Sweden)

    Thomas Farkas

    2014-11-01

    Full Text Available Companies spend a significant part of their investment in order to create a Brand experience for the consumer. Besides large sums spent on the design of consumer goods, companies such as Apple are eager to create a brand experience by implementing a certain store design. Hence, these companies have a well-reasoned urge to protect such distinct store designs utilizing the current intellectual property system. In the tradition of the U.S. approach, where the get-up of a business venue can be protected by trade dress law, the most recent European Jurisprudence seems to tend towards the protection of such a get-up by trade mark law. As this could be good news for companies with a distinct store concept and design, this new approach also raises some concern: How will the protection of the get-up of a business venue affect competition? What are the measures to guarantee only distinct and non-functional store designs will find their way into the holy land of trade mark protection? This article analyzes and compares the current legal situation in the U.S. and the EU and discusses the available measures in place that will safeguard an undistorted competition.

  8. 26 CFR 1.177-1 - Election to amortize trademark and trade name expenditures.

    Science.gov (United States)

    2010-04-01

    ... franchises or rights to the use of a trademark or trade name. Generally, section 177 will apply to... beginning after December 31, 1955, shall, within the time prescribed by law (including extensions thereof...

  9. 7 CFR 1206.52 - Patents, copyrights, trademarks, information, publications, and product formulations.

    Science.gov (United States)

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Patents, copyrights, trademarks, information... Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE MANGO PROMOTION, RESEARCH, AND INFORMATION Mango Promotion, Research...

  10. Real-time billboard trademark detection and recognition in sports video

    Science.gov (United States)

    Bu, Jiang; Lao, Song-Yan; Bai, Liang

    2013-03-01

    Nowadays, different applications like automatic video indexing, keyword based video search and TV commercials can be developed by detecting and recognizing the billboard trademark. We propose a hierarchical solution for real-time billboard trademark recognition in various sports video, billboard frames are detected in the first level, fuzzy decision tree with easily-computing features are employed to accelerate the process, while in the second level, color and regional SIFT features are combined for the first time to describe the appearance of trademarks, and the shared nearest neighbor (SNN) clustering with x2 distance is utilized instead of traditional K-means clustering to construct the SIFT vocabulary, at last, Latent Semantic Analysis (LSA) based SIFT vocabulary matching is performed on the template trademark and the candidate regions in billboard frame. The preliminary experiments demonstrate the effectiveness of the hierarchical solution, and real time constraints are also met by our solution.

  11. Physicochemical characterization of different trademarks of compound Yerba Maté and their herbs

    OpenAIRE

    Scipioni,Griselda Patricia; Ferreyra,Darío Jorge; Schmalko,Miguel Eduardo

    2007-01-01

    The objectives of this study were to evaluate the physicochemical characteristics of the main herbs used in the mixture of yerba maté with other aromatic herbs and the characterization of the trademarks of compound yerba maté. Moisture, water extract, total ash, acid-insoluble ash and caffeine concentration were determined. Results showed higher values of moisture content, total and aci-insoluble ash and lower water extracts in the herbs. Determinations were carried out in nine trademarks of ...

  12. Diphonix trademark Resin: A review of its properties and applications

    International Nuclear Information System (INIS)

    Chiarizia, R.; Horwitz, E.P.; Alexandratos, S.D.

    1995-01-01

    The recently developed Diphonix trademark resin is a new multifunctional chelating ion exchange resin containing seminally substituted diphosphonic acid ligands chemically bonded to a styrene-based polymeric matrix. Diphonix can be regarded as a dual mechanism polymer, with a sulfonic acid cation exchange group allowing for rapid access, mostly non-specific, of ions into the polymeric network, and the diphosphonic acid group responsible for specificity (recognition) for a number of metal cations. The Diphonix resin exhibits an extraordinarily strong affinity for actinides, especially in the tetra- and hexavalent oxidation states. It has potential applications in TRU and mixed waste treatment and characterization, and in the development of new procedures for rapid actinide preconcentration and separation from environmental samples. Metal uptake studies have been extended to alkaline earth cations, to transition and post transition metal species, and to metal sorption from neutral or near neutral solutions. Also the kinetic behavior of the resin has been investigated in detail. Influence of the most commonly occurring matrix constituents (Na, Ca, Al, Fe, hydrofluoric, sulfuric, oxalic and phosphoric acids) on the uptake of actinide ions has been measured. This review paper summarizes the most important results studies on the Diphonix resin and gives an overview of the applications already in existence or under development in the fields of mixed waste treatment, actinide separation procedures, treatment of radwaste from nuclear power plants, and removal of iron from copper electrowinning solutions

  13. Savings potential of ENERGY STAR (registered trademark) voluntary labeling programs

    International Nuclear Information System (INIS)

    Webber, Carrie A.; Brown, Richard E.

    1998-01-01

    In 1993 the U.S. Environmental Protection Agency (EPA) introduced ENERGY STAR (registered trademark), a voluntary labeling program designed to identify and promote energy-efficient products. Since then EPA, now in partnership with the U.S. Department of Energy (DOE), has introduced programs for more than twenty products, spanning office equipment, residential heating and cooling equipment, new homes, commercial and residential lighting, home electronics, and major appliances. We present potential energy, dollar and carbon savings forecasts for these programs for the period 1998 to 2010. Our target market penetration case represents our best estimate of future ENERGY STAR savings. It is based on realistic market penetration goals for each of the products. We also provide results under the assumption of 100% market penetration; that is, we assume that all purchasers buy ENERGY STAR-compliant products instead of standard efficiency products throughout the analysis period. Finally, we assess the sensitivity of our target penetration case forecasts to greater or lesser marketing success by EPA and DOE, lower-than-expected future energy prices, and higher or lower rates of carbon emission by electricity generators. The potential savings of ENERGY STAR are substantial. If all purchasers chose Energy Star-compliant products instead of standard efficiency products over the next 15 years, they would save more than$100 billion on their energy bills during those 15 years. (Bill savings are in 1995 dollars, discounted at a 4% real discount rate.)

  14. Quantum-CEP trademark for mixed waste processing

    International Nuclear Information System (INIS)

    Nahass, P.; Sekula-Moise, P.A.; Chanenchuk, C.A.

    1994-01-01

    No commercially available technology exists to effectively treat the hundreds of thousands of tons of mixed waste stored and generated in the United States and worldwide. Catalytic Extraction Processing (CEP) is an innovative flexible recycling technology which has inherent advantages for processing mixed wastes in a wide variety of chemical and physical forms. CEP uses a molten metal bath to completely dissociate feeds and recombine them with selected reactants to form useful products. Dissolved carbon in the metal bath creates a reducing atmosphere, readily converting hydrocarbons to synthesis gas, metals to alloys in their reduced state, and inorganics to an engineered ceramic phase. Process conditions can be manipulated to strongly favor partitioning of select radionuclides to a nonleachable vitreous phase, ready for final form disposal. Molten Metal Technology has adapted its CEP technology for radioactive processing and has delivered Quantum-CEP trademark units to customers for demonstration of mixed waste processing leading to commercial scale installations for reducing both private and government inventories. Agreements have also been reached to build commercial CEP facilities to recycle hazardous and industrial wastes

  15. The AMTEX Partnership{trademark}: Creating and implementing a vision

    Energy Technology Data Exchange (ETDEWEB)

    Liebetrau, S.F.; Erickson, M.D.; Lemon, D.K.

    1993-12-01

    The vision and creativity of the multilaboratory team nominated for a special award resulted in the AMTEX Partnership{trademark}, a pace-setting agreement between US Department of Energy national laboratories and the US textile industry. The AMTEX Partnership is a role model for America to follow that brings the resources of government to bear on industrial needs while preserving the American values of free enterprise and fairness of opportunity. Together, the nominees created an important vision of the future. They capitalized on a government-sponsored workshop that provided an opportunity for industry to hear about laboratory capabilities. At the workshop, they attracted the attention of the integrated textile industry, a major segment of US industry whose economic future is very much at risk. They listened to the industry representatives, grasped the scope and implications of the industry`s needs - and recognized the potential for large-scale collaboration. In keeping with the scale of this prospect, they guided nine national laboratories from traditional ways of technology transfer into a cooperative venture with an entire vertically integrated industry.

  16. Results of immunoscintigraphy of osteomyelitis (LeukoScan) trademark

    International Nuclear Information System (INIS)

    Gratz, S.; Becker, W.

    2000-01-01

    99mTc-labeled antigranulocyte monoclonal antibody Fab' fragments have shown a high sensitivity and specificity for detecting osteomyelitis in prospective studies. We retrospectively evaluated the use of LeukoScan trademark (Immunomedics, Morris Plains, N.J.) in clinical routine for the detection of bone and soft tissue infections and we want to present the results of our findings as well as some of the more interesting cases in this occasion. Imaging infection can be performed fast and easy with 99m Tc-Fab' fragments due to a fast targeting of infection and good background clearance, which increases in imaging quality. The application of 99m Tc-Fab' fragments gives good results in patients with bone and soft tissue infections of peripheral bones, as well as in patients with infected prostheses and infected arthritis. The use of 99m Tc-Fab' fragments should not be limited to these patients only, since good results can also be achieved in patients with infections of vascular grafts, of appendicitis and of endocarditis as well. A higher number of false-negative results has to be expected in case of subacute/chronic infections instead. Independent of the grade of infection acute/subacute infections of the spine always show 'cold lesions'. If cold lesions are used as guide for diagnosing a pathologic finding, an increase in sensitivity together with a decrease in specificity can be achieved. (orig.) [de

  17. Immediate and intermediate-term results of optical coherence tomography guided atherectomy in the treatment of peripheral arterial disease: Initial results from the VISION trial

    International Nuclear Information System (INIS)

    Cawich, Ian; Paixao, Andre R.M.; Marmagkiolis, Konstantinos; Lendel, Vasili; Rodriguez-Araujo, Gerardo; Rollefson, William A.; Mego, David M.; Cilingiroglu, Mehmet

    2016-01-01

    Background: Long-term patency rates for percutaneous peripheral arterial interventions are suboptimal. Optical coherence tomography (OCT) guided atherectomy may yield superior patency by optimizing plaque removal while preserving the tunica media and adventitia. Methods: The VISION study is a multicenter prospective study of patients with peripheral arterial disease undergoing OCT guided atherectomy with the Pantheris™ device. In 11 patients enrolled in a single center, we report procedural and clinical outcomes, at 30 days and 6 months. Results: The mean age was 63 ± 11 years and 73% (n = 8) were men. The target lesion was in the superficial femoral artery in 82% (n = 9) of the patients. Mean stenosis severity was 87% ± 10% and mean lesion length was 39 ± 31 mm. Procedural success was observed in all patients with no device related complications. Mean post-atherectomy stenosis was 18% ± 15%. Almost all excised tissue consisted of intimal plaque (94%). At 30 days, significant improvements in Rutherford class, VascuQoL scores and ABI were observed, 0.9 ± 0.8 vs. 3.1 ± 0.7 (p = 0.01), 4.9 ± 1.9 vs. 3.6 ± 1.5 (p = 0.03) and 1.04 ± 0.19 vs. 0.80 ± 0.19 (p < 0.01) respectively. At 6 months, there were significant improvements in Rutherford class (1.0 ± 1.0 vs. 3.1 ± 0.7, p = 0.01) and ABI (0.93 ± 0.19 versus 0.80 ± 0.19, p = 0.02) but not in VascuQoL scores (3.7 ± 1.4 versus 3.6 ± 1.5, p = 0.48). Target lesion revascularization occurred in 18% (n = 2) of the patients. Conclusion: OCT guided atherectomy resulted in high procedural success, no device related complications and encouraging results up to 6 months. Histological analysis suggested little injury to the media and adventitia. Larger studies are needed to confirm the efficacy of this approach. - Highlights: • OCT- guided atherectomy may yield superior patency by optimizing plaque removal and preserving the tunica media and adventitia. • OCT guided atherectomy resulted in high procedural

  18. Immediate and intermediate-term results of optical coherence tomography guided atherectomy in the treatment of peripheral arterial disease: Initial results from the VISION trial

    Energy Technology Data Exchange (ETDEWEB)

    Cawich, Ian; Paixao, Andre R.M. [Arkansas Heart Hospital, Peripheral Vascular Institute, Little Rock, AR (United States); Marmagkiolis, Konstantinos [Citizens Memorial Heart and Vascular Institute, Bolivar, MO (United States); University of Missouri, Columbia, MO (United States); Lendel, Vasili; Rodriguez-Araujo, Gerardo; Rollefson, William A.; Mego, David M. [Arkansas Heart Hospital, Peripheral Vascular Institute, Little Rock, AR (United States); Cilingiroglu, Mehmet, E-mail: Cilingiroglumehmet@gmail.com [Arkansas Heart Hospital, Peripheral Vascular Institute, Little Rock, AR (United States); Koc University, School of Medicine, Istanbul (Turkey)

    2016-10-15

    Background: Long-term patency rates for percutaneous peripheral arterial interventions are suboptimal. Optical coherence tomography (OCT) guided atherectomy may yield superior patency by optimizing plaque removal while preserving the tunica media and adventitia. Methods: The VISION study is a multicenter prospective study of patients with peripheral arterial disease undergoing OCT guided atherectomy with the Pantheris™ device. In 11 patients enrolled in a single center, we report procedural and clinical outcomes, at 30 days and 6 months. Results: The mean age was 63 ± 11 years and 73% (n = 8) were men. The target lesion was in the superficial femoral artery in 82% (n = 9) of the patients. Mean stenosis severity was 87% ± 10% and mean lesion length was 39 ± 31 mm. Procedural success was observed in all patients with no device related complications. Mean post-atherectomy stenosis was 18% ± 15%. Almost all excised tissue consisted of intimal plaque (94%). At 30 days, significant improvements in Rutherford class, VascuQoL scores and ABI were observed, 0.9 ± 0.8 vs. 3.1 ± 0.7 (p = 0.01), 4.9 ± 1.9 vs. 3.6 ± 1.5 (p = 0.03) and 1.04 ± 0.19 vs. 0.80 ± 0.19 (p < 0.01) respectively. At 6 months, there were significant improvements in Rutherford class (1.0 ± 1.0 vs. 3.1 ± 0.7, p = 0.01) and ABI (0.93 ± 0.19 versus 0.80 ± 0.19, p = 0.02) but not in VascuQoL scores (3.7 ± 1.4 versus 3.6 ± 1.5, p = 0.48). Target lesion revascularization occurred in 18% (n = 2) of the patients. Conclusion: OCT guided atherectomy resulted in high procedural success, no device related complications and encouraging results up to 6 months. Histological analysis suggested little injury to the media and adventitia. Larger studies are needed to confirm the efficacy of this approach. - Highlights: • OCT- guided atherectomy may yield superior patency by optimizing plaque removal and preserving the tunica media and adventitia. • OCT guided atherectomy resulted in high procedural

  19. Use of in-situ Dual Vacuum Extraction trademark for remediation of soil and ground water

    International Nuclear Information System (INIS)

    Dodson, M.E.; Trowbridge, B.E.; Ott, D.

    1994-01-01

    Dual Vacuum Extraction trademark provides a rapid and cost-effective method of remediating soil and ground water contaminated with volatile organic compounds. The system involves the removal of both water and vapors through the same borehole by use of entrainment. This technology provides for the remediation of the vadose zone, capillary fringe, smear zone, and existing water table. The effectiveness of this technology is shown in a case study. A release from an underground storage tank was responsible for a hydrocarbon plume spreading over approximately 50,000 ft 2 . The release produced vadose-zone contamination in the silty and sandy clays from 10 to 30 ft below ground surface (bgs) with total petroleum hydrocarbon (TPH) concentrations up to 1,400 mg/kg. In addition, a layer of free-floating liquid hydrocarbon was present on a shallow aquifer located at 25 ft bgs in thicknesses ranging from 0.5 to 3.0 ft. An in-situ dual-extraction system was installed to remediate the soils and ground water to levels as required by the Los Angeles Regional Water Quality Control Board (RWQCB). The system operated 24 hr a day, with an operating efficiency of over 99%. After 196 days (28 weeks), over 17,000 lb of hydrocarbons had been extracted from the soils. Seven confirmatory soil borings in the area of highest initial hydrocarbon concentrations indicated that TPH and benzene, toluene, ethylbenzene, xylene (BTEX) concentrations had decreased over 99% from initial soil concentrations

  20. Mechanical properties of Nextel trademark 312 fiber-reinforced SiC matrix composites

    International Nuclear Information System (INIS)

    Vaidyanathan, K.R.; Sankar, J.; Kelkar, A.D.; Weaver, B.

    1995-01-01

    Vapor phase synthesis is emerging as a method for the preparation of near final-shape, ceramic matrix composites for advanced structural applications. Oxide fiber-reinforced silicon carbide matrix composites are currently being developed for these applications. The mechanical properties of Nextel trademark 312 fiber reinforced SiC matrix composites fabricated employing the forced-flow, thermal gradient chemical vapor infiltration process (FCVI) were evaluated at room temperature in pure tension. The composites were fabricated with a 0.15 μm pyrolytic carbon interface layer for improving the toughness of the composite system. Because of the available FCVI apparatus, only short length specimens (7--8 cm) could be fabricated. Room temperature tensile strengths were measured and compared to room temperature flexure strength results for the composite. Excellent toughness and composite behavior was obtained for the composite system. Fractography as well as possible factors responsible for the differences in tensile and flexural strengths for the composite system is presented in this paper

  1. Evaluation of Directional Atherectomy Studied by Intravascular Ultrasound in Femoropopliteal Artery Stenosis

    International Nuclear Information System (INIS)

    Tielbeek, Alexander V.; Vroegindeweij, Dammis; Gussenhoven, Elma J.; Buth, Jacob; Landman, Guido H.M.

    1997-01-01

    Purpose: To evaluate the role of intravascular ultrasound (IVUS) before and after directional atherectomy (DA) in the treatment of femoropopliteal artery stenosis. Methods: In 12 patients with 16 stenoses IVUS was performed before and immediately after an angiographically successful DA. This was defined as a diameter reduction (DR) ≤ 50%, which was calculated using the minimal lumen diameter compared with the diameter of a nearby 'normal' segment. In the presence of residual plaque on IVUS an additional DA was performed. Endpoints studied were DR ≤ 30% on IVUS compared with the IVUS findings of the angiographically normal reference segment, or when no additional atherosclerotic material could be removed by further DA passages. Results: Additional DA (mean 1.6 per lesion) had to be performed in all patients. Initial DA increased the cross-sectional free lumen area (FLA) from 3.8 ± 2.0 mm 2 to 8.1 ± 2.7 mm 2 (p= 0.0004). Additional DA increased FLA to 9.3 ± 2.3 mm 2 (p= 0.002) after the second passage and to 9.8 ± 2.4 mm 2 (p= 0.09) after the final DA run. The plaque area (PLA) before DA decreased from 18.1 ± 4.2 mm 2 to 15.4 ± 4.8 mm 2 (p= 0.002) after the first passage, and to 13.5 ± 5.0 mm 2 (p= 0.004) and 12.8 ± 4.4 mm 2 (p= 0.07) after the second and final DA runs, respectively. PLA of the reference segment (9.5 ± 5.7 mm 2 ) was significantly smaller (p= 0.006) than the final PLA of the treated lesion, indicating a large amount of retained plaque. As a result of DA there was an increase in the area bordered by the medial layer, i.e., the total vessel area (from 21.9 ± 4.7 mm 2 to 23.0 ± 4.7 mm 2 ), significantly in eccentric and soft lesions. On IVUS, dissection and plaque rupture after the final passage was seen in 12 of 16 stenoses; two dissections were seen on the completion angiogram. After the final passage in all stenoses except three, the DR with IVUS was ≤ 30%. Conclusion: Lumen enlargement following DA is predominantly due to plaque

  2. Pooled analysis of the CONFIRM Registries: outcomes in renal disease patients treated for peripheral arterial disease using orbital atherectomy.

    Science.gov (United States)

    Lee, Michael S; Yang, Tae; Adams, George L; Mustapha, Jihad; Das, Tony

    2014-08-01

    Patients with renal disease typically have severely calcified peripheral arterial disease. As a result, this population may have worse clinical outcomes following endovascular intervention compared to patients without renal insufficiency. Clinical trials typically exclude this patient population. Analysis of the CONFIRM I-III registries revealed 1105 patients with renal disease (1777 lesions) and 1969 patients without renal disease (2907 lesions) who underwent orbital atherectomy. This subanalysis compared the composite procedural complication rate including dissection, perforation, slow flow, vessel closure, spasm, embolism, and thrombus formation in patients with and without renal disease. Patients with renal disease had a higher prevalence of diabetes (Patherectomy resulted in similar low rates of procedural complications in the renal disease group compared with the non-renal disease group despite more unfavorable baseline clinical and lesion characteristics in the renal disease group.

  3. Successful rotational atherectomy over RG3 guidewire after failure of various techniques to deliver RotaWire.

    Science.gov (United States)

    Kaneko, Umihiko; Kashima, Yoshifumi; Kanno, Daitaro; Sugie, Takuro; Kobayashi, Ken; Fujita, Tsutomu

    2017-10-01

    Although performing rotational atherectomy (RA) requires guidewire exchange for the dedicated guidewire, RotaWire guidewire (Boston Scientific) exhibits much lower performance than conventional guidewire. Consequently, there are times when RotaWire cannot be advanced past the lesion independently or using a microcatheter exchange technique, rendering RA impossible. We present a case of a heavily calcified, device-uncrossable, and non-expansible chronic total occlusion lesion successfully revascularized with RA over RG3 guidewire (Asahi Intecc), which has a length of 330 cm, hydrophilic coating, and a 0.010-inch-long shaft. RG3 provided excellent cross-ability and RA could also be performed over RG3 without guidewire exchange for the RotaWire.

  4. DIWA trademark. AREVA's approach of intelligent computer-aided support of water chemistry monitoring in power plants

    International Nuclear Information System (INIS)

    Fandrich, Joerg

    2011-01-01

    The complexity of power plant operation makes stringent demands on the chemical quality of the coolant in process systems and loops. Optimal water chemistry ensures high corrosion resistance of these systems and is thus essential for safe and economic long term plant operation. The market offers a huge variety of commercial software packages for water chemistry control. Most of these computer programs have to be considered as data analysis or, respectively, data acquisition programs. Some of them require manual data input (Laboratory Information Management Systems), others are capable of performing a fully automated data acquisition. However, the plant operator typically is left alone with the actual interpretation of all collected and validated data, which would be the main characteristic feature of an analysis (or monitoring) system. The data validation is typical being performed by means of numerical methods in the broadest sense. This activity requires a long working experience and specific skills by the plant chemistry operator. True diagnostic systems need to be significantly more advanced. They contain the capability of data interpretation and derivation of specific diagnoses. This is combined with additional explanations on how the diagnoses were derived. Additionally, further recommendations are offered on how to proceed to reach the normal operational behavior as soon as possible. AREVA's DIWA trademark system features a fuzzy logic expert system that is based on expert knowledge. It is built on symptoms, which are combined in rules as part of the fuzzy tool set. These components can be edited without programming knowledge, which significantly reduces training efforts. It makes the system more robust, more compact and simpler compared to other so-called expert systems. DIWA trademark represents the knowledge in a natural way, in which other conventional expert system may have difficulties or need a larger set of rule algorithms. (orig.)

  5. Successful Rotational Atherectomy for an Angulated Calcified Lesion in an Anomalous Right Coronary Artery Using the “Mother-and-Child” Technique

    Directory of Open Access Journals (Sweden)

    Manabu Ogita

    2018-01-01

    Full Text Available Percutaneous coronary intervention (PCI involving the anomalous coronary artery is challenging with respect to difficulty in achieving stable catheterization. Rotational atherectomy (RA can facilitate severely calcified lesions to improve stent delivery and stent expansion; however, its utility in tortuous and angulated coronary arteries is limited with difficulty in delivery of the RA burr. The mother-and-child technique is effective for complex PCIs with increased backup force for device delivery in such complicated cases. We report a case of successful rotational atherectomy using the “mother-and-child” technique with a Dio thrombus aspiration catheter for an angulated calcified lesion in an anomalous origin of the right coronary artery.

  6. One-Year Outcomes Following Directional Atherectomy of Infrapopliteal Artery Lesions: Subgroup Results of the Prospective, Multicenter DEFINITIVE LE Trial.

    Science.gov (United States)

    Rastan, Aljoscha; McKinsey, James F; Garcia, Lawrence A; Rocha-Singh, Krishna J; Jaff, Michael R; Noory, Elias; Zeller, Thomas

    2015-12-01

    To report a subgroup analysis of the prospective, multicenter, single-arm DEFINITIVE LE trial to assess the effectiveness of directional atherectomy for the treatment of infrapopliteal artery lesions at 1 year. In the DEFINITIVE LE trial, follow-up assessments occurred up to 1 year postprocedure. Of the 800 patients enrolled, 145 subjects with 189 infrapopliteal lesions met the criteria for this analysis. Seventy (48.3%) and 75 (51.7%) patients were suffering critical limb ischemia (CLI) and intermittent claudication, respectively; 68.3% (99/145) had diabetes. The mean lesion length was 58±44 mm (all lesions); 20.2% were occluded. The primary endpoint for patients with claudication was duplex ultrasound-derived primary patency, while for subjects with CLI it was freedom from major amputation of the target limb at 1 year. Endpoints and adverse events were independently assessed. Procedure success (≤30% residual stenosis) was achieved in 84% of treated lesions. The 1-year primary patency rate was 84% (claudicants 89.6% and CLI patients 78%, p=0.11), and the freedom from major amputation rate was 97.1% (claudicants 100% and CLI 93.8%, p=0.03). In both claudication and CLI patients, significant improvements in Rutherford category and objective measures of walking distance and quality of life were seen at 1 year in comparison to baseline. This study demonstrates that directional atherectomy in infrapopliteal arteries results in promising technical and clinical results at 1 year for claudicant as well as CLI patients. © The Author(s) 2015.

  7. Clinical and haemodynamic evolution of lesions treated by means of atherectomy with SilverHawk in the femoropopliteal sector

    International Nuclear Information System (INIS)

    Ibanez, Maria Antonia; Cenizo, Noelia; Rio, Lourdes; Sanchez, Ana; San Norberto, Enrique; Brizuela, Jose-Antonio; Gutierrez, Vicente; Vaquero, Carlos

    2011-01-01

    The objective of the work is to study the clinical and haemodynamic evolution, over 1 year, in patients with femoropopliteal arterial pathology treated by means of atherectomy with the SilverHawk device. Materials and methods: Nineteen (19) patients were treated between December 2008 and May 2009, collecting data on sex, age, comorbidity and clinical degree, with prospective monitoring over 12 months of clinical symptoms, physical examination and ecodoppler, obtaining results on diameter and peak systolic velocity at different arterial levels. Results: Of the 19 patients, 14 were men and 5 women, with a mean age of 70 years, hypertensive (73%), diabetic (63%) and smokers (63%). Six (6) presented disabling claudication and 13 critical ischemia with advanced distal trophic lesions in 5. A good arteriographic result was obtained in 12 cases, a stent was placed on the superficial femoral artery in 5 due to suboptimal outcome. Contrast extravasation was observed in 2, with femoropopliteal bypass performed and one exclusion with endoprosthesis for repair. In the ecodoppler after 1, 3, 6 and 12 months, a progressive reduction in lumen diameter and peak intraarterial systolic velocity was observed, particularly on the distal superficial femoral artery. After one year, 7 patients (36.8%) were symptom-free, 5 (26.3%) presented mild or moderate intermittent claudication and 1 patient (5.3%) presented localised distal trophic lesion. Four (4) major amputations were performed, in 2 the knee was preserved, there were 3 thromboses due to the procedure, a secondary endovascular procedure was performed in one case and a femoropopliteal bypass in another, and there were 2 non procedure-related deaths. Discussion: atherectomy with SilverHawk achieves an improvement in clinical degree, with a good rate of extremity salvage in patients with critical ischemia. In the first year, the ecodoppler shows evolution of the arteriopathy, without this necessarily meaning a clinical worsening.

  8. Clinical and haemodynamic evolution of lesions treated by means of atherectomy with SilverHawk in the femoropopliteal sector

    Energy Technology Data Exchange (ETDEWEB)

    Ibanez, Maria Antonia, E-mail: marianim5@yahoo.es [Department of Angiology and Vascular Surgery, Valladolid University Hospital, Valladolid, C/Ramon y Cajal no 3, 47005 Valladolid (Spain); Cenizo, Noelia, E-mail: noecen@yahoo.es [Department of Angiology and Vascular Surgery, Valladolid University Hospital, Valladolid, C/Ramon y Cajal no 3, 47005 Valladolid (Spain); Rio, Lourdes, E-mail: mlriosol@yahoo.es [Department of Angiology and Vascular Surgery, Valladolid University Hospital, Valladolid, C/Ramon y Cajal no 3, 47005 Valladolid (Spain); Sanchez, Ana, E-mail: assantiago@yahoo.es [Department of Angiology and Vascular Surgery, Valladolid University Hospital, Valladolid, C/Ramon y Cajal no 3, 47005 Valladolid (Spain); San Norberto, Enrique, E-mail: esannorberto@hotmail.com [Department of Angiology and Vascular Surgery, Valladolid University Hospital, Valladolid, C/Ramon y Cajal no 3, 47005 Valladolid (Spain); Brizuela, Jose-Antonio, E-mail: brizsanz@yahoo.es [Department of Angiology and Vascular Surgery, Valladolid University Hospital, Valladolid, C/Ramon y Cajal no 3, 47005 Valladolid (Spain); Gutierrez, Vicente, E-mail: vgutierrezalonso@gmail.com [Department of Angiology and Vascular Surgery, Valladolid University Hospital, Valladolid, C/Ramon y Cajal no 3, 47005 Valladolid (Spain); Vaquero, Carlos, E-mail: cvaquero@med.uva.es [Department of Angiology and Vascular Surgery, Valladolid University Hospital, Valladolid, C/Ramon y Cajal no 3, 47005 Valladolid (Spain)

    2011-11-15

    The objective of the work is to study the clinical and haemodynamic evolution, over 1 year, in patients with femoropopliteal arterial pathology treated by means of atherectomy with the SilverHawk device. Materials and methods: Nineteen (19) patients were treated between December 2008 and May 2009, collecting data on sex, age, comorbidity and clinical degree, with prospective monitoring over 12 months of clinical symptoms, physical examination and ecodoppler, obtaining results on diameter and peak systolic velocity at different arterial levels. Results: Of the 19 patients, 14 were men and 5 women, with a mean age of 70 years, hypertensive (73%), diabetic (63%) and smokers (63%). Six (6) presented disabling claudication and 13 critical ischemia with advanced distal trophic lesions in 5. A good arteriographic result was obtained in 12 cases, a stent was placed on the superficial femoral artery in 5 due to suboptimal outcome. Contrast extravasation was observed in 2, with femoropopliteal bypass performed and one exclusion with endoprosthesis for repair. In the ecodoppler after 1, 3, 6 and 12 months, a progressive reduction in lumen diameter and peak intraarterial systolic velocity was observed, particularly on the distal superficial femoral artery. After one year, 7 patients (36.8%) were symptom-free, 5 (26.3%) presented mild or moderate intermittent claudication and 1 patient (5.3%) presented localised distal trophic lesion. Four (4) major amputations were performed, in 2 the knee was preserved, there were 3 thromboses due to the procedure, a secondary endovascular procedure was performed in one case and a femoropopliteal bypass in another, and there were 2 non procedure-related deaths. Discussion: atherectomy with SilverHawk achieves an improvement in clinical degree, with a good rate of extremity salvage in patients with critical ischemia. In the first year, the ecodoppler shows evolution of the arteriopathy, without this necessarily meaning a clinical worsening.

  9. Application of the biological forced air soil treatment (BIOFAST trademark) technology to diesel contaminated soil

    International Nuclear Information System (INIS)

    Lyons, K.A.; Leavitt, M.E.; Graves, D.A.; Stanish, S.M.

    1993-01-01

    A subsurface Biological Forced Air Soil Treatment (BIOFAST trademark) system was constructed at the Yellow Freight System, Inc. (Yellow Freight) New Haven facility in Connecticut as a means of expediting the remediation of soils impacted by a diesel fuel release. Prior to beginning construction activities the soils were evaluated for the feasibility of bioremediation based on soil characteristics including contaminant degrading bacteria, moisture content, and pH. Based on results of stimulant tests with oxygen and nutrients, the addition of fertilizer during the construction of the cell was recommended. Following the removal of underground storage tanks, the bioremediation cell was constructed by lining the enlarged excavation with high density polyethylene (HDPE) and backfilling alternating layers of nutrient-laden soil and pea gravel. Passive and active soil vapor extraction (SVE) piping was included in the gravel layers and connected to a blower and vapor treatment unit, operated intermittently to supply oxygen to the subsurface cell. Operating data have indicated that the bacteria are generating elevated levels of CO 2 , and the SVE unit is evacuating the accumulated CO 2 from the soils and replacing it with fresh air. These data suggest that the bioremediation process is active in the soils. Soil samples collected from within the soil pit subsequent to installation and again after 10 months of operation indicate that TPH concentrations have decreased by as much as 50%

  10. Effective endovascular treatment of calcified femoropopliteal disease with directional atherectomy and distal embolic protection: final results of the DEFINITIVE Ca⁺⁺ trial.

    Science.gov (United States)

    Roberts, David; Niazi, Khusrow; Miller, William; Krishnan, Prakash; Gammon, Roger; Schreiber, Theodore; Shammas, Nicolas W; Clair, Daniel

    2014-08-01

    The purpose of the DEFINITIVE Ca(++) study was to evaluate the safety and effectiveness of directional atherectomy and distal embolic protection, used together to treat moderate to severely calcified femoropopliteal lesions. Despite advances in endovascular treatment modalities, treatment of calcified lesions remains a challenge. A total of 133 subjects with 168 moderate to severely calcified lesions were enrolled. Lesions were treated with directional atherectomy devices, coupled with distal embolic protection. The 30-day freedom from MAE rate was 93.1%. Per angiographic core laboratory assessment, the primary effectiveness endpoint (≤50% residual diameter stenosis) was achieved in 92.0% (lower confidence bound of 87.6%) of lesions. By core lab analysis, these results did not achieve the success criteria (90%) for the primary effectiveness objective. Per site assessment, the objective was met with the endpoint being achieved in 97.0% (lower confidence bound 93.8%). A mean residual diameter stenosis of 33.3% was achieved with the directional atherectomy device. This was further decreased to 24.1% with the use of adjunctive therapy. The proportion of asymptomatic subjects [Rutherford Clinical Category (RCC) = 0] increased from 0% at baseline to 52.3% at the 30-day follow-up visit. In total, 88.5% of subjects experienced an improvement of one or more Rutherford categories. The results of the DEFINITIVE Ca++ study demonstrate that the SilverHawk and TurboHawk atherectomy devices are safe and effective in the endovascular treatment of moderate to severely calcified lesions in the superficial femoral and/or popliteal arteries when used with the SpiderFX distal embolic protection device. © 2014 The Authors. Catheterization and Cardiovascular Interventions. Published by Wiley Periodicals, Inc.

  11. Effective Endovascular Treatment of Calcified Femoropopliteal Disease With Directional Atherectomy and Distal Embolic Protection: Final Results of the DEFINITIVE Ca++ Trial

    Science.gov (United States)

    Roberts, David; Niazi, Khusrow; Miller, William; Krishnan, Prakash; Gammon, Roger; Schreiber, Theodore; Shammas, Nicolas W; Clair, Daniel

    2014-01-01

    Objectives The purpose of the DEFINITIVE Ca++ study was to evaluate the safety and effectiveness of directional atherectomy and distal embolic protection, used together to treat moderate to severely calcified femoropopliteal lesions. Background Despite advances in endovascular treatment modalities, treatment of calcified lesions remains a challenge. Methods A total of 133 subjects with 168 moderate to severely calcified lesions were enrolled. Lesions were treated with directional atherectomy devices, coupled with distal embolic protection. Results The 30-day freedom from MAE rate was 93.1%. Per angiographic core laboratory assessment, the primary effectiveness endpoint (≤50% residual diameter stenosis) was achieved in 92.0% (lower confidence bound of 87.6%) of lesions. By core lab analysis, these results did not achieve the success criteria (90%) for the primary effectiveness objective. Per site assessment, the objective was met with the endpoint being achieved in 97.0% (lower confidence bound 93.8%). A mean residual diameter stenosis of 33.3% was achieved with the directional atherectomy device. This was further decreased to 24.1% with the use of adjunctive therapy. The proportion of asymptomatic subjects [Rutherford Clinical Category (RCC) = 0] increased from 0% at baseline to 52.3% at the 30-day follow-up visit. In total, 88.5% of subjects experienced an improvement of one or more Rutherford categories. Conclusions The results of the DEFINITIVE Ca++ study demonstrate that the SilverHawk™ and TurboHawk™ atherectomy devices are safe and effective in the endovascular treatment of moderate to severely calcified lesions in the superficial femoral and/or popliteal arteries when used with the SpiderFX™ distal embolic protection device. © 2014 Wiley Periodicals, Inc. PMID:24402764

  12. Preintervention lesion remodelling affects operative mechanisms of balloon optimised directional coronary atherectomy procedures: a volumetric study with three dimensional intravascular ultrasound

    Science.gov (United States)

    von Birgelen, C; Mintz, G; de Vrey, E A; Serruys, P; Kimura, T; Nobuyoshi, M; Popma, J; Leon, M; Erbel, R; de Feyter, P J

    2000-01-01

    AIMS—To classify atherosclerotic coronary lesions on the basis of adequate or inadequate compensatory vascular enlargement, and to examine changes in lumen, plaque, and vessel volumes during balloon optimised directional coronary atherectomy procedures in relation to the state of adaptive remodelling before the intervention.
DESIGN—29 lesion segments in 29 patients were examined with intravascular ultrasound before and after successful balloon optimised directional coronary atherectomy procedures, and a validated volumetric intravascular ultrasound analysis was performed off-line to assess the atherosclerotic lesion remodelling and changes in plaque and vessel volumes that occurred during the intervention. Based on the intravascular ultrasound data, lesions were classified according to whether there was inadequate (group I) or adequate (group II) compensatory enlargement.
RESULTS—There was no significant difference in patient and lesion characteristics between groups I and II (n = 10 and 19), including lesion length and details of the intervention. Quantitative coronary angiographic data were similar for both groups. However, plaque and vessel volumes were significantly smaller in group I than in II. In group I, 9 (4)% (mean (SD)) of the plaque volume was ablated, while in group II 16 (11)% was ablated (p = 0.01). This difference was reflected in a lower lumen volume gain in group I than in group II (46 (18) mm3 v 80 (49) mm3 (p atherectomy procedures. Plaque ablation was found to be particularly low in lesions with inadequate compensatory vascular enlargement.


Keywords: intravascular ultrasound; ultrasonics; remodelling; coronary artery disease; atherectomy PMID:10648496

  13. Intravenous contrast medium application in elderly patients - evaluation of Iopentol (Imagopaque trademark 300); Intravenoese Kontrastmittel-Applikation bei aelteren Patienten - Anwendungsbeobachtung von Iopentol (Imagopaque trademark 300)

    Energy Technology Data Exchange (ETDEWEB)

    Rathsmann, P.; Jacobs, G.F.; Mueller, R.D. [Zentrum fuer Klinische Radiologie, Kliniken Essen-Sued (Germany)

    2004-12-01

    Purpose: We examined the subjective compatibility of elderly patients who received the intravenous contrast medium Iopentol (Imagopaque trademark 300). In addition, objective data were acquired to show possible interactions between contrast media and organ systems in old patients. Methods and materials: A CT scan with intravenous application of contrast media was performed on 132 patients ranging in age from 75 to 96 years. The patients were questioned about their individual sensations. In addition, blood pressure, creatinine and CT-densitometry were acquired as objective date. Results: The patients' individual sensations and clinical data show a very low rate of complications. Mild allergic reactions were noticed in two patients. No severe anaphylactic reactions were encountered. Statistically significant changes in blood pressure before and after administration of the contrast medium were not observed. The serum creatinine concentration was unchanged after application of contrast media. For CT-densitometry, the patients were divided into two groups, one group with patients 75-84 years and the other group with patients 85-96 years of age. CT-densitometry showed no age-related differences. The protocol of contrast administration resulted in excellent opacification of the examined regions, only the liver did not enhance in some cases before the opacification of the portal vein. Conclusion: It is shown that old age alone is no reason to withhold contrast media containing iodine when performing CT. For the evaluation of the liver, however, the peculiarities of old age have to be taken into account and the interval between injection of the contrast medium and beginning of the spiral-CT has to be extended. (orig.)

  14. Results of immunoscintigraphy of osteomyelitis (LeukoScan) {sup trademark}; Ergebnisse zur Immunszintigraphie der Osteomyelitis (LeukoScan) {sup trademark}

    Energy Technology Data Exchange (ETDEWEB)

    Gratz, S.; Becker, W. [Goettingen Univ. (Germany). Abt. fuer Nuklearmedizin

    2000-05-01

    99mTc-labeled antigranulocyte monoclonal antibody Fab' fragments have shown a high sensitivity and specificity for detecting osteomyelitis in prospective studies. We retrospectively evaluated the use of LeukoScan {sup trademark} (Immunomedics, Morris Plains, N.J.) in clinical routine for the detection of bone and soft tissue infections and we want to present the results of our findings as well as some of the more interesting cases in this occasion. Imaging infection can be performed fast and easy with {sup 99m}Tc-Fab' fragments due to a fast targeting of infection and good background clearance, which increases in imaging quality. The application of {sup 99m}Tc-Fab' fragments gives good results in patients with bone and soft tissue infections of peripheral bones, as well as in patients with infected prostheses and infected arthritis. The use of {sup 99m}Tc-Fab' fragments should not be limited to these patients only, since good results can also be achieved in patients with infections of vascular grafts, of appendicitis and of endocarditis as well. A higher number of false-negative results has to be expected in case of subacute/chronic infections instead. Independent of the grade of infection acute/subacute infections of the spine always show 'cold lesions'. If cold lesions are used as guide for diagnosing a pathologic finding, an increase in sensitivity together with a decrease in specificity can be achieved. (orig.) [German] {sup 99m}Tc-markierte Antigranulozytenantikoerper-Fab'-Fragmente konnten in prospektiven Studien eine hohe Sensitivitaet und Spezifitaet bei der Detektion von Osteomyelitiden unter Beweis stellen. Retrospektiv haben wir die Anwendung von {sup 99m}Tc-markierten Fab'-Fragmenten ({sup 99m}Tc-Fab') (LeukoScan {sup trademark}, Immunomedics, Morris Plains, N.J.) in der klinischen Routine zum Nachweis von Knochen- und Weichteilentzuendungen ausgewertet und moechten einen Teil unserer Ergebnisse sowie einige

  15. Full-Scale Evaluation of DuraDeck (registered trademark) and MegaDeck (trademark) Matting Systems

    Science.gov (United States)

    2013-07-01

    plates studded with threaded bolts were placed ERDC/GSL TR-13-27 10 underneath two pre-drilled corners of the panel. The plates were positioned so...metal plates studded with threaded ERDC/GSL TR-13-27 4 Figure 1. DuraDeck® mat panel, top surface. Figure 2. DuraDeck® mat panel, bottom surface...ERDC/GSL TR-13-27 5 bolts , as shown in Figure 3, underneath the mat corners and then installing special connector nuts from the top surface

  16. The PERC trademark process: Existing and potential applications for induction coupled plasma technology in hazardous and radioactive waste treatment

    International Nuclear Information System (INIS)

    Blutke, A.S.; Vavruska, J.S.; Serino, J.F.

    1996-01-01

    Plasma Technology, Inc. (PTI), a Santa Fe, New Mexico corporation has developed the Plasma Energy Recycle and Conversion (PERC)trademark treatment process as a safe and environmentally clean alternative to conventional thermal destruction technologies. The PERC trademark treatment process uses as its heat source an advanced Induction Coupled Plasma (ICP) torch connected to a reaction chamber system with an additional emission control system. For example, organic-based gas, liquid, slurry, and/or solid waste streams can be converted into usable or even salable products while residual emissions are reduced to an absolute minimum. In applications for treatment of hazardous and radioactive waste streams, the PERC system could be used for destruction of the hazardous organic constituents and/or significant waste volume reduction while capturing the radioactive fraction in a non-leachable form. Like Direct Current (DC) and Alternating Current (AC) arc plasma systems, ICP torches offer sufficient energy to decompose, melt and/or vitrify any waste stream. The decision for an arc plasma or an IC plasma system has to be made on a case by case evaluation and is highly dependent on the specific waste stream's form and composition. Induction coupled plasma technology offers one simple, but significant difference compared to DC or AC arc plasma systems: the ICP torch is electrodeless. To date, enormous research effort has been spent to improve the lifetime of electrodes and the effectiveness of related cooling systems. Arc plasma systems are established in research laboratories worldwide and are approaching a broad use in commercial applications. ICP technology has been improved relatively recently, but nowadays offers complete new and beneficial approaches in the field of waste conversion and treatment

  17. Two-Year Clinical Outcomes of Newer-Generation Drug-Eluting Stent Implantation Following Rotational Atherectomy for Heavily Calcified Lesions.

    Science.gov (United States)

    Jinnouchi, Hiroyuki; Kuramitsu, Shoichi; Shinozaki, Tomohiro; Kobayashi, Yohei; Hiromasa, Takashi; Morinaga, Takashi; Mazaki, Toru; Sakakura, Kenichi; Soga, Yoshimitsu; Hyodo, Makoto; Shirai, Shinichi; Ando, Kenji

    2015-01-01

    Clinical outcomes of implantation of the newer-generation drug-eluting stent (DES) following rotational atherectomy for heavily calcified lesions remain unclear in the real-world setting. We enrolled 252 consecutive patients (273 lesions) treated with newer-generation DES following rotational atherectomy. The primary endpoint was the cumulative 2-year incidence of major adverse cardiovascular events (MACE), defined as cardiac death, myocardial infarction, clinically-driven target lesion revascularization, and definite stent thrombosis. Complete clinical follow-up information at 2-year was obtained for all patients. The mean age was 73.2±9.0 years and 155 patients (61.5%) were male. Cumulative 2-year incidence of MACE (cardiac death, myocardial infarction, clinically-driven target lesion revascularization and definite stent thrombosis) was 20.3% (7.0%, 2.1%, 18.1% and 2.1%, respectively). Predictors of MACE were presenting with acute coronary syndrome (hazard ratio [HR]: 3.80, 95% confidence interval [CI]: 1.29-11.2, P=0.02), hemodialysis (HR: 1.93, 95% CI: 1.04-3.56, P=0.04) and previous coronary artery bypass graft (HR: 2.26, 95% CI: 1.02-5.00, P=0.045). PCI for calcified lesions requiring rotational atherectomy is still challenging even in the era of newer-generation DES.

  18. Impact of lesion location on procedural and acute angiographic outcomes in patients with critical limb ischemia treated for peripheral artery disease with orbital atherectomy: A CONFIRM registries subanalysis.

    Science.gov (United States)

    Lee, Michael S; Mustapha, Jihad; Beasley, Robert; Chopra, Paramjit; Das, Tony; Adams, George L

    2016-02-15

    This analysis compares the procedural and acute angiographic outcomes in patients with critical limb ischemia (CLI) treated with orbital atherectomy in above-the-knee (ATK)/popliteal (POP) lesions versus below-the-knee (BTK) lesions. Lesion location affects the procedural outcomes and the opportunity for limb salvage in patients with CLI suffering from peripheral artery disease (PAD). The CONFIRM registry series was analyzed and includes 1109 real-world patients (1544 lesions) suffering from CLI treated with orbital atherectomy. The rates of dissection, perforation, slow flow, vessel closure, spasm, embolism, and thrombus formation were compared between CLI patients with ATK/POP lesions and BTK lesions. Patients with ATK/POP lesions had a higher final residual stenosis (10 vs. 9%; P = 0.004) and use of more adjunctive therapies (e.g. balloons and stents; 1.3 vs. 1.1%; P atherectomy was successful in CLI patients regardless of lesion location. BTK lesions were associated with increased rates of perforation, slow flow and spasm which may be explained by more challenging procedural characteristics in these patients such as smaller vessel size and tortuosity. The higher incidence of emboli in ATK/POP lesions is most likely attributed to the higher prevalence of severe calcium observed in this cohort. © 2015 Wiley Periodicals, Inc.

  19. Bioglass {sup trademark} coated poly(DL-lactide) foams for tissue engineering scaffolds

    Energy Technology Data Exchange (ETDEWEB)

    Gough, J.E. [Materials Science Centre, UMIST, Manchester M1 7HS (United Kingdom); Arumugam, M. [Department of Materials Science and Metallurgy, University of Cambridge, Cambridge (United Kingdom); Blaker, J. [Department of Materials and Centre for Tissue Engineering and Regenerative Medicine, Imperial College London, London SW7 2BP (United Kingdom); Boccaccini, A.R. [Dept. of Materials and Center for Tissue Engineering and Regenerative Medicine, Imperial College London, London SW7 28P (United Kingdom)

    2003-07-01

    The purpose of this study was to prepare poly(DL-lactic acid) (PDLLA)/Bioglass trademark composites of foam-like structure, to measure the degree of bioactivity of the composites by studying the formation of hydroxyapatite (HA) after immersion in simulated body fluid (SBF) and to test the initial attachment of human osteoblasts within the porous network. It was found that crystalline HA formed on the Bioglass trademark coated PDLLA foams after 7 days of immersion in SBF. HA formed also on the surfaces of non-coated PDLLA foams, however the rate and amount of HA formation were much lower than in the composites. The rapid formation of HA on the Bioglass trademark /PDLLA foam surfaces confirmed the high bioactivity of these materials. Osteoblasts attached within the porous network throughout the depth of the foams. Cell density was found to be higher in the PDLLA/Bioglass trademark composites compared to the pure PDLLA foams. The composite foams developed here exhibit the required bioactivity to be used as scaffolds for bone tissue engineering. (Abstract Copyright [2003], Wiley Periodicals, Inc.) [German] Die vorliegende Arbeit befasst sich mit der Herstellung von poroesen Verbundwerkstoffen bestehend aus Poly(DL-Laktidsaeure) (PDLLA) und Bioglass trademark und der anschliessenden Untersuchung der Bioaktivitaet. Die Bioaktivitaet wurde anhand von In-vitro-Methoden untersucht: Durch Ermittlung der Bildungsrate von Hydroxylapatit (HA) auf der Oberflaeche nach Eintauchen in simulierter Koerperfluessigkeit (SBF) und mittels Zellkulturstudien mit menschlichen Osteoblasten. Nach 7 Tagen in SBF hatte die Bildung von kristallinem HA auf der Oberflaeche von mit Bioglass trademark -beschichteten PDLLA Schaeumen stattgefunden. Auf der Oberflaeche von unbeschichtetem PDLLA konnte ebenfalls die Bildung von HA gezeigt werden, jedoch war die Bildungsrate hier bedeutend langsamer verglichen mit den Verbundwerkstoffen. Die rasche Formung von HA auf der Bioglass trademark /PDLLA

  20. CHROMAT trademark Version 1.1--Soil Chromium Attenuation Evaluation Model

    International Nuclear Information System (INIS)

    Felmy, A.R.; Rai, D.; Zachara, J.M.; Thapa, M.; Gold, M.

    1992-07-01

    This document is the user's manual and technical reference for the Soil Chromium Attenuation Model (CHROMAT trademark), a computer code designed to calculate both the dissolved Cr concentration and the amount of Cr attenuated in soils as a result of the geochemical reactions that occur as Cr-containing leachates migrate through porous soils. The dissolved Cr concentration and the amount of Cr attenuated are calculated using thermodynamic (mechanistic) data for aqueous complexation reactions, adsorption/ desorption reactions, and precipitation/dissolution reactions involving both CR(III) and Cr(VI) species. Use of this mechanistic approach means that CHROMAT trademark requires a minimum amount of site-specific data on leachate and soil characteristics. CHROMAT trademark is distributed in executable form for IBM and IBM-compatible personal computers through a license from the Electric Power Research Institute (EPRI). The user interacts with CHROMAT trademark using menu-driven screen displays. Interactive on-line help options are available. Output from the code can be obtained in tabular or graphic form. This manual describes the development of CHROMAT trademark, including experimental data development in support of the model and model validation studies. The thermodynamic data and computational algorithm are also described. Example problems and results are included

  1. PROTECTION OF WORKS TITLES FROM THE PERSPECTIVE OF COPYRIGHT PROTECTION AND TRADEMARK PROTECTION

    Directory of Open Access Journals (Sweden)

    George-Mihai IRIMESCU

    2017-05-01

    Full Text Available The main purpose of the paper is assessing the possibilities of protecting the titles of works. One possibility is the protection by means of registered or unregistered trademarks. This route presents difficulties because of the distinctiveness perspective. In this sense, the European case-law has recently developed a constant practice and outlined a series of criteria that should be taken into consideration when examining a trademark consisting of a title. Another possibility is protecting the title under the provisions of the copyright law. From this respect, the practice has not yet determined a constant practice. However, the dominant opinion is that the originality criterion should be taken into consideration when assessing the protection of a tile. Finally, brief conclusion are made, including short remarks on the cumulative protection of titles, both as trademarks and under the copyright law.

  2. Oxygen Plasma Modification of Poss-Coated Kapton(Registered TradeMark) HN Films

    Science.gov (United States)

    Wohl, C. J.; Belcher, M. A.; Ghose, S.; Connell, J. W.

    2008-01-01

    The surface energy of a material depends on both surface composition and topographic features. In an effort to modify the surface topography of Kapton(Registered TradeMark) HN film, organic solutions of a polyhedral oligomeric silsesquioxane, octakis(dimethylsilyloxy)silsesquioxane (POSS), were spray-coated onto the Kapton(Registered TradeMark) HN surface. Prior to POSS application, the Kapton(Registered TradeMark) HN film was activated by exposure to radio frequency (RF)-generated oxygen plasma. After POSS deposition and solvent evaporation, the films were exposed to various durations of RF-generated oxygen plasma to create a topographically rich surface. The modified films were characterized using optical microscopy, attenuated total reflection infrared (ATR-IR) spectroscopy, and high-resolution scanning electron microscopy (HRSEM). The physical properties of the modified films will be presented.

  3. “Mark my words” - Trademarks and Fundamental Rights in the EU

    DEFF Research Database (Denmark)

    Schovsbo, Jens Hemmingsen

    2017-01-01

    of ‘constitiutionalization’ in EU law whereby courts increasingly rely on fundamental rights when they interpret the rules of IPR. After a presentation of the historical and legislative background for the changes and the related development in copyright law, the likely impact of the new trademark rules is discussed......This paper analyses the new provisions in EU law that trademark rules should be “applied in a way that ensures full respect for fundamental rights and freedoms, and in particular the freedom of expression”. It is pointed out how these provisions are part of a broader trend....... It is concluded that even though the constitutionalization is not going to revolutionize EU trademark law, it will require courts to consider in a more pronounced way the interests of users’ of trade marks (such as artists or commercial users) vis-à-vis trade mark holders’ interests. This in turn may affect...

  4. Effect of fiber coatings on room and elevated temperature mechanical properties of Nicalon trademark fiber reinforced Blackglas trademark ceramic matrix composites (CMCs)

    International Nuclear Information System (INIS)

    Aly, E.I.; Freitag, D.W.; Littlefield, J.E.

    1993-01-01

    With the development of silicon organometallic preceramic polymers as precursors for producing oxidation resistant ceramic matrices, through the polymer pyrolysis route, the fabrication of lightweight, complex advanced aircraft and missile structures from fiber reinforced composites is increasingly becoming more feasible. Besides refinement of processing techniques, the potential for achieving this objective depends upon identifying and developing the proper debond barrier coating layer, between the fiber and the matrix, for optimization of strength, toughness, and durability properties. Blackglas trademark based CMC's reinforced with Nicalon trademark SiC fibers with different types of coatings were fabricated. Coating schemes evaluated include CVD applied single layer boron nitride (BN) composition, dual-layer coatings of BN/SiC, and triple-layer coatings of SiC BN/SiC. Results of tensile and flexural property tests, scanning electron microscopy (SEM) of fracture surfaces, and auger electron spectroscopy (AES) microanalysis of the fiber/matrix interface have been discussed

  5. 76 FR 82279 - Electronic Delivery of Search Results From the United States Patent and Trademark Office to the...

    Science.gov (United States)

    2011-12-30

    ...] Electronic Delivery of Search Results From the United States Patent and Trademark Office to the European... United States Patent and Trademark Office (USPTO) has recently begun electronic delivery of search... the search results from a previously filed patent application to which the European patent application...

  6. 16 CFR 301.43 - Use of deceptive trade or corporate names, trademarks or graphic representations prohibited.

    Science.gov (United States)

    2010-01-01

    ..., trademarks or graphic representations prohibited. 301.43 Section 301.43 Commercial Practices FEDERAL TRADE... Regulations § 301.43 Use of deceptive trade or corporate names, trademarks or graphic representations prohibited. No person shall use in labeling, invoicing or advertising any fur or fur product a trade name...

  7. Updated fracture incidence rates for the US version of FRAX (registered trademark)

    Science.gov (United States)

    Evaluation of results produced by the US version of FRAX (trademarked) indicates that this tool overestimates the likelihood of major osteoporotic fracture. In an attempt to correct this, we updated underlying baseline fracture rates for the model. We used US hospital discharge data from 2006 to ca...

  8. The parody defense against trademark bullies: analysis of the Louis Vuitton vs. Mob Case

    Directory of Open Access Journals (Sweden)

    Daniela Molano Lozano

    2017-12-01

    Full Text Available The present note aims to give a better understanding of parody as an exception to the exclusive rights provided to copyright holders and trademark owners. With this purpose, the note uses the Louis Vuitton vs. MOB case as a reference.

  9. Expanding the Intellectual Property Knowledge Base at University Libraries: Collaborating with Patent and Trademark Resource Centers

    Science.gov (United States)

    Wallace, Martin; Reinman, Suzanne

    2018-01-01

    Patent and Trademark Resource Centers are located in libraries throughout the U.S., with 43 being in academic libraries. With the importance of incorporating a knowledge of intellectual property (IP) and patent research in university curricula nationwide, this study developed and evaluated a partnership program to increase the understanding of IP…

  10. Improvement of Legislation on Administrative Responsibility for the Illegal Use of Trademarks and Application Practice

    Directory of Open Access Journals (Sweden)

    Permyakova N. A.

    2012-11-01

    Full Text Available The article deals with the issues of legislation improvement concerning administrative responsibility for illegal use of trademarks. The author exposes problematic questions of law enforcement on bringing to administrative responsibility under Art. 14.10 of the RF Administrative Code

  11. Fuel and power coproduction: The Liquid Phase Methanol (LPMEOH{trademark}) process demonstration at Kingsport

    Energy Technology Data Exchange (ETDEWEB)

    Drown, D.P.; Brown, W.R.; Heydorn, E.C.; Moore, R.B.; Schaub, E.S.; Brown, D.M.; Jones, W.C.; Kornosky, R.M.

    1997-12-31

    The Liquid Phase Methanol (LPMEOH{trademark}) process uses a slurry bubble column reactor to convert syngas (primarily a mixture of carbon monoxide and hydrogen) to methanol. Because of its superior heat management, the process is able to be designed to directly handle the carbon monoxide (CO)-rich syngas characteristic of the gasification of coal, petroleum coke, residual oil, wastes, or of other hydrocarbon feedstocks. When added to an integrated gasification combined cycle (IGCC) power plant, the LPMEOH{trademark} process converts a portion of the CO-rich syngas produced by the gasifier to methanol, and the remainder of the unconverted gas is used to fuel the gas turbine combined-cycle power plant. The LPMEOH{trademark} process has the flexibility to operate in a daily electricity demand load-following manner. Coproduction of power and methanol via IGCC and the LPMEOH{trademark} process provides opportunities for energy storage for electrical demand peak shaving, clean fuel for export, and/or chemical methanol sales.

  12. “Territorial Aspects of Community Trademarks – the Single Market’s Splendid Sovereignty”

    NARCIS (Netherlands)

    Machnicka, A.A.

    2014-01-01

    Intellectual property rights are traditionally subject to the principle of territoriality, meaning that their protection is extended only to the territorial jurisdiction of the national granting authority (usually patent and trademark offices). In the light of cross-border commercial expansion that

  13. SOx-NOx-Rox Box{trademark} flue gas clean-up demonstration. Final report

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1995-09-01

    Babcock and Wilcox`s (B and W) SOx-NOx-Rox Box{trademark} process effectively removes SOx, NOx and particulate (Rox) from flue gas generated from coal-fired boilers in a single unit operation, a high temperature baghouse. The SNRB technology utilizes dry sorbent injection upstream of the baghouse for removal of SOx and ammonia injection upstream of a zeolitic selective catalytic reduction (SCR) catalyst incorporated in the baghouse to reduce NOx emissions. Because the SOx and NOx removal processes require operation at elevated gas temperatures (800--900 F) for high removal efficiency, high-temperature fabric filter bags are used in the baghouse. The SNRB technology evolved from the bench and laboratory pilot scale to be successfully demonstrated at the 5-MWe field scale. This report represents the completion of Milestone M14 as specified in the Work Plan. B and W tested the SNRB pollution control system at a 5-MWe demonstration facility at Ohio Edison`s R.E. Burger Plant located near Shadyside, Ohio. The design and operation were influenced by the results from laboratory pilot testing at B and W`s Alliance Research Center. The intent was to demonstrate the commercial feasibility of the SNRB process. The SNRB facility treated a 30,000 ACFM flue gas slipstream from Boiler No. 8. Operation of the facility began in May 1992 and was completed in May 1993. About 2,300 hours of high-temperature operation were achieved. The main emissions control performance goals of: greater than 70% SO{sub 2} removal using a calcium-based sorbent; greater than 90% NOx removal with minimal ammonia slip; and particulate emissions in compliance with the New Source Performance Standards (NSPS) of 0.03 lb/million Btu were exceeded simultaneously in the demonstration program when the facility was operated at optimal conditions. Testing also showed significant reductions in emissions of some hazardous air pollutants.

  14. Intravenous contrast medium application in elderly patients - evaluation of Iopentol (Imagopaque trademark 300)

    International Nuclear Information System (INIS)

    Rathsmann, P.; Jacobs, G.F.; Mueller, R.D.

    2004-01-01

    Purpose: We examined the subjective compatibility of elderly patients who received the intravenous contrast medium Iopentol (Imagopaque trademark 300). In addition, objective data were acquired to show possible interactions between contrast media and organ systems in old patients. Methods and materials: A CT scan with intravenous application of contrast media was performed on 132 patients ranging in age from 75 to 96 years. The patients were questioned about their individual sensations. In addition, blood pressure, creatinine and CT-densitometry were acquired as objective date. Results: The patients' individual sensations and clinical data show a very low rate of complications. Mild allergic reactions were noticed in two patients. No severe anaphylactic reactions were encountered. Statistically significant changes in blood pressure before and after administration of the contrast medium were not observed. The serum creatinine concentration was unchanged after application of contrast media. For CT-densitometry, the patients were divided into two groups, one group with patients 75-84 years and the other group with patients 85-96 years of age. CT-densitometry showed no age-related differences. The protocol of contrast administration resulted in excellent opacification of the examined regions, only the liver did not enhance in some cases before the opacification of the portal vein. Conclusion: It is shown that old age alone is no reason to withhold contrast media containing iodine when performing CT. For the evaluation of the liver, however, the peculiarities of old age have to be taken into account and the interval between injection of the contrast medium and beginning of the spiral-CT has to be extended. (orig.)

  15. Safety and Effectiveness of the Nav-6 Filter in Preventing Distal Embolization During Jetstream Atherectomy of Infrainguinal Peripheral Artery Lesions.

    Science.gov (United States)

    Banerjee, Avantika; Sarode, Karan; Mohammad, Atif; Brilakis, Emmanouil S; Banerjee, Subhash; Shammas, Gail A; Shammas, Nicolas W

    2016-08-01

    The risk of distal embolization (DE) during infrainguinal peripheral artery interventions (PAI) is often mitigated by the use of embolic protection devices. There are limited data on the use of filters with the Jetstream (JS) atherectomy device, a rotational cutter with aspiration capacity. The Nav-6 filter is uniquely suited for use with the JS due to its wire compatibility and detachment from the filter; however, data on the off-label use of this combination have not been reported. Consecutive patients between October 2008 and April 2015 undergoing endovascular infrainguinal PAI with JS were analyzed as part of the Excellence in Peripheral Artery Disease (XL-PAD) registry (NCT01904851). Patients were divided into two subgroups with Nav-6 filter use vs no filter use. Descriptive and univariate analyses were performed. Among 141 patients (mean age, 67.8 ± 10.8 years; 169 lesions) included in this study, the Nav-6 filter was used in 82 (59%). Use of a filter was more frequent in longer lesions (146 ± 106 mm vs 91 ± 72 mm; P=.01), in more severe stenoses (95% vs 87%; P=.04), and in chronic total occlusions (33% vs 8.3%; P=.01). Patients receiving filters had longer procedure duration (102 ± 51 min vs 66 ± 41 min; P=.01) and longer fluoroscopy times (31 ± 16 min vs 21 ± 10 min; Patherectomy was predominantly used during complex infrainguinal PAI and was associated with less occurrence of DE.

  16. Using the modern Silverhawk™ atherectomy catheter to characterize biliary structures that appear malignant: review of initial experience

    Science.gov (United States)

    Schwartz, Jason J; Thiesset, Heather F; Clayton, Frederic; Adler, Douglas G; Hutson, William R; Carlisle, James G

    2011-01-01

    Background Diagnosis of a biliary stricture often hinges on cytological interpretation. In the absence of accompanying stroma, these results can often be equivocal. In theory, advanced shave biopsy techniques would allow for the preservation of tissue architecture and a more accurate definition of biliary pathology. Objectives We sought to determine the initial diagnostic utility of the modern Silverhawk™ atherectomy (SA) catheter in the evaluation of biliary strictures that appear to be malignant. Methods A total of 141 patients with biliary pathology were identified during a retrospective review of medical records for the years 2006–2011. The SA catheter was employed 12 times in seven patients for whom a tissue diagnosis was otherwise lacking. Results Neoplasia was definitively excluded in seven specimens from four patients. These four individuals were followed for 1–5 years to exclude the development of cholangiocarcinoma (CC). Samples were positive for CC in three patients, one of whom became eligible for neoadjuvant therapy and orthotopic liver transplantation. Conclusions The SA catheter appears to be a useful adjunct in diagnosing patients with biliary pathology. The existence of this technique, predicated on tissue architecture, may impact therapy, allow more timely diagnosis, and exclude cases of equivocal cytology. Although the initial results of SA use are promising, more experience is required to effectively determine its clinical accuracy. PMID:21999597

  17. Technique optimization of orbital atherectomy in calcified peripheral lesions of the lower extremities: the CONFIRM series, a prospective multicenter registry.

    Science.gov (United States)

    Das, Tony; Mustapha, Jihad; Indes, Jeffrey; Vorhies, Robert; Beasley, Robert; Doshi, Nilesh; Adams, George L

    2014-01-01

    The purpose of CONFIRM registry series was to evaluate the use of orbital atherectomy (OA) in peripheral lesions of the lower extremities, as well as optimize the technique of OA. Methods of treating calcified arteries (historically a strong predictor of treatment failure) have improved significantly over the past decade and now include minimally invasive endovascular treatments, such as OA with unique versatility in modifying calcific lesions above and below-the-knee. Patients (3135) undergoing OA by more than 350 physicians at over 200 US institutions were enrolled on an "all-comers" basis, resulting in registries that provided site-reported patient demographics, ABI, Rutherford classification, co-morbidities, lesion characteristics, plaque morphology, device usage parameters, and procedural outcomes. Treatment with OA reduced pre-procedural stenosis from an average of 88-35%. Final residual stenosis after adjunctive treatments, typically low-pressure percutaneous transluminal angioplasty (PTA), averaged 10%. Plaque removal was most effective for severely calcified lesions and least effective for soft plaque. Shorter spin times and smaller crown sizes significantly lowered procedural complications which included slow flow (4.4%), embolism (2.2%), and spasm (6.3%), emphasizing the importance of treatment regimens that focus on plaque modification over maximizing luminal gain. The OA technique optimization, which resulted in a change of device usage across the CONFIRM registry series, corresponded to a lower incidence of adverse events irrespective of calcium burden or co-morbidities. Copyright © 2013 The Authors. Wiley Periodicals, Inc.

  18. Rotational atherectomy as endovascular haute couture: a road map of tools and techniques for the interventional management of burr entrapment.

    Science.gov (United States)

    Dahdouh, Ziad; Abdel-Massih, Tony; Roule, Vincent; Sarkis, Antoine; Grollier, Gilles

    2013-12-01

    Rotational atherectomy (RA) is used as a debulking technique prior to stenting in some specialized cardiac centers for calcified coronary lesions amenable to percutaneous coronary intervention (PCI). A specific possible complication, burr entrapment, is unusual but carries serious risks and may sometimes necessitate surgery as a rescue procedure. However, different modalities using a percutaneous approach were proposed as a bail-out. We aim to propose a framework for possible management for trapped RA burr. A literature review of the most relevant cases of entrapped burr during PCI was performed. Twelve cases were reported and different solutions were discussed. Surgery was needed in only 1 patient to retrieve the trapped burr, and in all the other cases, different percutaneous solutions were successful to retract the trapped device. These cases illustrate that burr entrapment during RA, albeit rare, may occur and may transform a relatively simple PCI to a procedure failure. Although prevention is better than treatment, the operators should be aware of such serious complication and they should keep in mind that various possible percutaneous solutions may be successful to retrieve the burr and to avoid surgery. © 2013, Wiley Periodicals, Inc.

  19. Immediate and intermediate-term results of optical coherence tomography guided atherectomy in the treatment of peripheral arterial disease: Initial results from the VISION trial.

    Science.gov (United States)

    Cawich, Ian; Paixao, Andre R M; Marmagkiolis, Konstantinos; Lendel, Vasili; Rodriguez-Araujo, Gerardo; Rollefson, William A; Mego, David M; Cilingiroglu, Mehmet

    Long-term patency rates for percutaneous peripheral arterial interventions are suboptimal. Optical coherence tomography (OCT) guided atherectomy may yield superior patency by optimizing plaque removal while preserving the tunica media and adventitia. The VISION study is a multicenter prospective study of patients with peripheral arterial disease undergoing OCT guided atherectomy with the Pantheris™ device. In 11 patients enrolled in a single center, we report procedural and clinical outcomes, at 30days and 6months. The mean age was 63±11years and 73% (n=8) were men. The target lesion was in the superficial femoral artery in 82% (n=9) of the patients. Mean stenosis severity was 87%±10% and mean lesion length was 39±31mm. Procedural success was observed in all patients with no device related complications. Mean post-atherectomy stenosis was 18%±15%. Almost all excised tissue consisted of intimal plaque (94%). At 30days, significant improvements in Rutherford class, VascuQoL scores and ABI were observed, 0.9±0.8 vs. 3.1±0.7 (p=0.01), 4.9±1.9 vs. 3.6±1.5 (p=0.03) and 1.04±0.19 vs. 0.80±0.19 (patherectomy resulted in high procedural success, no device related complications and encouraging results up to 6months. Histological analysis suggested little injury to the media and adventitia. Larger studies are needed to confirm the efficacy of this approach. Copyright © 2016 Elsevier Inc. All rights reserved.

  20. JetStream Rotational and Aspiration Atherectomy in Treating In-Stent Restenosis of the Femoropopliteal Arteries: Results of the JETSTREAM-ISR Feasibility Study.

    Science.gov (United States)

    Shammas, Nicolas W; Shammas, Gail A; Banerjee, Subhash; Popma, Jeffrey J; Mohammad, Atif; Jerin, Michael

    2016-04-01

    To evaluate the outcomes and stent-device interaction of the JetStream atherectomy device in the treatment of in-stent restenosis (ISR) of the femoropopliteal segment. The JetStream XC atherectomy device, a rotational cutter with aspiration capacity, was evaluated in a prospective cohort of 29 patients (mean age 69.9 ± 11.7 years; 11 men) with femoropopliteal ISR in 32 limbs (ClinicalTrials.gov identifier NCT01722877). Lesion length was 17.4 ± 13.1 cm. The primary effectiveness outcome was acute success (≤ 30% residual narrowing with no serious adverse events). The primary safety endpoint was major adverse events. Secondary endpoints included clinically driven target lesion revascularization (TLR) at 6 months and 1 year and loss of stent integrity as assessed by an angiographic core laboratory. Treated length was 19.5 ± 12.9 cm. Acute success was obtained in 29/32 (91%) limbs. Acute device success (atherectomy alone) was 76% (22/29). Adjunctive balloon angioplasty was performed in all cases at a mean pressure of 11.6 ± 3.3 atm. Embolic filter protection was used in 16 (50%) of 32 limbs. Macrodebris was noted in 2 (12%) of 16 filters. Distal embolization requiring treatment occurred in 3/32 (9.4%) limbs (2 with no filter). Other non-procedure-related adverse events were 1 (3%) death (nonvascular) and 1 (3%) case of major bleeding. There were no new stent fractures or deformities (n=24) postatherectomy. Follow-up was completed on 27 patients (29 limbs) at 6 and 12 months. TLR at these time points occurred in 4/29 (14%) and 12/29 (41%) patients. Patency (duplex-derived peak systolic velocity ratio atherectomy using the XC device has favorable acute results in treating femoropopliteal ISR with high procedure success, no device-stent interaction, and favorably low TLR rates. A multicenter trial is needed to confirm these results. © The Author(s) 2016.

  1. Treatment of diffuse in-stent restenosis with rotational atherectomy followed by radiation therapy with a 188Re-MAG3-filled balloon: six-month clinical and angiographic results of R4 registry

    International Nuclear Information System (INIS)

    Moon, D. H.; Oh, S. J.; Park, S. W.; Hong, M. K.; Lee, C. H.; Kim, J. Z.; Park, S. J.; Lee, H. K.

    2000-01-01

    Intracoronary β-irradiation after rotational atherectomy may be a reasonable approach to prevent recurrent in-stent restenosis (ISR). This study was done to evaluate the feasibility and efficacy of β-radiation therapy with a 188 Re-MAG3-filled balloon following rotational atherectomy for ISR. Fifty consecutive patients with diffuse ISR (length >10 mm) in native coronary arteries underwent rotational atherectomy and adjunctive balloon angioplasty followed by β-irradiation using 188 Re-MAG3-filled balloon catheter. The radiation doses was 15 Gy at 1.0 mm deep into vessel wall. Mean length of the lesion and irradiated segment was 25.6±12.7 mm and 37.6±11.2 mm, respectively. The radiation was delivered successfully to all patients, with a mean irradiation time of 20.1±61 7 sec. No adverse event including myocardial infarction, death, or stent thrombosis occurred during the follow-up period (mean 10.3±3.7 mon) and non-target vessel revascularization was needed in one patient. Six-month binary angiographic restenosis rate was 10.4% (2 focal ISR and 3 edge restenosis) and loss index was 0.17±0.31. Irradiation using 188 Re-MAG3-filled balloon following rotational atherectomy for patients with diffuse ISR may improve the clinical and angiographic outcomes. Further prospective randomized trials are warranted to evaluate the synergistic effect of debulking and irradiation in patients with diffuse ISR

  2. Treatment of diffuse in-stent restenosis with rotational atherectomy followed by radiation therapy with a {sup 188}Re-MAG3-filled balloon: six-month clinical and angiographic results of R4 registry

    Energy Technology Data Exchange (ETDEWEB)

    Moon, D. H.; Oh, S. J.; Park, S. W.; Hong, M. K.; Lee, C. H.; Kim, J. Z.; Park, S. J.; Lee, H. K. [College of Medicine, Ulsan Univ., Seoul (Korea, Republic of)

    2000-07-01

    Intracoronary {beta}-irradiation after rotational atherectomy may be a reasonable approach to prevent recurrent in-stent restenosis (ISR). This study was done to evaluate the feasibility and efficacy of {beta}-radiation therapy with a {sup 188}Re-MAG3-filled balloon following rotational atherectomy for ISR. Fifty consecutive patients with diffuse ISR (length >10 mm) in native coronary arteries underwent rotational atherectomy and adjunctive balloon angioplasty followed by {beta}-irradiation using {sup 188}Re-MAG3-filled balloon catheter. The radiation doses was 15 Gy at 1.0 mm deep into vessel wall. Mean length of the lesion and irradiated segment was 25.6{+-}12.7 mm and 37.6{+-}11.2 mm, respectively. The radiation was delivered successfully to all patients, with a mean irradiation time of 20.1{+-}61 7 sec. No adverse event including myocardial infarction, death, or stent thrombosis occurred during the follow-up period (mean 10.3{+-}3.7 mon) and non-target vessel revascularization was needed in one patient. Six-month binary angiographic restenosis rate was 10.4% (2 focal ISR and 3 edge restenosis) and loss index was 0.17{+-}0.31. Irradiation using {sup 188}Re-MAG3-filled balloon following rotational atherectomy for patients with diffuse ISR may improve the clinical and angiographic outcomes. Further prospective randomized trials are warranted to evaluate the synergistic effect of debulking and irradiation in patients with diffuse ISR.

  3. Directional atherectomy facilitates the interventional procedure and leads to a low rate of recurrent stenosis in left anterior descending and left circumflex artery ostium stenoses: subgroup analysis of the FLEXI‐CUT study

    Science.gov (United States)

    Dahm, J B; Ruppert, J; Hartmann, S; Vogelgesang, D; Hummel, A; Felix, S B

    2006-01-01

    Objectives To examine by retrospective analysis of data from the FLEXI‐CUT monocentre registry whether atherectomy can effectively simplify complex stent implantation in ostial bifurcation lesions by reducing the procedure to stenting of the left anterior descending (LAD) or left circumflex (LCX) artery ostium alone. Patients and methods All patients who had been enrolled in the prospective FLEXI‐CUT study (directional atherectomy with adjunctive balloon angioplasty) were retrospectively analysed on the basis of significant LAD or LCX ostial stenosis (⩾ 70% stenosis) deriving from an undiseased left main stem. The primary combined end point was the rate of target lesion revascularisation (TLR) and binary restenosis; secondary end points were procedural success and major adverse cardiac events (MACE) at the six‐month follow up. Results Of 30 patients enrolled with significant LAD or LCX ostium stenosis, 29 were effectively treated with directional atherectomy (96.7% procedural success). All patients underwent single‐vessel stenting procedures of solely the LAD or LCX ostium. At follow up, binary stenosis was 25% (6 of 24), TLR (angiographic plus clinical) 10.3% (3 of 29) and total MACE 6.9% (2 of 29). Conclusions Directional atherectomy with single‐vessel stenting procedures facilitates the interventional treatment of LAD and LCX ostium stenosis, and leads to remarkably low TLR and binary stenosis at follow up. PMID:16449510

  4. Plain packaging and indirect expropriation of trademark rights under BITs: does FCTC help to establish a right to regulate tobacco products?

    Science.gov (United States)

    Lo, Chang-Fa

    2012-12-01

    Recently the giant tobacco company Philip Morris served its notice to launch an investor-to-state dispute settlement proceeding against the Australian Government for its introduction of plain packaging requirements on tobacco products. It is an important event in the field of intellectual property, investment and international health law. The fundamental questions involved are whether the restriction of trademark rights as a result of the plain packaging requirement is a compensable indirect expropriation under BITs or whether it falls within the scope of government's right to regulate and thus become not compensable. This paper is of the view that the requirement of plain packaging will deprive the essential value or core function of trademark rights and thus constitutes an indirect expropriation under BITs. However, such indirect expropriation meets the public interest requirement and the necessity requirement. The paper further argues that sovereign States have an inherent right to regulate domestic economic activities. Since the pain packaging requirements provided in the FCTC Guidelines are expected to protect the value of human lives and health, the protected values clearly outweigh the affected commercial interests of tobacco companies. Also the justification for host States to adopt a plain packaging policy is strong. Thus, the interpreters of BITs need to pay higher respect to the host State's sovereign power concerning its right to regulate tobacco products for a legitimate purpose. The conclusion of the paper is that the host States should enjoy a defense of the right to regulate to refuse compensation. The author believes that this is the only reasonable conclusion to avoid possible conflicts between different treaty systems (BITs and the FCTC) and between different legal systems and fields (trademark law, investment law and international health law).

  5. Tritium stripping in a nitrogen glove box using palladium/zeolite and SAES St 198 trademark

    International Nuclear Information System (INIS)

    Klien, J.E.; Wermer, J.R.

    1995-01-01

    Glove box clean-up experiments were conducted in a nitrogen glove box using palladium deposited on zeolite (Pd/z) and a SAES St 198 trademark getter as tritium stripping materials. Protium/deuterium samples spiked with tritium were released into a 620 liter glove box to simulate tritium releases in a 10,500 liter glove box. The Pd/z and the SAES St 198 trademark stripper beds produced a reduction in tritium activity of approximately two to three orders of magnitude and glove box clean-up was limited by a persistent background tritium activity level. Attempts to significantly reduce the glove box activity to lower levels without purging were unsuccessful

  6. Affect of Bioglass {sup trademark} repeat dosage on mineralisation of embryonic bone 'in vitro'

    Energy Technology Data Exchange (ETDEWEB)

    Maroothynaden, J. [Imperial Coll. of Medicine, London (United Kingdom). Microgravity Tissue Engineering Lab.; Hench, L.L. [Imperial Coll. of Science, Technology and Medicine, London (United Kingdom). Dept. of Materials

    2001-07-01

    Utilising 45S5 Bioglass {sup trademark} extracts, as described previously, 16-day gestation embryonic mouse long-bones were cultured for 4-days while exposed to the same Bioglass{sup circledR} soluble extract solution for two different exposure times. In the first culture, all embryonic femurs were exposed to fresh 45S5 Bioglass {sup trademark} extract every 98 hours. In the second, the long-bones were exposed to fresh 45S5 Bioglass {sup trademark} extract solution every 48 hours. A simultaneous control culture was performed. All embryonic long-bone cultures mineralised after 4-days culture. Increasing the frequency of 45S5 Bioglass {sup trademark} exposure, from one exposure every 96 hrs to fresh exposures every 48 hrs, significantly increased the length and mineral content of the embryonic long-bones. (orig.)

  7. FRHAM-TEX trademark cool suit - OST reference No. 1854. Deactivation and decommissioning focus area

    International Nuclear Information System (INIS)

    1998-02-01

    This paper describes a demonstration project for the FRHAM-TEX Cool Suit trademark manufactured by FRHAM Safety Products. It is a one-piece, disposable, breathable, waterproof coverall designed to permit moisture generated by the wearer to be transmitted outside the suit. The performance of this suit was compared to a Tyvek reg-sign suit as a baseline. The suit is proposed as safety ware for workers at decontamination and decommissioning projects

  8. Electrochemical oxidation of drug residues in water by the example of tetracycline, gentamicin and Aspirin {sup trademark}

    Energy Technology Data Exchange (ETDEWEB)

    Weichgrebe, D.; Danilova, E.; Rosenwinkel, K.H. [Inst. of Water Quality and Waste Management, Univ. of Hannover, Hannover (Germany); Vedenjapin, A.; Baturova, M. [Inst. of Organic Chemistry, Russian Academy of Science, Moscow (Russian Federation)

    2003-07-01

    The electrochemical oxidation as a method to destroy drug residues like Aspirin {sup trademark}, tetracycline or gentamicin in water was investigated with C-Anode (modified by manganese oxides) and Pt Anode. The mechanism of Aspirin {sup trademark} and tetracycline oxidation and the influence of the biocide effect was observed using GC-MS and three different microbiological tests. In general the biological availability increases with progressive oxidation of the antibiotics. (orig.)

  9. Clinical implications of a new TSH-receptor-antibody-assay (DYNOtest {sup trademark} TRAKhuman) in autoimmune thyroid diseases; Klinische Implikationen eines neuen TSH-Rezeptor-Antikoerper-Assays (DYNOtest {sup trademark} TRAKhuman) bei autoimmunen Schilddruesenerkrankungen

    Energy Technology Data Exchange (ETDEWEB)

    Meller, J.; Schreivogel, I.; Becker, W. [Goettingen Univ. (Germany). Abt. fuer Nuklearmedizin; Bergmann, A.; Morgenthaler, N. [B.R.A.H.M.S Diagnostica, Berlin (Germany); Huefner, M. [Goettingen Univ. (Germany). Abt. Innere Medizin

    2000-07-01

    Aim: Conventional radioreceptor-antibody-assays (RAAs) fail in the detection of TSH-receptor antibodies (TRAKs) in 10-30% of patients with Graves' disease (GD). The aim of this study was the evaluation of the diagnostic and clinical impact of a new RRA (DYNOtest {sup trademark} TRAKhuman) which uses the human recombinant TSH-Receptor in the diagnosis of autoimmune thyroid disease. Methods: Sera from 142 consecutive patients (GD: n=50, autoimmune thyroiditis/AIT: n=92) and from 55 controls (31 patients without any thyroid disease and 14 with euthyroid goiter) were evaluated both with the DYNOtest {sup trademark} TRAKhuman-assay and a conventional RRA (TRAK-Assay {sup trademark}). Thyroid in vitro parameters and thyroid sonography were performed in all patients. Results: The DYNOtest {sup trademark} TRAK-assay was significantly superior to the conventional RRA in the diagnosis of GD (p<0,00012), especially in those who were treated by thionamides (p<0,003) and in the diagnosis of TRAK-positive patients with AIT (p<0,003). The majority of TRAK-positive AIT-patients suffered from hypothyroidism. One false positive result in patients with euthyroid goiter was found in the TRAK-Assay {sup trademark} as well as in the DYNOtest {sup trademark} TRAKhuman-Assay. Therefore the specifity of the DYNOtest {sup trademark} TRAKhuman was not inferior compared with the conventional assay. Conclusion: The DYNOtest {sup trademark} TRAK-assay is superior in the diagnostic work up of Graves' disease compared with a conventional TRAK-assay and offers an equal specifity. (orig.) [German] Ziel: Bei konventionellen Radiorezeptor-Antikoerper-Assays (RRAs) misslingt der Nachweis von TSH-Rezeptor Antikoerpern (TRAKS) bei 10-30% der immunogenen Hyperthyreosen (IH). Ziel der Studie war es, den diagnostischen und klinischen Stellenwertes eines neuen RRA (DYNOtest {sup trademark} TRAKhuman) bei autoimmunen Schilddruesenerkrankungen zu evaluieren. Methoden: Serumproben von 142

  10. Tyrosine phosphorylation of platelet derived growth factor β receptors in coronary artery lesions: implications for vascular remodelling after directional coronary atherectomy and unstable angina pectoris

    Science.gov (United States)

    Abe, J; Deguchi, J; Takuwa, Y; Hara, K; Ikari, Y; Tamura, T; Ohno, M; Kurokawa, K

    1998-01-01

    Background—Growth factors such as platelet derived growth factor (PDGF) have been postulated to be important mediators of neointimal proliferation observed in atherosclerotic plaques and restenotic lesions following coronary interventions. Binding of PDGF to its receptor results in intrinsic receptor tyrosine kinase activation and subsequent cellular migration, proliferation, and vascular contraction.
Aims—To investigate whether the concentration of PDGF β receptor tyrosine phosphorylation obtained from directional coronary atherectomy (DCA) samples correlate with atherosclerotic plaque burden, the ability of diseased vessels to remodel, coronary risk factors, and clinical events.
Methods—DCA samples from 59 patients and 15 non-atherosclerotic left internal thoracic arteries (LITA) were analysed for PDGF β receptor tyrosine phosphorylation content by receptor immunoprecipitation and antiphosphotyrosine western blot. The amount of PDGF β receptor phosphorylation was analysed in relation to angiographic follow up data and clinical variables.
Results—PDGF β receptor tyrosine phosphorylation in the 59 DCA samples was greater than in the 15 non-atherosclerotic LITA (mean (SD) 0.84 (0.67) v 0.17 (0.08) over a control standard, p atherectomy;  restenosis PMID:9616351

  11. Acute procedural outcomes of orbital atherectomy for the treatment of common femoral artery disease: Sub-analysis of the CONFIRM Registries.

    Science.gov (United States)

    Lee, Michael S; Heikali, Daniel; Mustapha, Jihad; Adams, George; Mahmud, Ehtisham

    2017-08-01

    This analysis compared the angiographic outcomes of patients treated with orbital atherectomy for calcified common femoral artery (CFA) and superficial femoral artery (SFA) disease. The ideal revascularization strategy for CFA disease is unknown. Endarterectomy has been considered the standard of care for CFA disease for over 50 years. Endovascular intervention is becoming more commonly used to revascularize the CFA given the advances in technology and the less invasive nature of the procedure. Patient demographics, lesion characteristics, and procedure data for all CONFIRM patients with at least one CFA lesion location ( n=147 patients; n=200 lesions) were compared to patients with at least one SFA lesion location ( n=1508 patients; n=2367 lesions). The primary endpoint was angiographic complication, defined as the composite of dissection, perforation, slow flow, closure, spasm, embolism, or thrombosis. The CFA group had more patients with Rutherford class 4 and shorter lesion length. The CFA group had a higher final residual stenosis, shorter total run time, and shorter total inflation time. The primary endpoint was lower in the CFA group compared with the SFA group (17% vs 24%, p=0.02), driven by a lower dissection rate (10% vs 15%, p=0.04). Plaque modification of the CFA with orbital atherectomy was safe and compared favorably with SFA disease. The need for bail-out stenting was low. A randomized trial is needed to determine the ideal treatment strategy for calcified CFA disease.

  12. RESEARCH ON THE EVOLUTION OF THE TOP ROMANIAN TRADEMARKS IN THE DOMESTIC MARKET

    Directory of Open Access Journals (Sweden)

    Agatha POPESCU

    2015-04-01

    Full Text Available The paper analyzed the position of the Romanian trademarks using the data provided by Unlock Market Research Company in 2010 and 2014. The statistical parameters: average, variance, standard deviation and variation coefficient, and the Point Method and Comparison Method were used to process the collected data. In 2014, among the top 50 brands in Romania's market, the top 10 positions were occupied by the following trademarks: Borsec, Dero, Gerovital, Dorna, Arctic, Dacia, Elmiplant, Aqua Carpatica, Farmec and Petrom. Food industry came on the 1st position with 17 brands and on the 3rd position after telephony and finance and banking, based on the average positions of its trademarks. By field of activity, based on the average position, the 1st three positions were occupied by Machinery construction and Chemical and extractive industry, Alcoholic beverages, and Wood working industry. On the last position was situated Telephony. As a final conclusion, consumers behavior reflected an intensive orientation to the Romanian brands belonging to food industry, care and health sector and also of the appliances for household reflecting a new behavior to assure a higher living standards.

  13. Coil embolization of anterior circulation aneurysms supported by the solitaire trademark AB neurovascular remodeling device

    International Nuclear Information System (INIS)

    Klisch, Joachim; Clajus, Christin; Sychra, Vojtech; Eger, Cornelia; Strasilla, Christoph; Rosahl, Steffen; Gerlach, Ruediger; Baer, Ingrid; Hoch, Heinrich; Herbon, Uta; Borota, Ljubisa; Jonasson, Per; Liebig, Thomas

    2010-01-01

    The purpose of the study is to evaluate patients with wide-necked or complex aneurysms of the anterior circulation who underwent Solitaire trademark AB Neurovascular Remodeling Device-assisted coil embolization. From February 2008 to March 2009, consecutive data were collected from 45 patients with anterior circulation aneurysms. Eighteen of the patients presented with acute subarachnoid hemorrhage. Forty-six aneurysms were treated with the aid of different applications (n=49) of the Solitaire trademark AB Remodeling Device followed by standard coiling procedure (n = 43) using bioactive coils or/and bare coils. Successful positioning of the remodeling device was obtained in 95.9% of the cases. There were two thromboembolic complications (4.1%) and one severe vasospasm requiring retrieval of the device. Permanent procedural morbidity was observed in one patient (2%). The proportion of patients in whom Raymond class 1 occlusion was obtained was 53.5% (n=23). Raymond class 2 occlusion was achieved in 42% (n=18) and Raymond class 3 occlusion in 4.7% (n=2). Thirty-nine patients left the hospital with a good clinical status. The initial technical and clinical results of Solitaire trademark AB device-assisted coiling of aneurysms in the anterior circulation are highly encouraging. This technique may enhance the possibilities of the endovascular treatment of these aneurysms in clinical routine. (orig.)

  14. Long-Term Outcomes After Percutaneous Lower Extremity Arterial Interventions With Atherectomy vs. Balloon Angioplasty - Propensity Score-Matched Registry.

    Science.gov (United States)

    Janas, Adam; Buszman, Piotr P; Milewski, Krzysztof P; Wiernek, Szymon; Janas, Ksenia; Pruski, Maciej; Wojakowski, Wojciech; Błachut, Aleksandra; Picheta, Wojciech; Buszman, Pawel; Kiesz, Stefan

    2017-02-24

    The impact of endovascular revascularization of the lower extremity arteries with atherectomy (AT) compared with percutaneous transluminal angioplasty (PTA) is still unclear. Therefore, the aim of the study was to compare long-term outcomes after percutaneous PTA and AT in patients requiring endovascular revascularization.Methods and Results:This was a single-center, retrospective registry of obstructive and symptomatic PAD patients who underwent endovascular revascularization. PTA was performed in 215 patients, and AT in 204 (Silver Hawk, EV3, n=125; CSI 360°, n=66; Pathway Medical Technologies, n=13). There were no significant between-group differences in baseline characteristics except for increased CAD, dialysis and CLI prevalence in the PTA group. Following propensity score analysis 131 well-matched pairs were included in analysis. Bail-out stenting was more frequent in the reference group (PTA, 6.1% vs. AT, 0%; P=0.004). At 6- and 12-month follow-up there were no differences in TLR between the groups (PTA, 8.3% vs. AT, 5.3%; P=0.47; and PTA, 16.7% vs. AT, 13.7%; P=0.73, respectively). The difference was in favor of AT at 24-month follow-up (PTA, 29.0% vs. AT, 16.7%; P=0.05). No difference was observed in amputation rate (PTA, 0.7% vs AT, 1.5%; P=0.62). On Kaplan-Meier analysis there were no significant differences between groups in time to TLR, amputation or death. AT was associated with lower risk of TLR, and this should be confirmed in randomized controlled trials.

  15. Clinical predictors of mortality following rotational atherectomy and stent implantation in high‐risk patients: A single center experience

    Science.gov (United States)

    Édes, István F.; Ruzsa, Zoltán; Szabó, György; Nardai, Sándor; Becker, Dávid; Benke, Kálmán; Szilveszter, Bálint

    2015-01-01

    Objectives Our aim was to assess the procedural success and determine the clinical predictors of postprocedure mortality, following rotational atherectomy (RA) and stenting in high‐risk patients. Background RA is mainly used to facilitate stenting in complex lesions. Outcomes involving RA and stenting have been investigated, yet high‐risk patients have not been adequately described. Methods Data of 218 consecutive patients who underwent RA were evaluated in a prospective register. Primary endpoints were the angiographic success and long‐term mortality. Secondary endpoints were procedural success, consumption of the angioplasty equipment, and periprocedural major adverse cardiac events. The impact of the relevant angiographic and clinical characteristics on long‐term mortality was analyzed using uni‐ and multivariate Cox regression analysis. Results Mean age of the patients was 70 ± 8.2 years, diabetes was present in 44%, and chronic renal failure in 29%. Prior myocardial infarction and three‐vessel disease amounted to 42.2% and 32.6%, respectively. Altogether, 52.8% of patients underwent RA after a failed, non‐RA intervention attempt, and 30.7% of cases presented as acute coronary syndromes. Angiographic success was 100%, and all patients received stents after RA. Periprocedural major adverse cardiac events occurred in five (2.3%) patients. Postprocedural death was investigated, with a mean follow‐up of 36 months. Mortality amounted to 37.2%. Multivariate analysis revealed that left ventricular ejection fraction < 50%, glomerular filtration rate < 60 ml/min, cardiogenic shock, and diabetes were the only independent mortality predictors. Conclusions We have found that RA and stenting is feasible and viable in an elderly high‐risk population, with exceptional procedural success and acceptable long‐term results. © 2015 Wiley Periodicals, Inc. PMID:26032270

  16. Company Slogan and a Vivid Image of a Trademark - as Main Components of a Strong Brand

    Directory of Open Access Journals (Sweden)

    Igor BELOSTECINIC

    2015-12-01

    Full Text Available Among other methods, good brand managers always affect clients and strengthen their fidelity to the brand by means of company advertising slogans and vivid images associated with this brand. Slogans may function as useful “levers” or “hooks” helping clients to understand the essence of a trademark and its peculiarity, as well as to nail in clients' minds the established image of a strong brand. One of the “hooks” attracting attention to brand and helping to nail it in a common man's mind – is a company (advertising slogan - short message or motto, which actively presents the key theme of the brand in general or of a certain advertising campaign, and contains substantial information, reflecting the essence of campaign's or product's marketing offer. One must admit that it is nice to recall favorite philosopher's aphorisms or sayings while getting up in the morning, and to whistle an aria from a renowned opera on your way to work. However, more often people sing unsophisticated verses about the “sign of a good taste” and get annoyed by a trivial call to “have a break” going round in their heads. This means that the advertisement of popular chocolate bars and drinks has hit its target. The main lever for success in generation of a positive and recognizable brand image - is the slogan and its graphic image in consumer's mind. Together with other brand components (logo, corporate colors, sound or music image a slogan generates the system of constant elements which ensure the brand's internal unity and are aimed at creation of exposure effect. To some extent, we all are “ad eaters” and are always capable of estimating an ad, even if it is at the level of feelings: whether we like it or not. So why a certain advertisement can make us smile, elicit good feelings and cause an urge to buy product/service that is being advertised, and another one - evokes disappointment and annoyance? The answer is obvious: the first one was

  17. Optimizing sound quality with AACHENHEAD {sup trademark} -technology; Optimierung der Geraeuschqualitaet mit der AACHENHEAD {sup trademark} -Technologie

    Energy Technology Data Exchange (ETDEWEB)

    Krohn, C. [HEAD acoustics GmbH (Germany)

    1997-08-01

    The sound quality of interior and exterior vehicle noise is gaining more and more importance. Not only that modern vehicles show a considerably lower noise level, the characteristic sound of a vehicle influences the buyer`s choice of a car. The acoustic engineer is faced with a complex task. In addition to reducing the noise level he has to make sure that the sound design goes along with the product. This is where aurally-adequate sound diagnosis is needed. Conventional methods, e.g. measuring the noise level or third-octave spectrum, alone cannot solve this specific task. HEAD acoustics offers the full range of aurally-adequate measurement and analysis systems, starting with the Artificial Head Measurement System and making the recorded data available for further analysis with the Binaural Analysis System BAS or the Mobile Sound Quality Laboratory SQlab. This full range of systems helps the acoustic engineer to solve his tasks for improving sound quality in a fast and cost-effective way. (orig.) [Deutsch] Kaum jemand wuerde ein Geraeusch mit verschlossenen Ohren beurteilen. Dennoch ist dies in der Praxis durchaus noch ueblich. Konventionelle Analyseverfahren in der Akustik und Schwingungsmesstechnik verlassen sich ausschliesslich auf den Augenschein. Dieser Aufsatz zeigt neue Wege von HEAD acoustics in diesem Bereich der Messtechnik. (orig.)

  18. Facility Composer (Trademark) and PACES (Trademark) Integration: Development of an XML Interface Based on Industry Foundation Classes

    Science.gov (United States)

    2007-11-01

    GA TIFTON 13921 GA MACON 13974 GA ATHENS 13981 GA FORT VALLEY 13998 GA ALBANY AREA 13999 GA SAVANNAH INTL APT ModelGroup List ERDC...PropertySingleValue> <name>Heat Generating System</name> <nominalValue> <Text>Hot Water Boilers - Gas Fired</Text> </nominalValue...ALABAMA AR ARKANSAS AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT DC DISTRICT OF COLUMBIA DE DELAWARE FL FLORIDA GA GEORGIA HI HAWAII

  19. Development of a Continuum Damage Mechanics Material Model of a Graphite-Kevlar(Registered Trademark) Hybrid Fabric for Simulating the Impact Response of Energy Absorbing Kevlar(Registered Trademark) Hybrid Fabric for Simulating the Impact Response of Energy Absorbing

    Science.gov (United States)

    Jackson, Karen E.; Fasanella, Edwin L.; Littell, Justin D.

    2017-01-01

    This paper describes the development of input properties for a continuum damage mechanics based material model, Mat 58, within LS-DYNA(Registered Trademark) to simulate the response of a graphite-Kevlar(Registered Trademark) hybrid plain weave fabric. A limited set of material characterization tests were performed on the hybrid graphite-Kevlar(Registered Trademark) fabric. Simple finite element models were executed in LS-DYNA(Registered Trademark) to simulate the material characterization tests and to verify the Mat 58 material model. Once verified, the Mat 58 model was used in finite element models of two composite energy absorbers: a conical-shaped design, designated the "conusoid," fabricated of four layers of hybrid graphite-Kevlar(Registered Trademark) fabric; and, a sinusoidal-shaped foam sandwich design, designated the "sinusoid," fabricated of the same hybrid fabric face sheets with a foam core. Dynamic crush tests were performed on components of the two energy absorbers, which were designed to limit average vertical accelerations to 25- to 40-g, to minimize peak crush loads, and to generate relatively long crush stroke values under dynamic loading conditions. Finite element models of the two energy absorbers utilized the Mat 58 model that had been verified through material characterization testing. Excellent predictions of the dynamic crushing response were obtained.

  20. Registered Trademarks… Reflections on the use of trademarks, consumption patterns and marketing strategies in rural areas of Argentina (1900-1930

    Directory of Open Access Journals (Sweden)

    Andrea Lluch

    2013-06-01

    Full Text Available Trademarks are highly valuable devices that serve a relevant purpose in trade and consumption patterns. However, trademarks have been largely neglected by Argentina's economic history historiography. This article discusses how and when trademarks emerged and spread in Argentina's rural area in the early 20th century. It describes this gradual process, pointing out that, by the late 1920s, trademarks had already become a prominent feature in rural marketing strategies and consumption patterns. The study also analyzes how these processes contributed to shaping retailers' business practices as well as generic consumer goods' marketing channels (particularly, in the food and beverage industries

  1. Physicochemical characterization of different trademarks of compound Yerba Maté and their herbs

    Directory of Open Access Journals (Sweden)

    Griselda Patricia Scipioni

    2007-07-01

    Full Text Available The objectives of this study were to evaluate the physicochemical characteristics of the main herbs used in the mixture of yerba maté with other aromatic herbs and the characterization of the trademarks of compound yerba maté. Moisture, water extract, total ash, acid-insoluble ash and caffeine concentration were determined. Results showed higher values of moisture content, total and aci-insoluble ash and lower water extracts in the herbs. Determinations were carried out in nine trademarks of compound yerba maté. In most cases they complied with the standards of the country with the exception of one trademark from Argentina.A erva-mate composta é um produto que se consome amplamente na região do MERCOSUL. Obtém-se misturando erva-mate com outras ervas aromáticas. O objetivo desta pesquisa foi o estudo das características físico-químicas das principais ervas usadas na mistura e a caracterização das marcas de erva-mate composta. Determinou-se a umidade, extração de água, cinzas totais, cinzas insolúveis ácidas e a concentração de cafeína. Encontraram-se nas ervas, valores padrões diferentes aos da erva-mate tais como valores maiores de conteúdo de umidade, cinzas totais, cinzas insolúveis ácidas e menores extratos de água. Fizeram-se determinações em nove marcas de erva-mate composta. Na maioria dos casos, cumpriam com as normas do país, exceto uma marca da Argentina

  2. Champagne, Cognac, Rioja, Jerez and Vales dos Vinhedos: Conflicts between trademarks and geographical indications of wines and spirits in Brazil

    Directory of Open Access Journals (Sweden)

    da Silva Barbosa Patrícia Maria

    2016-01-01

    Full Text Available The world wine trade generated around 30 billion Euros in 2015. The wine consumer appreciates attributes such as tradition, quality and distinctiveness, characteristics that are associated with the terroir. In this segment, trademarks and geographical indications (GI are relevant distinctive signs for the consumers' choice. Issues involving the protection of these signs have become increasingly stronger in the same proportion of the trade growth. Wine GIs hold a long tradition in the international scenario, particularly the European. In Brazil, the trademarks have a broader protection history, and the GIs were only acknowledged with the 1996 Industrial Property Law. Nevertheless, Brazil stands out as an emergent market for wines. The databank of the National Institute of Industrial Property (INPI-Brazil shows that 30% of all applications for GI protection are for wines and spirits. Such figures indicate the growing importance of the GI for the segment. The purpose of this paper is to analyze the applications for trademarks and GIs for wines and spirits, based on the INPI databank. For such, some foreign GIs have been chosen, for their historic and commercial importance, as well as one national GI, the first acknowledged in the segment. Among the results, several applications for trademarks from different applicants containing the searched terms have been found. From these results, it is believed that the coexistence and overlap of trademarks and GIs indicate the need for a review of the national legislation.

  3. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions.

    Science.gov (United States)

    Stavroulakis, Konstantinos; Schwindt, Arne; Torsello, Giovanni; Stachmann, Arne; Hericks, Christiane; Bosiers, Michel J; Beropoulis, Efthymios; Stahlhoff, Stefan; Bisdas, Theodosios

    2017-04-01

    To report a single-center study comparing drug-coated balloon (DCB) angioplasty vs directional atherectomy with antirestenotic therapy (DAART) for isolated lesions of the popliteal artery. Seventy-two patients were treated with either DCB angioplasty alone (n=31) or with DAART (n=41) for isolated popliteal artery stenotic disease between October 2009 and December 2015. The majority of patients presented with lifestyle-limiting claudication (74% vs 86%, respectively). Vessel calcification (29% vs 29%, respectively), mean lesion length (47 vs 42 mm, respectively), and number of runoff vessels were comparable between the groups. The primary outcome measure was primary patency; secondary outcomes were technical success (<30% residual stenosis or bailout stenting), secondary patency, and freedom from clinically driven target lesion revascularization (TLR). The technical success rate following DCB was 84% vs 93% (p=0.24) after DAART. The 12-month primary patency rate was significantly higher in the DAART group (65% vs 82%; hazard ratio 2.64, 95% confidence interval 1.09 to 6.37, p=0.021), while freedom from TLR did not differ between the 2 treatment strategies (82% vs 94%, p=0.072). Secondary patency at 12 months was identical for both groups (96% vs 96%). Although not statistically significant, bailout stenting was more common after DCB angioplasty (16% vs 5% for DAART, p=0.13) and aneurysmal degeneration of the popliteal artery was seen more often after DAART (7% vs 0% for DCB alone, p=0.25). Popliteal artery injury was observed in 2 patients treated using DAART (5% vs 0% for DCB alone, p=0.5), whereas distal embolization rates were comparable between the groups (3% for DCB alone vs 5% for DAART, p=0.99). In this study, the use of DAART was associated with a higher primary patency rate compared with DCB angioplasty for isolated popliteal lesions. Nonetheless, both treatment options were associated with excellent 12-month secondary patency. Aneurysmal degeneration of

  4. Production of strontium-82 for the Cardiogen trademark PET generator: a project of the Department of Energy Virtual Isotope Center

    International Nuclear Information System (INIS)

    Phillips, D.R.; Peterson, E.J.; Taylor, W.A.; Jamriska, D.J.; Hamilton, V.T.; Kitten, J.J.; Valdez, F.O.; Salazar, L.L.; Pitt, L.R.; Heaton, R.C.; Kolsky, K.L.; Mausner, L.F.; Kurczak, S.; Zhuikov, B.L.; Kokhanyuk, V.M.; Konyakhin, N.A.; Nortier, F.M.; Walt, T.N. van der; Hanekom, J.; Sosnowski, K.M.; Carty, J.S.

    2000-01-01

    In December of 1989, the United States Food and Drug Administration approved 82 Rb chloride in saline solution for cardiological perfusion imaging by positron emission tomography (PET). The solution is derived from a 82 Sr generator system that is presently manufactured by Bristol Myers Squibb and distributed for clinical application in the United States by Bracco Diagnostics, Inc. Many years of research and development by people in several institutions led up to the approval for clinical use. Currently, there are about 15 sites in the U.S. that perform clinical myocardial perfusion imaging by PET using 82 Rb chloride from the generator. In order to manufacture the generators, Bristol Myers Squibb requires about 1600 mCi of 82 Sr every 30 days. The United States Department of Energy and MDS Nordion, Canada are the current suppliers with qualified Drug Master Files for the production and distribution of this nuclide for the Cardiogen trademark generator. These two entities have worked together over the years to assure the regular, reliable supply of the 82 Sr. Here we describe the facilities and methods used by the Department of Energy in its Virtual Isotope Center to make and distribute the nuclide. (orig.)

  5. 78 FR 16835 - Privacy Act of 1974; System of Records

    Science.gov (United States)

    2013-03-19

    ...: Martha Sneed, ATTN: Public Search Facility, United States Patent and Trademark Office, P.O. Box 1450...: Unclassified. System location: Public Search Facility, United States Patent and Trademark Office, Madison East... and other representatives of commercial firms offering patent search services to the public...

  6. 小微企业实施商标战略的困境与对策%PREDICAMENT AND COUNTERMEASURES OF SMALL & MICRO-BUSINESSES IN IMPLEMENTING TRADEMARK STRATEGY

    Institute of Scientific and Technical Information of China (English)

    李文江; 郭雨洁

    2015-01-01

    The existence and development of small and micro enterprises give not only strong support to the de-velopment of the national economy,but also provide vast space for national employment. Therefore governments at all levels have gradually introduced a number of supportive policies. Following the successive promulgation of the strategy of developing the country through science and technology and the strategy of intellectual proper-ty,technology-based small and micro-businesses attach greater importance to the role of intellectual property in the development of enterprises,such as brand development,patented technology and so on. However,in prac-tice,small and micro-businesses are faced with not only some misunderstanding as to how to cultivate and es-tablish their own brands through trademark registration,such as passing off a famous brand,paying no attention to registered trademark,ignoring the use of registered trademarks and so on,they are also plagued by the exist-ing system including restricted personal trademark applications,inconvenient electronic filing,rejecting and re-viewing application at higher costs. Small and micro enterprises should choose proper trademark strategy ac-cording to their own characteristics,such as small scale,weak in strength and low productivity. The State Trademark Bureau should effectively support the development of small and micro-businesses through the revi-sion of trademark law which will optimize and refine trademark registration rules.%小微企业的存在与发展不仅有力支撑了国民经济的发展,而且成为国民就业的广阔空间,为此,我国各级政府都陆续出台了许多扶持政策。在科技兴国战略和知识产权战略相继颁布后,科技型小微企业更加重视知识产权在企业发展中的作用,如品牌建设、专利技术等。然而,实践中小微企业如何通过商标注册培育和树立自身品牌,不仅面临着一些认识误区,

  7. Number of Blades-up Runs Using JetStream XC Atherectomy for Optimal Tissue Debulking in Patients with Femoropopliteal Artery In-Stent Restenosis.

    Science.gov (United States)

    Shammas, Nicolas W; Shammas, Gail A; Aasen, Nicole; Jarvis, Gary

    2015-12-01

    Rotational atherectomy with the use of the JetStream XC device is indicated for treatment of infrainguinal arterial obstructive disease. The number of blades-up (BU) runs needed for optimal tissue debulking in femoropopliteal in-stent restenosis (ISR) is unknown. In the present series, 6 patients (15 lesions) were treated for femoropopliteal ISR with the JetStream XC device. Minimal luminal diameter or percent stenosis improved significantly from baseline after 2 BU runs, but no further gain was seen between 2 and 4 BU runs (P > .05). However, adjunctive balloon angioplasty reduced percent stenosis significantly following BU runs. In conclusion, the JetStream XC device achieved optimal acute angiographic results in treating femoropopliteal ISR following 2 BU runs and adjunctive balloon angioplasty. Copyright © 2015 SIR. Published by Elsevier Inc. All rights reserved.

  8. Dataset of calcified plaque condition in the stenotic coronary artery lesion obtained using multidetector computed tomography to indicate the addition of rotational atherectomy during percutaneous coronary intervention

    Directory of Open Access Journals (Sweden)

    Yasushi Akutsu

    2016-06-01

    Full Text Available Our data shows the regional coronary artery calcium scores (lesion CAC on multidetector computed tomography (MDCT and the cross-section imaging on MDCT angiography (CTA in the target lesion of the patients with stable angina pectoris who were scheduled for percutaneous coronary intervention (PCI. CAC and CTA data were measured using a 128-slice scanner (Somatom Definition AS+; Siemens Medical Solutions, Forchheim, Germany before PCI. CAC was measured in a non-contrast-enhanced scan and was quantified using the Calcium Score module of SYNAPSE VINCENT software (Fujifilm Co. Tokyo, Japan and expressed in Agatston units. CTA were then continued with a contrast-enhanced ECG gating to measure the severity of the calcified plaque condition. We present that both CAC and CTA data are used as a benchmark to consider the addition of rotational atherectomy during PCI to severely calcified plaque lesions.

  9. MarCell trademark software for modeling bone marrow radiation cell kinetics

    International Nuclear Information System (INIS)

    Hasan, J.S.; Jones, T.D.; Morris, M.D.

    1997-01-01

    Differential equations were used to model cellular injury, repair, and compensatory proliferation in the irradiated bone marrow. Recently, that model was implemented as MarCell trademark, a user-friendly MS-DOS computer program that allows users from a variety of technical disciplines to evaluate complex radiation exposure. The software allows menu selections for different sources of ionizing radiation. Choices for cell lineages include progenitor, stroma, and malignant, and the available species include mouse, rat, dog, sheep, swine, burro, and man. An attractive feature is that any protracted irradiation can be compared with an equivalent prompt dose (EPD) in terms of cell kinetics for either the source used or for a reference such as 250 kVp x rays or 60 Co. EPD is used to mean a dose rate for which no meaningful biological recovery occurs during the period of irradiation. For human as species, output from MarCell trademark includes: risk of 30-day mortality; risk of whole-body cancer and leukemia based either on radiation-induced cytopenia or compensatory cell proliferation; cell survival and repopulation plots as functions of time or dose; and 4-week recovery following treatment. copyright 1997 American Association of Physicists in Medicine

  10. Flowsheet Validation For The Permanganate Digestion Of REILLEX(trademark) HPQ Anion Resin

    International Nuclear Information System (INIS)

    Kyser, E.

    2009-01-01

    The flowsheet for the digestion of Reillex(trademark) HPQ was validated both under the traditional alkaline conditions and under strongly acidic conditions. Due to difficulty in performing a pH adjustment in the large tank where this flowsheet must be performed, the recommended digestion conditions were changed from pH 8-10 to 8 M HNO 3 . Thus, no pH adjustment of the solution is required prior to performing the permanganate addition and digestion and the need to sample the digestion tank to confirm appropriate pH range for digestion may be avoided. Neutralization of the acidic digestion solution will be performed after completion of the resin digestion cycle. The amount of permanganate required for this type of resin (Reillex(trademark) HPQ) was increased from 1 kg/L resin to 4 kg/L resin to reduce the amount of residual resin solids to a minimal amount ( 2 ) solids (1.71 kg/L resin) and involves the generation of a significant liquid volume due to the low solubility of permanganate. However, since only two batches of resin (40 L each) are expected to be digested, the total waste generated is limited.

  11. Thermoluminescent signal fading of encapsulated lif: Mg,Ti detectors in PTFE-Teflon registered trademark

    International Nuclear Information System (INIS)

    Sasho Nikolovski, Sasho; Nikolovska, Lidija; Velevska, Marija; Velev, Velko

    2010-01-01

    Fading is a process when the latent information of a detector is unintentionally lost mainly due to the thermal influence. Thermoluminescent (TL) detectors have different sensitivities as far as the fading effect. Encapsulated TL detectors mounted within shielded filter holders are used during the personal monitoring of occupationally exposed persons in R. Macedonia. PTFE-Teflon registered trademark polymer is an example of encapsulation material that has a temperature resistance and it allows the luminescence signal to pass through. Since the encapsulated TL detectors cannot be submitted to annealing treatment in an oven, another fading reduction method is needed. The TL evaluation method suggested in this work is based on a specific glow-curve region. Irradiations were conducted using 90Sr/90Y source. Post-irradiation fade investigations were conducted for evaluation periods that varied up to 4 months. Two areas of the TL glow-curve were selected with the WimRems software. They correspond to the high and the low fading emission peaks (the lower temperature peaks display a greater degree of thermal fading than the higher temperature peaks). Post-irradiation fade is a contributing factor that affects the response of a thermoluminescent (TL) phosphor as a function of time. PTFE - Polytetrafluoroethylene most well known by the DuPont brand name Teflon registered trademark. (Author)

  12. Evaluating the Effectiveness of NASA's Destination Tomorrow(Trademark) 2000-2001 Program

    Science.gov (United States)

    Pinelli, Thomas E.; Perry, Jeannine

    2002-01-01

    NASA's Destination Tomorrow(trademark) series consists of 30-minute educational television programs that focus on NASA research, past, present, and future and are designed for educators, parents, and adult (lifelong) learners. Programs in this award-winning series follow a magazine style format with segments ranging from 3-5 minutes to 6-8 minutes. An associated web site provides summaries of stories and links to related program material. The development of the programs is based on educational theory, principles, and research as they pertain to how adults learn and apply knowledge. The five programs in the 2000-2001 season were produced in English and dubbed in Spanish. Telephone interviews with managers of cable access television stations were conducted in January 2002. NASA's Destination Tomorrow(trademark) interviewees reported that (1) from a programming standpoint, the most appealing aspects of the series are its production quality and educational value, (2) programs in the series are 'better than average' when compared to other education programming, (3) the programs are very credible, (4) the programs are successful in educating people about what NASA does, and (5) the programs have been 'very well received' by their audiences.

  13. An investigation of the applicability of the new ion exchange resin, Reillex{trademark}-HPQ, in ATW separations. Milestone 4, Final report

    Energy Technology Data Exchange (ETDEWEB)

    Ashley, K.R.; Ball, J.; Grissom, M.; Williamson, M.; Cobb, S.; Young, D.; Wu, Yen-Yuan J.

    1993-09-07

    The investigations with the anion exchange resin Reillex{trademark}-HPQ is continuing along several different paths. The topics of current investigations that are reported here are: The sorption behavior of chromium(VI) on Reillex{trademark}-HPQ from nitric acid solutions and from sodium hydroxide/sodium nitrate solutions; sorption behavior of F{sup {minus}} on Reillex{trademark}-HPQ resin in acidic sodium nitrate solution; sorption behavior of Cl{sup {minus}} on Reillex{trademark}-HPQ resin in acidic sodium nitrate solution; sorption behavior of Br{sup {minus}} on Reillex{trademark}-HPQ resin in acidic sodium nitrate solution; and the Honors thesis by one of the students is attached as Appendix II (on ion exchange properties of a new macroperous resin using bromide as the model ion in aqueous nitrate solutions).

  14. How Shorebilly Brewing Company Won the Trademark Battle, but Lost the War: A Cautionary Tale for Entrepreneurs

    Science.gov (United States)

    Koval, Michael R.

    2018-01-01

    This article demonstrates how the case at hand, Teal Bay Alliances, LLC v. Southbound One, Inc., can be used as the core of a business case to teach students not only the basics of trademark law, but also as a real-world cautionary tale whose moral boils down to this: lawyers and businesspeople approach legal disputes from very different…

  15. 75 FR 39493 - United States Patent and Trademark Office Draft Strategic Plan for FY 2010-2015

    Science.gov (United States)

    2010-07-09

    ... plan includes the USPTO's mission statement, vision statement and a description of the strategic goals... achieve its vision. Full details on how the USPTO plans to implement the strategic plan, including funding...] United States Patent and Trademark Office Draft Strategic Plan for FY 2010-2015 AGENCY: United States...

  16. This Bud's for You: Understanding International Intellectual Property Law through the Ongoing Dispute over the Budweiser Trademark

    Science.gov (United States)

    Bird, Robert C.

    2006-01-01

    There is little doubt that topics related to beer would be of some interest to college students. Anheuser-Busch, well known for its Budweiser beer and humorous advertising, faces a global trademark challenge to its "Budweiser" name. This battle between a global American company and a small Czech brewery is an opportunity for interesting…

  17. Eichrom's ABEC trademark resins: Alkaline radioactive waste treatment, radiopharmaceutical, and potential hydrometallurgical applications

    International Nuclear Information System (INIS)

    Bond, A.H.; Gula, M.J.; Chang, F.; Rogers, R.D.

    1997-01-01

    Eichrom's ABEC trademark resins selectivity extract certain anions from high ionic strength acidic, neutral, or strongly alkaline media, and solute stripping can be accomplished by eluting with water. ABEC resins are stable to pH extreme and radiolysis and operate in high ionic strength and/or alkaline solutions where anion-exchange is often ineffective. Potential applications of the ABEC materials include heavy metal and ReO 4 - separations in hydrometallurgy and purification of perrhenate iodide, and iodate in radiopharmaceutical production. Separation of 99m TcO 4 - from its 99 MoO 4 2- parent and stripping with water or physiological saline solution have been demonstrated for radiopharmaceutical applications. Removal of 99 TcO 4 - and 129 I - from alkaline tank wastes has also been successfully demonstrated. The authors will discuss the scale-up studies, process-scale testing, and market development of this new extraction material

  18. The Community Trademark and the Office for Harmonization on the Internal Market (OHIM

    Directory of Open Access Journals (Sweden)

    Cornel Grigorut

    2012-05-01

    Full Text Available The registration of products and services through the Community trade mark give them anextended protection, acceptable throughout the European Union (EU. By means of a single registration,protection is obtained in all the 27 Member States and the previously recorded Community trademarks orthose presented for registration automatically extend their effects in the countries that will join the EuropeanUnion. The advantage of registering a Community trade mark is highlighted by minimal registration costs,extended protection across the EU and a minimal time to become legal, for the benefit of exporters and ofthose providing services, in order to avoid divergence (payment of damages and conflicts with thecompanies and businesses in this area.

  19. GenMol trademark supramolecular descriptors predicting reliable sensitivity of energetic compounds

    Energy Technology Data Exchange (ETDEWEB)

    Benazet, Stephane; Jacob, Guy [SNPE Materiaux Energetiques, Vert Le Petit (France); Pepe, Gerard [CINaM UPR-CNRS 3118, Campus de Luminy Case, Marseille (France)

    2009-04-15

    Structure/activity relationship methodology has been applied to the problem of the prediction of the energetic molecule's sensitivity. This parameter knowledge is of great importance to increase the safety of operations in the field of synthesis and manipulation of such compounds. It has been shown that descriptors of the solid state interactions and surface topology issued from GenMol {sup trademark} software calculations greatly enhanced the correlation between measured and predicted sensitivity. As the structural parameters used to establish the descriptors are experimental ones, their physical significance is particularly preserved which allows to give a good prediction for impact or friction sensitivity by the so defined descriptors. (Abstract Copyright [2009], Wiley Periodicals, Inc.)

  20. Absorption of uv-radiation by Chibro trademark -Uvelin eye drops

    International Nuclear Information System (INIS)

    Schreder, J.G.; Blumthaler, M.; Daxer, A.; Ettl, A.

    1998-01-01

    The preparation Chibro trademark -Uvelin is recommended against both solar and artificial uv-radiation. At wavelengths greater than 290 nm and at an effective layer thickness of 10 μm measurements with a high resolution doublemonochromator showed a transmission larger than 90%. The solar spectrum is characterised by almost no irradiance on the earth's surface for wavelengths smaller than 290 nm due to absorption in the atmospheric ozon layer. Therefore, no significant protective effect of the eye-drops against keratitis and cataract under solar exposure can be expected. A significantly better sagging of the radiation of artificial UV-sources with a high amount of UV-C is reached. The recommended application as chemical protective goggles in this spectral range is not permissible. (orig.) [de

  1. Precombustion desulfurization using Microcel{trademark} and multi-gravity separator

    Energy Technology Data Exchange (ETDEWEB)

    Yoon, R.H.; Luttrell, G.H.; Venkatraman, P. [Virginia Polytechnic Institute and State Univ., Blacksburg, VA (United States)

    1994-12-31

    Studies conducted at the Center for Coal and Minerals Processing (CCMP) indicate that surface-based processes such as froth flotation are inefficient in removing pyrite from fine coal. This shortcoming has been attributed to the fact that pyrite can become hydrophobic under certain conditions and to the inability of flotation to reject middling particles. To overcome these deficiencies, a new processing scheme has been developed at CCMP which involved the use of the Microcel{trademark} flotation column in combination with a centrifugal flowing-film separator, called a Multi-Gravity Separator (MGS). The flotation column removes ash-forming minerals such as clay, while the MGS is effective in removing pyrite. Preliminary test data obtained with high-sulfur coals shows that this processing scheme can nearly double the pyritic sulfur rejection with little loss in clean coal yield. This article discusses the underlying principles of the new circuit and provides test results obtained using eastern U.S. coals.

  2. Integration of MATLAB Simulink(Registered Trademark) Models with the Vertical Motion Simulator

    Science.gov (United States)

    Lewis, Emily K.; Vuong, Nghia D.

    2012-01-01

    This paper describes the integration of MATLAB Simulink(Registered TradeMark) models into the Vertical Motion Simulator (VMS) at NASA Ames Research Center. The VMS is a high-fidelity, large motion flight simulator that is capable of simulating a variety of aerospace vehicles. Integrating MATLAB Simulink models into the VMS needed to retain the development flexibility of the MATLAB environment and allow rapid deployment of model changes. The process developed at the VMS was used successfully in a number of recent simulation experiments. This accomplishment demonstrated that the model integrity was preserved, while working within the hard real-time run environment of the VMS architecture, and maintaining the unique flexibility of the VMS to meet diverse research requirements.

  3. Evaluation of Material Models within LS-DYNA(Registered TradeMark) for a Kevlar/Epoxy Composite Honeycomb

    Science.gov (United States)

    Polanco, Michael A.; Kellas, Sotiris; Jackson, Karen

    2009-01-01

    The performance of material models to simulate a novel composite honeycomb Deployable Energy Absorber (DEA) was evaluated using the nonlinear explicit dynamic finite element code LS-DYNA(Registered TradeMark). Prototypes of the DEA concept were manufactured using a Kevlar/Epoxy composite material in which the fibers are oriented at +/-45 degrees with respect to the loading axis. The development of the DEA has included laboratory tests at subcomponent and component levels such as three-point bend testing of single hexagonal cells, dynamic crush testing of single multi-cell components, and impact testing of a full-scale fuselage section fitted with a system of DEA components onto multi-terrain environments. Due to the thin nature of the cell walls, the DEA was modeled using shell elements. In an attempt to simulate the dynamic response of the DEA, it was first represented using *MAT_LAMINATED_COMPOSITE_FABRIC, or *MAT_58, in LS-DYNA. Values for each parameter within the material model were generated such that an in-plane isotropic configuration for the DEA material was assumed. Analytical predictions showed that the load-deflection behavior of a single-cell during three-point bending was within the range of test data, but predicted the DEA crush response to be very stiff. In addition, a *MAT_PIECEWISE_LINEAR_PLASTICITY, or *MAT_24, material model in LS-DYNA was developed, which represented the Kevlar/Epoxy composite as an isotropic elastic-plastic material with input from +/-45 degrees tensile coupon data. The predicted crush response matched that of the test and localized folding patterns of the DEA were captured under compression, but the model failed to predict the single-cell three-point bending response.

  4. Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study.

    Science.gov (United States)

    Zeller, Thomas; Langhoff, Ralf; Rocha-Singh, Krishna J; Jaff, Michael R; Blessing, Erwin; Amann-Vesti, Beatrice; Krzanowski, Marek; Peeters, Patrick; Scheinert, Dierk; Torsello, Giovanni; Sixt, Sebastian; Tepe, Gunnar

    2017-09-01

    Studies assessing drug-coated balloons (DCB) for the treatment of femoropopliteal artery disease are encouraging. However, challenging lesions, such as severely calcified, remain difficult to treat with DCB alone. Vessel preparation with directional atherectomy (DA) potentially improves outcomes of DCB. DEFINITIVE AR study (Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency-A Pilot Study of Anti-Restenosis Treatment) was a multicenter randomized trial designed to estimate the effect of DA before DCB to facilitate the development of future end point-driven randomized studies. One hundred two patients with claudication or rest pain were randomly assigned 1:1 to DA+DCB (n=48) or DCB alone (n=54), and 19 additional patients with severely calcified lesions were treated with DA+DCB. Mean lesion length was 11.2±4.0 cm for DA+DCB and 9.7±4.1 cm for DCB ( P =0.05). Predilation rate was 16.7% for DA+DCB versus 74.1% for DCB; postdilation rate was 6.3% for DA+DCB versus 33.3% for DCB. Technical success was superior for DA+DCB (89.6% versus 64.2%; P =0.004). Overall bail-out stenting rate was 3.7%, and rate of flow-limiting dissections was 19% for DCB and 2% for DA+DCB ( P =0.01). One-year primary outcome of angiographic percent diameter stenosis was 33.6±17.7% for DA+DCB versus 36.4±17.6% for DCB ( P =0.48), and clinically driven target lesion revascularization was 7.3% for DA+DCB and 8.0% for DCB ( P =0.90). Duplex ultrasound patency was 84.6% for DA+DCB, 81.3% for DCB ( P =0.78), and 68.8% for calcified lesions. Freedom from major adverse events at 1 year was 89.3% for DA+DCB and 90.0% for DCB ( P =0.86). DA+DCB treatment was effective and safe, but the study was not powered to show significant differences between the 2 methods of revascularization in 1-year follow-up. An adequately powered randomized trial is warranted. http://www.clinicaltrials.gov. Unique Identifier: NCT01366482. Copyright © 2017 The

  5. Local-Rapid Evaluation of Atmospheric Conditions (L-REAC (trademark)) System, Design and Development. Volume 3. (Operational L-REAC (trademark))

    Science.gov (United States)

    2011-09-01

    Meter/Second, and Degrees Solar Radiation Pyranometer Kipp/Zonen CM3 Watts/Meter 2 Micrologger ALL Campbell Scientific CR23X Weather-Resistant...calibration instrument. Wind Monitor Relative Humidity Pyranometer ** [ ] [] Micro- Logger Barometer Temperature Temperature 11 Figure 6. RM Young

  6. Shared technologies in the development of the Titan 250 trademark gas turbine system; Anwendung bewaehrter Technologien bei der Entwicklung des Titan 250 trademark Gasturbinensystems

    Energy Technology Data Exchange (ETDEWEB)

    Stang, Ulrich; Knodle, Mark; Novaresi, Mark [Solar Turbines, Inc., San Diego, CA (United States); Ottoboni, Luigi [Turbomach SA, Riazzino (Switzerland)

    2010-07-01

    The Titan 250 gas turbine and C85 centrifugal gas compressor are the latest additions to the Solar Turbines product family. These new products leverage core technologies that have been developed and proven in several other well-established products. The Titan 250 gas turbine is a conservative hybrid design grounded in advanced aerodynamic, thermal and mechanical design tools and methodologies. It is ISO rated at 22.4 MW (30,000 HP), with a best-in-class shaft efficiency of 40% reducing fuel costs and emissions. The engine is a two-shaft design that includes a 16-stage axial flow compressor (PR 24:1), a dry low emissions combustor (<15 ppmv NOx), a two-stage gas producer turbine operating at a firing temperature of 1200 C (2200 F), and a three-stage, maximum efficiency, fully shrouded power turbine. (orig.)

  7. Weldability of superalloys alloy 718 and ATI {sup registered} 718Plus trademark. A study performed by Varestraint testing

    Energy Technology Data Exchange (ETDEWEB)

    Jacobsson, Jonny [The Production Technology Centre Univ. West, Trollhaettan (Sweden). GKN Aerospace Sweden; Chalmers Univ. of Technology, Gothenburg (Sweden). Dept. of Industrial and Material Science; Andersson, Joel [The Production Technology Centre Univ. West, Trollhaettan (Sweden). Dept. of Engineering Science; Brederholm, Anssi; Haenninen, Hannu [Aalto Univ., Helsinki (Finland). Dept. of Engineering Design and Production

    2017-11-01

    In this study, the old and well-known alloy 718 is compared with the newly developed ATI {sup registered} 718Plus trademark from the weldability point of view. This is done in order to gain new information that have not been documented and established yet among the high-temperature materials with high strength, oxidation resistance, thermal stability and sufficient weldability, yet. ATI {sup registered} 718Plus trademark shows a lower sensitivity to hot cracking than alloy 718 with approximately 10 mm total crack length (TCL) difference in Varestraint testing. In the solution-annealed condition at 982 C for 4.5 h followed by air cooling, the crack sensitivity is decreased as compared to the mill-annealed condition. Along the crack path and also ahead of the crack tip, γ-Laves eutectic is present in both alloys. The microhardness measurements showed similar hardness level of 250 HV in the weld metal of both alloys and even in the parent material of alloy 718. ATI {sup registered} 718Plus trademark parent metal had hardness of 380 HV and a small increase of less than 50 HV was observed for both studied alloys in the heat affected zone (HAZ). For the same grain size of ATI {sup registered} 718Plus trademark (8.3 μm) and alloy 718 (15.6 μm), the susceptibility to liquation cracking may increase with increasing grain size. With a small grain size, there is a possibility to accommodate more trace elements (B, S, P) due to the larger grain boundary area. The impurity elements were found in relatively small precipitates, typically borides (0.2 μm), phosphides (0.1 to 0.5 μm) and carbo-sulphides. The solidification sequence of alloy 718 and ATI {sup registered} 718Plus trademark is relatively similar, where the liquid starts to solidify as γ-phase followed by γ/MC reaction at about 1260 C and then final γ/Laves eutectic reaction at around 1150 C. Detailed knowledge about weldability of alloy 718 and ATI {sup registered} 718Plus trademark can be used for material

  8. Calcification remodeling index characterized by cardiac CT as A novel parameter to predict the use of rotational atherectomy for coronary intervention of lesions with moderate to severe calcification

    Energy Technology Data Exchange (ETDEWEB)

    Yu, Meng Meng; Li, Yue Hua; Li, Wen Bin; Lu, Zhi Gang; Wei, Meng; Zhang, Jia Yin [Shanghai Jiao Tong University Affiliated Sixth People' s Hospital, Shanghai (China)

    2017-09-15

    To assess the feasibility of calcification characterization by coronary computed tomography angiography (CCTA) to predict the use of rotational atherectomy (RA) for coronary intervention of lesions with moderate to severe calcification. Patients with calcified lesions treated by percutaneous coronary intervention (PCI) who underwent both CCTA and invasive coronary angiography were retrospectively included in this study. Calcification remodeling index was calculated as the ratio of the smallest vessel cross-sectional area of the lesion to the proximal reference luminal area. Other parameters such as calcium volume, regional Agatston score, calcification length, and involved calcium arc quadrant were also recorded. A total of 223 patients with 241 calcified lesions were finally included. Lesions with RA tended to have larger calcium volume, higher regional Agatston score, more involved calcium arc quadrants, and significantly smaller calcification remodeling index than lesions without RA. Receiver operating characteristic curve analysis revealed that the best cutoff value of calcification remodeling index was 0.84 (area under curve = 0.847, p < 0.001). Calcification remodeling index ≤ 0.84 was the strongest independent predictor (odds ratio: 251.47, p < 0.001) for using RA. Calcification remodeling index was significantly correlated with the incidence of using RA to aid PCI. Calcification remodeling index ≤ 0.84 was the strongest independent predictor for using RA prior to stent implantation.

  9. Calcification remodeling index characterized by cardiac CT as A novel parameter to predict the use of rotational atherectomy for coronary intervention of lesions with moderate to severe calcification

    International Nuclear Information System (INIS)

    Yu, Meng Meng; Li, Yue Hua; Li, Wen Bin; Lu, Zhi Gang; Wei, Meng; Zhang, Jia Yin

    2017-01-01

    To assess the feasibility of calcification characterization by coronary computed tomography angiography (CCTA) to predict the use of rotational atherectomy (RA) for coronary intervention of lesions with moderate to severe calcification. Patients with calcified lesions treated by percutaneous coronary intervention (PCI) who underwent both CCTA and invasive coronary angiography were retrospectively included in this study. Calcification remodeling index was calculated as the ratio of the smallest vessel cross-sectional area of the lesion to the proximal reference luminal area. Other parameters such as calcium volume, regional Agatston score, calcification length, and involved calcium arc quadrant were also recorded. A total of 223 patients with 241 calcified lesions were finally included. Lesions with RA tended to have larger calcium volume, higher regional Agatston score, more involved calcium arc quadrants, and significantly smaller calcification remodeling index than lesions without RA. Receiver operating characteristic curve analysis revealed that the best cutoff value of calcification remodeling index was 0.84 (area under curve = 0.847, p < 0.001). Calcification remodeling index ≤ 0.84 was the strongest independent predictor (odds ratio: 251.47, p < 0.001) for using RA. Calcification remodeling index was significantly correlated with the incidence of using RA to aid PCI. Calcification remodeling index ≤ 0.84 was the strongest independent predictor for using RA prior to stent implantation.

  10. Calcification Remodeling Index Characterized by Cardiac CT as a Novel Parameter to Predict the Use of Rotational Atherectomy for Coronary Intervention of Lesions with Moderate to Severe Calcification

    Science.gov (United States)

    Yu, Mengmeng; Li, Yuehua; Li, Wenbin; Lu, Zhigang; Wei, Meng

    2017-01-01

    Objective To assess the feasibility of calcification characterization by coronary computed tomography angiography (CCTA) to predict the use of rotational atherectomy (RA) for coronary intervention of lesions with moderate to severe calcification. Materials and Methods Patients with calcified lesions treated by percutaneous coronary intervention (PCI) who underwent both CCTA and invasive coronary angiography were retrospectively included in this study. Calcification remodeling index was calculated as the ratio of the smallest vessel cross-sectional area of the lesion to the proximal reference luminal area. Other parameters such as calcium volume, regional Agatston score, calcification length, and involved calcium arc quadrant were also recorded. Results A total of 223 patients with 241 calcified lesions were finally included. Lesions with RA tended to have larger calcium volume, higher regional Agatston score, more involved calcium arc quadrants, and significantly smaller calcification remodeling index than lesions without RA. Receiver operating characteristic curve analysis revealed that the best cutoff value of calcification remodeling index was 0.84 (area under curve = 0.847, p < 0.001). Calcification remodeling index ≤ 0.84 was the strongest independent predictor (odds ratio: 251.47, p < 0.001) for using RA. Conclusion Calcification remodeling index was significantly correlated with the incidence of using RA to aid PCI. Calcification remodeling index ≤ 0.84 was the strongest independent predictor for using RA prior to stent implantation. PMID:28860893

  11. Combined use of directional atherectomy and drug-coated balloon for the endovascular treatment of common femoral artery disease: immediate and one-year outcomes.

    Science.gov (United States)

    Cioppa, Angelo; Stabile, Eugenio; Salemme, Luigi; Popusoi, Grigore; Pucciarelli, Armando; Iacovelli, Fortunato; Arcari, Antonella; Coscioni, Enrico; Trimarco, Bruno; Esposito, Giovanni; Tesorio, Tullio

    2017-02-20

    Surgical endarterectomy is the therapy of choice for atherosclerotic common femoral artery (CFA) obstruction. Recently, some large single-centre series have shown encouraging results for the percutaneous treatment of CFA obstructions. The purpose of this study was to evaluate the safety, feasibility, and one-year efficacy of the endovascular treatment of CFA obstructions with combined use of directional atherectomy (DA) and a paclitaxel-coated balloon (DCB). Between January 2012 and July 2014, 30 consecutive patients with severely calcified obstructions of the common femoral artery were treated in our centre using DA followed by DCB dilatation. Provisional stenting was allowed in the case of a suboptimal result. Twenty cases (66%) were isolated CFA interventions, whereas five (17%) and five (17%) also involved inflow and outflow vessels, respectively. Chronic total CFA occlusions (CTO) were recanalised in six cases (20%). Procedural success was achieved in all cases; stenting was needed in three cases (10%). At one year, restenosis and target lesion revascularisation were observed in two of 30 (6.6%) and one of 30 (3.3%) patients, respectively. The secondary patency rate was 96.7%. This single-centre prospective study suggests that the combined use of DA and DCB is a safe and effective alternative to surgery, a treatment option for common femoral artery lesions and provides encouraging results in this setting.

  12. Hubble Space Telescope Metallized Teflon(registered trademark) FEP Thermal Control Materials: On-Orbit Degradation and Post-Retrieval Analysis

    Science.gov (United States)

    Townsend, Jacqueline A.; Hansen, Patricia A.; Dever, J. A.; deGroh, K. K.; Banks, B.; Wang, L.; He, C.

    1988-01-01

    During the Hubble Space Telescope (HST) Second Servicing Mission (SM2), degradation of unsupported Teflon(Registered Trademark) FEP (fluorinated ethylene propylene), used as the outer layer of the multilayer insulation (MLI) blankets, was evident as large cracks on the telescope light shield. A sample of the degraded outer layer was retrieved during the mission and returned to Earth for ground testing and evaluation. The results of the Teflon(Registered Trademark) FEP sample evaluation and additional testing of pristine Teflon(Registered Trademark) FEP led the investigative team to theorize that the HST damage was caused by thermal cycling with deep-layer damage from electron and proton radiation which allowed the propagation of cracks along stress concentrations , and that the damage increased with the combined total dose of electrons, protons, UV and x-rays along with thermal cycling. This paper discusses the testing and evaluation of the retrieved Teflon(Registered Trademark) FEP.

  13. Comparative Advertisements in the Business World: Need for Interplay of Trademark Law, Consumer Law and Competition Law

    OpenAIRE

    Sreenivasulu, Neeruganti Shanmuka

    2018-01-01

    Comparative advertisements also known as disparaging advertisements are regulated for the purpose of ensuring that nobody should negatively portray or present the competitors goods, and services or image and reputation in the business world. Though trademarks serve the purpose of identifying, representing and also advertising the brand of the business, business world often aims to reach out to the consumer through audiovisual means such as advertisements. Audiovisual advertisements would attr...

  14. Recent Updates to SWANFAR (registered trademark), a 5DVAR Data Assimilation System for SWAN

    Science.gov (United States)

    2016-11-10

    inside surf zone. Blue, red, and black lines illustrate heights of small, medium, and large waves as they approach shore (from right to left). If...small, medium, or large offshore waves. Only assimilation from outside the surf zone (such as within the dashed box region) will accu- rately reflect...involv- ing a systematic and consistent examination of much larger global wave datasets and many more model simulations at global , regional, and local

  15. Final environmental assessment for the Liquid Phase Methanol (LPMEOH trademark) Project

    International Nuclear Information System (INIS)

    1995-06-01

    The proposed project is to demonstrate on a commercial scale the production of methanol from coal-derived synthesis gas using the LPMEOH trademark process. The methanol produced during this demonstration will be used as a chemical feedstock (on-site) and/or as an alternative fuel in stationary and transportation applications (off-site). In addition, the production of dimethyl ether (DME) as a mixed co-product with methanol may be demonstrated for a six month period under the proposed project pending the results of laboratory/pilot-scale research on scale-up. The DME would be used as fuel in on-site boilers. The proposed LPMEOH facility would occupy approximately 0.6 acres of the 3,890-acre Eastman Chemical facility in Kingsport, TN. The effects of the proposed project include changes in air emissions, wastewater discharge, cooling water discharge, liquid waste quantities, transportation activities, socioeconomic effects, and quantity of solids for disposal. No substantive negative impacts or environmental concerns were identified

  16. Savings estimates for the ENERGY STAR (registered trademark) voluntary labeling program: 2001 status report

    Energy Technology Data Exchange (ETDEWEB)

    Webber, Carrie A.; Brown, Richard E.; Mahajan, Akshay; Koomey, Jonathan G.

    2002-02-15

    ENERGY STAR(Registered Trademark) is a voluntary labeling program designed to identify and promote energy-efficient products, buildings and practices. Operated jointly by the Environmental Protection Agency (EPA) and the U.S. Department of Energy (DOE), ENERGY STAR labels exist for more than thirty products, spanning office equipment, residential heating and cooling equipment, commercial and residential lighting, home electronics, and major appliances. This report presents savings estimates for a subset of ENERGY STAR program activities, focused primarily on labeled products. We present estimates of the energy, dollar and carbon savings achieved by the program in the year 2000, what we expect in 2001, and provide savings forecasts for two market penetration scenarios for the period 2001 to 2020. The target market penetration forecast represents our best estimate of future ENERGY STAR savings. It is based on realistic market penetration goals for each of the products. We also provide a forecast under the assumption of 100 percent market penetration; that is, we assume that all purchasers buy ENERGY STAR-compliant products instead of standard efficiency products throughout the analysis period.

  17. Bioremediation of soils and sediments containing PAHs and PCP using Daramend trademark

    International Nuclear Information System (INIS)

    Seech, A.; Burwell, S.; Marvan, I.

    1994-01-01

    A full-scale demonstration of Grace Dearborn's Daramend trademark for bioremediation of soil containing chlorinated phenols, PAHs and petroleum hydrocarbons is being conducted at an industrial wood treatment site in Ontario. A pilot-scale demonstration of Daramend for the clean-up of sediments contaminated with PAHs was also conducted. The full-scale demonstration, which includes bioremediation of approximately 4,500 m 3 of soil, was initiated at a wood preserving facility in Ontario, in the summer of 1993. The soil contains chlorinated phenols, PAHs and total petroleum hydrocarbons at concentrations of up to 700, 1,400 and 6,300 mg/kg respectively. Full-scale bioremediation at this site employs the same Daramend protocols and organic amendment treatments that were used at the pilot-scale phase where the PAH, total petroleum hydrocarbon, and pentachlorophenol concentrations were reduced to below the Canadian clean-up guidelines for industrial soils. In addition, the toxicity of the soil to earthworms was eliminated while the rate of seed germination was increased to that of an agricultural soil during the pilot scale demonstration phase. The ex-situ portion of the full-scale demonstration is currently being audited by the EPA under the SITE program. This paper will focus on the ex-situ work. The pilot-scale demonstration of sediment remediation consisted of ex-situ bioremediation of approximately 90 tonnes of PAH-contaminated sediment in a confined treatment area

  18. Savings estimates for the ENERGY STAR (registered trademark) voluntary labeling program: 2001 status report; TOPICAL

    International Nuclear Information System (INIS)

    Webber, Carrie A.; Brown, Richard E.; Mahajan, Akshay; Koomey, Jonathan G.

    2002-01-01

    ENERGY STAR(Registered Trademark) is a voluntary labeling program designed to identify and promote energy-efficient products, buildings and practices. Operated jointly by the Environmental Protection Agency (EPA) and the U.S. Department of Energy (DOE), ENERGY STAR labels exist for more than thirty products, spanning office equipment, residential heating and cooling equipment, commercial and residential lighting, home electronics, and major appliances. This report presents savings estimates for a subset of ENERGY STAR program activities, focused primarily on labeled products. We present estimates of the energy, dollar and carbon savings achieved by the program in the year 2000, what we expect in 2001, and provide savings forecasts for two market penetration scenarios for the period 2001 to 2020. The target market penetration forecast represents our best estimate of future ENERGY STAR savings. It is based on realistic market penetration goals for each of the products. We also provide a forecast under the assumption of 100 percent market penetration; that is, we assume that all purchasers buy ENERGY STAR-compliant products instead of standard efficiency products throughout the analysis period

  19. Performance evaluation of the PITBULL trademark pump for the removal of hazardous waste

    International Nuclear Information System (INIS)

    Hatchell, B.K.; Combs, W.H.; Hymas, C.R.; Powell, M.R.; Rinker, M.W.; White, M.

    1998-09-01

    One objective of the Waste Removal Project at the Department of Energy's Savannah River Site (SRS) is to explore methods to successfully remove waste heels that will remain in the high-level waste tanks after bulk waste removal has been completed. Tank closure is not possible unless this residue is removed. As much as 151,000 liters of residue can remain after a conventional waste removal campaign. The waste heels can be comprised of sludge, zeolite, and silica. The heels are generally hardened or compacted insoluble particulate with relatively rapid settling velocities. A PITBULL trademark pump is being considered by SRS to retrieve sludge-type waste from Tank 19. Sections 1 through 4 of this report present the scope and objectives of the test program, describe the principles of operation of the PITBULL, and present the test approach, set-up, and instrumentation. Test results, including pumping rates with water and slurry, are provided in Section 5, along with considerations for remote operation. Conclusions and recommendations are provided in Section 6

  20. Development of dispersion-strengthened XD (trademark) Cu alloys for high heat-flux applications

    Science.gov (United States)

    Kumar, K. Sharvan

    1993-01-01

    In a previous effort sponsored by NASA LeRC, the XD(trademark) process was used to produce ZrB2 particulate reinforcements in Cu and the resulting extruded material was microstructurally characterized and evaluated in tension over a range of temperatures. A problem that was encountered in that study was microstructural inhomogeneity resulting from the frequent presence of 'ZrB2 agglomerates' that were several microns in size. The presence of these agglomerates was attributed to improper mixing of powders in the green compact used in the XD process for elemental boron powder segregation. In this program, several milling parameters were examined in an effort to optimize this processing step; two levels of ZrB2 reinforcements were considered (7 vol. percent and 15 vol. percent). Microstructures of the reacted powder mass were examined to verify the absence of these agglomerates. Larger bathes of powder were then mixed, reacted, machined to size, canned, and extruded. The microstructure and tensile properties of these extrusions were examined, and the measured properties were correlated with the observed microstructure. Large unreacted or partially reacted Zr particles were present. These particles affected the mechanical properties deleteriously, and their presence is attributed to insufficient heat of reaction during XD synthesis. Alternate processing routes are recommended.

  1. CPICOR{trademark}: Clean power from integrated coal-ore reduction

    Energy Technology Data Exchange (ETDEWEB)

    Wintrell, R.; Miller, R.N.; Harbison, E.J.; LeFevre, M.O.; England, K.S.

    1997-12-31

    The US steel industry, in order to maintain its basic iron production, is thus moving to lower coke requirements and to the cokeless or direct production of iron. The US Department of Energy (DOE), in its Clean Coal Technology programs, has encouraged the move to new coal-based technology. The steel industry, in its search for alternative direct iron processes, has been limited to a single process, COREX{reg_sign}. The COREX{reg_sign} process, though offering commercial and environmental acceptance, produces a copious volume of offgas which must be effectively utilized to ensure an economical process. This volume, which normally exceeds the internal needs of a single steel company, offers a highly acceptable fuel for power generation. The utility companies seeking to offset future natural gas cost increases are interested in this clean fuel. The COREX{reg_sign} smelting process, when integrated with a combined cycle power generation facility (CCPG) and a cryogenic air separation unit (ASU), is an outstanding example of a new generation of environmentally compatible and highly energy efficient Clean Coal Technologies. This combination of highly integrated electric power and hot metal coproduction, has been designated CPICOR{trademark}, Clean Power from Integrated Coal/Ore Reduction.

  2. Not a mystery. Inner containment of the pressurized water reactor (EPR trademark type)

    Energy Technology Data Exchange (ETDEWEB)

    Ostermann, Dirk; Wienand, Burkhard; Krumb, Christian [AREVA NP GmbH (Germany)

    2012-11-01

    The containment of the advanced pressurized water reactor EPR trademark type is developed on the basis of the French nuclear power plant operational experience and consists of - The reinforced outer containment structure, designed to withstand external hazards (e.g. APC), - The pre-stressed inner containment structure, designed to bear the loads resulting from internal hazards (LOCA), - The steel liner, designed to provide leak tightness resulting from internal hazards. The main advantage of the pre-stressed inner containment design is that the structure remains in linear-elastic behavior during the whole life-time. Even in case of postulated design accidents (LOCA) concrete tensile strains are strongly limited. Due to pre-stressing the concrete structure remains practically free of cracks. Due to pre-stressing the leak tightness ensuring steel liner, embedded into the inner concrete shell, is exposed to more favorable compression loads. In addition to detailed calculations several test programs have been performed to verify and confirm the predicted behavior in normal operation and in accident condition. (orig.)

  3. An electrochemical method for on-line monitoring of biofilm activity in cooling water using the BIoGEORGE trademark probe

    International Nuclear Information System (INIS)

    Licina, G.J.; Nekoksa, G.; Howard, R.L.

    1994-01-01

    The presence of active microorganisms on piping and components in cooling water systems can have a profound effect on the corrosion performance of such systems. Microbiologically influenced corrosion (MIC) can result in premature failures of critical and support systems, increased downtime of equipment for repairs and maintenance, and increased operating costs associated with mitigation measures. In some cases, MIC has forced premature replacement of tanks, heat exchangers, and piping systems with a severe effect on plant availability. Monitoring methods that alert plant operators that biofilm formation is occurring on pipe work and components permit the operators to initiate mitigation actions before biofouling becomes severe or MIC has occurred. An electrochemical probe to permit on-line monitoring of biofilm activity under power plant or other industrial exposure conditions is under development. This device, the BIoGEORGE trademark electrochemical biofilm monitor, permits on-line evaluations of the effects of biofilm formation upon the surfaces of passive alloys such as stainless steels exposed to cooling water environments. Benchtop experiments have shown that biofilm formation on stainless steel surfaces can be detected by an electrochemical indication well in advance of any visual evidence of biofilm or corrosion on the electrodes. The design of the probe, results of benchtop experiments, and a description of its installation at the Browns Ferry Nuclear Plant are described

  4. Demonstration Of LEACHXS(trademark)/Orchestra Capabilities By Simulating Constituent Release From A Cementitious Waste Form In A Reinforced Concrete Vault

    International Nuclear Information System (INIS)

    Langton, C.; Meeussen, J.; Sloot, H.

    2010-01-01

    The objective of the work described in this report is to demonstrate the capabilities of the current version of LeachXS(trademark)/ORCHESTRA for simulating chemical behavior and constituent release processes in a range of applications that are relevant to the CBP. This report illustrates the use of LeachXS(trademark)/ORCHESTRA for the following applications: (1) Comparing model and experimental results for leaching tests for a range of cementitious materials including cement mortars, grout, stabilized waste, and concrete. The leaching test data includes liquid-solid partitioning as a function of pH and release rates based on laboratory column, monolith, and field testing. (2) Modeling chemical speciation of constituents in cementitious materials, including liquid-solid partitioning and release rates. (3) Evaluating uncertainty in model predictions based on uncertainty in underlying composition, thermodynamic, and transport characteristics. (4) Generating predominance diagrams to evaluate predicted chemical changes as a result of material aging using the example of exposure to atmospheric conditions. (5) Modeling coupled geochemical speciation and diffusion in a three layer system consisting of a layer of Saltstone, a concrete barrier, and a layer of soil in contact with air. The simulations show developing concentration fronts over a time period of 1000 years. (6) Modeling sulfate attack and cracking due to ettringite formation. A detailed example for this case is provided in a separate article by the authors (Sarkar et al. 2010). Finally, based on the computed results, the sensitive input parameters for this type of modeling are identified and discussed. The chemical speciation behavior of substances is calculated for a batch system and also in combination with transport and within a three layer system. This includes release from a barrier to the surrounding soil as a function of time. As input for the simulations, the physical and chemical properties of the

  5. Implementation of a Semantic Network Service (SNS) in the context of the German Environmental Information Network (gein trademark). Vol. 1 and 2; Erstellung eines semantischen Netzwerkservice (SNS) fuer das Umweltinformationsnetz Deutschland - German Environmental Information Network (gein trademark). Bd. 1 und 2

    Energy Technology Data Exchange (ETDEWEB)

    Bandholtz, T.

    2003-05-01

    Encouraged by the success of the thesaurus-based automatic indexing of environmental information provided by the German Environmental Information Network (gein {sup trademark}, http://www.gein.de), the terminology collections of gein {sup trademark} have been integrated and cross-networked in a comprehensive Topic Map. On this base, the text analysis module could be considerably enhanced. Any access to the terminology and its methods has been provided by means of Web Services. gein {sup trademark} (starting with version 2003) incorporates these Web Services in the productive installation. Besides that, SNS provides basic functionality for terminology editors. (orig.)

  6. Engineering and innovative erection concept for the containment liner for an EPR trademark

    International Nuclear Information System (INIS)

    Goehring, Rainer

    2010-01-01

    The determination of the optimal design of the containment liner considering amount of material, manufacturing and erection was the challenge for the engineering team of Babcock Noell GmbH. The construction costs of a Nuclear Power Plant are also impacted by the erection time of components. Therefore, it is necessary to optimize the erection times and consequently essentially to shorten. One possibility has been demonstrated by Babcock Noell GmbH with the erection concept of a containment liner. The liner is preassembled on the pre-assembly place in rings of up to 12 meter height, with the nominal diameter of 47 meter and a weight of approximately up to 200 tonnes. These rings, as well as the containment cup and the dome, are lifted with a heavy load crane into the reactor building. Several load cases for normal operation and accidental conditions as well as severe accidents have been analysed. The special load cases in the vicinity of penetrations and anchor plates have been calculated. The results of theses analyses have been considered in the actual design of the liner. This is the topic of the speech '' Computational Concept for the Containment Liner for EPR trademark '', given by Mr. Franz Nagelstutz, Abt. Planning, Babcock Noell GmbH und Mr. Nils Anders, Babcock Noell GmbH, Abt. Planning. With this concept, the construction activities on the inner containment wall are only five times disrupted by the welding and coating of the circumferential weld (approx. 25 calendar days). In comparison with the common known erection concept of welding of liner shells in situ, at least 20 weeks are saved on the schedule. An integrated concept from planning, manufacturing and erection of this large component has been implemented. It could be demonstrated that within the given time frame, with the required quality and within the required tolerances the containment liner for the Nuclear Power Plant can be delivered to the Client. (orig.)

  7. Friction Stir Weld Inspection Through Conductivity Imaging Using Shaped Field MWM(Registered Trademark) - Arrays

    Science.gov (United States)

    Goldfine, Neil; Grundy, David; Zilberstein, Vladimir; Kinchen, David G.; McCool, Alex (Technical Monitor)

    2002-01-01

    Friction Stir Welds (FSW) of Al 2195-T8 and Al 2219-T8, provided by Lockheed Martin Michoud Operations, were inspected for lack-of-penetration (LOP) defects using a custom designed MWM-Array, a multi-element eddy-current sensor. MWM (registered trademark) electrical conductivity mapping demonstrated high sensitivity to LOP as small as 0.75 mm (0.03 in.), as confirmed by metallographic data that characterized the extent of LOP defects. High sensitivity and high spatial resolution was achieved via a 37-element custom designed MWM-Array allowing LOP detection using the normalized longitudinal component of the MWM measured conductivity. This permitted both LOP detection and correlation of MWM conductivity features with the LOP defect size, as changes in conductivity were apparently associated with metallurgical features within the near-surface layer of the LOP defect zone. MWM conductivity mapping reveals information similar to macro-etching as the MWM-Array is sensitive to small changes in conductivity due to changes in microstructure associated with material thermal processing, in this case welding. The electrical conductivity measured on the root side of FSWs varies across the weld due to microstructural differences introduced by the FSW process, as well as those caused by planar flaws. Weld metal, i.e., dynamically recrystallized zone (DXZ), thermomechanically affected zone (TMZ), heat-affected zone (HAZ), and parent metal (PM) are all evident in the conductivity maps. While prior efforts had met with limited success for NDE (Nondestructive Evaluation) of dissimilar alloy, Al2219 to Al2195 FSW, the new custom designed multi-element MWM-Array achieved detection of all LOP defects even in dissimilar metal welds.

  8. Initial clinical experience with a new percutaneous peripheral atherectomy device for the treatment of femoro-popliteal stenoses; Erste klinische Erfahrungen mit einem neuen Atherektomiekatheter zur Behandlung femoro-poplitealer Stenosen

    Energy Technology Data Exchange (ETDEWEB)

    Zeller, T.; Frank, U.; Buergelin, K.; Schwarzwaelder, U.; Neumann, F.J. [Herz-Zentrum Bad Krozingen (Germany). Abt. Angiologie; Krankenberg, H. [Kardiologische Gemeinschaftspraxis Mathey, Schofer u. Partner, Hamburg (Germany); Reimers, B. [Centro Civile Mirano (Italy)

    2004-01-01

    Background: Evaluation of the efficacy and safety of a new 7F-atherectomy device (30-day endpoint) for the treatment of short and mid-length arterial lesions with a reference diameter of 2.5-7 mm. Material and Methods: Fifty-eight femoto-popliteal stenoses in 46 patients (67% male, mean age 66{+-} 9 years) with chronic peripheral occlusive disease of the lower limbs [Rutherford stage 2: n = 13 (28%); stage 3: n = 29 (63%); stage 4: 2 (4%), stage 5: n = 2 (4%]), were treated with directional atherectomy. Target lesion characteristics: Common femoral artery: n = 1 (2%), superficial femoral artery: n = 47 (81%); popliteal artery, n = 10 (17%); instent n = 3 (5%). Thirty (65%) of the interventions were performed using an antegrade approach, 16 (35%) interventions in cross-over technique. Mean degree of stenosis was 83 {+-} 11 mm, mean length of lesion was 37 {+-} 37 mm. Results: 6.5 {+-} 2 (4-10) passes of the lesion were performed with the catheter. Three lesions were treated after predilatation, 55 (95%) interventions as primary atherectomy. In 31/58 lesions (53%) additional balloon angioplasty was performed, in 1 lesion (2%) additional stent placement was needed. The mean degree of stenosis after atherectomy was reduced to 29 {+-} 20% (0-60%) after additional balloon angioplasty, it was 11 {+-} 10% (0-30%). A residual stenosis of < 50% after plain atherectomy was achieved in 55 (95%) lesions, of < 30% in 49 (84%). Complications: 3 (6,5%) cases of embolism of debris were detected and treated successfully by aspiration. The mean ankle-brachial index increased from 0.62 {+-} 0.12 to 0.92 {+-} 0.36 before discharge, and to 0.86 {+-} 0.17 after 30 days. Rutherford stage after 30 days: stage 0: n = 038 (83%); Stage 1: n = 4 (8%); Stage 2: n = 3 (6%); Stage 5: n = 1 (2%). (orig.) [German] Ziel der Arbeit: Multizentrische Anwendungs- und Sicherheits-Studie (30 Tage Follow-up) eines neuen 7F-Atherektomiekatheters zur Behandlung peripherer kurzer und mittellanger Stenosen mit

  9. Rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: Two-year clinical outcome of the randomized ROTAXUS trial.

    Science.gov (United States)

    de Waha, Suzanne; Allali, Abdelhakim; Büttner, Heinz-Joachim; Toelg, Ralph; Geist, Volker; Neumann, Franz-Josef; Khattab, Ahmed A; Richardt, Gert; Abdel-Wahab, Mohamed

    2016-03-01

    In the randomized ROTAXUS trial, routine lesion preparation of complex calcified coronary lesions using rotational atherectomy (RA) prior to paclitaxel-eluting stent implantation did not reduce the primary endpoint of angiographic late lumen loss at 9 months compared to stenting without RA. So far, no long-term data of prospective head-to-head comparisons between both treatment strategies have been reported. ROTAXUS randomly assigned patients with complex calcified coronary lesions to RA followed by stenting (n = 120) or stenting without RA (n = 120). The primary endpoint of the current analysis was the occurrence of major adverse cardiac events (MACE) at 2-year follow-up defined as the composite of death, myocardial infarction, and target vessel revascularization (TVR). At 2 years, MACE occurred in 32 patients in the RA group and 37 patients in the standard therapy group (29.4% vs. 34.3%, P = 0.47). The rates of death (8.3% vs. 7.4%, P = 1.00), myocardial infarction (8.3% vs. 6.5%, P = 0.80), target lesion revascularization (TLR, 13.8% vs. 16.7%, P = 0.58), and TVR (19.3% vs. 22.2%, P = 0.62) were similar in both groups. Despite high rates of initial angiographic success, nearly one third of patients enrolled in ROTAXUS experienced MACE within 2-year follow-up, with no differences between patients treated with or without RA. © 2015 Wiley Periodicals, Inc.

  10. Report on the performance and operating characteristics of the Burle C83061E QUANTACON trademark photomultiplier tube

    International Nuclear Information System (INIS)

    Sandberg, V.D.; Thompson, T.N.; Helvy, F.A.

    1989-01-01

    The Burle C83061E QUANTACON trademark is a 10.4 inch diameter photomultiplier tube with improved photoelectron collection optics. We report here on the first tests of this newly developed tube. We find the single photoelectron charge resolution to be excellent, with a peak to (noise) valley ratio exceeding 3 and with a transit time spread of less than 2.3 ns (FWHM) for full photocathode illumination at the single photoelectron level. A design for a fast anode pulse base is also presented. 11 refs., 8 figs

  11. Application of foresight methods in applications for patents and trademarks in Spain; Aplicacion de metodos de prevision en las solicitudes de patentes y marcas en Espana

    Energy Technology Data Exchange (ETDEWEB)

    Hidalgo Nuchera, A.; Glabaly Marquez, S.

    2011-07-01

    Patent and trademark offices which run according to principles of new management have an inherent need for dependable forecasting data in planning capacity and service levels. The predictive approach adopted for the time series of Spanish patents and trademarks applications (1979-2009) has been the use of different techniques of time series prediction in a short-term time horizon. The methods used can be grouped into two specifics areas: regression models of trends and time series models advanced. The results of this study show that it is possible to model the series of patents and trademarks applications with different models, especially ARIMA, with satisfactory model adjustment and relatively low error. (Author) 33 refs.

  12. PVMaT improvements in the manufacturing of the PVI Powergrid{trademark}: Final technical report, 27 October 1997--31 October 1998

    Energy Technology Data Exchange (ETDEWEB)

    Kaminar, N.R.; Alexander, T.; Amaya, J.; Bottenberg, W.R.; Carrie, P.; Chen, K.; Hobden, P.; Lawyer, G.; Zimmermann, J.; Sherring, C.

    1999-10-20

    Photovoltaics International, LLC (PVI), is improving the manufacturing of the Powergrid{trademark} under the Photovoltaic Manufacturing Technology (PVMaT) program in five basic areas: development of an advanced, state-of-the-art lens extrusion system; development of an advanced, state-of-the-art module side extrusion system; development of a second generation automated receiver assembly station; development of low-cost roll-formed steel panel frame members; and development of an automated module assembly process with low usage of volatile organic compounds and hazardous materials. The results of the program were as follows: (1) Manufacturing improvements have led to dramatic improvements in performance, quality, durability and cost. (2) The first ever ethylene vinyl acetate encapsulation system for photovoltaic concentrators was developed, thereby eliminating volatile organic compounds and hazardous materials in the encapsulation process. (3) An in-house extrusion system was developed that produces the highest quality cell assemblies at low labor cost. (4) An advanced automated cell assembly station was developed that produces quality cell assemblies at low labor cost. (5) Solvents have been eliminated in the module assembly eliminating volatile organic compounds and hazardous materials. (6) Roll formed steel panel frame members have been introduced to production that have dramatically reduced cost. (7) A snap-together module assembly has been developed that provides low-cost field assembly of components and thereby also greatly reduced shipping cost. The Powergrid has the potential to be very low cost in the short term. The PVI PVMaT program should allow PVI to reach the cost goals set by the company. This, in turn, will allow PVI to become a substantial player in the PV market and will allow the DOE goals of increased application of PV to become a reality.

  13. Randomized Comparison of Paclitaxel-Eluting Balloon and Stenting Versus Plain Balloon Plus Stenting Versus Directional Atherectomy for Femoral Artery Disease (ISAR-STATH).

    Science.gov (United States)

    Ott, Ilka; Cassese, Salvatore; Groha, Philipp; Steppich, Birgit; Hadamitzky, Martin; Ibrahim, Tareq; Kufner, Sebastian; Dewitz, Karl; Hiendlmayer, Regina; Laugwitz, Karl-Ludwig; Schunkert, Heribert; Kastrati, Adnan; Fusaro, Massimiliano

    2017-06-06

    Atherosclerosis in the superficial femoral artery is common in patients suffering from peripheral artery disease. Paclitaxel-eluting balloon (PEB) angioplasty, stenting, and directional atherectomy (DA) have provided new options for the treatment of superficial femoral artery disease; however, the comparative efficacy of these interventional strategies remains uncertain. One hundred and fifty-five patients with symptomatic peripheral artery disease due to de novo superficial femoral artery stenotic or occlusive lesions were randomized to treatment with plain balloon angioplasty (BA) followed by PEB angioplasty and stenting (n=48), BA and stenting (n=52), or DA with distal protection and bailout stenting (n=55). The primary end point of the study was percentage diameter stenosis after 6 months measured by angiography. Other end points included target lesion revascularization, thrombosis, ipsilateral amputation, binary restenosis, and all-cause mortality at 6 and 24 months. Baseline and lesion characteristics were comparable in all groups with a mean lesion length of 65.9±46.8 mm and 56% total occlusions. At 6 months angiography, the percent diameter stenosis was significantly lower in patients treated by PEB angioplasty and stenting (34±31%) as compared with BA angioplasty and stenting (56±29%, P =0.009) or DA (55±29%, P =0.007). Similarly, binary restenosis was significantly lower after treatment with PEB and stenting as compared with BA and stenting or DA. Clinical follow-up at 24 months revealed a lower risk for target lesion revascularization after PEB angioplasty and stenting as compared with BA and stenting or DA. We found no difference in terms of target lesion thrombosis and mortality among groups, and no patient underwent amputation. Treatment of de novo superficial femoral artery lesions with PEB angioplasty and stenting is superior to BA angioplasty and stenting or DA in terms of angiographic diameter stenosis at 6 months and target lesion

  14. Differences in patient selection and outcomes between SilverHawk atherectomy and laser ablation in the treatment of femoropopliteal in-stent restenosis: a retrospective analysis from a single center.

    Science.gov (United States)

    Shammas, Nicolas W; Shammas, Gail A; Jerin, Michael

    2013-12-01

    To analyze differences in the application and outcomes of SilverHawk atherectomy (SH) and excimer laser ablation (ELA) in the treatment of femoropopliteal in-stent restenosis (ISR) in an unselected cohort of patients treated at a single center. Between January 2005 and June 2010, 81 consecutive patients (46 men; mean age 69.1 years, range 43-86) underwent directional atherectomy (41 SH, 40 ELA) for femoropopliteal ISR lesions. Data were reviewed retrospectively on procedural outcomes, major adverse events, and 1-year target lesion revascularization (TLR) obtained from medical records and supplemented with telephone calls. The primary endpoint was symptom-driven TLR at 1 year; secondary endpoints were death and amputation. ELA was utilized more frequently than SH in longer lesions (210.4±104 vs. 126.2±79.3 mm, respectively; p=0.001), subacute presentation (55% vs. 14.6%, p=0.001), TASC D lesions (47.5% vs. 12.2%), and in patients with more angiographic thrombus (42.5% vs. 4.9%, p=0.001). Final angiographic success (<30% residual narrowing post final treatment) was similar between ELA and SH (92.5% vs. 100%, respectively, p=0.12). Bailout stenting was significantly higher with ELA vs. SH (50.0% vs. 24.4%, p=0.022). At 1 year, TLR had occurred in 48.7% of the ELA patients vs. 31.7% of the SH cases (p=0.171). Regression analysis confirmed that SH was a predictor of TLR at 1 year (hazard ratio 2.679, 95% CI 1.015 to 7.073, p=0.047). Both SH and ELA continue to have a high TLR rate in treating ISR of the femoral and popliteal arteries. A higher rate of delayed failure is seen with SH and an earlier, steeper loss of TLR-free survival is seen with ELA.

  15. I Phone, You Phone, We All Phone with iPhone: Trademark Law and Ethics from an International and Domestic Perspective

    Science.gov (United States)

    Cowart, Tammy W.; Chumney, Wade M.

    2011-01-01

    In today's Internet-based and global business environment, the legal issues companies face will often involve issues of intellectual property. Virtually every product people purchase is protected by a trademark, a patent, and/or copyrights. Thus, basic concepts of intellectual property are a natural component in any business law or legal…

  16. Non-Academic Jobs for Fellows in Law Firms, Patent and Trademark Office and Scientific Intellectual Property | Center for Cancer Research

    Science.gov (United States)

    This workshop helps CCR fellows and staff scientists learn about and better position themselves for potential job opportunities at law firms, patent and trademark, and intellectual property protection across the biotechnology and pharmaceutical industries. Guest speakers will shed light on how to best position yourself for obtaining these types of positions and how to improve

  17. NuFab trademark anti-contamination suit - OST reference No. 1855. Deactivation and decommissioning focus area

    International Nuclear Information System (INIS)

    1998-02-01

    Radiation workers at all US Department of Energy (DOE) sites require some form of protective clothing when performing radiological work. A large number of contaminated facilities at DOE site are currently or will eventually undergo some form of decontamination and decommissioning (D ampersand D), requiring some type of protective clothing, often in multiple layers. Protective clothing that does not allow perspiration to escape causes heat stress, which lowers worker comfort and productivity. This report describes the NuFab trademark anti-contamination. The suit is a one-piece, disposable, breathable, waterproof coverall with a single front zipper. Constructed of tri-laminated composite material using spun-bonded polypropylene and microporous film layers, the suit is certified as incineratorable

  18. Developing Systems Engineering Graduate Programs Aligned to the Body of Knowledge and Curriculum to Advance Systems Engineering (BKCASE (trademark)) Guidelines

    Science.gov (United States)

    2011-06-01

    2011 6 Topic 2 (Article Title) Lorem ipsum dolor sit amet[1], consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore ...consequat. Duis autem vel eum iriure dolor [2] in hendrerit in vulputate velit esse molestie consequat, vel illum dolor eu feugiat nulla facilisis at...vero eros et accumsan et iusto odio dignissim qui blandit praesent luptatum zzril delenit augue duis dolore te feugait nulla facilisi. Lorem

  19. Radar System Characterization Extended to Hardware-in-the-Loop Simulation for the Lab-Volt (Trademark) Training System

    Science.gov (United States)

    2007-09-01

    Analysis and Design. Wiley- Interscience, 111 River Street, Hoboken, NJ, 3 edition, 2005. ISBN 0-471-66782. 2. Carlos A. Coello Coello, David A. Van ... Veldhuizen and Gary B. Lamont. Evolu- tionary Algorithms for solving Multi-Objective Problems. Kluwer Academic Pub- lishers, 233 Spring Street, New York...Building, Suite 1035, 150 South Independence Mall West, Philadelphia, PA 19106, 2000. 27. Van Blaricum, G. F. “Tactical Air Surveillance RADAR Netting

  20. Effects of Heating on Teflon(Registered Trademark) FEP Thermal Control Material from the Hubble Space Telescope

    Science.gov (United States)

    deGroh, Kim; Gaier, James R.; Hall, Rachelle L.; Norris, Mary Jo; Espe, Matthew P.; Cato, Daveen R.

    1999-01-01

    Metallized Teflon(Registered Trademark) FEP (fluorinated ethylene propylene) thermal control material on the Hubble Space Telescope (HST) is degrading in the space environment. Teflon(Registered Trademark) FEP thermal control blankets (space-facing FEP) retrieved during the first servicing mission (SM1) were found to be embrittled on solar facing surfaces and contained microscopic cracks. During the second servicing mission (SM2) astronauts noticed that the FEP outer layer of the multi-layer insulation (MLI) covering the telescope was cracked in many locations around the telescope. Large cracks were observed on the light shield, forward shell and equipment bays. A tightly curled piece of cracked FEP from the light shield was retrieved during SM2 and was severely embrittled, as witnessed by ground testing. A Failure Review Board (FRB) was organized to determine the mechanism causing the MLI degradation. Density, x-ray crystallinity and solid state nuclear magnetic resonance (NMR) analyses of FEP retrieved during SM1 were inconsistent with results of FEP retrieved during SM2. Because the retrieved SM2 material curled while in space, it experienced a higher temperature extreme during thermal cycling, estimated at 200 C, than the SM1 material, estimated at 50 C. An investigation on the effects of heating pristine and FEP exposed on HST was therefore conducted. Samples of pristine. SM1, and SM2 FEP were heated to 200 C and evaluated for changes in density and morphology. Elevated temperature exposure was found to have a major impact on the density of the retrieved materials. Characterization of polymer morphology of as-received and heated FEP samples by NMR provided results that were consistent with the density results. These findings have provided insight to the damage mechanisms of FEP in the space environment.

  1. 关键词推广使用他人商标的反不正当竞争法规制%The Regulation on Anti-unfair Competition of Using Others’ Trademarks as Keyword Promotion

    Institute of Scientific and Technical Information of China (English)

    刘润涛

    2016-01-01

    There is an ongoing debate on the attributes of trademarks that only be used as keywords of search engine promotion, namely trademark infringement, unfair competition or legitimate use. There are many different judgments in judicial practice. This paper begins from the theory and practice of trademark use in keyword promotion, and argues that the behavior that trademarks are used only as keywords does not belong to trademark use in trademark law, and it is not easy to confuse the public. Although trademark use as keyword promotion does not constitute trademark infringement in trademark law, it may be adjusted by anti-unfair competition law if it is achieved by unfair means and clearly violates the principle of honesty and credit and the generally recognized business ethics. Otherwise, the law should not intervene and leave the market to choose. We should prevent improperly expanding the application of anti-unfair competition to hinder the free competition, and carry out the legal policy of promoting innovation and encouraging free competition.%仅将他人商标用作关键词进行搜索引擎推广,是商标侵权行为、不正当竞争行为抑或不侵权,争议较大,司法实践很多判决出现截然不同的结果。文章从关键词推广是否构成商标使用的理论与实践梳理入手,分析仅将他人的商标用作搜索关键词不属于商标使用,不会导致相关公众混淆。

  2. Gasification of residual waste by the PreCon {sup trademark} process on the basis of high-temperature Winkler gasification (HTW); Vergasung von Restmuell nach dem PreCon {sup trademark} -Verfahren auf Basis der Hochtemperatur-Winkler Vergasung (HTW)

    Energy Technology Data Exchange (ETDEWEB)

    Klein, J; Luetge, C; Deutsch, M [Krupp Uhde GmbH, Dortmund (Germany); Wischnewski, R; Mittelstaedt, A [Rheinbraun AG, Koeln (Germany)

    1998-09-01

    The HTW process is an established technology. Experiments in the laboratory and in a demonstration plant resulted in a valid design basis for the PreCon {sup trademark} process. The economic efficiency and competitive strength of the process is outlined. (orig./SR) [Deutsch] Das HTW-Verfahren praesentiert sich als eine bewaehrte, grosstechnisch erprobte Technologie fuer eine geaenderte Applikation. Die Umsetzung der in den Versuchen im Technikum und an der Demonstrationsanlage gewonnenen positiven Ergebnisse fuehrt zu einer abgesicherten Auslegungsgrundlage fuer das PreCon {sup trademark} -Verfahren. Die Wirtschaftlichkeit und Wettbewerbsfaehigkeit des Verfahrens laesst sich schon heute darstellen. (orig./SR)

  3. What Intellectual Property Lawyers can learn from Barbra Streisand, Sepp Blatter, and the "Coca-Cola Cry-Baby": Dealing with "Trademark Bullying" in South Africa

    OpenAIRE

    André M Louw

    2013-01-01

    This article suggests some pause for reflection amongst intellectual property lawyers, and for serious consideration of the words of an internationally-renowned IP law expert: "Possessing a right does not mean that it is a good idea to enforce it always, and to the hilt. Discretion may be nine parts of possession". It provides some prominent, recent examples of trademark bullying or overly-aggressive enforcement in the IP law context. These examples are mainly from other jurisdictions but the...

  4. HOGEN{trademark} proton exchange membrane hydrogen generators: Commercialization of PEM electrolyzers

    Energy Technology Data Exchange (ETDEWEB)

    Smith, W.F.; Molter, T.M. [Proton Energy Systems, Inc., Rocky Hill, CT (United States)

    1997-12-31

    PROTON Energy Systems` new HOGEN series hydrogen generators are Proton Exchange Membrane (PEM) based water electrolyzers designed to generate 300 to 1000 Standard Cubic Feet Per Hour (SCFH) of high purity hydrogen at pressures up to 400 psi without the use of mechanical compressors. This paper will describe technology evolution leading to the HOGEN, identify system design performance parameters and describe the physical packaging and interfaces of HOGEN systems. PEM electrolyzers have served US and UK Navy and NASA needs for many years in a variety of diverse programs including oxygen generators for life support applications. In the late 1970`s these systems were advocated for bulk hydrogen generation through a series of DOE sponsored program activities. During the military buildup of the 1980`s commercial deployment of PEM hydrogen generators was de-emphasized as priority was given to new Navy and NASA PEM electrolysis systems. PROTON Energy Systems was founded in 1996 with the primary corporate mission of commercializing PEM hydrogen generators. These systems are specifically designed and priced to meet the needs of commercial markets and produced through manufacturing processes tailored to these applications. The HOGEN series generators are the first step along the path to full commercial deployment of PEM electrolyzer products for both industrial and consumer uses. The 300/1000 series are sized to meet the needs of the industrial gases market today and provide a design base that can transition to serve the needs of a decentralized hydrogen infrastructure tomorrow.

  5. 78 FR 20179 - Changes to Representation of Others Before The United States Patent and Trademark Office

    Science.gov (United States)

    2013-04-03

    ... United States Court of Appeals for the Federal Circuit. See Unitherm Food Systems, Inc. v. Swift-Ekrich... communications about a practitioner's services, including advertising, and corresponds to ABA Model Rule 7.1...

  6. Sequence analysis of laci mutations obtained from lung cells of radon-exposed big blue trademark transgenic mice

    International Nuclear Information System (INIS)

    Layton, A.D.; Cross, F.T.; Steigler, G.L.; Stillwell, L.S.; Jostes, R.F.; Lutze, L.H.

    1994-01-01

    We have exposed Big Blue trademark transgenic mice by inhalation to 320, 640 and 960 Working Level Months (WLM) of radon progeny. Mice were sacrificed after 3, 6 and 9 days; the time periods required to obtain the exposures. Control mice were also sacrificed at each time interval. In each case all tissues were excised, flash frozen in liquid nitrogen, and stored at -80 degrees C for further analysis. Twelve lacI mutations have been isolated from the lung tissue of a mouse from the 960-WLM exposure group; the lacI genes from these mutants have been sequenced. Sequence data indicate that three of the mutants have a C;G deletion at BP 978 and are possibly clonal in origin. Two mutants have multiple events within the gene: one has a an A:T to C:G transversion and a C:G insertion separated by 291 BPs; the second has a G:C to A:T transition as well as an A:T deletion followed by 6 base pairs downstream by a T:A insertion. Other mutations include a single G:C to A:T transition, a two base pair deletion, and a C:G to T:A transition. Mutant plaques are being evaluated from individual mice at other dose levels. Time course experiments are also planned. These studies will help define the molecular fine structure of mutations induced by high-LET radiation exposure

  7. Sequence analysis of LACI mutations obtained from lung cells of control and radon-exposed Big Blue trademark transgenic mice

    International Nuclear Information System (INIS)

    Jostes, R.F.; Cross, F.T.; Stillwell, L.

    1995-01-01

    We have exposed Stratagene Big Blue trademark transgenic mice by inhalation to 310, 640 and 960 Working Level Months (WLM) of radon progency. Twelve LacI mutations have been isolated from the lung tissue of a mouse from the 960-WLM group and the LacI gene sequenced. Mutations are scored only if they occur unambiguously in both strands of the mutant gene; the entire gene is evaluated. In addition, sixteen LacI mutations were isolated from the lung tissue of a mouse from the 640-WLM group; seven have been completely sequenced. Nine LacI mutations from the lung tissue of unirradiated control mice have been sequenced. Sequence data from the unirradiated mice are similar to that found in lung tissue at Stratagene; predominately G:C to A:T transitions in the protein associated region. The mutation spectrum from radon-irradiated mice is markedly different from that obtained with the control, unirradiated mice. Small deletions and insertions compromise 53% of the mutations in the irradiated mice. No multiple events have been noted in the spontaneous mutations; six of the mutations obtained from radon-irradiated mice (26%) have multiple events within the gene. In some, deletions, insertions are base changes occur together. The mutational events in the irradiated mice are approximately equally distributed throughout the gene. The breakpoint rejoining regions of large deletions obtained from the radon-irradiated mice are being studied at the University of California, San Francisco

  8. Development of a new neutron shielding material, TN trademark Resin Vyal for transport/storage casks for radioactive materials

    Energy Technology Data Exchange (ETDEWEB)

    Abadie, P. [COGEMA Logistics (AREVA Group), Saint-Quentin-en-Yvelines (France)

    2004-07-01

    TN trademark Resin Vyal, a patent pending composite, is a new neutron shielding material developed by COGEMA LOGISTICS for transport/storage casks of radioactive materials (spent fuel, reprocessed fuel,..). This material is composed of a thermosetting resin (vinylester resin in solution of styrene) and two mineral fillers (alumine hydrate and zinc borate). Its shielding ability for neutron radiation is related to a high hydrogen content (for slowing down neutrons) and a high boron content (for absorbing neutrons). Source of hydrogen is organic matrix (resin) and alumine hydrate; source of boron is zinc borate. Atomic concentrations are equal to 5.10{sup 22} at/cm{sup 3} for hydrogen and 9.10{sup 20} at/cm{sup 3} for boron. Due to the flame retardant character of components, the final material has a good fire resistance (it is auto-extinguishable). Its density is equal to 1,8. The manufacturing process of these material is easy: it consists in mixing the fillers and pouring in-situ (in cask); so, the curing of this composite, which leads to a three-dimensional structure, takes place at ambient temperature. Temperature resistance of this material was evaluated by performing exposition tests of samples at different temperatures (150 C to 170 C). According to tests results, its maximal temperature of use was confirmed equal to 160 C.

  9. Development of a new neutron shielding material, TN trademark Resin Vyal for transport/storage casks for radioactive materials

    International Nuclear Information System (INIS)

    Abadie, P.

    2004-01-01

    TN trademark Resin Vyal, a patent pending composite, is a new neutron shielding material developed by COGEMA LOGISTICS for transport/storage casks of radioactive materials (spent fuel, reprocessed fuel,..). This material is composed of a thermosetting resin (vinylester resin in solution of styrene) and two mineral fillers (alumine hydrate and zinc borate). Its shielding ability for neutron radiation is related to a high hydrogen content (for slowing down neutrons) and a high boron content (for absorbing neutrons). Source of hydrogen is organic matrix (resin) and alumine hydrate; source of boron is zinc borate. Atomic concentrations are equal to 5.10 22 at/cm 3 for hydrogen and 9.10 20 at/cm 3 for boron. Due to the flame retardant character of components, the final material has a good fire resistance (it is auto-extinguishable). Its density is equal to 1,8. The manufacturing process of these material is easy: it consists in mixing the fillers and pouring in-situ (in cask); so, the curing of this composite, which leads to a three-dimensional structure, takes place at ambient temperature. Temperature resistance of this material was evaluated by performing exposition tests of samples at different temperatures (150 C to 170 C). According to tests results, its maximal temperature of use was confirmed equal to 160 C

  10. Tensile and electrical properties of unirradiated and irradiated Hycon 3HP{trademark} CuNiBe

    Energy Technology Data Exchange (ETDEWEB)

    Zinkle, S.J.; Eatherly, W.S. [Oak Ridge National Lab., TN (United States)

    1996-10-01

    The unirradiated tensile properties of two different heats of Hycon 3HP{trademark} CuNiBe (HT Temper) have been measured over the temperature range of 20-500{degrees}C for longitudinal and long transverse orientations. The room temperature electrical conductivity has also been measured for both heats. Both heats exhibited a very good combination of strength and conductivity at room temperature. The strength remained relatively high at all test temperatures, with a yield strength of 420-520 MPa at 500{degrees}C. However, low levels of ductility (<5% uniform elongation) were observed at test temperatures above 200-250{degrees}C, due to flow localization adjacent to grain boundaries. Fission neutron irradiation to a dose of {approximately}0.7 dpa at temperatures between 100 and 240{degrees}C produced a slight increase in strength and a significant decrease in ductility. The measured tensile elongation increased with increasing irradiation temperature, with a uniform elongation of {approximately}3.3% observed at 240{degrees}C. The electrical conductivity decreased slightly following irradiation, due to the presence of defect clusters and Ni, Zn, Co transmutation products. The data indicate that CuNiBe alloys have irradiated tensile and electrical properties comparable or superior to CuCrZr and oxide dispersion strengthened copper at temperatures <250{degrees}C, and may be suitable for certain fusion energy structural applications.

  11. Monolithically interconnected Silicon-Film{trademark} module technology: Annual technical report, 25 November 1997--24 November 1998

    Energy Technology Data Exchange (ETDEWEB)

    Hall, R.B.; Ford, D.H.; Rand, J.A.; Ingram, A.E.

    1999-11-11

    AstroPower continued its development of an advanced thin-silicon-based photovoltaic module product. This module combines the performance advantages of thin, light-trapped silicon layers with the capability of integration into a low-cost, monolithically interconnected array. This report summarizes the work carried out over the first year of a three-year, cost-shared contract, which has yielded the following results: Development of a low-cost, insulating, ceramic substrate that provides mechanical support at silicon growth temperatures, is matched to the thermal expansion of silicon, provides the optical properties required for light trapping through random texturing, and can be formed in large areas on a continuous basis. Different deposition techniques have been investigated, and AstroPower has developed deposition processes for the back conductive layer, the p-type silicon layer, and the mechanical/chemical barrier layer. Polycrystalline films of silicon have been grown on ceramics using AstroPower's Silicon-Film{trademark} process. These films are from 50 to 75 {micro}m thick, with columnar grains extending through the thickness of the film. Aspect ratios from 5:1 to 20:1 have been observed in these films.

  12. What Intellectual Property Lawyers can learn from Barbra Streisand, Sepp Blatter, and the "Coca-Cola Cry-Baby": Dealing with "Trademark Bullying" in South Africa

    Directory of Open Access Journals (Sweden)

    André M Louw

    2013-12-01

    Full Text Available This article suggests some pause for reflection amongst intellectual property lawyers, and for serious consideration of the words of an internationally-renowned IP law expert: "Possessing a right does not mean that it is a good idea to enforce it always, and to the hilt. Discretion may be nine parts of possession". It provides some prominent, recent examples of trademark bullying or overly-aggressive enforcement in the IP law context. These examples are mainly from other jurisdictions but they are directly relevant to some of the IP law challenges present in South Africa at the moment. The article further examines why lawyers and rights' holders engage in trademark bullying (why it's done, and start to deal briefly with some of the legal implications. A future article is to examine the legal aspects of trademark bullying in much more detail and considers its legitimacy within the context of IP law, more generally, and some other areas of law, more specifically.

  13. 論美國關鍵字商標初始興趣混淆的民事責任與我國的議題現況評析──以網路搜尋引擎業者與資訊儲存服務提供者為中心 Civil Liability for Trademark Initial Interest Confusion to Keywords in US and Current Evaluation in Taiwan —Centering on Search Engine and Information Storage Service Provider

    Directory of Open Access Journals (Sweden)

    程法彰 Fa-Chang Cheng

    2016-06-01

    transitional stage until reaching the ultimate indirect tort liability for search engine providers and information storage providers, this article would suggest that to set minimum behavior requirements through the enactment of the Electronic Communications Act be the first step. With respect to implementing indirect tort liability into Taiwan’s legal system, the author also conceives a tentative contributory liability (induced infringement liability provision to the Taiwan Trademark Law, which is based upon the counterpart in the US legal system.

  14. Application of TREECS (trademark) to Strontium 90 for Borschi Watershed near Chernobyl, Ukraine

    Science.gov (United States)

    2012-08-01

    near Chernobyl , Ukraine by Mark S. Dortch PURPOSE: The Training Range Environmental Evaluation and Characterization System (TREECS™) (http... Chernobyl Nuclear Power Plant, Ukraine. At this site, TREECS™ was used as a modeling tool to predict the fate of radionuclides. This application also...Web site noted above. Borschi watershed is located 3 km south of the Chernobyl Nuclear Power Plant (Figure 1). Radio- strontium-90, 90Sr, which is a

  15. The Instrumented Frisbee(Registered TradeMark) as a Prototype for Planetary Entry Probes

    Science.gov (United States)

    Lorenz, Ralph D.

    2005-01-01

    A Frisbee has been equipped with sensors, batteries and micro-controllers for data acquisition to record its translational accelerations and attitude motion. The experiments explore the capabilities and limitations of sensors on a rapidly-rotating platform moving in air, and illustrate several of the complex gyrodynamic aspects of frisbee flight. The experiments constitute an instructive exercise in aerospace vehicle systems integration and in attitude reconstruction.

  16. Cryogenic control system of the large COMPASS polarized target

    CERN Document Server

    Gautheron, F; Baum, G; Berglund, P; Doshita, N; Görtz, S; Gustafsson, K K; Horikawa, N; Kisselev, Yu V; Koivuniemi, J H; Kondo, K; Meyer, Werner T; Reicherz, G

    2004-01-01

    The dilution refrigerator used to cool the large COMPASS polarized target is monitored through a PC running LabVIEW trademark 6.1 under Windows 2000 trademark . About 60 parameters of the target (temperatures, pressures, flow rates) are continuously plotted and checked. They are periodically recorded in an Oracle trademark database and in a data file. An alarm for every parameter can be individually activated and optionally connected to a GSM (Global System for Mobile Communication) delivery message system. A web server receives and publishes the online status of the target with online tables and graphics on a dedicated COMPASS polarized target information web site. A Siemens programmable logic controller (PLC) powered by an uninterruptable source keeps the cryogenic system safe and stable during the long beam periods by controlling valves and interlocks. This safety feature protects the dilution refrigerator against potential damages in case of power failure.

  17. Temporal changes in radial access use, associates and outcomes in patients undergoing PCI using rotational atherectomy between 2007 and 2014: results from the British Cardiovascular Intervention Society national database.

    Science.gov (United States)

    Kinnaird, Tim; Cockburn, James; Gallagher, Sean; Choudhury, Anirban; Sirker, Alex; Ludman, Peter; de Belder, Mark; Copt, Samuel; Mamas, Mamas; de Belder, Adam

    2018-04-01

    Access site choice for cases requiring rotational atherectomy (PCI-ROTA) is poorly defined. Using the British Cardiovascular Intervention Society PCI database, temporal changes and contemporary associates/outcomes of access site choice for PCI-ROTA were studied. Data were analysed from 11,444 PCI-ROTA procedures performed in England and Wales between 2007 and 2014. Multivariate logistic regression was used to identify predictors of access site choice and its association with outcomes. For PCI-ROTA, radial access increased from 19.6% in 2007 to 58.6% in 2014. Adoption of radial access was slower in females, those with prior CABG, and in patients with chronic occlusive (CTO) or left main disease. In 2013/14, the strongest predictors of femoral artery use were age (OR 1.02, [1.005-1.036], P = .008), CTO intervention (OR 1.95, [1.209-3.314], P = .006), and history of previous CABG (OR 1.68, [1.124-2.515], P = .010). Radial access was associated with reductions in overall length of stay, and increased rates of same-day discharge. Procedural success rates were similar although femoral access use was associated with increased access site complications (2.4 vs. 0.1%, P PCI-ROTA results in similar procedural success when compared to femoral access but is associated with shorter length of stay, and lower rates of vascular complication, major bleeding and transfusion. Copyright © 2018 Elsevier Inc. All rights reserved.

  18. UNIX trademark in high energy physics: What we can learn from the initial experiences at Fermilab

    International Nuclear Information System (INIS)

    Butler, J.N.

    1991-03-01

    The reasons why Fermilab decided to support the UNIX operating system are reviewed and placed in the content of an overall model for high energy physics data analysis. The strengths and deficiencies of the UNIX environment for high energy physics are discussed. Fermilab's early experience in dealing with a an ''open'' multivendor environment, both for computers and for peripherals, is described. The human resources required to fully exploit the opportunities are clearly growing. The possibility of keeping the development and support efforts within reasonable bounds may depend on our ability to collaborate or at least to share information even more effectively than we have in the past. 7 refs., 4 figs., 5 tabs

  19. Innovative technology summary report: Houdini trademark I and II remotely operated vehicle

    International Nuclear Information System (INIS)

    1998-07-01

    The US Department of Energy (DOE) is responsible for cleaning up and closing 273 large, aging, underground tanks the department has used for storing approximately 1 million gal of high- and low-level radioactive and mixed waste. The waste's radioactivity precludes humans from working in the tanks. A remote-controlled retrieval method must be used. The Houdini robot addresses the need for vehicle-based, rugged, remote manipulation systems that can perform waste retrieval, characterization, and inspection tasks. Houdini-I was delivered to ORNL in September 1996, deployed in a cold test facility in November, and first deployed in the gunite tanks in June 1997. Since then, it has seen continuous (still on-going) service at ORNL, providing a critical role in the cleanup of two gunite tanks, W-3 and W-4, in the GAAT NTF. Houdini-I has proven rugged, capable of waste retrieval, and able to withstand high reaction force operations such as wall core sampling. It's even able to operate while hanging, which was the case when Houdini was used to cut and remove cables and steel pipes hanging below manways in Tank W-3. Based upon the lessons learned at ORNL, Houdini's design has been completely overhauled. A second generation system, Houdini-II, is now being built

  20. Selective removal/recovery of RCRA metals from waste and process solutions using polymer filtration{trademark} technology

    Energy Technology Data Exchange (ETDEWEB)

    Smith, B.F. [Los Alamos National Lab., NM (United States)

    1997-10-01

    Resource Conservation and Recovery Act (RCRA) metals are found in a number of process and waste streams at many DOE, U.S. Department of Defense, and industrial facilities. RCRA metals consist principally of chromium, mercury, cadmium, lead, and silver. Arsenic and selenium, which form oxyanions, are also considered RCRA elements. Discharge limits for each of these metals are based on toxicity and dictated by state and federal regulations (e.g., drinking water, RCRA, etc.). RCRA metals are used in many current operations, are generated in decontamination and decommissioning (D&D) operations, and are also present in old process wastes that require treatment and stabilization. These metals can exist in solutions, as part of sludges, or as contaminants on soils or solid surfaces, as individual metals or as mixtures with other metals, mixtures with radioactive metals such as actinides (defined as mixed waste), or as mixtures with a variety of inert metals such as calcium and sodium. The authors have successfully completed a preliminary proof-of-principle evaluation of Polymer Filtration{trademark} (PF) technology for the dissolution of metallic mercury and have also shown that they can remove and concentrate RCRA metals from dilute solutions for a variety of aqueous solution types using PF technology. Another application successfully demonstrated is the dilute metal removal of americium and plutonium from process streams. This application was used to remove the total alpha contamination to below 30 pCi/L for the wastewater treatment plant at TA-50 at Los Alamos National Laboratory (LANL) and from nitric acid distillate in the acid recovery process at TA-55, the Plutonium Facility at LANL (ESP-CP TTP AL16C322). This project will develop and optimize the PF technology for specific DOE process streams containing RCRA metals and coordinate it with the needs of the commercial sector to ensure that technology transfer occurs.

  1. Selective removal/recovery of RCRA metals from waste and process solutions using polymer filtration trademark technology

    International Nuclear Information System (INIS)

    Smith, B.F.

    1997-01-01

    Resource Conservation and Recovery Act (RCRA) metals are found in a number of process and waste streams at many DOE, U.S. Department of Defense, and industrial facilities. RCRA metals consist principally of chromium, mercury, cadmium, lead, and silver. Arsenic and selenium, which form oxyanions, are also considered RCRA elements. Discharge limits for each of these metals are based on toxicity and dictated by state and federal regulations (e.g., drinking water, RCRA, etc.). RCRA metals are used in many current operations, are generated in decontamination and decommissioning (D ampersand D) operations, and are also present in old process wastes that require treatment and stabilization. These metals can exist in solutions, as part of sludges, or as contaminants on soils or solid surfaces, as individual metals or as mixtures with other metals, mixtures with radioactive metals such as actinides (defined as mixed waste), or as mixtures with a variety of inert metals such as calcium and sodium. The authors have successfully completed a preliminary proof-of-principle evaluation of Polymer Filtration trademark (PF) technology for the dissolution of metallic mercury and have also shown that they can remove and concentrate RCRA metals from dilute solutions for a variety of aqueous solution types using PF technology. Another application successfully demonstrated is the dilute metal removal of americium and plutonium from process streams. This application was used to remove the total alpha contamination to below 30 pCi/L for the wastewater treatment plant at TA-50 at Los Alamos National Laboratory (LANL) and from nitric acid distillate in the acid recovery process at TA-55, the Plutonium Facility at LANL (ESP-CP TTP AL16C322). This project will develop and optimize the PF technology for specific DOE process streams containing RCRA metals and coordinate it with the needs of the commercial sector to ensure that technology transfer occurs

  2. Effectiveness of Sealed Double-Ring Infiltrometers trademark and effects of changes in atmospheric pressure on hydraulic conductivity

    International Nuclear Information System (INIS)

    McMullin, S.R.

    1994-01-01

    The Savannah River Site is currently evaluating some 40 hazardous and radioactive-waste sites for remediation. Among the remedial alternatives considered is closure using a kaolin clay cap. The hydraulic conductivity suggested by the US Environmental Protection Agency is 1.0 x 10 -7 cm/sec. One instrument to measure this value is the Sealed Double-Ring Infiltrometer trademark (SDRI). Six SDRI were recently installed on a kaolin test cap. Test results demonstrated uniform performance of these instruments. However, the test data showed as much as an order of magnitude of variation over time. This variation is attributed to both internal structural heterogeneity and variable external boundary conditions. The internal heterogeneity is caused by construction variability within a specified range of moisture and density. The external influences considered are temperature and barometric pressure. Temperature was discharged as a source of heterogeneity because of a lack of correlation with test data and a negligible impact from the range of variability. However, a direct correlation was found between changes in barometric pressure and hydraulic conductivity. This correlation is most pronounced when pressure changes occur over a short period of time. Additionally, this correlation is related to a single soil layer. When the wetting front passes into a more porous foundation layer, the correlation with pressure changes disappears. Conclusions are that the SDRI performs adequately, with good repeatability of results. The duration of test is critical to assure a statistically valid data set. Data spikes resulting from pressure changes should be identified, and professional judgment used to determine the representative hydraulic conductivity. Further evaluation is recommended to determine the impact of pressure change on the actual hydraulic conductivity

  3. Reference Material Kydex(registered trademark)-100 Test Data Message for Flammability Testing

    Science.gov (United States)

    Engel, Carl D.; Richardson, Erin; Davis, Eddie

    2003-01-01

    The Marshall Space Flight Center (MSFC) Materials and Processes Technical Information System (MAPTIS) database contains, as an engineering resource, a large amount of material test data carefully obtained and recorded over a number of years. Flammability test data obtained using Test 1 of NASA-STD-6001 is a significant component of this database. NASA-STD-6001 recommends that Kydex 100 be used as a reference material for testing certification and for comparison between test facilities in the round-robin certification testing that occurs every 2 years. As a result of these regular activities, a large volume of test data is recorded within the MAPTIS database. The activity described in this technical report was undertaken to mine the database, recover flammability (Test 1) Kydex 100 data, and review the lessons learned from analysis of these data.

  4. The VASIMR[registered trademark] VF-200-1 ISS Experiment as a Laboratory for Astrophysics

    Science.gov (United States)

    Glover Tim W.; Squire, Jared P.; Longmier, Benjamin; Cassady, Leonard; Ilin, Andrew; Carter, Mark; Olsen, Chris S.; McCaskill, Greg; Diaz, Franklin Chang; Girimaji, Sharath; hide

    2010-01-01

    The VASIMR[R] Flight Experiment (VF-200-1) will be tested in space aboard the International Space Station (ISS) in about four years. It will consist of two 100 kW parallel plasma engines with opposite magnetic dipoles, resulting in a near zero-torque magnetic system. Electrical energy will come from ISS at low power level, be stored in batteries and used to fire the engine at 200 kW. The VF-200-1 project will provide a unique opportunity on the ISS National Laboratory for astrophysicists and space physicists to study the dynamic evolution of an expanding and reconnecting plasma loop. Here, we review the status of the project and discuss our current plans for computational modeling and in situ observation of a dynamic plasma loop on an experimental platform in low-Earth orbit. The VF-200-1 project is still in the early stages of development and we welcome new collaborators.

  5. UNIX trademark in high energy physics: What we can learn from the initial experiences at Fermilab

    Energy Technology Data Exchange (ETDEWEB)

    Butler, J.N.

    1991-03-01

    The reasons why Fermilab decided to support the UNIX operating system are reviewed and placed in the content of an overall model for high energy physics data analysis. The strengths and deficiencies of the UNIX environment for high energy physics are discussed. Fermilab's early experience in dealing with a an open'' multivendor environment, both for computers and for peripherals, is described. The human resources required to fully exploit the opportunities are clearly growing. The possibility of keeping the development and support efforts within reasonable bounds may depend on our ability to collaborate or at least to share information even more effectively than we have in the past. 7 refs., 4 figs., 5 tabs.

  6. Assessing coal combustion and sourcing strategies using EPRI`s CQIM{sup {trademark}}

    Energy Technology Data Exchange (ETDEWEB)

    Stallard, G.S.; Jennison, K.D. [Black & Veatch, Overland Park, KS (United States)

    1995-12-01

    Understanding the cost and performance issues associated with coal quality or, more precisely, specific constituents within coal is an important ingredient of engineering and planning processes. Such processes can cover a wide range of activities, including how to most cost-effectively burn local coal supplies, how to identify what technologies or designs should be employed for new facilities, and how to identify potentially viable {open_quotes}new{close_quotes} coal supplies. Selection of coals, coal blends, or coal benefication processes is a complex problem. Similarly, it is difficult for industry participants (ministries, regulators, distribution companies, etc.) To correlate fuel selection strategies to overall power system performance costs. The underlying need to understand coal quality impacts on the financial efficiency of a plant is increasingly important in light of economic and environmental pressures faced by today`s power industry. The Coal Quality Impact Model (CQIM{reg_sign}) offers an ideal platform for understanding and evaluating coal quality impacts. Developed by Black & Veatch for the electric Power Research Institute (EPRI), CQIM is a computer {open_quotes}tool{close_quotes} that is dedicated to maintaining state-of-the-art status by continually incorporating the latest technologies or modeling techniques as they become available. By taking advantage of research efforts and a sound engineering modeling approach, the CQIM is capable of predicting plant-wide performance impacts and translating them into costs.

  7. Impressions and purchasing intentions of Japanese consumers regarding pork produced by 'Ecofeed,' a trademark of food-waste or food co-product animal feed certified by the Japanese government.

    Science.gov (United States)

    Sasaki, Keisuke; Aizaki, Hideo; Motoyama, Michiyo; Ohmori, Hideyuki; Kawashima, Tomoyuki

    2011-02-01

    Impressions and purchasing intentions of Japanese consumers regarding pork produced by 'Ecofeed', a trademark of food-waste or co-product animal feeds certified by the Japanese government, were investigated by a questionnaire on the Internet. 'Ecofeed' did not elicit specific impressions as compared to domestic, imported, Kurobuta (in Japan), and specific pathogen-free (SPF) pork. Purchasing intent for 'Ecofeed' pork was the second lowest of the five pork products. Knowledge and purchasing experience regarding 'Ecofeed' pork was the lowest of the five pork products. Respondents were classified into four categories according to their impressions of 'Ecofeed' pork. The largest category of respondents did not have any specific impression of 'Ecofeed' pork and had little knowledge of pork farming. A category that had a positive impression for 'Ecofeed' pork had high knowledge of the pork farming system. In order to establish 'Ecofeed' pork in Japan, our results suggest that information disclosure and education about 'Ecofeed', its certification system, environmental benefits and the current self-efficiency ratio of animal feed, are needed. © 2010 The Authors. Journal compilation © 2010 Japanese Society of Animal Science.

  8. Hydrostratigraphy and recharge distributions from direct measurements of hydraulic conductivity using the UFA trademark method

    International Nuclear Information System (INIS)

    Wright, J.; Conca, J.L.; Chen, X.

    1994-03-01

    The simulation of contaminant migration and movement through subsurface materials surrounding hazardous and mixed waste sties requires knowledge of the transport characteristics of the soils, sediments, and rocks of the site under unsaturated and saturated conditions. The hydraulic conductivity, diffusion coefficient, and retardation factor must be known in order to use existing and developing models of contaminant release from subsurface systems. The new Unsaturated Flow Apparatus (UFA) method makes it possible to measure transport parameters in a very short time while replicating the wide range of conditions that exist in the field. The chemical, physical, and mineralogical properties of each soil sample are compared to transport parameters measured by the UFA method to determine the primary physical parameter/hydrologic characteristic relationships for predicting volatile organic compound (VOC) and water migration in arid soils and sediments. The Plutonium Finishing Plant in the 200-West Area at the Hanford Site is the site of a mixed-waste contaminant plume. The plume contains carbon tetrachloride (CCl 4 ) as the primary VOC, Pu and Am as the primary radionuclides, water, aqueous sodium nitrate solutions, and other organics (lard oil, tributylphoshate, chloroform). An estimated 3.5 million gal of liquid waste was discharged to three unlined cribs (similar to septic tanks drain fields) between 1955 and 1973. This project investigated unsaturated transport phenomena using the new UFA method to optimize long-term experimental and demonstration strategies for site remediation. Three unexpected benefits resulted from the UFA method in FY 1993: hydrostratigraphic mapping, subsurface flux and recharge mapping, and pore water extraction from vadose zone samples for chemical analysis. 54 refs

  9. Ecolotree{sup {trademark}} cap at the Barje Landfill, Ljubljana, Slovenia, prototype demonstration

    Energy Technology Data Exchange (ETDEWEB)

    Licht, L.; Schnoor, J. [Univ. of Iowa, Iowa City, IA (United States)

    1995-12-01

    The Ecolotree{reg_sign} Buffer uses strategically planted Populus spp. (poplar) trees and forbs to prevent water pollution while growing fiber for biomass fuels, paper pulps, and construction materials. The concept, developed at the University of Iowa, uses root systems that act as a pump to predictable depths greater than 1.5 m (5 ft). The plant uptakes water, nutrients (nitrogen, phosphorus, etc.), and adsorbable organics (such as herbicides) from soil. When the plant survival, growth rate, rooted soil depth, and water uptake are predictable, the site`s hydrology can be managed, and regulatory agencies are more willing to issue operating permits that include this vegetated barrier. Poplars transpire 600 to 1000 kilograms of water for every kilogram of stem dry matter (DM) growth. Measured poplar growth rates for 4-year old trees was 16,600 kg DM/hectare/yr. Conservatively, the water uptake calculated using the 600:1 water/stem growth ratio is 10,000,000 liters/hectare/yr. When transpiration exceeds rainfall, plants remove stored water from rooted soils. This dehydrating action effectively gives the soil a water storage capacity during winter dormancy. This Ecolotree{reg_sign} Buffer technology develops the ability to greatly reduce water leakage without the need for membrane or clay layers in landfill cover soils. This concept is now being used to manage water at American and Slovenian landfills. In contrast with U.S. Environmental Protection Agency-approved clay or geomembrane covers designed with slight regard for plant growth, this cover focuses on reestablishing a vigorous ecosystem. While accomplishing the primary goal of protecting groundwater purity, the Ecolotree{reg_sign} Buffer grows a productive cover that stabilizes soil slopes, produces marketable crops, develops wildlife habitat, and provides a more pleasing ambiance.

  10. Modeling Constellation Virtual Missions Using the Vdot(Trademark) Process Management Tool

    Science.gov (United States)

    Hardy, Roger; ONeil, Daniel; Sturken, Ian; Nix, Michael; Yanez, Damian

    2011-01-01

    system can evolve into a process management server for the actual process.

  11. Waste Tank Vapor Project: Vapor characterization of Tank 241-C-103: Report for SUMMA trademark canister samples received 11/29/93 (sample jobs 4 and 5)

    International Nuclear Information System (INIS)

    Clauss, T.R.; Lucke, R.B.; McVeety, B.; Allwine, K.J.; Fruchter, J.S.

    1994-09-01

    The purpose of Sample Jobs 4 and 5 was to determine whether the organic nitrites observed on the outside of tank 241-C-103 originated in the tank or from degradation products of the high-efficiency particulate air (HEPA) filter. The plan was to take samples from either side of the HE-PA filter. The relative level of organic nitrites would help determine whether they were produced in the filter or the tank. Pacific Northwest Laboratory was responsible for analyzing the SUMMA trademark canisters collected in support of this study. The laboratory was to analyze the SUMMA trademark Canister samples according to letters of instruction and report all semivolatile and volatile organic constituents detected in the tank headspace. Pacific Northwest Laboratory was also to submit a letter report to the Program Manager of all qualitative and quantitative analytical data, and estimate concentrations of any aliphatic nitrites identified. This was one of the first sampling activities for this program, and a number of errors were made both in the field and in the laboratory. Because of these errors, the samples and results were of questionable value. Therefore, Westinghouse program management asked that the analysis of the samples for this report not be completed. This report describes the few results that were generated before we were asked to stop work on this activity. In addition to analyzing SUMMA trademark canisters, PNL operates a site portable weather station near tank 241-C-103. Pacific Northwest Laboratory was required to collect atmospheric data starting 11/15/93, but the weather station was already collecting data during the time of both these two sample jobs (11/12/93 and 11/16/93). Therefore, a summary of the atmospheric data is also presented in this report

  12. MCNP trademark directions

    International Nuclear Information System (INIS)

    Hendricks, J.S.

    1994-01-01

    The MCNP code development program is a relatively large and rapidly changing project in the small and highly-specialized field of radiation transport, specifically radiation protection and shielding. A number of major new MCNP initiatives are described in the subsequent papers in this session. The focus of this paper is the important new developments not described elsewhere and a number of recent developments that have been available since MCNP4A but have gone unnoticed. In particular, we report for the first time a new MCNP quality assurance initiative providing 97% test coverage, a new MCNP feature enabling plotting of nuclear data, and the other new features developed so far for MCNP4B. Finally, an attempt is made to articulate how all these fit together into the overall MCNP development program

  13. CH2M Hill Hanford Group, Inc., Standards and Requirements Identification Document (SRID) Requirements Management System and Requirements Specification

    International Nuclear Information System (INIS)

    JOHNSON, A.L.

    2000-01-01

    The current Tank Farm Contractor (TFC) for the U. S. Department of Energy, Office of River Protection (ORP), River Protection Project (RPP), CH2M Hill Hanford Group, Inc. (CHG), will use a computer based requirements management system. The system will serve as a tool to assist in identifying, capturing, and maintaining the Standards/Requirements Identification Document (S/RID) requirements and links to implementing procedures and other documents. By managing requirements as one integrated set, CHG will be able to carry out its mission more efficiently and effectively. CHG has chosen the Dynamic Object Oriented Requirements System (DOORS(trademark)) as the preferred computer based requirements management system. Accordingly, the S/RID program will use DOORS(trademark). DOORS(trademark) will replace the Environmental Requirements Management Interface (ERMI) system as the tool for S/RID data management. The DOORS(trademark) S/RID test project currently resides on the DOORSTM test server. The S/RID project will be migrated to the DOORS(trademark) production server. After the migration the S/RID project will be considered a production project and will no longer reside on the test server

  14. Evaluation of iopentol (Imagopaque trademark 350) in CT enhancement. A multi-centre monitoring trial assessing adverse events and diagnostic information - results from 1823 patients in France

    International Nuclear Information System (INIS)

    Oxaal, M.; Lambrechts, M.; Bunouf, P.; Menuet, J.F.

    1997-01-01

    Objectives: To evaluate the safety and efficacy of iopentol 350 mg I/ml (Imagopaque trademark /Ivepaque trademark , Nycomed Imaging As, Oslo, Norway), a monomeric non-ionic contrast medium for computed tomography, in a large population. To identify predictive factors for patient safety. Materials and methods: One thousand eight hundred and twenty-three (1,823) patients form 48 centres in France were included during a 5-month period. Safety was evaluated by registering adverse events (AEs) reported by the patients, and data were analysed using a multiple factor model. Results: Only 2.6% of the patients experienced AEs other than discomfort. There were no serious AEs. Overall, AEs were more frequent in patients under 50 years of age, in women, and in patients who received contrast medium as a single bolus. Contrast enhancement was considered adequate or better in 98.9% of the patients. A large variation in discomfort (local warmth/chill or pain) frequency was seen between centres, ranging from 0% to 81%. This result implies that factors other than the CM influence the incidence of discomfort. Conclusions: This first study in a large population shows that iopentol 350 mg I/ml is well tolerated and provides CT images of excellent, good or adequate quality in the vast majority of patients. Age, sex and injection procedure were shown to be independent predictors in the AE survey. (orig.)

  15. TN trademark FLEX: a new generation of fluorocarbon o-rings developed by COGEMA logistics with enhanced characteristics at low temperature (-40 C)

    International Nuclear Information System (INIS)

    Issard, H.; Andre, R.

    2004-01-01

    Three main types of elastomers are used for the sealing of radioactive material transport casks with elastomeric gaskets: EPDM, fluorocarbons type Viton registered (standard designation: FKM) and silicon rubbers. Each rubber has specific characteristics in terms of temperature range, permeability, coefficient of expansion.. For the casks where high temperatures can be reached (200 C in continuous using), FKM gaskets are generally used. The problem is that this type of gasket does not guarantee the leaktightness at -40 C, which is a regulatory requirement. Two solutions are generally used: to specify a minimum heat load or a minimum ambient temperature. The direct consequence is that it is impossible to get B(U) approvals on the new concepts when FKM gaskets are used but only B(M) approvals, which generate significant additional justification costs (multiple submittals of Safety Analysis Reports, calculation of the minimum heat load or of the minimum ambient temperature..). Thus, it is important to develop gaskets with the same performance as FKM gaskets at high temperature but with enhanced performance at low temperature (and mainly, which guarantee the leaktightness at -40 C). COGEMA LOGISTICS has qualified a new generation of fluorocarbon O-rings (TN trademark FLEX gaskets) which can be used in continuous service on a -47 C/+200 C temperature range. TN trademark FLEX gaskets will be implemented on new casks designs

  16. The Protection of Sports Trademarks in the Recent Case Law of the Court of Justice of the European Union = Ochrona sportowych znaków towarów w świetle najnowszego orzecznictwa TSUE

    Directory of Open Access Journals (Sweden)

    Paweł Szwajdler

    2016-03-01

    Nicolaus Copernicus University in Torun, Poland       Abstract               The main aim of this work is to give an answer to the question: are sports trademarks treated in EU in different way than other trademarks?  The author of this article was inspired by two recent judgements of EU Court of Justice. First of them is related to sports shoes and second one to football club crest. Above- mentioned judgement are interesting, because both of them concern marks, which are similar to registered trademarks. Therefore, it is able to show boundaries of the protection of sports trademarks.  This paper contains also overall considerations about trademarks, sports trademarks and their protection.   Abstrakt               Głównym celem niniejszego artykułu jest udzielenie odpowiedzi na pytanie, czy sportowe znaki towarowe podlegają w Unii Europejskiej szczególnej ochronie prawnej. Inspirację dla zarysowanych w zdaniu poprzednim rozważań stanowią dwa wyroki Trybunału Sprawiedliwości Unii Europejskiej. Pierwszy spośród nich dotyczy ochrony konturów herbu klubu piłkarskiego, natomiast drugi dotyka problemów związanych z charakterystycznym znakiem umieszczanym na produktach znanej marki butów sportowych. Omawiane w niniejszej pracy wyroki są wyjątkowo interesujące, ponieważ wiążą się z ochroną znaków li tylko przypominających zarejestrowane ZTUE. Artykuł zawiera również ogólne refleksje na temat znaków towarowych, sportowych znaków towarowych oraz przeciwdziałania ich naruszeniom.   Słowa kluczowe: sport, znak towarowy, TSUE, prawo własności intelektualnej, sportowy znak towarowy Key word: sport, trademark, sports trademark, EU Court of Justice, intellectual property rights

  17. Development of a Quantitative TaqMan(trademark)-PCR Assay and Feasibility of Atmosphoric Collection for Coccidioides Immits for Ecological Studies

    International Nuclear Information System (INIS)

    Daniels, J.I.; Wilson, W.J.; DeSantis, T.Z.; Gouveia, F.J.; Anderson, G.L.; Shinn, J.H.; Pletcher, R.; Johnson, S.M.; Pappagianis, D.

    2002-01-01

    Understanding and then modeling the complex relationships between environmental, climatological, and biological systems can present great opportunities for developing effective strategies to prevent outbreaks of environmentally linked infectious disease. For example, a report from the American Academy of Microbiology (Rose et al., 2001) points out that including climatic signals and ecological triggers into the decision making process for disease management, is going to be essential for developing a proactive approach for protecting public health, and circumventing the practice of having to wait for clinical cases to appear before any action is taken. To meet this grand challenge, specific and sensitive analytical techniques and effective collection devices are required for finding the microorganisms of concern in environmentally relevant media (air, soil, water, vegetation, etc.), and a multidisciplinary approach is needed for evaluating all of the environmental and biological data and building the applicable predictive models. In this study, the unique capabilities in biotechnology and environmental science available at Lawrence Livermore National Laboratory (LLNL) are combined with the distinguished and highly regarded expertise for clinically investigating and treating infectious disease at the Department of Microbiology and Immunology in the School of Medicine of the University of California, Davis, in order to develop, standardize, validate, and test safely the feasibility of applying advanced polymerase chain reaction (PCR) technology and new air-sample collection media that would be appropriate for addressing comprehensively the environmentally linked, medically important infectious disease Valley Fever (coccidioidomycosis). The responsible agent for this disease is the airborne spore (arthroconidia) of the pathogenic fungus Coccidioides immitis, which is a microorganism that is endemic to California, Arizona, and the southwestern United States, and also is

  18. Linear accelerator Dynaray-CH: a central component of the BBC radiotherapy system

    International Nuclear Information System (INIS)

    Vogt, H.

    1983-01-01

    The author describes the newly developed range of linear accelerators Dynaray-CH 4 to 20. These modern installations for radiotherapy are used to generate photon and electron beams. The accelerators employ the proven BBC control system PROCONTIC (registered trademark), innovatory systems for movement control and actual-value display as well as the new radiation monitor system. (Auth.)

  19. Phase Change Permeation Technology For Environmental Control Life Support Systems

    Science.gov (United States)

    Wheeler, Raymond M.

    2014-01-01

    Use of a phase change permeation membrane (Dutyion [Trademark]) to passively and selectively mobilize water in microgravity to enable improved water recovery from urine/brine for Environment Control and Life Support Systems (ECLSS) and water delivery to plans for potential use in microgravity.

  20. El TLT (Trademark Law Treaty y los retos para la Superintendencia de Industria y Comercio como Oficina Nacional de Propiedad Industrial

    Directory of Open Access Journals (Sweden)

    María Carolina Corcione Morales

    2010-11-01

    Full Text Available La Superintendencia de Industria y Comercio, como Oficina Nacional de Propiedad Industrial, se enfrentará a un nuevo sistema de registro de marcas una vez sea incorporado a nuestro ordenamiento el Tratado sobre Derecho de Marcas (Trademark Law Treaty –tlt–. Los retos procesales que se avecinan al introducirse el registro multiclase en el actual sistema colombiano ameritan un análisis detenido del contenido del tratado y de las medidas que el gobierno colombiano deberá adoptar para garantizar una implementación exitosa del instrumento internacional. La entrada en vigencia del tlt, si bien no implica un reto que obligue a replantear las fuentes y principios del derecho de la propiedad industrial, es un desafío de índole procesal que hace necesario adecuar el actual funcionamiento de la Superintendencia de Industria y Comercio a los aspectos humano y tecnológico.